Reference;Reference;Reference;Reference;Reference;Reference;Reference;Reference;Reference;Epitope;Epitope;Epitope;Epitope;Epitope;Epitope;Epitope;Epitope;Epitope;Epitope;Epitope;Epitope;Epitope;Related Object;Related Object;Related Object;Related Object;Related Object;Related Object;Related Object;Related Object;Related Object;Related Object;Related Object;Host;Host;Assay;Assay;Assay;Assay;Assay;Assay;Assay;Assay;MHC;MHC;Assay Comments
MHC ligand ID;Reference ID;Type;PubMed ID;Authors;Journal;Date;Title;Submission ID;Epitope ID;Object Type;Description;Starting Position;Ending Position;Non-peptidic epitope ChEBI ID;Antigen Name;Parent Protein;Parent Protein Accession;Organism Name;Parent Species;Parent Species Accession;Epitope Comments;Epitope Relationship;Object Type;Description;Starting Position;Ending Position;Non-peptidic object Accession;Synonyms;Antigen Name;Parent Protein;Organism Name;Parent Organism;Name;Host ID;Location of assay data in the manuscript;Method/Technique;Assay Group;Units;Qualitative Measure;Measurement Inequality;Quantitative measurement;PDB ID;Allele Name;MHC allele class;Assay Comments
5208;580;Literature;15210799;"Andrew I Webb; Natalie A Borg; Michelle A Dunstone; Lars Kjer-Nielsen; Travis Beddoe; James McCluskey; Francis R Carbone; Stephen P Bottomley; Marie-Isabel Aguilar; Anthony W Purcell; Jamie Rossjohn";J Immunol;2004;The structure of H-2K(b) and K(bm8) complexed to a herpes simplex virus determinant: evidence for a conformational switch that governs T cell repertoire selection and viral resistance.;;61086;Linear peptide;SSIEFARL;498;505;;Glycoprotein B precursor;Envelope glycoprotein B;P10211;Human alphaherpesvirus 1;Human alphaherpesvirus 1;10298;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;1T0M;H2-Kb;I;
6667;680;Literature;15644207;"Rob Meijers; Char-Chang Lai; Yuting Yang; Jin-Huan Liu; Weimin Zhong; Jia-Huai Wang; Ellis L Reinherz ";J Mol Biol;2005;Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.;;60493;Linear peptide;SQLKNNAKEI;468;477;;Hemagglutinin precursor;Hemagglutinin;P03452;Influenza A virus (A/Swine/Indiana/1726/1988(H1N1));Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;1WBX;H2-Db;I;
6668;680;Literature;15644207;"Rob Meijers; Char-Chang Lai; Yuting Yang; Jin-Huan Liu; Weimin Zhong; Jia-Huai Wang; Ellis L Reinherz ";J Mol Biol;2005;Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.;;61151;Linear peptide;SSLENFRAYV;224;233;;Polymerase subunit;Polymerase acidic protein;P03433;Influenza A virus (A/swine/Cotes d'Armor/1482/1999(H1N1));Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1WBY;H2-Db;I;
6669;680;Literature;15644207;"Rob Meijers; Char-Chang Lai; Yuting Yang; Jin-Huan Liu; Weimin Zhong; Jia-Huai Wang; Ellis L Reinherz ";J Mol Biol;2005;Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.;;61497;Linear peptide;SSYRRPVGI;703;711;;RNA-directed RNA polymerase catalytic subunit;RNA-directed RNA polymerase catalytic subunit;P03431;Influenza A virus (A/Ann Arbor/6/1960(H2N2));Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;1WBZ;H2-Kb;I;
6701;684;Literature;14734527;"Martin H&uuml;lsmeyer; Maria Teresa Fiorillo; Francesca Bettosini; Rosa Sorrentino; Wolfram Saenger; Andreas Ziegler; Barbara Uchanska-Ziegler";J Exp Med;2004;Dual, HLA-B27 subtype-dependent conformation of a self-peptide.;;55635;Linear peptide;RRKWRRWHL;400;408;;Vasoactive intestinal polypeptide receptor 1 precursor;Vasoactive intestinal polypeptide receptor 1;P32241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;1OGT;HLA-B*27:05;I;
6702;684;Literature;14734527;"Martin H&uuml;lsmeyer; Maria Teresa Fiorillo; Francesca Bettosini; Rosa Sorrentino; Wolfram Saenger; Andreas Ziegler; Barbara Uchanska-Ziegler";J Exp Med;2004;Dual, HLA-B27 subtype-dependent conformation of a self-peptide.;;55635;Linear peptide;RRKWRRWHL;400;408;;Vasoactive intestinal polypeptide receptor 1 precursor;Vasoactive intestinal polypeptide receptor 1;P32241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1OF2;HLA-B*27:09;I;
7222;726;Literature;15004033;"Andrew I Webb; Michelle A Dunstone; Weisan Chen; Marie-Isabel Aguilar; Qiyuan Chen; Heather Jackson; Linus Chang; Lars Kjer-Nielsen; Travis Beddoe; James McCluskey; Jamie Rossjohn; Anthony W Purcell";J Biol Chem;2004;Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue.;;59278;Linear peptide;SLLMWITQC;157;165;;Cancer/testis antigen 1;Cancer/testis antigen 1;P78358;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2 Tables II, III and PDB 1S9W;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1S9W;HLA-A*02:01;I;
7223;726;Literature;15004033;"Andrew I Webb; Michelle A Dunstone; Weisan Chen; Marie-Isabel Aguilar; Qiyuan Chen; Heather Jackson; Linus Chang; Lars Kjer-Nielsen; Travis Beddoe; James McCluskey; Jamie Rossjohn; Anthony W Purcell";J Biol Chem;2004;Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue.;;59282;Linear peptide;SLLMWITQS;;;;;;;;;;This peptide is an analog of cancer/testis antigen NY-ESO-1 peptide 157-165, where cysteine at position 9 is substituted by serine.;analog;Fragment of a Natural Sequence Molecule;SLLMWITQC;157;165;;;Cancer/testis antigen 1;Cancer/testis antigen 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 1, 3, Table II and PDB 1S9Y;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1S9Y;HLA-A*02:01;I;
7224;726;Literature;15004033;"Andrew I Webb; Michelle A Dunstone; Weisan Chen; Marie-Isabel Aguilar; Qiyuan Chen; Heather Jackson; Linus Chang; Lars Kjer-Nielsen; Travis Beddoe; James McCluskey; Jamie Rossjohn; Anthony W Purcell";J Biol Chem;2004;Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue.;;59276;Linear peptide;SLLMWITQA;;;;;;;;;;This peptide is an analog of cancer/testis antigen NY-ESO-1 peptide 157-165, where cysteine at position 9 is susbtituted by alanine.;analog;Fragment of a Natural Sequence Molecule;SLLMWITQC;157;165;;;Cancer/testis antigen 1;Cancer/testis antigen 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 1, 3, Table II and PDB 1S9X;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;1S9X;HLA-A*02:01;I;
7225;728;Literature;15494511;"Michael Probst-Kepper; Hans-J&uuml;rgen Hecht; Hanne Herrmann; Viktoria Janke; Frank Ocklenburg; J&uuml;rgen Klempnauer; Benoit J van den Eynde; Siegfried Weiss";J Immunol;2004;Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B*3501.;;38421;Linear peptide;LPAVVGLSPGEQEY;;;;ribosomal protein S1-like DNA-binding protein;;;Homo sapiens;Homo sapiens;9606;This peptide was discovered as derived from a tumor-associated Ag, recognized by a tumor-infiltrating CD8 T cell clone. This CTL clone was shown to recognize this antigenic peptide from alternative reading frame of the human M-CSF (alt.M-CSF)4, and presented by HLA-B*3501. Epitope is encoded by DNA sequence 27262660 (GenBank ID) positions 240-281, which are part of an alternate reading frame of the gene coding for human M-CSF.;;;;;;;;;;;;human (Homo sapiens);9606;Tables I, II, Figure 1 and PDB 1XH3;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;1XH3;HLA-B*35:01;I;
15937;1147;Literature;9741848;"M Bouvier; H C Guo; K J Smith; D C Wiley";Proteins;1998;Crystal structures of HLA-A*0201 complexed with antigenic peptides with either the amino- or carboxyl-terminal group substituted by a methyl group.;;20351;Linear peptide;GILGFVFTL + DMPA(L9);58;66;;Matrix protein 1;Matrix protein 1;P03485;Influenza A virus;Influenza A virus;11320;The epitope is from influenza virus matrix protein M1, peptide 58-66, with L9 substituted by a methyl group, 1,2-dimethylpropylamine,  NHCH(CH(CH3)2)CH3.;;;;;;;;;;;;human (Homo sapiens);9606;Tables II, III, Figures 2, 4, and PDB 1B0R;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;1B0R;HLA-A*02:01;I;No interpretable electron density was observed at the P4-Gly and P5-Phe positions of the peptide.
15944;1148;Literature;15735650;"Stephen J Turner; Katherine Kedzierska; Helen Komodromou; Nicole L La Gruta; Michelle A Dunstone; Andrew I Webb; Richard Webby; Helen Walden; Wiedong Xie; James McCluskey; Anthony W Purcell; Jamie Rossjohn; Peter C Doherty";Nat Immunol;2005;Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations.;;61151;Linear peptide;SSLENFRAYV;224;233;;PA;Polymerase acidic protein;P03433;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;Table 2, Figure 1 and PDB 1YN6;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;1YN6;H2-Db;I;
15946;1148;Literature;15735650;"Stephen J Turner; Katherine Kedzierska; Helen Komodromou; Nicole L La Gruta; Michelle A Dunstone; Andrew I Webb; Richard Webby; Helen Walden; Wiedong Xie; James McCluskey; Anthony W Purcell; Jamie Rossjohn; Peter C Doherty";Nat Immunol;2005;Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations.;;61150;Linear peptide;SSLENFAAYV;;;;;;;;;;Peptide PA R7A is an analog of PA224 containing a mutation at position 7 (Arg->Ala).;analog;Fragment of a Natural Sequence Molecule;SSLENFRAYV;224;233;;;PA;Polymerase acidic protein;Influenza A virus (A/X-31(H3N2));Influenza A virus;mouse (Mus musculus);10090;Table 2, Figure 1 and PDB 1YN7;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1YN7;H2-Db;I;
16156;1154;Literature;16041067;"Thomas Blicher; Jette Sandholm Kastrup; S&oslash;ren Buus; Michael Gajhede";Acta Crystallogr D Biol Crystallogr;2005;High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide.;;33667;Linear peptide;KTFPPTEPK;362;370;;Nucleoprotein;Nucleoprotein;P59595;Severe acute respiratory syndrome-related coronavirus;Severe acute respiratory syndrome-related coronavirus;694009;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;1X7Q;HLA-A*11:01;I;
22534;1445;Literature;16148128;"Christine Kellenberger; Alain Roussel; Bernard Malissen";J Immunol;2005;The H-2Kk MHC peptide-binding groove anchors the backbone of an octameric antigenic peptide in an unprecedented mode.;;15483;Linear peptide;FEANGNLI;259;266;;Hemagglutinin precursor;Hemagglutinin;P03452;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 1 and 2, Table 2;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;1ZT1;H2-Kk;I;
22537;1445;Literature;16148128;"Christine Kellenberger; Alain Roussel; Bernard Malissen";J Immunol;2005;The H-2Kk MHC peptide-binding groove anchors the backbone of an octameric antigenic peptide in an unprecedented mode.;;57429;Linear peptide;SEFLLEKRI;560;568;;Large T antigen;;;Macaca mulatta polyomavirus 1;Macaca mulatta polyomavirus 1;1891767;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 3, Table 2;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;1ZT7;H2-Kk;I;The structure contains two identical complexes in the asymmetric unit.
23042;1460;Literature;12479822;"Adnane Achour; Jakob Micha&euml;lsson; Robert A Harris; Jacob Odeberg; Per Grufman; Johan K Sandberg; Victor Levitsky; Klas K&auml;rre; Tatyana Sandalova; Gunter Schneider";Immunity;2002;A structural basis for LCMV immune evasion: subversion of H-2D(b) and H-2K(b) presentation of gp33 revealed by comparative crystal structure.Analyses.;;30015;Linear peptide;KAVYNFATM;;;;glycoprotein GP;Pre-glycoprotein polyprotein GP complex;P09991;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;11623;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;1N5A;H2-Db;I;In the assay, nonamer KAVYNFATM has been used. It differs from gp33 natural epitope by one substitution at the C-terminal C9M.
23043;1460;Literature;12479822;"Adnane Achour; Jakob Micha&euml;lsson; Robert A Harris; Jacob Odeberg; Per Grufman; Johan K Sandberg; Victor Levitsky; Klas K&auml;rre; Tatyana Sandalova; Gunter Schneider";Immunity;2002;A structural basis for LCMV immune evasion: subversion of H-2D(b) and H-2K(b) presentation of gp33 revealed by comparative crystal structure.Analyses.;;30015;Linear peptide;KAVYNFATM;;;;glycoprotein GP;Pre-glycoprotein polyprotein GP complex;P09991;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;11623;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;1N59;H2-Kb;I;In the assay, nonamer KAVYNFATM has been used. It differs from gp33 natural epitope by one substitution at the C-terminal C9M.
1003223;1450;Literature;15100292;"Lucas Malard Velloso; Jakob Micha&euml;lsson; Hans-Gustaf Ljunggren; Gunter Schneider; Adnane Achour";J Immunol;2004;Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.;;30020;Linear peptide;KAVYNLATM;;;;;;;;;;The epitope differs from gp33 natural epitope by two substitutions at the C-terminal C9M and F6L. Protein name is taken from Hudrisier et al. (1997) Virology 234: 62 [PMID: 9234947].;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Table I, Figure 1 and PDB 1S7V;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1S7V;H2-Db;I;
1003224;1450;Literature;15100292;"Lucas Malard Velloso; Jakob Micha&euml;lsson; Hans-Gustaf Ljunggren; Gunter Schneider; Adnane Achour";J Immunol;2004;Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.;;30020;Linear peptide;KAVYNLATM;;;;;;;;;;The epitope differs from gp33 natural epitope by two substitutions at the C-terminal C9M and F6L. Protein name is taken from Hudrisier et al. (1997) Virology 234: 62 [PMID: 9234947].;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Table I, Figure 1 and PDB 1S7R;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;1S7R;H2-Kb;I;There are two complexes in the asymmetric unit.
1003225;1450;Literature;15100292;"Lucas Malard Velloso; Jakob Micha&euml;lsson; Hans-Gustaf Ljunggren; Gunter Schneider; Adnane Achour";J Immunol;2004;Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.;;29889;Linear peptide;KALYNFATM;;;;;;;;;;The epitope differs from gp33 natural epitope by two substitutions at the C-terminal C9M and V3L. Protein name is taken from Hudrisier et al. (1997) Virology 234: 62 [PMID: 9234947].;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Table I, Figure 1 and PDB 1S7W;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;1S7W;H2-Db;I;There are four complexes in the asymmetric unit.
1003226;1450;Literature;15100292;"Lucas Malard Velloso; Jakob Micha&euml;lsson; Hans-Gustaf Ljunggren; Gunter Schneider; Adnane Achour";J Immunol;2004;Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.;;29889;Linear peptide;KALYNFATM;;;;;;;;;;The epitope differs from gp33 natural epitope by two substitutions at the C-terminal C9M and V3L. Protein name is taken from Hudrisier et al. (1997) Virology 234: 62 [PMID: 9234947].;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Table I, Figure 1 and PDB 1S7S;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;1S7S;H2-Kb;I;The coordinates for the first N-terminal residue of the peptide were not resolved in the structure.
1004788;1000265;Literature;7506996;"A C Young; W Zhang; J C Sacchettini; S G Nathenson";Cell;1994;The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection.;;4602;Linear peptide;ASNENMETM;366;374;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;1HOC;H2-Db;I;
1004944;1000277;Literature;7694806;"D R Madden; D N Garboczi; D C Wiley";Cell;1993;The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2.;;20354;Linear peptide;GILGFVFTL;58;66;;Matrix protein 1;Matrix protein 1;P03485;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;1HHI;HLA-A*02:01;I;
1004945;1000277;Literature;7694806;"D R Madden; D N Garboczi; D C Wiley";Cell;1993;The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2.;;27125;Linear peptide;ILKEPVHGV;896;904;;Gag-Pol polyprotein;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;1HHJ;HLA-A*02:01;I;
1004946;1000277;Literature;7694806;"D R Madden; D N Garboczi; D C Wiley";Cell;1993;The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2.;;65108;Linear peptide;TLTSCNTSV;197;205;;Envelope glycoprotein gp160 precursor;Envelope glycoprotein gp160;P04578;Human immunodeficiency virus type 1 (BRU ISOLATE);Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;1HHG;HLA-A*02:01;I;
1004947;1000277;Literature;7694806;"D R Madden; D N Garboczi; D C Wiley";Cell;1993;The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2.;;37257;Linear peptide;LLFGYPVYV;11;19;;Protein Tax-1;Protein Tax-1;P14079;Human T-cell lymphotrophic virus type 1 (Caribbean isolate);Primate T-lymphotropic virus 1;194440;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;1HHK;HLA-A*02:01;I;
1004948;1000277;Literature;7694806;"D R Madden; D N Garboczi; D C Wiley";Cell;1993;The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2.;;16833;Linear peptide;FLPSDFFPSV;18;27;;Core antigen;Capsid protein;Q76R61;Hepatitis B virus LSH/chimpanzee;Hepatitis B virus;10407;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;1HHH;HLA-A*02:01;I;
1005002;1000291;Literature;12796775;"Guillaume B E Stewart-Jones; Andrew J McMichael; John I Bell; David I Stuart; E Yvonne Jones";Nat Immunol;2003;A structural basis for immunodominant human T cell receptor recognition.;;20354;Linear peptide;GILGFVFTL;58;66;;Matrix protein 1;Matrix protein 1;P03485;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Table 1 and PDB 1OGA;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;1OGA;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex bound by the JM22 TCR was determined.
1022902;1000422;Literature;15657948;"Guillame B E Stewart-Jones; Kati di Gleria; Simon Kollnberger; Andrew J McMichael; E Yvonne Jones; Paul Bowness";Eur J Immunol;2005;Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705.;;55620;Linear peptide;RRIYDLIEL;258;266;;Epstein-Barr nuclear antigen 6;Epstein-Barr nuclear antigen 6;P03204;Human herpesvirus 4 strain B95-8;Human gammaherpesvirus 4;10376;The species strain is not provided in the paper, it is obtained through a BLAST search.;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;2BSR;HLA-B*27:05;I;
1022905;1000422;Literature;15657948;"Guillame B E Stewart-Jones; Kati di Gleria; Simon Kollnberger; Andrew J McMichael; E Yvonne Jones; Paul Bowness";Eur J Immunol;2005;Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705.;;33250;Linear peptide;KRWIILGLNK;264;273;;Gag polyprotein;Gag polyprotein;P04591;Human immunodeficiency virus type 1 (Z2/CDC-Z34 ISOLATE);Human immunodeficiency virus 1;11676;The species strain is not provided in the paper, it is obtained through a BLAST search.;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;2BSS;HLA-B*27:05;I;
1022906;1000422;Literature;15657948;"Guillame B E Stewart-Jones; Kati di Gleria; Simon Kollnberger; Andrew J McMichael; E Yvonne Jones; Paul Bowness";Eur J Immunol;2005;Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705.;;60867;Linear peptide;SRYWAIRTR;383;391;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Texas/1/1977(H3N2));Influenza A virus;11320;The species strain is not provided in the paper, it is obtained from a BLAST search.;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;2BST;HLA-B*27:05;I;
1207338;1297;Literature;12218131;"Bo Wang; Ashawni Sharma; Robert Maile; Mohamed Saad; Edward J Collins; Jeffrey A Frelinger";J Immunol;2002;Peptidic termini play a significant role in TCR recognition.;;30015;Linear peptide;KAVYNFATM;;;;;;;;;;Variant of epitope gp33 from LCMV,  where C9 is changed to M.;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;1FFN;H2-Db;I;
1207339;1297;Literature;12218131;"Bo Wang; Ashawni Sharma; Robert Maile; Mohamed Saad; Edward J Collins; Jeffrey A Frelinger";J Immunol;2002;Peptidic termini play a significant role in TCR recognition.;;57044;Linear peptide;SAVYNFATM;;;;;;;;;;Variant of epitope gp33 from LCMV,  where K1 is changed to S and C9 is changed to M.;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;1FFP;H2-Db;I;
1207340;1297;Literature;12218131;"Bo Wang; Ashawni Sharma; Robert Maile; Mohamed Saad; Edward J Collins; Jeffrey A Frelinger";J Immunol;2002;Peptidic termini play a significant role in TCR recognition.;;508;Linear peptide;AAVYNFATM;;;;;;;;;;Variant of epitope gp33 from LCMV,  where K1 is changed to A and C9 is changed to M.;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;1FFO;H2-Db;I;
1212420;1000986;Literature;10993729;"A C Tissot; C Ciatto; P R Mittl; M G Gr&uuml;tter; A Pl&uuml;ckthun";J Mol Biol;2000;Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex.;;30001;Linear peptide;KAVYNFATC;33;41;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;P09991;Lymphocytic choriomeningitis virus (strain WE);Lymphocytic choriomeningitis mammarenavirus;11623;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 2, 3, 4, Table 3 and PDB 1FG2;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;1FG2;H2-Db;I;The crystal structure of the epitope in complex with H-2Db was determined by molecular replacement.
1212444;1000985;Literature;11580250;"C Ciatto; A C Tissot; M Tschopp; G Capitani; F Pecorari; A Pl&uuml;ckthun; M G Gr&uuml;tter";J Mol Biol;2001;Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides.;;58282;Linear peptide;SGVENPGGYCL;276;286;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;P09991;Lymphocytic choriomeningitis virus (strain WE);Lymphocytic choriomeningitis mammarenavirus;11623;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1JPF;H2-Db;I;
1212445;1000985;Literature;11580250;"C Ciatto; A C Tissot; M Tschopp; G Capitani; F Pecorari; A Pl&uuml;ckthun; M G Gr&uuml;tter";J Mol Biol;2001;Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides.;;17516;Linear peptide;FQPQNGQFI;396;404;;Nucleoprotein;Nucleoprotein;P09992;Lymphocytic choriomeningitis virus (strain Armstrong);Lymphocytic choriomeningitis mammarenavirus;11623;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1JPG;H2-Db;I;
1267200;1001081;Literature;16473882;"Vesselin Mitaksov; Daved H Fremont";J Biol Chem;2006;Structural definition of the H-2Kd peptide-binding motif.;;67436;Linear peptide;TYQRTRALV;147;155;;Nucleocapsid protein;Nucleoprotein;P03466;Influenza A virus (A/England/939/69 x A/PR/8/34);Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;2FWO;H2-Kd;I;
1353276;1003369;Literature;12753896;"Carlo Ciatto; Guido Capitani; Alain C Tissot; Fr&eacute;d&eacute;ric Pecorari; Andreas Pl&uuml;ckthun; Markus G Gr&uuml;tter";FEBS Lett;2003;Structural analysis of mycobacterial and murine hsp60 epitopes in complex with the class I MHC molecule H-2Db.;;56874;Linear peptide;SALQNAASIA;499;508;;60 kDa chaperonin 2;60 kDa chaperonin 2;P9WPE7;Mycobacterium tuberculosis variant bovis;Mycobacterium tuberculosis;1773;"The epitope possesses a non-standard P&Omega; anchor residue AlaP10 forming a set of conserved hydrogen bonds with MHC side chains. The peptide rises above the floor of the binding site and kinks between AlaP6 and SerP8. Consequently, AlaP7 is completely solvent-exposed. Only hydrogen bonds crucial for the conformation of C-terminal part of the peptide are discussed in the paper and curated. They result in an overall shift of the peptide backbone towards the alpha2-helix of MHC, when compared to other H-2D(b)-bound peptides.";;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;1N3N;H2-Db;I;There are 4 similar complex molecules in the asymmetric structural unit. In the paper, the analysis is restricted to MolA, which is curate here.
1356624;1002939;Literature;8624812;"K J Smith; S W Reid; K Harlos; A J McMichael; D I Stuart; J I Bell; E Y Jones";Immunity;1996;Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53.;;32738;Linear peptide;KPIVQYDNF;141;149;;liver stage-specific antigen-1;;;Plasmodium falciparum;Plasmodium falciparum;5833;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2 to 5;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1A1O;HLA-B*53:01;I;
1356628;1002939;Literature;8624812;"K J Smith; S W Reid; K Harlos; A J McMichael; D I Stuart; J I Bell; E Y Jones";Immunity;1996;Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53.;;65812;Linear peptide;TPYDINQML;84;92;;gag protein;Gag polyprotein;P18095;Human immunodeficiency virus 2;Human immunodeficiency virus 2;11709;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2 to 5;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1A1M;HLA-B*53:01;I;
1383771;1004673;Literature;12391232;"Lars Kjer-Nielsen; Craig S Clements; Andrew G Brooks; Anthony W Purcell; Marcos R Fontes; James McCluskey; Jamie Rossjohn";J Immunol;2002;The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization.;;16878;Linear peptide;FLRGRAYGL;11;19;;nuclear antigen EBNA-3;Epstein-Barr nuclear antigen 3;P12977;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table II;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;1M05;HLA-B*08:01;I;The asymmetric unit contains two similar HLA-B8-FLR complexes packed as a dimer. Two cadmium ions in the asymmetric unit were added for the crystallization. Cadmium-mediated contacts do not relate to the dimer-mediated contacts.
1403131;1004503;Literature;17082594;"John J Miles; Natalie A Borg; Rebekah M Brennan; Fleur E Tynan; Lars Kjer-Nielsen; Sharon L Silins; Melissa J Bell; Jacqueline M Burrows; James McCluskey; Jamie Rossjohn; Scott R Burrows";J Immunol;2006;TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.;;24536;Linear peptide;HPVGEADYFEY;407;417;;EBNA-1 protein;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;2FYY;HLA-B*35:01;I;The central four residues of the peptide (EADY) were not resolved in the assay.
1403132;1004503;Literature;17082594;"John J Miles; Natalie A Borg; Rebekah M Brennan; Fleur E Tynan; Lars Kjer-Nielsen; Sharon L Silins; Melissa J Bell; Jacqueline M Burrows; James McCluskey; Jamie Rossjohn; Scott R Burrows";J Immunol;2006;TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.;;24536;Linear peptide;HPVGEADYFEY;407;417;;EBNA-1 protein;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;2FZ3;HLA-B*35:08;I;
1403982;1004506;Literature;17057332;"Gustav R&oslash;der; Thomas Blicher; Sune Justesen; Birthe Johannesen; Ole Kristensen; Jette Kastrup; S&oslash;ren Buus; Michael Gajhede";Acta Crystallogr D Biol Crystallogr;2006;"Crystal structures of two peptide-HLA-B*1501 complexes; structural characterization of the HLA-B62 supertype.";;35533;Linear peptide;LEKARGSTY;274;282;;Epstein-Barr nuclear antigen 3;Epstein-Barr nuclear antigen 3;P12977;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1-2 and Figures 1-3;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1XR8;HLA-B*15:01;I;
1403983;1004506;Literature;17057332;"Gustav R&oslash;der; Thomas Blicher; Sune Justesen; Birthe Johannesen; Ole Kristensen; Jette Kastrup; S&oslash;ren Buus; Michael Gajhede";Acta Crystallogr D Biol Crystallogr;2006;"Crystal structures of two peptide-HLA-B*1501 complexes; structural characterization of the HLA-B62 supertype.";;27079;Linear peptide;ILGPPGSVY;91;99;;Ubiquitin-conjugating enzyme E2 E2;Ubiquitin-conjugating enzyme E2 E2;Q96LR5;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 3 and Figures 1-3;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;1XR9;HLA-B*15:01;I;
1404663;1004650;Literature;12530975;"Lars Kjer-Nielsen; Craig S Clements; Anthony W Purcell; Andrew G Brooks; James C Whisstock; Scott R Burrows; James McCluskey; Jamie Rossjohn";Immunity;2003;A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity.;;16878;Linear peptide;FLRGRAYGL;11;19;;nuclear antigen EBNA-3;Epstein-Barr nuclear antigen 3;P12977;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;1MI5;HLA-B*08:01;I;The structure contains the TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated.
1417163;1002511;Literature;16275762;"Fleur E Tynan; Diah Elhassen; Anthony W Purcell; Jacqueline M Burrows; Natalie A Borg; John J Miles; Nicholas A Williamson; Kate J Green; Judy Tellam; Lars Kjer-Nielsen; James McCluskey; Jamie Rossjohn; Scott R Burrows";J Exp Med;2005;The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.;;3732;Linear peptide;APQPAPENAY;77;86;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human herpesvirus 4 strain B95-8;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;2AXF;HLA-B*35:08;I;
1417427;1002511;Literature;16275762;"Fleur E Tynan; Diah Elhassen; Anthony W Purcell; Jacqueline M Burrows; Natalie A Borg; John J Miles; Nicholas A Williamson; Kate J Green; Judy Tellam; Lars Kjer-Nielsen; James McCluskey; Jamie Rossjohn; Scott R Burrows";J Exp Med;2005;The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.;;3732;Linear peptide;APQPAPENAY;77;86;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human herpesvirus 4 strain B95-8;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;2AXG;HLA-B*35:01;I;
1417439;1004559;Literature;16148129;"John J Miles; Diah Elhassen; Natalie A Borg; Sharon L Silins; Fleur E Tynan; Jacqueline M Burrows; Anthony W Purcell; Lars Kjer-Nielsen; Jamie Rossjohn; Scott R Burrows; James McCluskey";J Immunol;2005;CTL recognition of a bulged viral peptide involves biased TCR selection.;;13701;Linear peptide;EPLPQGQLTAY;54;64;;BZLF1;Trans-activator protein BZLF1;P03206;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table V;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;1ZSD;HLA-B*35:01;I;
1418285;1002475;Literature;15557346;"Michael J Miley; Ilhem Messaoudi; Beatrix M Metzner; Yudong Wu; Janko Nikolich-Zugich; Daved H Fremont";J Exp Med;2004;Structural basis for the restoration of TCR recognition of an MHC allelic variant by peptide secondary anchor substitution.;;61086;Linear peptide;SSIEFARL;498;505;;glycoprotein B;Envelope glycoprotein B;P10211;Human alphaherpesvirus 1;Human alphaherpesvirus 1;10298;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 1 to 5;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;1RK0;H2-Kb;I;
1418289;1002475;Literature;15557346;"Michael J Miley; Ilhem Messaoudi; Beatrix M Metzner; Yudong Wu; Janko Nikolich-Zugich; Daved H Fremont";J Exp Med;2004;Structural basis for the restoration of TCR recognition of an MHC allelic variant by peptide secondary anchor substitution.;;57471;Linear peptide;SEIEFARL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;SSIEFARL;498;505;;gB-1;glycoprotein B;Envelope glycoprotein B;Human alphaherpesvirus 1;Human alphaherpesvirus 1;mouse (Mus musculus);10090;Figures 1 to 5;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;1RK1;H2-Kb;I;
1459444;1006043;Literature;17142892;"Thomas Blicher; Jette Sandholm Kastrup; Lars &Oslash;stergaard Pedersen; S&oslash;ren Buus; Michael Gajhede";Acta Crystallogr Sect F Struct Biol Cryst Commun;2006;Structure of HLA-A*1101 in complex with a hepatitis B peptide homologue.;;2024;Linear peptide;AIMPARFYPK;;;;;;;;;;This peptide is an analog of the naturally occurring Hepatitis B virus DNA polymerase peptide aa 110-118 (IMPARFYPK).;analog;Fragment of a Natural Sequence Molecule;IMPARFYPK;110;118;;;Protein P;Protein P;Hepatitis B virus;Hepatitis B virus;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;2HN7;HLA-A*11:01;I;The HLA complex was formed in the presence of 87% pure IMPARFYPK peptide (110-118 naturally occured peptide in HBV DNA polymerase. The crystals contained a peptide with an additional N-terminal alanine.
1460327;1002501;Literature;16478731;"Ann Glithero; Jose Tormo; Klaus Doering; Mayumi Kojima; E Yvonne Jones; Tim Elliott";J Biol Chem;2006;The crystal structure of H-2D(b) complexed with a partial peptide epitope suggests a major histocompatibility complex class I assembly intermediate.;;46682;Linear peptide;NYPAL;328;332;;Nucleoprotein;Nucleoprotein;O57286;Murine respirovirus;Murine respirovirus;11191;The full-length epitope FAPGNYPAL is also curated [PMID: 10023771]. NYPAL pentapeptide was shown can promote H-2Db folding and form complexes with H-2Db of intermediate stability in vitro.;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;2CII;H2-Db;I;
1460328;1006526;Literature;10023771;"A Glithero; J Tormo; J S Haurum; G Arsequell; G Valencia; J Edwards; S Springer; A Townsend; Y L Pao; M Wormald; R A Dwek; E Y Jones; T Elliott";Immunity;1999;Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity.;;15248;Linear peptide;FAPGNYPAL;324;332;;nucleoprotein;Nucleoprotein;O57286;Murine respirovirus;Murine respirovirus;11191;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;1CE6;H2-Db;I;
1460333;1006526;Literature;10023771;"A Glithero; J Tormo; J S Haurum; G Arsequell; G Valencia; J Edwards; S Springer; A Townsend; Y L Pao; M Wormald; R A Dwek; E Y Jones; T Elliott";Immunity;1999;Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity.;;15255;Linear peptide;FAPSNYPAL + GLYC(S4);;;;;;;;;;The epitope is an analog of  wild type peptide FAPGNYPAL from Sendai virus NP.;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;1QLF;H2-Db;I;
1478567;1008008;Literature;15849183;"Fleur E Tynan; Natalie A Borg; John J Miles; Travis Beddoe; Diah El-Hassen; Sharon L Silins; Wendy J M van Zuylen; Anthony W Purcell; Lars Kjer-Nielsen; James McCluskey; Scott R Burrows; Jamie Rossjohn";J Biol Chem;2005;High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance.;;38458;Linear peptide;LPEPLPQGQLTAY;52;64;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human herpesvirus 4 strain B95-8;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;1ZHK;HLA-B*35:01;I;The electron density for all epitope atoms was very well defined.
1480800;1008008;Literature;15849183;"Fleur E Tynan; Natalie A Borg; John J Miles; Travis Beddoe; Diah El-Hassen; Sharon L Silins; Wendy J M van Zuylen; Anthony W Purcell; Lars Kjer-Nielsen; James McCluskey; Scott R Burrows; Jamie Rossjohn";J Biol Chem;2005;High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance.;;38458;Linear peptide;LPEPLPQGQLTAY;52;64;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human herpesvirus 4 strain B95-8;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;1ZHL;HLA-B*35:08;I;The electron density for all epitope atoms was very well defined.
1483907;1008247;Literature;1325657;"W Zhang; A C Young; M Imarai; S G Nathenson; J C Sacchettini";Proc Natl Acad Sci U S A;1992;Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition.;;54039;Linear peptide;RGYVYQGL;52;59;;nucleocapsid protein;Uncharacterized protein;Q89035;Vesicular stomatitis virus;Vesicular stomatitis virus;11276;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 1, 2 , 3 and 4;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;2MHA;H2-Kb;I;There are two MHC/Epitope complexes in the asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-microglobulin: B, epitope chain: E. Complex II : MHC alpha-chain: C,  beta2-microglobulin: D, epitope chain: F. There are no major differences between the two complexes. For the purposes of the paper an  averaged structure was used. Clear electron density was found for all the atoms in the epitope-binding groove, and more specifically for all the epitope residues. From the MHC molecule, only the first 270 residues of the alpha-chain were included in the structure, since the alpha-chain C-terminus was disordered.
1489557;1012307;Literature;18540051;"Gustav R&oslash;der; Ole Kristensen; Jette S Kastrup; S&oslash;ren Buus; Michael Gajhede";Acta Crystallogr Sect F Struct Biol Cryst Commun;2008;Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501.;;70629;Linear peptide;VQQESSFVM;1775;1783;;Replicase polyprotein 1ab;Replicase polyprotein 1ab;P0C6X7;Severe acute respiratory syndrome-related coronavirus;Severe acute respiratory syndrome-related coronavirus;694009;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3C9N;HLA-B*15:01;I;
1492664;1007776;Literature;18083574;"Michael Koch; Simon Camp; Trevor Collen; David Avila; Jan Salomonsen; Hans-Joachim Wallny; Andrew van Hateren; Lawrence Hunt; Jansen P Jacob; Fiona Johnston; Denise A Marston; Iain Shaw; P Rod Dunbar; Vincenzo Cerundolo; E Yvonne Jones; Jim Kaufman";Immunity;2007;Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding.;;20113;Linear peptide;GHAEEYGAETL;20;30;;Hemoglobin subunit alpha-A (Hemoglobin alpha-A chain) (Alpha-A-globin);Hemoglobin subunit alpha-A;P01994;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;chicken (Gallus gallus);9031;Figures 2, 3, 4, Table 1 and PDB 3BEV (v1.2);x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3BEV;BF2*2101;I;
1492665;1007776;Literature;18083574;"Michael Koch; Simon Camp; Trevor Collen; David Avila; Jan Salomonsen; Hans-Joachim Wallny; Andrew van Hateren; Lawrence Hunt; Jansen P Jacob; Fiona Johnston; Denise A Marston; Iain Shaw; P Rod Dunbar; Vincenzo Cerundolo; E Yvonne Jones; Jim Kaufman";Immunity;2007;Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding.;;53656;Linear peptide;REVDEQLLSV;324;333;;Tubulin beta-6 chain (Beta-tubulin class-VI);Tubulin beta-6 chain;P09207;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;chicken (Gallus gallus);9031;Figures 2, 3, 4, Table 1 and PDB 3BEW (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3BEW;BF2*2101;I;There are two MHC/Epitope complexes in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-microglobulin chain: B, epitope chain: C. Complex II : MHC alpha-chain: D, beta2-microglobulin chain: E, epitope chain: F. The 3-D crystal structure of the epitope assembled into a complex with BF2*2101 and beta2-microglobulin was solved to 2.6 angstroms. Positions 2, 8 and 10 of the peptide anchored the peptide, while the central residues (positions 4- 6) bulged out of the binding groove.
1494255;1008246;Literature;1323877;"D H Fremont; M Matsumura; E A Stura; P A Peterson; I A Wilson";Science;1992;Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb.;;54039;Linear peptide;RGYVYQGL;52;59;;nucleocapsid protein;Uncharacterized protein;Q89035;Vesicular stomatitis virus;Vesicular stomatitis virus;11276;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;2VAA;H2-Kb;I;Clear electron density was observed for the main chain of the MHC heavy chain, except for residues 219-227, that correspond to a surface exposed loop with extremely weak density. Clear density was also seen for beta-2m chain with the exception of the N-terminal residue Ile1 which was slightly disordered. Lastly, the bound peptide also showed clear electron density.
1494268;1008246;Literature;1323877;"D H Fremont; M Matsumura; E A Stura; P A Peterson; I A Wilson";Science;1992;Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb.;;15248;Linear peptide;FAPGNYPAL;324;332;;nucleoprotein;Nucleoprotein;O57286;Murine respirovirus;Murine respirovirus;11191;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;2VAB;H2-Kb;I;Clear electron density was observed for the main chain of the MHC heavy chain, except for residues 219-227, that correspond to a surface exposed loop with extremely weak density. Clear density was also seen for beta-2m chain with the exception of the N-terminal residue I1 which was slightly disordered. Lastly, the bound peptide also showed clear electron density.
1500053;1010181;Literature;12563259;"Jean-Baptiste Reiser; Claudine Darnault; Claude Gr&eacute;goire; Thomas Mosser; Gilbert Mazza; Alice Kearney; P Anton van der Merwe; Juan Carlos Fontecilla-Camps; Dominique Housset; Bernard Malissen";Nat Immunol;2003;CDR3 loop flexibility contributes to the degeneracy of TCR recognition.;;78685;Linear peptide;INFDFNTI;207;214;;potassium channel tetramerisation domain containing 20;BTB/POZ domain-containing protein KCTD20;Q8CDD8;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 3 and Supplementaary Table 2;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1NAN;H2-Kb;I;There are two copies of the MHC/Epitope complex in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I: MHC alpha-chain: H, beta2-microglobulin chain: P, epitope chain: M. Complex II: MHC alpha-chain: L, beta2-microglobulin chain: I, epitope chain: Q.
1503154;1012397;Literature;18270323;"Katherine K Wynn; Zara Fulton; Leanne Cooper; Sharon L Silins; Stephanie Gras; Julia K Archbold; Fleur E Tynan; John J Miles; James McCluskey; Scott R Burrows; Jamie Rossjohn; Rajiv Khanna";Blood;2008;Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection.;;6849;Linear peptide;CPSQEPMSIYVY;103;114;;65 kDa lower matrix phosphoprotein;65 kDa phosphoprotein;Q6SW59;Human herpesvirus 5 strain AD169;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 5;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3BW9;HLA-B*35:08;I;HLA B*3508 in complexes with CPS epitope is deposited as [PDB:3BW9].
1503182;1012397;Literature;18270323;"Katherine K Wynn; Zara Fulton; Leanne Cooper; Sharon L Silins; Stephanie Gras; Julia K Archbold; Fleur E Tynan; John J Miles; James McCluskey; Scott R Burrows; Jamie Rossjohn; Rajiv Khanna";Blood;2008;Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection.;;17423;Linear peptide;FPTKDVAL;188;195;;65 kDa lower matrix phosphoprotein;65 kDa phosphoprotein;Q6SW59;Human herpesvirus 5 strain AD169;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 5;x-ray crystallography;3D structure;angstroms;Positive;=;1.3;3BWA;HLA-B*35:08;I;HLA B*3508 in complexes with FPT epitope is deposited as [PDB:3BWA].
1503322;1008131;Literature;9707600;"Y Ghendler; M K Teng; J H Liu; T Witte; J Liu; K S Kim; P Kern; H C Chang; J H Wang; E L Reinherz";Proc Natl Acad Sci U S A;1998;Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands.;;54027;Linear peptide;RGYLYQGL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;RGYVYQGL;52;59;;;Nucleoprotein;;Vesicular stomatitis virus;Vesicular stomatitis virus;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;1OSZ;H2-Kb;I;The complex crystallized under very similar condition as the wild-type VSV8 peptide (RGYVYQGL) in complex with H-2-Kb [PDB: 2VAA], resulting in similar conformations.
1504469;1005009;Literature;15272181;"Minghai Zhou; Yanhui Xu; Zhiyong Lou; David K Cole; Xiaojuan Li; Yiwei Liu; Po Tien; Zihe Rao; George F Gao";Acta Crystallogr D Biol Crystallogr;2004;Complex assembly, crystallization and preliminary X-ray crystallographic studies of MHC H-2Kd complexed with an HBV-core nonapeptide.;;62747;Linear peptide;SYVNTNMGL;87;95;;core protein;Capsid protein;Q76R61;Hepatitis B virus;Hepatitis B virus;10407;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 1,  Table 1 and PDB 1VGK (v1.2);x-ray crystallography;3D structure;angstroms;Positive;=;2.1;1VGK;H2-Kd;I;The crystal structure of the epitope/H-2Kd complex was determined.
1505354;1007938;Literature;18275829;"Jeffrey Ishizuka; Guillaume B E Stewart-Jones; Anton van der Merwe; John I Bell; Andrew J McMichael; E Yvonne Jones";Immunity;2008;The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain.;;20354;Linear peptide;GILGFVFTL;58;66;;Matrix protein 1;Matrix protein 1;P03485;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 2;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;2VLL;HLA-A*02:01;I;The are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta-2-microglobulin chain: B, epitope chain: C. Complex II : MHC alpha-chain: D, beta-2-microglobulin chain: E, epitope chain: F.
1509252;1012917;Literature;11391001;"B E Gewurz; R Gaudet; D Tortorella; E W Wang; H L Ploegh; D C Wiley";Proc Natl Acad Sci U S A;2001;Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2.;;37257;Linear peptide;LLFGYPVYV;11;19;;transcriptional activator Tax;Protein Tax-1;P14079;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;194440;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1 to 4;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1IM3;HLA-A*02:01;I;"The crystal structure contains the MHC/epitope complex bound to the human cytomegalovirus (HCMV) glycoprotein US2 (Unique Short). The crystallographic asymmetric unit contains four copies the US2/MHC/Peptide complex. The following residues had a well ordered electron density and were included in the refined atomic model: MHC: 1-275, beta2-microglobulin 0-99, Tax epitope: 1-9, US2:43-137. No electron density was observed for US2 residues 15&ndash;42 and 138&ndash;140. The US2 binding site on the MHC molecule is distant from the epitope binding groove and does not affect the MHC/peptide binding."
1509255;1008907;Literature;18238896;"Nicole L La Gruta; Paul G Thomas; Andrew I Webb; Michelle A Dunstone; Tania Cukalac; Peter C Doherty; Anthony W Purcell; Jamie Rossjohn; Stephen J Turner";Proc Natl Acad Sci U S A;2008;Epitope-specific TCRbeta repertoire diversity imparts no functional advantage on the CD8+ T cell response to cognate viral peptides.;;39494;Linear peptide;LSLRNPILV;62;70;;Protein PB1-F2;Protein PB1-F2;P0C0U1;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3BUY;H2-Db;I;
1510122;1004408;Literature;9878435;"R Menssen; P Orth; A Ziegler; W Saenger";J Mol Biol;1999;Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus.;;78730;Linear peptide;LPPLDITPY;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LPPHDITPY;98;106;;EBNA3C;EBNA3C latent protein;Epstein-Barr nuclear antigen 6;Human gammaherpesvirus 4;Human gammaherpesvirus 4;human (Homo sapiens);9606;Table 1, Figures 1, 2, 3, 4 and PDB 1A9E;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;1A9E;HLA-B*35:01;I;The yielding crystals belong to the space group C222-1. Clear electron density was observed for all the epitope residues.
1510123;1004408;Literature;9878435;"R Menssen; P Orth; A Ziegler; W Saenger";J Mol Biol;1999;Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus.;;78730;Linear peptide;LPPLDITPY;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LPPHDITPY;98;106;;EBNA3C;EBNA3C latent protein;Epstein-Barr nuclear antigen 6;Human gammaherpesvirus 4;Human gammaherpesvirus 4;human (Homo sapiens);9606;Table 1, Figures 1, 2, 3, 4 and PDB 1A9B;x-ray crystallography;3D structure;angstroms;Positive;=;3.2;1A9B;HLA-B*35:01;I;The yielding crystals belong to the space group P212121. This structure is identical to the structure of the same complex with the space group C2221 [PDB: 1A9E]. There are two copies of the MHC/Epitope in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-microglobulin chain: B, epitope chain: C. Complex II : MHC alpha-chain: D, beta2-microglobulin chain: E, epitope chain: F.
1510377;1012965;Literature;15845547;"Tatyana Sandalova; Jakob Micha&euml;lsson; Robert A Harris; Jacob Odeberg; Gunter Schneider; Klas K&auml;rre; Adnane Achour";J Biol Chem;2005;A structural basis for CD8+ T cell-dependent recognition of non-homologous peptide ligands: implications for molecular mimicry in autoreactivity.;;78692;Linear peptide;KALYNYAPI;556;564;;dopamine beta hydroxylase;Dopamine beta-hydroxylase;Q05754;Rattus norvegicus;Rattus norvegicus;10116;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 2;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;1ZHB;H2-Db;I;There are four MHC/Epitope complexes in the crystallographic asymmetric unit. Clear electron density  was observed for all MHC residues contacting the epitope and for all epitope residues.
1510521;1007939;Literature;18322201;"Noah S Butler; Alex Theodossis; Andrew I Webb; Michelle A Dunstone; Roza Nastovska; Sri Harsha Ramarathinam; Jamie Rossjohn; Anthony W Purcell; Stanley Perlman";J Immunol;2008;Structural and biological basis of CTL escape in coronavirus-infected mice.;;80100;Linear peptide;XSLWNGPHL + MCM(X1);;;;;;;;;;To stabilize the epitope, the C residue was substituted with L-alpha-aminobutyric acid (Aba), an isostereomer of cystein. Aba-modified peptides are not affected by oxidative damage, cysteinylation, or dimerization. The Aba-modified S510 was equally stimulatory as native peptide when reacted with CNS-derived lymphocytes in IFN-gamma intracellular staining assays.;analog;Fragment of a Natural Sequence Molecule;CSLWNGPHL;510;518;;;spike glycoprotein (S);Spike glycoprotein;Murine hepatitis virus strain JHM;Murine coronavirus;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;2ZOK;H2-Db;I;There are four heterodimers in the crystallographic asymmetric unit. In all four of them, the residues have highly ordered electron density and have identical conformations. All structural features and comparisons apply for any of the four heterodimers. PDB chains for each complex are: Complex I : alpha-chain: A, beta-chain: B, epitope chain: I. Complex II : alpha-chain: C, beta-chain: D, epitope chain: J. Complex III : alpha-chain: E, beta-chain: F, epitope chain: K. Complex IV : alpha-chain: G, beta-chain: H, epitope chain: L. The first epitope residue is modified Ala to alpha-aminobutyric acid.
1510528;1007939;Literature;18322201;"Noah S Butler; Alex Theodossis; Andrew I Webb; Michelle A Dunstone; Roza Nastovska; Sri Harsha Ramarathinam; Jamie Rossjohn; Anthony W Purcell; Stanley Perlman";J Immunol;2008;Structural and biological basis of CTL escape in coronavirus-infected mice.;;80099;Linear peptide;XSLSNGPHL + MCM(X1);;;;;;;;;;To stabilize the epitope, the C residue was substituted with L-alpha-aminobutyric acid (Aba), an isostereomer of cystein. Aba-modified peptides are not affected by oxidative damage, cysteinylation, or dimerization. The Aba-modified S510 was equally stimulatory as native peptide when reacted with CNS-derived lymphocytes in IFN-gamma intracellular staining assays. The epitope has a substitution: W513 -> S513.;analog;Fragment of a Natural Sequence Molecule;CSLWNGPHL;510;518;;;spike glycoprotein (S);Spike glycoprotein;Murine hepatitis virus strain JHM;Murine coronavirus;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;2ZOL;H2-Db;I;There are two heterodimers in the crystallographic asymmetric unit. In both of them, the residues have highly ordered electron density and have identical conformations. PDB chains for each complex are: Complex I : alpha-chain: A, beta-chain: B, epitope chain: E. Complex II : alpha-chain: C, beta-chain: D, epitope chain: F. The first epitope residue is modified Ala to alpha-aminobutyric acid.
1510658;1004497;Literature;17259989;"Fleur E Tynan; Hugh H Reid; Lars Kjer-Nielsen; John J Miles; Matthew C J Wilce; Lyudmila Kostenko; Natalie A Borg; Nicholas A Williamson; Travis Beddoe; Anthony W Purcell; Scott R Burrows; James McCluskey; Jamie Rossjohn";Nat Immunol;2007;A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule.;;13701;Linear peptide;EPLPQGQLTAY;54;64;;BZLF1;Trans-activator protein BZLF1;P03206;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;2NW3;HLA-B*35:08;I;No clear electron density was observed for epitope residues 9-10. The mobile side chain of epitope residue L8 was not resolved.
1511738;1009526;Literature;18245382;"Gijsbert M Grotenbreg; Nadia R Roan; Eduardo Guillen; Rob Meijers; Jia-Huai Wang; George W Bell; Michael N Starnbach; Hidde L Ploegh";Proc Natl Acad Sci U S A;2008;Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers.;;79818;Linear peptide;FAPGNYXAL + MCM(X7);;;;;;;;;;The epitope residue P7 was substituted with the photocleavable 3-amino-3-(2-nitro)phenyl-propanoic acid (Anp) residue.;analog;Fragment of a Natural Sequence Molecule;FAPGNYPAL;324;332;;NP;nucleoprotein;Nucleoprotein;Murine respirovirus;Murine respirovirus;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;2VE6;H2-Db;I;There are four complexes in the crystallographic asymmetric unit. The electron density for complex I is most clearly defined, and this was the one used for the description of the structure. The final model contains residues 1-277 of the heavy chain of H-2-Db, residues 1-99 of b2-microglobulin and the 9 residues of the S isomer of the photocleavabile SV9-P7*B peptide.  Electron density for the epitope was unambiguous. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta-2-microglobulin chain: B, epitope chain: C. Complex II : MHC alpha-chain: D, beta-2-microglobulin chain: E, epitope chain: F.
1511836;1012910;Literature;15537660;"Maria Teresa Fiorillo; Christine R&uuml;ckert; Martin H&uuml;lsmeyer; Rosa Sorrentino; Wolfram Saenger; Andreas Ziegler; Barbara Uchanska-Ziegler";J Biol Chem;2005;Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes.;;55734;Linear peptide;RRRWRRLTV;236;244;;Latent membrane protein 2;Latent membrane protein 2;P13285;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2 and Figure 1;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;1UXS;HLA-B*27:05;I;The peptide residues had unambiguous electron density.
1511837;1012910;Literature;15537660;"Maria Teresa Fiorillo; Christine R&uuml;ckert; Martin H&uuml;lsmeyer; Rosa Sorrentino; Wolfram Saenger; Andreas Ziegler; Barbara Uchanska-Ziegler";J Biol Chem;2005;Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes.;;55734;Linear peptide;RRRWRRLTV;236;244;;Latent membrane protein 2;Latent membrane protein 2;P13285;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2 and Figure 1;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;1UXW;HLA-B*27:09;I;The peptide residues had unambiguous electron density.
1511839;1012909;Literature;16962135;"Susan J Gagnon; Oleg Y Borbulevych; Rebecca L Davis-Harrison; Richard V Turner; Marale Damirjian; Alison Wojnarowicz; William E Biddison; Brian M Baker";J Mol Biol;2006;T cell receptor recognition via cooperative conformational plasticity.;;130542;Linear peptide;LLFGKPVYV + SCM(K5);;;;;;;;;;The epitope is an analog of the Tax 11-19 peptide (LLFGYPVYV) with a Y5K substitution at position 5. This lysine was conjugated to indolyl-butyric acid (Tax-5K-4-(3-Indolyl)-butyric acid).;analog;Fragment of a Natural Sequence Molecule;LLFGYPVYV;11;19;;tax;transcriptional activator Tax;Protein Tax-1;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;human (Homo sapiens);9606;Table 1, Figure 3 and PDB 2GIT;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;2GIT;HLA-A*02:01;I;"There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I: MHC alpha-chain: A, beta-2-microglobulin chain: B, epitope chain: C. Complex II: MHC alpha-chain: D, beta-2-microglobulin chain: E, epitope chain: F.  No electron density was observed for the side chain atoms beyond C&epsilon; in Complex I and Cdelta of Complex II, for the IBA group of the peptide residue Lys-IBA (P5 residue). Thus, the atoms beyond Cdelta or C&epsilon; for P5 were excluded from the final model."
1583645;315553;Literature;10429675;"Q R Fan; D C Wiley";J Exp Med;1999;Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor.;;94909;Linear peptide;QYDDAVYKL;;;;;;;;;;The epitope is the consensus peptide motif  that was determined by pooled peptide sequencing.;;;;;;;;;;;;human (Homo sapiens);9606;Tables I, II, Figures 1, 2, 3, 4, 5, 6 and PDB 1QQD;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;1QQD;HLA-C*04:01;I;"The final model includes MHC residues 2&ndash;274, residues 0&ndash;98 of beta-2m and all peptide residues. The N and C termini of MHC chain residues 1 and 275 and the beta-2m C-terminus had no visible electron density. The side chains of MHC residues 104-108, 195&ndash;198 and beta-2m residues 17&ndash;19 had weak electron densities. Clear electron density was observed for the entire peptide."
1583747;1002486;Literature;14978103;"Markus G Rudolph; Lucy Q Shen; Stephen A Lamontagne; John G Luz; Joseph R Delaney; Qing Ge; Bryan K Cho; Deborah Palliser; Carol A McKinley; Jianzhu Chen; Ian A Wilson; Herman N Eisen";J Immunol;2004;A peptide that antagonizes TCR-mediated reactions with both syngeneic and allogeneic agonists: functional and structural aspects.;;94833;Linear peptide;GNYSFYAL;423;430;;insulin receptor;Insulin receptor;P15208;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Table I, III, Figure 5 and PDB 1LK2;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;1LK2;H2-Kb;I;The epitope residues had high quality electron density.
1583749;1012044;Literature;14555655;"Roman C Hillig; Martin H&uuml;lsmeyer; Wolfram Saenger; Karin Welfle; Rolf Misselwitz; Heinz Welfle; Christine Kozerski; Armin Volz; Barbara Uchanska-Ziegler; Andreas Ziegler";J Biol Chem;2004;Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association.;;94918;Linear peptide;RRLLRGHNQY;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;GRLLRGHNQY;131;140;;;Major histocompatibility complex, class I, B (HLA class I antigen) (MICA protein);HLA class I histocompatibility antigen, B-8 alpha chain;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Tables I, III, Figures 2, 3, 4, 5, 6, 7 and PDB 1JGD;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;1JGD;HLA-B*27:09;I;The final model includes all 276 MHC residues, 100 residues of  beta-2m (all 99 residues plus N-terminal methionine), and all epitope residues. There was well defined electron density in the peptide binding groove.
1584070;1012045;Literature;15226359;"Danielle Zernich; Anthony W Purcell; Whitney A Macdonald; Lars Kjer-Nielsen; Lauren K Ely; Nihay Laham; Tanya Crockford; Nicole A Mifsud; Mandvi Bharadwaj; Linus Chang; Brian D Tait; Rhonda Holdsworth; Andrew G Brooks; Stephen P Bottomley; Travis Beddoe; Chen Au Peh; Jamie Rossjohn; James McCluskey";J Exp Med;2004;Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion.;;95009;Linear peptide;EEFGRAFSF;77;85;;HLA-DPA1 protein;HLA class II histocompatibility antigen, DP alpha 1 chain;P20036;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables I, II, S1, Figure 5 and PDB 1SYV;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;1SYV;HLA-B*44:05;I;
1584071;1012045;Literature;15226359;"Danielle Zernich; Anthony W Purcell; Whitney A Macdonald; Lars Kjer-Nielsen; Lauren K Ely; Nihay Laham; Tanya Crockford; Nicole A Mifsud; Mandvi Bharadwaj; Linus Chang; Brian D Tait; Rhonda Holdsworth; Andrew G Brooks; Stephen P Bottomley; Travis Beddoe; Chen Au Peh; Jamie Rossjohn; James McCluskey";J Exp Med;2004;Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion.;;95010;Linear peptide;EEPTVIKKY;257;265;;Sorting nexin-5;Sorting nexin-5;Q9Y5X3;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables I, II, Figure 5 and PDB 1SYS;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;1SYS;HLA-B*44:03;I;
1584209;1013516;Literature;19139173;"Julia K Archbold; Whitney A Macdonald; Stephanie Gras; Lauren K Ely; John J Miles; Melissa J Bell; Rebekah M Brennan; Travis Beddoe; Matthew C J Wilce; Craig S Clements; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn";J Exp Med;2009;Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition.;;11804;Linear peptide;EENLLDFVRF;281;290;;Epstein-Barr nuclear antigen 6;Epstein-Barr nuclear antigen 6;P03204;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table S1 and PDB 3DX6;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3DX6;HLA-B*44:02;I;
1584210;1013516;Literature;19139173;"Julia K Archbold; Whitney A Macdonald; Stephanie Gras; Lauren K Ely; John J Miles; Melissa J Bell; Rebekah M Brennan; Travis Beddoe; Matthew C J Wilce; Craig S Clements; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn";J Exp Med;2009;Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition.;;11804;Linear peptide;EENLLDFVRF;281;290;;Epstein-Barr nuclear antigen 6;Epstein-Barr nuclear antigen 6;P03204;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table S1 and PDB 3DX7;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;3DX7;HLA-B*44:03;I;
1584211;1013516;Literature;19139173;"Julia K Archbold; Whitney A Macdonald; Stephanie Gras; Lauren K Ely; John J Miles; Melissa J Bell; Rebekah M Brennan; Travis Beddoe; Matthew C J Wilce; Craig S Clements; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn";J Exp Med;2009;Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition.;;11804;Linear peptide;EENLLDFVRF;281;290;;Epstein-Barr nuclear antigen 6;Epstein-Barr nuclear antigen 6;P03204;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table S1 and PDB 3DX8;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3DX8;HLA-B*44:05;I;
1584291;1013543;Literature;19047637;"Katherine Kedzierska; Carole Guillonneau; Stephanie Gras; Lauren A Hatton; Richard Webby; Anthony W Purcell; Jamie Rossjohn; Peter C Doherty; Stephen J Turner";Proc Natl Acad Sci U S A;2008;Complete modification of TCR specificity and repertoire selection does not perturb a CD8+ T cell immunodominance hierarchy.;;4564;Linear peptide;ASNENAETM;;;;;;;;;;The epitope is an analog of NP366 and has a mutation: M6->A6.;analog;Fragment of a Natural Sequence Molecule;ASNENMETM;366;374;;;nucleoprotein;Nucleoprotein;Influenza A virus;Influenza A virus;mouse (Mus musculus);10090;Figure 4, Table S3 and PDB 3CPL;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;3CPL;H2-Db;I;The structure of the epitope/H-2Db complex was solved by molecular replacement. The electron density for the peptide and for the residues within the peptide binding groove  was unambiguous. There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-m chain: B, epitope chain: E. Complex II : MHC alpha-chain: C, beta2-m chain: D, epitope chain: F.
1584445;1013547;Literature;17067310;"Eliada Lazoura; Jodie Lodding; William Farrugia; Paul A Ramsland; James Stevens; Ian A Wilson; Geoffrey A Pietersz; Vasso Apostolopoulos";Immunology;2006;Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide.;;94923;Linear peptide;SAPDFRPL;;;;;;;;;;The epitope is an analog of Mucin-1 peptide with the mutations: T5->F5 and A8->L8.;analog;Fragment of a Natural Sequence Molecule;SAPDTRPA;140;147;;MUC-1, Breast carcinoma-associated antigen DF3, Carcinoma-associated mucin, Episialin, H23AG, PEMT, Peanut-reactive urinary mucin, Polymorphic epithelial mucin, Tumor-associated epithelial membrane antigen, Tumor-associated mucin, PUM, EMA;Mucin-1;Mucin-1;Homo sapiens;Homo sapiens;mouse (Mus musculus);10090;Tables 1, 4, Figures 3, 4, 5 and PDB FO4;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;2FO4;H2-Kb;I;"The electron density for all residues was well-defined, except for the MHC polypeptide turn side chain regions. The final model consists of MHC heavy chain (residues 1&ndash;274), &szlig;2-m (residues 1&ndash;99), and all peptide residues."
1584690;1013539;Literature;11502003;"R C Hillig; P G Coulie; V Stroobant; W Saenger; A Ziegler; M H&uuml;lsmeyer";J Mol Biol;2001;High-resolution structure of HLA-A*0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene.;;95091;Linear peptide;GVYDGREHTV;230;239;;Melanoma-associated antigen 4;Melanoma-associated antigen 4;P43358;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, Table 2 and PDB 1I4F;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;1I4F;HLA-A*02:01;I;Clear electron density was observed for all residues of the MHC heavy chain, b2m and the peptide, with weak density only for the side-chains in one loop of b2m (residues 74-76). The final model includes all 275 residues of the MHC heavy chain, all 100 residues of b2m and the 10 peptide residues.
1584695;1004499;Literature;17109469;"Christopher S Hourigan; Maria Harkiolaki; Neil A Peterson; John I Bell; E Yvonne Jones; Chris A O'Callaghan";Eur J Immunol;2006;The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: steric hindrance influences TCR allo-recognition.;;95513;Linear peptide;KPIVVLHGY;72;80;;Cytochrome P450 2C9;Cytochrome P450 2C9;P11712;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 1 and PDB 2CIK;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;2CIK;HLA-B*35:01;I;
1584696;1002510;Literature;16221670;"Christine R&uuml;ckert; Maria Teresa Fiorillo; Bernhard Loll; Roberto Moretti; Jacek Biesiadka; Wolfram Saenger; Andreas Ziegler; Rosa Sorrentino; Barbara Uchanska-Ziegler";J Biol Chem;2006;Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLA-B27 subtype.;;126988;Linear peptide;RRRWHRWRL;412;420;;glucagon receptor;Glucagon receptor;P47871;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2 and Figures 2, 3, 4, and 5 and PDB 2A83;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;2A83;HLA-B*27:05;I;There was unambiguous electron density for the peptide, that revealed two possible conformations, termed pGR-A and pGR-B. These conformations differ for the peptide residues from R3 to R8.
1585185;1012980;Literature;11163232;"J A Speir; J Stevens; E Joly; G W Butcher; I A Wilson";Immunity;2001;Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa.;;95097;Linear peptide;ILFPSSERLISNR;29;41;;ATPase subunit 6;ATP synthase subunit a;P05504;Rattus norvegicus;Rattus norvegicus;10116;;;;;;;;;;;;;rat (Rattus norvegicus);10116;Tables 1, 2, Figures 2, 3, 4 and 1ED3;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;1ED3;RT1-A;I;There are two complexes in the crystallographic asymmetric unit. PDB chains for each complex are: Complex A : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex B: MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. There is an approximate 7 degrees rotation between the alpha3 and beta2-m domains of Complex B relative to Complex A, due to crystal packing. The epitope adopts two completely different conformations in the two complexes. The N-terminal residues of the epitope in Complex A rise more swiftly out of the binding groove, compared to the more gradual rise of the same residues of the epitope in Complex B. There was continuous electron density for the epitope. This assay refers to Complex A.
1585907;1013519;Literature;15814707;"Oleg Y Borbulevych; Tiffany K Baxter; Zhiya Yu; Nicholas P Restifo; Brian M Baker";J Immunol;2005;Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design.;;28864;Linear peptide;ITDQVPFSV;209;217;;Melanocyte protein Pmel 17 precursor;Melanocyte protein PMEL;P40967;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table I, Figures 1, 2, 3, 4 and PDB 1TVB;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;1TVB;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex A: MHC chain: A, beta2-m chain: B, epitope chain: C. Complex B: MHC chain: D, beta2-m chain: E, epitope chain: F. Both of the complexes are almost identical. The only differences are in the positioning of peptide residues Q4, F7, S8. For both complexes, unambiguous electron density was observed for the peptides.
1585908;1013519;Literature;15814707;"Oleg Y Borbulevych; Tiffany K Baxter; Zhiya Yu; Nicholas P Restifo; Brian M Baker";J Immunol;2005;Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design.;;27469;Linear peptide;IMDQVPFSV;;;;;;;;;;The epitope is an analog of the gp100(209-217) peptide with the mutation:  T2->M2.;analog;Fragment of a Natural Sequence Molecule;ITDQVPFSV;209;217;;;Melanocyte protein Pmel 17 precursor;Melanocyte protein PMEL;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table I, Figures 1, 2, 3, 4 and PDB 1TVH;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;1TVH;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex A: MHC chain: A, beta2-m chain: B, epitope chain: C. Complex B: MHC chain: D, beta2-m chain: E, epitope chain: F. Both of the complexes are almost identical. The only differences are in the positioning of peptide residues Q4, F7, S8. For both complexes, unambiguous electron density was observed for the peptides.
1585909;1013545;Literature;10843695;"A R Khan; B M Baker; P Ghosh; W E Biddison; D C Wiley";J Immunol;2000;The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site.;;35844;Linear peptide;LFGYPVYV;12;19;;transcriptional activator Tax;Protein Tax-1;P14079;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;194440;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1DUY;HLA-A*02:01;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex II :  MHC alpha-chain: D, beta2-m chain: E, epitope chain: F.
1585910;1013545;Literature;10843695;"A R Khan; B M Baker; P Ghosh; W E Biddison; D C Wiley";J Immunol;2000;The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site.;;37257;Linear peptide;LLFGYPVYV;11;19;;transcriptional activator Tax;Protein Tax-1;P14079;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;194440;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;1DUZ;HLA-A*02:01;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex II :  MHC alpha-chain: D, beta2-m chain: E, epitope chain: F.
1585915;1013577;Literature;11287414;"A K Sharma; J J Kuhns; S Yan; R H Friedline; B Long; R Tisch; E J Collins";J Biol Chem;2001;Class I major histocompatibility complex anchor substitutions alter the conformation of T cell receptor contacts.;;95098;Linear peptide;ILSALVGIL;;;;;;;;;;The epitope is a GP2 variant with mutations: I2 ->L2 and V5->L5. There are two MHC/Epitope molecules in the crystallographic asymmetric unit. The epitopes in the two molecules are not equivalent and the orientation of the P5 side chain is different. As such, each epitope is curated separately. This is epitope from Molecule 1.;analog;Fragment of a Natural Sequence Molecule;IISAVVGIL;654;662;;;Receptor tyrosine-protein kinase erbB-2 precursor;Receptor tyrosine-protein kinase erbB-2;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table II, Figures 2, 3 and PDB 1EEZ (molecule 1);x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1EEZ;HLA-A*02:01;I;There are two MHC/Epitope molecules in the crystallographic asymmetric unit. PDB chains for each molecule are: Molecule 1 : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Molecule 2 : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F.  There is clear electron density for the peptide terminal residues in both molecules. In molecule 1, the density is continuous over the peptide main chain but the side chain for residue P6 is undefined. In molecule 2, the electron density is broken at residues P6 and P7. The epitopes in the two molecules are not equivalent and the orientation of the P5 side chain is different. As such, each epitope is curated separately. This assay refers to Molecule 1.
1585916;1013577;Literature;11287414;"A K Sharma; J J Kuhns; S Yan; R H Friedline; B Long; R Tisch; E J Collins";J Biol Chem;2001;Class I major histocompatibility complex anchor substitutions alter the conformation of T cell receptor contacts.;;95099;Linear peptide;ILSALVGIV;;;;;;;;;;The epitope is a GP2 variant with mutations: I2 ->L2, V5->L5 and L9->V9.;analog;Fragment of a Natural Sequence Molecule;IISAVVGIL;654;662;;;Receptor tyrosine-protein kinase erbB-2 precursor;Receptor tyrosine-protein kinase erbB-2;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table II, Figures 2, 3 and PDB EEY;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1EEY;HLA-A*02:01;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex 1 : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex 2 : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. There is clear electron density for the peptide terminal residues in both molecules. There are some differences in the electron density of the peptides in the two molecules, but they do not affect the orientations of the peptide. There is a break in the electron density at residue P6 and P7 in both of the molecules. The orientation of P6 cannot be interpreted in either molecule.
1585964;1013578;Literature;10593938;"J J Kuhns; M A Batalia; S Yan; E J Collins";J Biol Chem;1999;Poor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptide.;;26666;Linear peptide;IISAVVGIL;654;662;;Receptor tyrosine-protein kinase erbB-2 precursor;Receptor tyrosine-protein kinase erbB-2;P04626;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table II, Figure 2 and PDB 1QR1;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;1QR1;HLA-A*02:01;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex II : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. The entire MHC molecule was well resolved and the positions of the peptide termini were also unambiguous. In contrast, the center of the GP2 peptide was disordered. In particular, the orientation of residue P6 was completely uninterpretable and the positions of residues P5 and P7 were not well defined. This was interpreted by the authors to mean that the peptide assumes more than one conformation within the peptide binding groove.
1587192;1013583;Literature;11584024;"J Buslepp; R Zhao; D Donnini; D Loftus; M Saad; E Appella; E J Collins";J Biol Chem;2001;T cell activity correlates with oligomeric peptide-major histocompatibility complex binding on T cell surface.;;95375;Linear peptide;FAPGFFPYL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;FAPGNYPAL;324;332;;NP;nucleoprotein;Nucleoprotein;Murine respirovirus;Murine respirovirus;human (Homo sapiens);9606;Table II, Figure 3 and PDB 1I7R;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1I7R;HLA-A*02:01;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex II : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F.
1587193;1013583;Literature;11584024;"J Buslepp; R Zhao; D Donnini; D Loftus; M Saad; E Appella; E J Collins";J Biol Chem;2001;T cell activity correlates with oligomeric peptide-major histocompatibility complex binding on T cell surface.;;95240;Linear peptide;ALWGFVPVL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;ALWGFFPVL;4;12;;;chromosome 15 open reading frame 24;ER membrane protein complex subunit 7;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table II, Figure 3 and PDB 1I7U;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;1I7U;HLA-A*02:01;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex II : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F.
1587194;1013583;Literature;11584024;"J Buslepp; R Zhao; D Donnini; D Loftus; M Saad; E Appella; E J Collins";J Biol Chem;2001;T cell activity correlates with oligomeric peptide-major histocompatibility complex binding on T cell surface.;;95241;Linear peptide;ALWGVFPVL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;ALWGFFPVL;4;12;;;chromosome 15 open reading frame 24;ER membrane protein complex subunit 7;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table II, Figure 3 and PDB 1I7T;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;1I7T;HLA-A*02:01;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex II : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F.
1587197;1013585;Literature;12244049;"Martin H&uuml;lsmeyer; Roman C Hillig; Armin Volz; Melanie R&uuml;hl; Werner Schr&ouml;der; Wolfram Saenger; Andreas Ziegler; Barbara Uchanska-Ziegler";J Biol Chem;2002;HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations.;;96334;Linear peptide;GRFAAAIAK;;;;;;;;;;The epitope was designed using the MHCPEP database [PMID: 9399876].;;;;;;;;;;;;human (Homo sapiens);9606;Figures  2, 3, 4, 5,Tables I, II, III and PDB 1JGE;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;1JGE;HLA-B*27:05;I;The final model contains all 276 residues of the MHC heavy chain, all 100 residues of beta2-m and all epitope residues. Well-defined electron density was observed in the peptide binding groove.
1587198;1013585;Literature;12244049;"Martin H&uuml;lsmeyer; Roman C Hillig; Armin Volz; Melanie R&uuml;hl; Werner Schr&ouml;der; Wolfram Saenger; Andreas Ziegler; Barbara Uchanska-Ziegler";J Biol Chem;2002;HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations.;;96334;Linear peptide;GRFAAAIAK;;;;;;;;;;The epitope was designed using the MHCPEP database [PMID: 9399876].;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3, 4, 5,Tables I, II, III and PDB 1K5N;x-ray crystallography;3D structure;angstroms;Positive;=;1.1;1K5N;HLA-B*27:09;I;The final model contains all 276 residues of the MHC heavy chain, all 100 residues of beta2-m and all epitope residues. Well-defined electron density was observed in the peptide binding groove.
1587614;1013608;Literature;9192660;"G K Balendiran; J C Solheim; A C Young; T H Hansen; S G Nathenson; J C Sacchettini";Proc Natl Acad Sci U S A;1997;The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide.;;75373;Linear peptide;YPNVNIHNF;190;198;;Spectrin beta chain, non-erythrocytic 1;Spectrin beta chain, non-erythrocytic 1;Q62261;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 2, Table 2;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;1LD9;H2-Ld;I;There are two molecules in the crystallographic asymmetric unit. Since the two molecules do not differ significantly, only one molecule was used in the analysis.
1588605;1013619;Literature;7708669;"D H Fremont; E A Stura; M Matsumura; P A Peterson; I A Wilson";Proc Natl Acad Sci U S A;1995;Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove.;;58560;Linear peptide;SIINFEKL;258;265;;ovalbumin;Gal d 2;P01012;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 1, 2 and PDB 1VAC;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;1VAC;H2-Kb;I;
1588606;1013619;Literature;7708669;"D H Fremont; E A Stura; M Matsumura; P A Peterson; I A Wilson";Proc Natl Acad Sci U S A;1995;Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove.;;96918;Linear peptide;SRDHSRTPM;438;446;;Alpha-glucosidase MAL32;Alpha-glucosidase MAL32;P38158;Saccharomyces cerevisiae;Saccharomyces cerevisiae;4932;;;;;;;;;;;;;mouse (Mus musculus);10090;PDB 1VAD;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;1VAD;H2-Kb;I;
1588607;1013590;Literature;1525820;"D R Madden; J C Gorga; J L Strominger; D C Wiley";Cell;1992;The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.;;96109;Linear peptide;ARAAAAAAA;;;;;;;;;;For the formation of the MHC/Epitope complex, a collection of peptides that bind to this MHC was used. The epitope sequence is a peptide model that was built into the MHC/Epitope structure to represent the single, dominant main chain conformation of the bound peptides.;;;;;;;;;;;;human (Homo sapiens);9606;PDB 1HSA;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;1HSA;HLA-B*27:05;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I: MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex II: MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. Each molecule in the asymmetric unit consists of residues 1-276 of the MHC heavy chain, 99 residues of beta2-m and 9 peptide residues. No electron density was found for side chains of MHC residues 108 and 268 and for the side chain of beta2-m residue 58. Very weak electron density was observed for MHC residues 220-229. For the crystallization of the MHC/Epitope complex, a co-crystallized collection of HLA-B27 peptides was used. As such, the electron density detected by the X-ray diffraction represents a superposition of the structures of the individual molecules found in the diffracting volume of the crystal. The peptide electron density observed represents a composite of the binding conformations of the different peptides in the co-crystallized population. Peptide electron density is clear for residue side chains of anchor positions P2, P3, and P9 (residues common to all peptides), weaker at variable side chain positions P1, P7, P8 and none found for residues P4, P5, and P6. A peptide model of sequence ARAAAAAAA was built into the structure to represent the single, dominant main chain conformation of the bound peptides.
1588608;1013584;Literature;9892618;"R Zhao; D J Loftus; E Appella; E J Collins";J Exp Med;1999;Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry.;;96278;Linear peptide;FAPGVFPYM;;;;;;;;;;The epitope is a disubstituted analogue of the synthetic peptide p1058 (FAPGFFPYL).;;;;;;;;;;;;mouse (Mus musculus);10090;Tables I, II, Figures 1, 2, 3, 4, 5, 6 and PDB 1BZ9;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;1BZ9;H2-Db;I;The crystal structure of H-2-Db complexed with the epitope p1027 was determined using the molecular replacement method. The epitope is a disubstituted analogue of the synthetic peptide p1058 (FAPGFFPYL). It is an equally good agonist towards TCR AHIII12.2 from a CD8+ CTL clone derived from a C57BL/6 mouse injected with the human lymphoblastoid cell line JY. It was chosen over p1058 to maximize the primary sequence differences between the two MHC/Epitope complexes examined in this study. Epitope main chain density is relatively weak near residue P5. This may indicate some flexibility around the middle of the peptide.
1588615;1013586;Literature;12470953;"Markus G Rudolph; James Stevens; Jeffrey A Speir; John Trowsdale; Geoffrey W Butcher; Etienne Joly; Ian A Wilson";J Mol Biol;2002;Crystal structures of two rat MHC class Ia (RT1-A) molecules that are associated differentially with peptide transporter alleles TAP-A and TAP-B.;;96105;Linear peptide;AQFSASASR;;;;;;;;;;The epitope was designed for high-affinity binding to the MHC by matching the anchor pocket requirements of the MHC as deduced from pool sequencing studies [PMID: 8624806].;;;;;;;;;;;;rat (Rattus norvegicus);10116;Tables 1, 2, Figures 1, 2, 3, 4 and PDB 1KJM;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;1KJM;RT1-Aa;I;There was clear electron density for the epitope.
1588617;1013586;Literature;12470953;"Markus G Rudolph; James Stevens; Jeffrey A Speir; John Trowsdale; Geoffrey W Butcher; Etienne Joly; Ian A Wilson";J Mol Biol;2002;Crystal structures of two rat MHC class Ia (RT1-A) molecules that are associated differentially with peptide transporter alleles TAP-A and TAP-B.;;96699;Linear peptide;NPRAMQALL;450;458;;ubiquilin 1;Ubiquilin-1;Q9JJP9;Rattus norvegicus;Rattus norvegicus;10116;The epitope was identified by mass spectrometry from natural peptides eluted from rat splenocytes [PMID: 10856297].;;;;;;;;;;;;rat (Rattus norvegicus);10116;Tables 1, 2, Figures 1, 2, 3, 4 and  PDB 1KJV;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;1KJV;RT1-Ac;I;There was clear electron density for the epitope.
1589004;1013621;Literature;7935798;"E J Collins; D N Garboczi; D C Wiley";Nature;1994;Three-dimensional structure of a peptide extending from one end of a class I MHC binding site.;;96646;Linear peptide;MLLSVPLLLG;1;10;;Calreticulin precursor;Calreticulin;P27797;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3 and PDB 2CLR;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;2CLR;HLA-A*02:01;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I: MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex II: MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. Clear electron density was observed for the entire length of the peptide.
1593316;1004511;Literature;16963442;"Julia K Archbold; Whitney A Macdonald; John J Miles; Rebekah M Brennan; Lars Kjer-Nielsen; James McCluskey; Scott R Burrows; Jamie Rossjohn";J Biol Chem;2006;Alloreactivity between disparate cognate and allogeneic pMHC-I complexes is the result of highly focused, peptide-dependent structural mimicry.;;95513;Linear peptide;KPIVVLHGY;72;80;;Cytochrome P450 2C9;Cytochrome P450 2C9;P11712;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;2H6P;HLA-B*35:01;I;
1593323;1013613;Literature;15128805;"Lenong Li; Marlene Bouvier";J Immunol;2004;Structures of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue.;;1913;Linear peptide;AIFQSSMTK;158;166;;reverse transcriptase;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Tables I, II, Figures 2, 3, 4, 5, 6 and PDB 1Q94;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;1Q94;HLA-A*11:01;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex 1': MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex 2': MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. Electron density for the entire peptide in both molecules was well resolved. Main chain conformations of the two molecules are essentially identical, but the side chain of P1 is rotated. Also, the side chains of residues P4, P6 and P7 adopt slightly different orientations in the two molecules.
1593324;1013613;Literature;15128805;"Lenong Li; Marlene Bouvier";J Immunol;2004;Structures of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue.;;52760;Linear peptide;QVPLRPMTYK;73;82;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Tables I, II, Figures 2, 3, 4, 6 and PDB 1QVO;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1QVO;HLA-A*11:01;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex 1: MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex 2: MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. Electron density for the entire peptide in both molecules was continuous and clearly visible. Although main chain conformations of the two molecules are essentially identical, side chains of P4, P5, P7 and P8 show slightly different orientations. Specifically, the re-orientation of the P7Side chain is due to a change in the conformation of the MHC residue A: Q156.
1594134;1013617;Literature;17719490;"Vesselin Mitaksov; Steven M Truscott; Lonnie Lybarger; Janet M Connolly; Ted H Hansen; Daved H Fremont";Chem Biol;2007;Structural engineering of pMHC reagents for T cell vaccines and diagnostics.;;58560;Linear peptide;SIINFEKL;258;265;;ovalbumin;Gal d 2;P01012;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;mouse (Mus musculus);10090;Table 1, Figures 1, 2, 3, 4 and PDB 2QRI;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;2QRI;H2-Kb;I;"The crystal structure contains the MHC/Epitope complex as a single-chain trimer (SCT). This is the first generation of SCT (SCTwt) which was designed by linking the C-terminus of the peptide by using a (G4-S)3 linker to the N-terminus of beta2m and linking the C-terminus of beta2m to the N-terminus of the MHC using a (G4-S)4 linker. The final electron density map was of excellent quality for main chain or side chain atoms of the peptide. Interpretable density was also observed for the entire peptide-beta2m linker. No electron density was observed for the beta2m-MHC linker and for residues 278&ndash;280 at the C terminus of the MHC molecule. There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2m chain: A, epitope chain: A. Complex II : MHC alpha-chain: B, beta2m chain: B, epitope chain: B."
1594993;1013622;Literature;9620676;"J A Speir; K C Garcia; A Brunmark; M Degano; P A Peterson; L Teyton; I A Wilson";Immunity;1998;Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes.;;97206;Linear peptide;APAAAAAAM;;;;;;;;;;"The epitope is a nine-residue (P1&ndash;P9) polyalanine peptide model, based on the influenza nucleoprotein epitope bound to H-2-Db [PDB: 1HOC]. The clear side chain electron density allowed the placement of the anchor residues P2 and  P9 in the model, but the other residues were left as alanines.";;;;;;;;;;;;mouse (Mus musculus);10090;Figure 1, Table 3 and PDB 1LDP;x-ray crystallography;3D structure;angstroms;Positive;=;3.1;1LDP;H2-Ld;I;"For the crystallization of the MHC/Epitope complex, the MHC with a mixture of bound peptide were used. Then, the crystal structure was used to construct two peptide models. Thus, the structure contains two peptide models in the MHC binding groove. The first model is a nine-residue (P1&ndash;P9) polyalanine peptide, based on the influenza NP epitope bound to H-2-Db [PDB: 1HOC]. The clear side chain electron density at P2 and P9 allowed the placement of these residues in the model, but the other residues were left as alanines. In the second peptide model, apart from the well defined P2 and P9 residues, the electron density for the remainder of the peptide indicated the presence of a broader range of residues compatible with known residue sequences of H-2-Ld binding peptides. Hence, the remaining residues were modeled after the  QL9 sequence. This peptide fit the electron density well. But, no single peptide model ideally represented the electron density of a peptide mixture. This assay refers to the first model."
1594994;1013622;Literature;9620676;"J A Speir; K C Garcia; A Brunmark; M Degano; P A Peterson; L Teyton; I A Wilson";Immunity;1998;Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes.;;97581;Linear peptide;QLSPFPFDL;932;940;;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Q60597;Mus musculus;Mus musculus;10090;The epitope is a peptide model of QL9. In this model, apart from the well defined P2 and P9 residues, the electron density for the remainder of the peptide indicated the presence of a broader range of residues compatible with known residue sequences of H-2-Ld binding peptides. Hence, the remaining residues were modeled after the  QL9 sequence.;;;;;;;;;;;;mouse (Mus musculus);10090;Table 3 and PDB 1LDP;x-ray crystallography;3D structure;angstroms;Positive;=;3.1;1LDP;H2-Ld;I;"For the crystallization of the MHC/Epitope complex, the MHC with a mixture of bound peptide were used. Then, the crystal structure was used to construct two peptide models. Thus, the structure contains two peptide models in the MHC binding groove. The first model is a nine-residue (P1&ndash;P9) polyalanine peptide, based on the influenza NP epitope bound to H-2-Db [PDB: 1HOC]. The clear side chain electron density at P2 and P9 allowed the placement of these residues in the model, but the other residues were left as alanines. In the second peptide model, apart from the well defined P2 and P9 residues, the electron density for the remainder of the peptide indicated the presence of a broader range of residues compatible with known residue sequences of H-2-Ld binding peptides. Hence, the remaining residues were modeled after the  QL9 sequence. This peptide fit the electron density well. But, no single peptide model ideally represented the electron density of a peptide mixture. This assay refers to the second model."
1595531;1013616;Literature;17719062;"Oleg Y Borbulevych; Francis K Insaidoo; Tiffany K Baxter; Daniel J Powell Jr; Laura A Johnson; Nicholas P Restifo; Brian M Baker";J Mol Biol;2007;Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition.;;155;Linear peptide;AAGIGILTV;27;35;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Q16655;Homo sapiens;Homo sapiens;9606;The epitope is a MART-1/Melan-A 27-35 peptide.;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figures 1, 2, 3, S1, S2, S5 and 2GUO (molecule 1);x-ray crystallography;3D structure;angstroms;Positive;=;1.9;2GUO;HLA-A*02:01;I;"There are two MHC/Epitope molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Molecule 1 (MOL 1) : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Molecule 2 (MOL 2) : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. Each MHC molecule in the asymmetric unit presents the peptide slightly differently. Residue P4 has different rotations in the two molecules, suggesting that this side chain is highly mobile. Residue P5 shows an alpha carbon shift of 0.5 &Aring;. Also, residue P7 is particularly dynamic, as its side chain was refined in two different conformations in MOL 2. This assay refers to Molecule 1."
1595533;1013616;Literature;17719062;"Oleg Y Borbulevych; Francis K Insaidoo; Tiffany K Baxter; Daniel J Powell Jr; Laura A Johnson; Nicholas P Restifo; Brian M Baker";J Mol Biol;2007;Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition.;;98690;Linear peptide;ALGIGILTV;;;;;;;;;;The epitope is an analog of a MART-1/Melan-A 27-35 peptide with the mutation: A2 -> L2.;analog;Fragment of a Natural Sequence Molecule;AAGIGILTV;27;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 2, Figures 1, 2, 3, S1, S4, S5 and 2GTZ (molecule 1);x-ray crystallography;3D structure;angstroms;Positive;=;1.7;2GTZ;HLA-A*02:01;I;"There are two MHC/epitope molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Molecule 1 (MOL 1A, MOL 1B) : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Molecule 2 (MOL 2) : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. Each MHC molecule in the asymmetric unit presents the peptide slightly differently. This structure shows the greatest main chain diversity, as the main chain in the center of the peptide in the first molecule occupies two discrete positions, termed MOL 1A and MOL 1B, with the alternative (MOL 1B) position occurring via large rotations in residue P4 of 147 degrees and in P5 of 207 degrees. Residue P5 shows an alpha carbon shift of 1.7 &Aring;, in the three different epitope positions. The side of residue P4 shifts by an almost 180 degrees flip in the two molecules, suggesting this side chain is highly mobile. Also, residue P7 is particularly dynamic, as its side chain was refined in two different conformations in MOL 2. clear electron density was observed for each of the various peptide conformations. This assay refers to Molecule 1."
1595535;1013616;Literature;17719062;"Oleg Y Borbulevych; Francis K Insaidoo; Tiffany K Baxter; Daniel J Powell Jr; Laura A Johnson; Nicholas P Restifo; Brian M Baker";J Mol Biol;2007;Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition.;;99827;Linear peptide;LAGIGILTV;;;;;;;;;;The epitope is an analog of a MART-1/Melan-A 27-35 peptide with the mutation: A1 -> L1.;analog;Fragment of a Natural Sequence Molecule;AAGIGILTV;27;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 2, Figures 1, 2, 3, S1, S3, S5 and 2GTW;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;2GTW;HLA-A*02:01;I;There are two MHC/epitope molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Molecule 1 (MOL 1) : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Molecule 2 (MOL 2) : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. Residue P7 showed conformational heterogeneity as it was refined in two conformations for both molecules.
1595537;1013616;Literature;17719062;"Oleg Y Borbulevych; Francis K Insaidoo; Tiffany K Baxter; Daniel J Powell Jr; Laura A Johnson; Nicholas P Restifo; Brian M Baker";J Mol Biol;2007;Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition.;;10987;Linear peptide;EAAGIGILTV;26;35;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Q16655;Homo sapiens;Homo sapiens;9606;The epitope is a MART-1/Melan-A 26-35 peptide.;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figures 1, 2, 3, S1, S2, S3, S4, S5 and 2GT9;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;2GT9;HLA-A*02:01;I;There are two MHC/epitope molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Molecule 1 (MOL 1) : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Molecule 2 (MOL 2) : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F.
1595543;1013634;Literature;10023770;"J A Speir; U M Abdel-Motal; M Jondal; I A Wilson";Immunity;1999;Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL.;;97602;Linear peptide;RGYVYQGL + GLYC(Q6);52;59;;nucleocapsid protein;Uncharacterized protein;Q89035;Vesicular stomatitis virus;Vesicular stomatitis virus;11276;The epitope is a modified VSV-8 peptide. The modification is glycosylation, with a galabiose (Gal-alpha(1,4)Gal-beta) glycan coupled to position 6 of the epitope via a homocysteine linker.;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 2, 3, Tables 2, 3 and PDB 1KBG;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1KBG;H2-Kb;I;Electron density for the epitope was continuous and well resolved, allowing unambiguous modeling of the glycosylated peptide. The modified P6 residue (HggP6) makes contacts with the beta2-m subunit of a neighboring H-2-Kb molecule in the crystal lattice.
1595545;1013620;Literature;7862664;"E J Collins; D N Garboczi; M N Karpusas; D C Wiley";Proc Natl Acad Sci U S A;1995;The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chain.;;14628;Linear peptide;EVAPPEYHRK;312;321;;MRG15 protein;Mortality factor 4-like protein 1;Q9UBU8;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3 and PDB 1TMC;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1TMC;HLA-A*68:01;I;The MHC molecule used had its alpha3 domain proteolytically removed. Unambiguous electron density was observed for the peptide except for the side chains of P7 and P9, which extend into solvent and may be disordered. Also, P9 contacts the beta2-m domain of another molecule in the crystal.
1596339;1013636;Literature;11751972;"David A Ostrov; Matthew M Roden; Wuxian Shi; Edith Palmieri; Gregory J Christianson; Lisa Mendoza; Gilbert Villaflor; Darcie Tilley; Nilabh Shastri; Howard Grey; Steven C Almo; Derry Roopenian; Stanley G Nathenson";J Immunol;2002;How H13 histocompatibility peptides differing by a single methyl group and lacking conventional MHC binding anchor motifs determine self-nonself discrimination.;;97661;Linear peptide;SSVVGVWYL;169;177;;Minor histocompatibility antigen H13;Minor histocompatibility antigen H13;Q9D8V0;Mus musculus;Mus musculus;10090;The epitope is a peptide from H13 (H13a).;;;;;;;;;;;;mouse (Mus musculus);10090;Table 1 and Figures 1, 2, 3, 4 and PDB 1INQ;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1INQ;H2-Db;I;
1596340;1013636;Literature;11751972;"David A Ostrov; Matthew M Roden; Wuxian Shi; Edith Palmieri; Gregory J Christianson; Lisa Mendoza; Gilbert Villaflor; Darcie Tilley; Nilabh Shastri; Howard Grey; Steven C Almo; Derry Roopenian; Stanley G Nathenson";J Immunol;2002;How H13 histocompatibility peptides differing by a single methyl group and lacking conventional MHC binding anchor motifs determine self-nonself discrimination.;;97660;Linear peptide;SSVIGVWYL;107;115;;minor histocompatibility antigen H13 isoform 1 [Mus musculus];Minor histocompatibility antigen H13;Q9D8V0;Mus musculus;Mus musculus;10090;The epitope is a peptide from H13 (H13b).;;;;;;;;;;;;mouse (Mus musculus);10090;Table 1 and Figures 1, 2, 3, 4 and PDB 1JUF;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;1JUF;H2-Db;I;
1597581;1013635;Literature;11544315;"P Sliz; O Michielin; J C Cerottini; I Luescher; P Romero; M Karplus; D C Wiley";J Immunol;2001;Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes.;;98690;Linear peptide;ALGIGILTV;;;;;;;;;;The epitope is an analog of a Melan-A/MART-1(27-35) peptide with the mutation: A2 -> L2. This analog was used because the MHC/natural peptide complexes are too unstable to purify and crystallize.;analog;Fragment of a Natural Sequence Molecule;AAGIGILTV;27;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Tables II, III, Figures 1, 2, 3 and PDB 1JHT;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1JHT;HLA-A*02:01;I;There was clear electron density for the epitope residues, except P4 and P5.
1597582;1013635;Literature;11544315;"P Sliz; O Michielin; J C Cerottini; I Luescher; P Romero; M Karplus; D C Wiley";J Immunol;2001;Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes.;;12941;Linear peptide;ELAGIGILTV;;;;;;;;;;The epitope is an analog of a Melan-A/MART-1(26-35) peptide with the mutation: A2 -> L2. This analog was used because the MHC/natural peptide complexes are too unstable to purify and crystallize.;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Tables II, III, Figures 1, 2, 3 and PDB 1JF1;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;1JF1;HLA-A*02:01;I;There was clear electron density for the epitope residues, except for the Calpha atom of residue P*. Also, there are two alternate conformations for residue P7.
1602966;1013947;Literature;12083518;"Vasso Apostolopoulos; Minmin Yu; Adam L Corper; Luc Teyton; Geoffrey A Pietersz; Ian F C McKenzie; Ian A Wilson; Magdalena Plebanski";J Mol Biol;2002;Crystal structure of a non-canonical low-affinity peptide complexed with MHC class I: a new approach for vaccine design.;;98995;Linear peptide;SAPDTRPA;140;147;;Mucin-1 precursor;Mucin-1;P15941;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;mouse (Mus musculus);10090;Table 2, Figure 2, 3, 4, 5 and PDB 1G7Q;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;1G7Q;H2-Kb;I;There was continuous and well resolved electron density for the peptide, except for the hydroxyl group of residue P5, which had weak density.
1602967;1013946;Literature;12083519;"Vasso Apostolopoulos; Minmin Yu; Adam L Corper; Wenjun Li; Ian F C McKenzie; Luc Teyton; Ian A Wilson; Magdalena Plebanski";J Mol Biol;2002;Crystal structure of a non-canonical high affinity peptide complexed with MHC class I: a novel use of alternative anchors.;;96918;Linear peptide;SRDHSRTPM;438;446;;Alpha-glucosidase MAL62;Alpha-glucosidase MAL32;P38158;Saccharomyces cerevisiae;Saccharomyces cerevisiae;4932;;;;;;;;;;;;;mouse (Mus musculus);10090;Table 3, Figures 1, 2, 3, 4 and PDB 1G7P;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;1G7P;H2-Kb;I;There was continuous and well resolved electron density for the peptide, except for the side chain density of residue P6.
1602968;1013639;Literature;15713487;"Martin H&uuml;lsmeyer; Karin Welfle; Thomas P&ouml;hlmann; Rolf Misselwitz; Ulrike Alexiev; Heinz Welfle; Wolfram Saenger; Barbara Uchanska-Ziegler; Andreas Ziegler";J Mol Biol;2005;Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide.;;98989;Linear peptide;RRLPIFSRL;481;489;;Butyrate response factor 2;Zinc finger protein 36, C3H1 type-like 2;P47974;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 2, 3, Figures 3, 4 and PDB 1W0V;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1W0V;HLA-B*27:05;I;The electron density was well defined in the peptide binding groove.
1602969;1013639;Literature;15713487;"Martin H&uuml;lsmeyer; Karin Welfle; Thomas P&ouml;hlmann; Rolf Misselwitz; Ulrike Alexiev; Heinz Welfle; Wolfram Saenger; Barbara Uchanska-Ziegler; Andreas Ziegler";J Mol Biol;2005;Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide.;;98989;Linear peptide;RRLPIFSRL;481;489;;Butyrate response factor 2;Zinc finger protein 36, C3H1 type-like 2;P47974;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 2, 3, Figures 3, 4 and PDB 1W0W;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;1W0W;HLA-B*27:09;I;The electron density was well defined in the peptide binding groove.
1603260;1013638;Literature;12939341;"Whitney A Macdonald; Anthony W Purcell; Nicole A Mifsud; Lauren K Ely; David S Williams; Linus Chang; Jeffrey J Gorman; Craig S Clements; Lars Kjer-Nielsen; David M Koelle; Scott R Burrows; Brian D Tait; Rhonda Holdsworth; Andrew G Brooks; George O Lovrecz; Louis Lu; Jamie Rossjohn; James McCluskey";J Exp Med;2003;A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition.;;95009;Linear peptide;EEFGRAFSF;46;54;;MHC class II HLA-DPA1 antigen;HLA class II histocompatibility antigen, DP alpha 1 chain;P20036;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table II, S1 Figures 4, 6, 7 and PDB 1M6O;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;1M6O;HLA-B*44:02;I;The electron density for the bound peptide, as well as the interacting residues, was unambiguous.
1603261;1013638;Literature;12939341;"Whitney A Macdonald; Anthony W Purcell; Nicole A Mifsud; Lauren K Ely; David S Williams; Linus Chang; Jeffrey J Gorman; Craig S Clements; Lars Kjer-Nielsen; David M Koelle; Scott R Burrows; Brian D Tait; Rhonda Holdsworth; Andrew G Brooks; George O Lovrecz; Louis Lu; Jamie Rossjohn; James McCluskey";J Exp Med;2003;A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition.;;95009;Linear peptide;EEFGRAFSF;46;54;;MHC class II HLA-DPA1 antigen;HLA class II histocompatibility antigen, DP alpha 1 chain;P20036;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table II, S1, Figures 4, 5, 7 and PDB 1N2R;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;1N2R;HLA-B*44:03;I;The electron density for the bound peptide, as well as the interacting residues, was unambiguous.
1603262;1013948;Literature;18549801;"Diana Chessman; Lyudmila Kostenko; Tessa Lethborg; Anthony W Purcell; Nicholas A Williamson; Zhenjun Chen; Lars Kjer-Nielsen; Nicole A Mifsud; Brian D Tait; Rhonda Holdsworth; Coral Ann Almeida; David Nolan; Whitney A Macdonald; Julia K Archbold; Anthony D Kellerher; Debbie Marriott; Simon Mallal; Mandvi Bharadwaj; Jamie Rossjohn; James McCluskey";Immunity;2008;Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.;;98894;Linear peptide;LSSPVTKSF;93;101;;Ig kappa chain C region;Ig kappa chain C region;;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 6, Table S1 and PDB 2RFX;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;2RFX;HLA-B*57:01;I;
1603433;1013640;Literature;16323248;"David K Cole; Pierre J Rizkallah; Feng Gao; Neil I Watson; Jonathan M Boulter; John I Bell; Malkit Sami; George F Gao; Bent K Jakobsen";Eur J Immunol;2006;Crystal structure of HLA-A*2402 complexed with a telomerase peptide.;;99851;Linear peptide;VYGFVRACL;461;469;;Telomerase reverse transcriptase;Telomerase reverse transcriptase;O14746;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, Figures 1, 2, 3, 4 and 2BCK;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;2BCK;HLA-A*24:02;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex II : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. The two molecules form a dimer linked by a sulfate mediated salt-bridge. Also, a pseudo twofold axis, centered on the sulfur atom, is formed between residues A: R79 and A: R83 of the one molecule and their equivalents of the other molecule. The peptides in the two molecules retain conserved conformations with respect to the buried residues, but show significant differences around P4 and P6 due to the inherent flexibility of the exposed residues.
1603434;1013645;Literature;18973345;"Lindsay L Jones; Leremy A Colf; Alexander J Bankovich; Jennifer D Stone; Yi-Gui Gao; Choi Mui Chan; Raven H Huang; K Christopher Garcia; David M Kranz";Biochemistry;2008;Different thermodynamic binding mechanisms and peptide fine specificities associated with a panel of structurally similar high-affinity T cell receptors.;;97581;Linear peptide;QLSPFPFDL;932;940;;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Q60597;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Table 2, Figure 6 and PDB 3ERY;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3ERY;H2-Ld;I;A platform Ld module containing only the alpha1 and alpha2 domains and five stability mutations (N30D, A49V, I66V, W97R, and K131R), called Ld-m31, was used for binding. There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, epitope chain: P. Complex II : MHC alpha-chain: B, epitope chain: Q. The beta2-m chain was missing from the MHC molecule. There was no discernible electron density  for the side chain of the central P5 residue. The peptide conformation in Complex I is similar to that of the TCR 2C with H-2-Ld/QL9 [PDB: 2OI9] structure, but in Complex II, the peptide structure is altered. Complex II contained large areas of the MHC molecule (residues 41-61 and 171-175) and the P2 of the peptide that did not contain adequate electron density to determine the structure. Moreover, the peptide region of Complex II had multiple contacts with the alpha2 helix of Complex I. In contrast, Complex I had good electron density throughout and the peptide region contained considerably fewer contacts with Complex II. For these reasons, only Complex I is used in the analysis.
1603587;1013644;Literature;18949029;"Noah S Butler; Alex Theodossis; Andrew I Webb; Roza Nastovska; Sri Harsha Ramarathinam; Michelle A Dunstone; Jamie Rossjohn; Anthony W Purcell; Stanley Perlman";PLoS Pathog;2008;Prevention of cytotoxic T cell escape using a heteroclitic subdominant viral T cell determinant.;;99840;Linear peptide;RCQIFANI + ABA(C2);;;;;;;;;;In order for the MHC/Epitope complexes to form readily, the C2 residue was modified with L-alpha-aminobutyric acid (Aba, an isostereomer of cysteine).;analog;Fragment of a Natural Sequence Molecule;RCQIFANI;598;605;;;spike glycoprotein (S);Spike glycoprotein;Murine hepatitis virus strain JHM;Murine coronavirus;mouse (Mus musculus);10090;Figures 5, 6, S3, Tables S1, S2 and PDB 2ZSV;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;2ZSV;H2-Kb;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-m chain: B, epitope chain: E. Complex II : MHC alpha-chain: C, beta2-m chain: D, epitope chain: F. The peptides in the two complexes display a virtually identical conformation.
1603588;1013644;Literature;18949029;"Noah S Butler; Alex Theodossis; Andrew I Webb; Roza Nastovska; Sri Harsha Ramarathinam; Michelle A Dunstone; Jamie Rossjohn; Anthony W Purcell; Stanley Perlman";PLoS Pathog;2008;Prevention of cytotoxic T cell escape using a heteroclitic subdominant viral T cell determinant.;;99841;Linear peptide;RCYIFANI + ABA(C2);;;;;;;;;;The epitope is an analog of S598 with the mutation: Q3->Y3. Also, in order for the MHC/Epitope complexes to form readily, the C2 residue was modified with L-alpha-aminobutyric acid (Aba, an isostereomer of cysteine).;analog;Fragment of a Natural Sequence Molecule;RCQIFANI;598;605;;;spike glycoprotein (S);Spike glycoprotein;Murine hepatitis virus strain JHM;Murine coronavirus;mouse (Mus musculus);10090;Figures 5, 6, S3, Tables S1, S2 and PDB 2ZSW;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;2ZSW;H2-Kb;I;There are four molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-m chain: H, epitope chain: M. Complex II : MHC alpha-chain: C, beta2-m chain: B, epitope chain: N. Complex III : MHC alpha-chain: E, beta2-m chain: D, epitope chain: O. Complex IV : MHC alpha-chain: G, beta2-m chain: F, epitope chain: P. the four copies of the peptide adopt virtually identical conformations.
1605391;1013616;Literature;17719062;"Oleg Y Borbulevych; Francis K Insaidoo; Tiffany K Baxter; Daniel J Powell Jr; Laura A Johnson; Nicholas P Restifo; Brian M Baker";J Mol Biol;2007;Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition.;;155;Linear peptide;AAGIGILTV;27;35;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Q16655;Homo sapiens;Homo sapiens;9606;The epitope is a MART-1/Melan-A 27-35 peptide.;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figures 1, 2, 3, S1, S2, S5 and 2GUO (molecule 2);x-ray crystallography;3D structure;angstroms;Positive;=;1.9;2GUO;HLA-A*02:01;I;"There are two MHC/epitope molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Molecule 1 (MOL 1) : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Molecule 2 (MOL 2) : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. Each MHC molecule in the asymmetric unit presents the peptide slightly differently. Residue P4 has different rotations in the two molecules, suggesting that this side chain is highly mobile. Residue P5 shows an alpha carbon shift of 0.5 &Aring;. Also, residue P7 is particularly dynamic, as its side chain was refined in two different conformations in MOL 2. This assay refers to Molecule 2."
1605392;1013616;Literature;17719062;"Oleg Y Borbulevych; Francis K Insaidoo; Tiffany K Baxter; Daniel J Powell Jr; Laura A Johnson; Nicholas P Restifo; Brian M Baker";J Mol Biol;2007;Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition.;;98690;Linear peptide;ALGIGILTV;;;;;;;;;;The epitope is an analog of a MART-1/Melan-A 27-35 peptide with the mutation: A2 -> L2.;analog;Fragment of a Natural Sequence Molecule;AAGIGILTV;27;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 2, Figures 1, 2, 3, S1, S4, S5 and 2GTZ (molecule 2);x-ray crystallography;3D structure;angstroms;Positive;=;1.7;2GTZ;HLA-A*02:01;I;"There are two MHC/epitope molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Molecule 1 (MOL 1A, MOL 1B) : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Molecule 2 (MOL 2) : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. Each MHC molecule in the asymmetric unit presents the peptide slightly differently. This structure shows the greatest main chain diversity, as the main chain in the center of the peptide in the first molecule occupies two discrete positions, termed MOL 1A and MOL 1B, with the alternative (MOL 1B) position occurring via large rotations in residue P4 of 147 degrees and in P5 of 207 degrees. Residue P5 shows an alpha carbon shift of 1.7 &Aring;, in the three different epitope positions. The side of residue P4 shifts by an almost 180 degrees flip in the two molecules, suggesting this side chain is highly mobile. Also, residue P7 is particularly dynamic, as its side chain was refined in two different conformations in MOL 2. clear electron density was observed for each of the various peptide conformations. This assay refers to Molecule 2."
1617224;1013977;Literature;11911820;"Jean Baptiste Reiser; Claude Gr&eacute;goire; Claudine Darnault; Thomas Mosser; Annick Guimezanes; Anne Marie Schmitt-Verhulst; Juan Carlos Fontecilla-Camps; Gilbert Mazza; Bernard Malissen; Dominique Housset";Immunity;2002;A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex.;;34055;Linear peptide;KVITFIDL;246;253;;GTP binding protein 1;GTP-binding protein 1;O08582;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 1, 2, Table 1, S3 and PDB 1KJ3;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1KJ3;H2-Kb;I;The crystal structure of the epitope bound to MHC-Kb was determined. There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I: MHC alpha-chain: H, beta2-m chain: L, epitope chain: P. Complex II: MHC alpha-chain: I, beta2-m chain: M, epitope chain: Q.
1617227;1013984;Literature;11994422;"John G Luz; Mingdong Huang; K Christopher Garcia; Markus G Rudolph; Vasso Apostolopoulos; Luc Teyton; Ian A Wilson";J Exp Med;2002;Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) Interactions.;;100016;Linear peptide;EQYKFYSV;61;68;;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4;Cytochrome c oxidase subunit NDUFA4;Q62425;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Table I, Figures 1, 2 and PDB 1LEG;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;1LEG;H2-Kb;I;
1649808;1013101;Literature;18650441;"Alessandra Beltrami; Maxim Rossmann; Maria Teresa Fiorillo; Fabiana Paladini; Rosa Sorrentino; Wolfram Saenger; Pravin Kumar; Andreas Ziegler; Barbara Uchanska-Ziegler";J Biol Chem;2008;Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes.;;108103;Linear peptide;RRKWRRWHL + CITR(R5);400;408;;Vasoactive intestinal polypeptide receptor 1 precursor;Vasoactive intestinal polypeptide receptor 1;P32241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1 and 2, Figures 1, 2, 3, 4 and PDB 3B6S;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3B6S;HLA-B*27:05;I;
1649810;1013101;Literature;18650441;"Alessandra Beltrami; Maxim Rossmann; Maria Teresa Fiorillo; Fabiana Paladini; Rosa Sorrentino; Wolfram Saenger; Pravin Kumar; Andreas Ziegler; Barbara Uchanska-Ziegler";J Biol Chem;2008;Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes.;;108103;Linear peptide;RRKWRRWHL + CITR(R5);400;408;;Vasoactive intestinal polypeptide receptor 1 precursor;Vasoactive intestinal polypeptide receptor 1;P32241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1 and 2, Figures 1, 2, 3, 4 and PDB 3B3I;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3B3I;HLA-B*27:09;I;
1709829;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;44920;Linear peptide;NLVPMVATV;485;493;;pp65;65 kDa phosphoprotein;Q6SW59;Human betaherpesvirus 5;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, S3, Table S1 and PDB 3GSO;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;3GSO;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
1713844;1018721;Literature;20064447;"Oleg Y Borbulevych; Kurt H Piepenbrink; Brian E Gloor; Daniel R Scott; Ruth F Sommese; David K Cole; Andrew K Sewell; Brian M Baker";Immunity;2009;T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility.;;42094;Linear peptide;MLWGYLQYV;549;557;;telomer length regulation protein TEL1;Serine/threonine-protein kinase TEL1;P38110;Saccharomyces cerevisiae RM11-1a;Saccharomyces cerevisiae;4932;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 1, S1 and PDB 3H7B;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3H7B;HLA-A*02:01;I;Mutation of the HLA-A2 heavy chain with A150P led to higher binding of the epitope.
1714848;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;135859;Linear peptide;NLVPSVATV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;NLVPMVATV;485;493;;;pp65;65 kDa phosphoprotein;Human betaherpesvirus 5;Human betaherpesvirus 5;human (Homo sapiens);9606;Figure S5, Table S1 and PDB 3GSQ;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3GSQ;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was solved by molecular replacement.
1714850;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;135861;Linear peptide;NLVPVVATV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;NLVPMVATV;485;493;;;pp65;65 kDa phosphoprotein;Human betaherpesvirus 5;Human betaherpesvirus 5;human (Homo sapiens);9606;Figure S5, Table S1 and PDB 3GSR;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3GSR;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was solved by molecular replacement.
1714851;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;135860;Linear peptide;NLVPTVATV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;NLVPMVATV;485;493;;;pp65;65 kDa phosphoprotein;Human betaherpesvirus 5;Human betaherpesvirus 5;human (Homo sapiens);9606;Figure S5, Table S1 and PDB 3GSU;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3GSU;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was solved by molecular replacement.
1714853;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;135858;Linear peptide;NLVPQVATV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;NLVPMVATV;485;493;;;pp65;65 kDa phosphoprotein;Human betaherpesvirus 5;Human betaherpesvirus 5;human (Homo sapiens);9606;Figure S5, Table S1 and PDB 3GSV;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3GSV;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was solved by molecular replacement.
1714854;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;135856;Linear peptide;NLVPMVAAV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;NLVPMVATV;485;493;;;pp65;65 kDa phosphoprotein;Human betaherpesvirus 5;Human betaherpesvirus 5;human (Homo sapiens);9606;Figure S5, Table S1 and PDB 3GSW;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3GSW;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was solved by molecular replacement.
1714855;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;135857;Linear peptide;NLVPMVAVV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;NLVPMVATV;485;493;;;pp65;65 kDa phosphoprotein;Human betaherpesvirus 5;Human betaherpesvirus 5;human (Homo sapiens);9606;Figure S5, Table S1 and PDB 3GSX;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3GSX;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was solved by molecular replacement.
1769828;1019190;Literature;20212169;"Alex Theodossis; Carole Guillonneau; Andrew Welland; Lauren K Ely; Craig S Clements; Nicholas A Williamson; Andrew I Webb; Jacqueline A Wilce; Roger J Mulder; Michelle A Dunstone; Peter C Doherty; James McCluskey; Anthony W Purcell; Stephen J Turner; Jamie Rossjohn";Proc Natl Acad Sci U S A;2010;Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.;;135302;Linear peptide;SSLENARAYV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;SSLENFRAYV;224;233;;RNA-directed RNA polymerase subunit P2;Polymerase acidic protein;Polymerase acidic protein;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;mouse (Mus musculus);10090;Figures 3, S3, Table S1 and PDB 3L3H;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;3L3H;H2-Db;I;The crystal structure of the epitope in complex with H-2Db was determined. There is one molecule in the asymmetric unit.
1769982;1019199;Literature;19955560;"Yeping Sun; Jun Liu; Meng Yang; Feng Gao; Jianfang Zhou; Yoshihiro Kitamura; Bin Gao; Po Tien; Yuelong Shu; Aikichi Iwamoto; Zhu Chen; George F Gao";J Gen Virol;2010;Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses.;;135263;Linear peptide;RLYQNPTTYI;204;213;;hemagglutinin;Hemagglutinin;P03452;Influenza A virus (A/Bar-headed Goose/Qinghai/61/05(H5N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;3MGO;HLA-A*02:01;I;The crystallographic asymmetrical unit contains four complex molecules with the peptides adopting the same conformation and there were no direct lattice contacts involving the peptides. The electron densities of RI-10 and KI-10 [PDB: 3MGT] peptides unambiguously identify their anchor residues Leu2 and Ile10, which point downwards and tether the peptides in the antigen-binding groove (Fig. 5a, b).
1769983;1019199;Literature;19955560;"Yeping Sun; Jun Liu; Meng Yang; Feng Gao; Jianfang Zhou; Yoshihiro Kitamura; Bin Gao; Po Tien; Yuelong Shu; Aikichi Iwamoto; Zhu Chen; George F Gao";J Gen Virol;2010;Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses.;;32268;Linear peptide;KLYQNPTTYI;205;214;;hemagglutinin;Hemagglutinin;P03452;Influenza A virus (A/Bar-headed Goose/Qinghai/61/05(H5N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;3MGT;HLA-A*02:01;I;The crystallographic asymmetrical unit contains four complex molecules with the peptides adopting the same conformation and there were no direct lattice contacts involving the peptides. The electron densities of RI-10 [PDB: 3MGO] and KI-10 [PDB: 3MGT] peptides unambiguously identify their anchor residues Leu2 and Ile10, which point downwards and tether the peptides in the antigen-binding groove (Fig. 5a, b).
1770487;1019046;Literature;20093428;"Daniel R Brims; Jie Qian; Irene Jarchum; Leann Mikesh; Edith Palmieri; Udupi A Ramagopal; Vladimir N Malashkevich; Rodolfo J Chaparro; Torben Lund; Masakazu Hattori; Jeffrey Shabanowitz; Donald F Hunt; Stanley G Nathenson; Steven C Almo; Teresa P Dilorenzo";Int Immunol;2010;Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect.;;135864;Linear peptide;VNDIFERI;67;74;;H2B histone family, member S;Histone H2B type F-S;P57053;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;mouse (Mus musculus);10090;Table 2, Fig. 3;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;3FOL;H2-Kwm7;I;"H-2Kb and H-2Kd, the allele naturally present in NOD mice, share 90 and 85% sequence identity with H-2Kwm7, respectively (Fig. 2A and B). Structural comparison of H-2Kb [PDB: 1KPU] and H-2Kd [PDB: 1VGK] with H-2Kwm7 in this complex with VNDIFERI peptide shows that the quaternary structure of H-2Kwm7 conforms to the canonical MHC fold (Fig. 3A). Crystallographic analysis did not provide an explanation for the remarkable conservation of Arg at P7 of the peptides purified from H-2Kwm7 molecules (Table 1; Fig. 1D), as this residue was found to be solvent exposed rather than serving as an anchor."
1770489;1019046;Literature;20093428;"Daniel R Brims; Jie Qian; Irene Jarchum; Leann Mikesh; Edith Palmieri; Udupi A Ramagopal; Vladimir N Malashkevich; Rodolfo J Chaparro; Torben Lund; Masakazu Hattori; Jeffrey Shabanowitz; Donald F Hunt; Stanley G Nathenson; Steven C Almo; Teresa P Dilorenzo";Int Immunol;2010;Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect.;;135854;Linear peptide;IQQSIERL;119;126;;NHP2-like protein 1;NHP2-like protein 1;P55769;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;mouse (Mus musculus);10090;Table 2, Fig. 3;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3FOM;H2-Kwm7;I;In the structure, the peptide was used with Ile8 (not Leu8) residue.
1770490;1019046;Literature;20093428;"Daniel R Brims; Jie Qian; Irene Jarchum; Leann Mikesh; Edith Palmieri; Udupi A Ramagopal; Vladimir N Malashkevich; Rodolfo J Chaparro; Torben Lund; Masakazu Hattori; Jeffrey Shabanowitz; Donald F Hunt; Stanley G Nathenson; Steven C Almo; Teresa P Dilorenzo";Int Immunol;2010;Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect.;;135863;Linear peptide;VNDIFEAI;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;VNDIFERI;67;74;;histone protein;H2B histone family, member S;Histone H2B type F-S;Homo sapiens;Homo sapiens;mouse (Mus musculus);10090;Table 2, Fig. 3;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3FON;H2-Kwm7;I;
1773141;1012894;Literature;10755612;"M Degano; K C Garcia; V Apostolopoulos; M G Rudolph; L Teyton; I A Wilson";Immunity;2000;A functional hot spot for antigen recognition in a superagonist TCR/MHC complex.;;58773;Linear peptide;SIYRYYGL;;;;;;;;;;The epitope is a synthetic peptide chosen for being the most efficient peptide to induce 2C TCR responses [PMID: 8752916].;analog;Fragment of a Natural Sequence Molecule;EQYKFYSV;61;68;;Ndufa4;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4;Cytochrome c oxidase subunit NDUFA4;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Table 1 and Figures 2, 4 and PDB 1G6R;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;1G6R;H2-Kb;I;
1773143;1013535;Literature;8906788;"D N Garboczi; P Ghosh; U Utz; Q R Fan; W E Biddison; D C Wiley";Nature;1996;Structure of the complex between human T-cell receptor, viral peptide and HLA-A2.;;37257;Linear peptide;LLFGYPVYV;11;19;;transcriptional activator Tax;Protein Tax-1;P14079;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;194440;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1 and Figures 1, 2, 3 and PDB 1AO7;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;1AO7;HLA-A*02:01;I;A ternary complex containing a soluble A6 alphabetaTCR with the Tax peptide bound to HLA-A2 was crystallized and the structure determined.
1774557;1013584;Literature;9892618;"R Zhao; D J Loftus; E Appella; E J Collins";J Exp Med;1999;Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry.;;2999;Linear peptide;ALWGFFPVL;4;12;;chromosome 15 open reading frame 24;ER membrane protein complex subunit 7;Q9NPA0;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables I, II, Figures 1, 2, 4, 5, 6 and PDB 1B0G;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;1B0G;HLA-A*02:01;I;The crystal structure of HLA-A*0201 complexed with the epitope p1049 was determined using the molecular replacement method. The epitope complexed with A2 is recognized by TCR AHIII12.2 from a CD8+ CTL clone derived from a C57BL/6 mouse injected with the human lymphoblastoid cell line JY. There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex II : MHC alpha-chain: d, beta2-m chain: e, epitope chain: F. Epitope main chain density is relatively weak near residue P5. This may indicate some flexibility around the middle of the peptide.
1778390;1019711;Literature;19234124;"Sarah Nicholls; Karen P Piper; Fiyaz Mohammed; Timothy R Dafforn; Stefan Tenzer; Mahboob Salim; Premini Mahendra; Charles Craddock; Peter van Endert; Hansj&ouml;rg Schild; Mark Cobbold; Victor H Engelhard; Paul A H Moss; Benjamin E Willcox";Proc Natl Acad Sci U S A;2009;Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.;;136896;Linear peptide;VLHDDLLEA;137;145;;histocompatibility (minor) HA-1;Minor histocompatibility protein HA-1;Q92619;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, Table S1 and PDB 3D25;x-ray crystallography;3D structure;angstroms;Positive;=;1.3;3D25;HLA-A*02:01;I;
1778864;1017865;Literature;20064448;"Whitney A Macdonald; Zhenjun Chen; Stephanie Gras; Julia K Archbold; Fleur E Tynan; Craig S Clements; Mandvi Bharadwaj; Lars Kjer-Nielsen; Philippa M Saunders; Matthew C J Wilce; Fran Crawford; Brian Stadinsky; David Jackson; Andrew G Brooks; Anthony W Purcell; John W Kappler; Scott R Burrows; Jamie Rossjohn; James McCluskey";Immunity;2009;T cell allorecognition via molecular mimicry.;;142137;Linear peptide;EEYLQAFTY;164;172;;ATP-binding cassette sub-family D member 3;ATP-binding cassette sub-family D member 3;P28288;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table S1, Figure S5 and PDB 3KPL;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3KPL;HLA-B*44:02;I;
1778880;1017865;Literature;20064448;"Whitney A Macdonald; Zhenjun Chen; Stephanie Gras; Julia K Archbold; Fleur E Tynan; Craig S Clements; Mandvi Bharadwaj; Lars Kjer-Nielsen; Philippa M Saunders; Matthew C J Wilce; Fran Crawford; Brian Stadinsky; David Jackson; Andrew G Brooks; Anthony W Purcell; John W Kappler; Scott R Burrows; Jamie Rossjohn; James McCluskey";Immunity;2009;T cell allorecognition via molecular mimicry.;;142137;Linear peptide;EEYLQAFTY;164;172;;ATP-binding cassette sub-family D member 3;ATP-binding cassette sub-family D member 3;P28288;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table S1, Figure S5 and PDB 3KPN;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3KPN;HLA-B*44:03;I;
1778881;1017865;Literature;20064448;"Whitney A Macdonald; Zhenjun Chen; Stephanie Gras; Julia K Archbold; Fleur E Tynan; Craig S Clements; Mandvi Bharadwaj; Lars Kjer-Nielsen; Philippa M Saunders; Matthew C J Wilce; Fran Crawford; Brian Stadinsky; David Jackson; Andrew G Brooks; Anthony W Purcell; John W Kappler; Scott R Burrows; Jamie Rossjohn; James McCluskey";Immunity;2009;T cell allorecognition via molecular mimicry.;;142137;Linear peptide;EEYLQAFTY;164;172;;ATP-binding cassette sub-family D member 3;ATP-binding cassette sub-family D member 3;P28288;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table S1, Figure S5 and PDB 3KPP;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3KPP;HLA-B*44:05;I;
1778883;1017865;Literature;20064448;"Whitney A Macdonald; Zhenjun Chen; Stephanie Gras; Julia K Archbold; Fleur E Tynan; Craig S Clements; Mandvi Bharadwaj; Lars Kjer-Nielsen; Philippa M Saunders; Matthew C J Wilce; Fran Crawford; Brian Stadinsky; David Jackson; Andrew G Brooks; Anthony W Purcell; John W Kappler; Scott R Burrows; Jamie Rossjohn; James McCluskey";Immunity;2009;T cell allorecognition via molecular mimicry.;;156273;Linear peptide;EEYLKAWTF;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EEYLQAFTY;164;172;;70 kDa peroxisomal membrane protein, PMP70;ATP-binding cassette sub-family D member 3;ATP-binding cassette sub-family D member 3;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table S1, Figure S5 and PDB 3KPM;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;3KPM;HLA-B*44:02;I;
1778884;1017865;Literature;20064448;"Whitney A Macdonald; Zhenjun Chen; Stephanie Gras; Julia K Archbold; Fleur E Tynan; Craig S Clements; Mandvi Bharadwaj; Lars Kjer-Nielsen; Philippa M Saunders; Matthew C J Wilce; Fran Crawford; Brian Stadinsky; David Jackson; Andrew G Brooks; Anthony W Purcell; John W Kappler; Scott R Burrows; Jamie Rossjohn; James McCluskey";Immunity;2009;T cell allorecognition via molecular mimicry.;;156273;Linear peptide;EEYLKAWTF;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EEYLQAFTY;164;172;;70 kDa peroxisomal membrane protein, PMP70;ATP-binding cassette sub-family D member 3;ATP-binding cassette sub-family D member 3;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table S1, Figure S5 and PDB 3KPQ;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3KPQ;HLA-B*44:05;I;
1778885;1017865;Literature;20064448;"Whitney A Macdonald; Zhenjun Chen; Stephanie Gras; Julia K Archbold; Fleur E Tynan; Craig S Clements; Mandvi Bharadwaj; Lars Kjer-Nielsen; Philippa M Saunders; Matthew C J Wilce; Fran Crawford; Brian Stadinsky; David Jackson; Andrew G Brooks; Anthony W Purcell; John W Kappler; Scott R Burrows; Jamie Rossjohn; James McCluskey";Immunity;2009;T cell allorecognition via molecular mimicry.;;156273;Linear peptide;EEYLKAWTF;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EEYLQAFTY;164;172;;70 kDa peroxisomal membrane protein, PMP70;ATP-binding cassette sub-family D member 3;ATP-binding cassette sub-family D member 3;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table S1, Figure S5 and PDB 3KPO;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;3KPO;HLA-B*44:03;I;
1779944;1017868;Literature;19617632;"Pravin Kumar; Ardeschir Vahedi-Faridi; Wolfram Saenger; Elena Merino; Jos&eacute; A L&oacute;pez de Castro; Barbara Uchanska-Ziegler; Andreas Ziegler";J Biol Chem;2009;Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens.;;150802;Linear peptide;IRAAPPPLF;2;10;;Lysosomal protective protein;Lysosomal protective protein;P10619;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, 4, Figures 2, 3, 4, 5, 6 and PDB 3BXN;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3BXN;HLA-B*14:02;I;
1779951;1017868;Literature;19617632;"Pravin Kumar; Ardeschir Vahedi-Faridi; Wolfram Saenger; Elena Merino; Jos&eacute; A L&oacute;pez de Castro; Barbara Uchanska-Ziegler; Andreas Ziegler";J Biol Chem;2009;Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens.;;150802;Linear peptide;IRAAPPPLF;2;10;;Lysosomal protective protein;Lysosomal protective protein;P10619;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, 4, Figures 2, 3, 4, 5, 6 and PDB 3BP4;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3BP4;HLA-B*27:05;I;
1779952;1017868;Literature;19617632;"Pravin Kumar; Ardeschir Vahedi-Faridi; Wolfram Saenger; Elena Merino; Jos&eacute; A L&oacute;pez de Castro; Barbara Uchanska-Ziegler; Andreas Ziegler";J Biol Chem;2009;Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens.;;150802;Linear peptide;IRAAPPPLF;2;10;;Lysosomal protective protein;Lysosomal protective protein;P10619;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, 4, Figures 2, 3, 4, 5, 6 and PDB 3BP7;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3BP7;HLA-B*27:09;I;
1780018;1011525;Literature;17644531;"Malkit Sami; Pierre J Rizkallah; Steve Dunn; Peter Molloy; Ruth Moysey; Annelise Vuidepot; Emma Baston; Penio Todorov; Yi Li; Feng Gao; Jonathan M Boulter; Bent K Jakobsen";Protein Eng Des Sel;2007;Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.;;59278;Linear peptide;SLLMWITQC;157;165;;Cancer/testis antigen 1;Cancer/testis antigen 1;P78358;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table II, Figure 1 and PDB 2PYE;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;2PYE;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex bound to the 1G4 c5c1 TCR was determined by molecular replacement.
1780020;1011525;Literature;17644531;"Malkit Sami; Pierre J Rizkallah; Steve Dunn; Peter Molloy; Ruth Moysey; Annelise Vuidepot; Emma Baston; Penio Todorov; Yi Li; Feng Gao; Jonathan M Boulter; Bent K Jakobsen";Protein Eng Des Sel;2007;Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.;;59278;Linear peptide;SLLMWITQC;157;165;;Cancer/testis antigen 1;Cancer/testis antigen 1;P78358;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table II, Figure 1 and PDB 2P5E;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;2P5E;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex bound to the 1G4 c58c61 TCR was determined by molecular replacement.
1780021;1011525;Literature;17644531;"Malkit Sami; Pierre J Rizkallah; Steve Dunn; Peter Molloy; Ruth Moysey; Annelise Vuidepot; Emma Baston; Penio Todorov; Yi Li; Feng Gao; Jonathan M Boulter; Bent K Jakobsen";Protein Eng Des Sel;2007;Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.;;59278;Linear peptide;SLLMWITQC;157;165;;Cancer/testis antigen 1;Cancer/testis antigen 1;P78358;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table II, Figure 1 and PDB 2P5W;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;2P5W;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex bound to the 1G4 c58c62 TCR was determined by molecular replacement.
1780033;1008123;Literature;10435578;"Y H Ding; B M Baker; D N Garboczi; W E Biddison; D C Wiley";Immunity;1999;Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical.;;37254;Linear peptide;LLFGYPRYV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LLFGYPVYV;11;19;;tax;transcriptional activator Tax;Protein Tax-1;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;1QSE;HLA-A*02:01;I;
1780034;1008123;Literature;10435578;"Y H Ding; B M Baker; D N Garboczi; W E Biddison; D C Wiley";Immunity;1999;Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical.;;37253;Linear peptide;LLFGYAVYV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LLFGYPVYV;11;19;;tax;transcriptional activator Tax;Protein Tax-1;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;1QRN;HLA-A*02:01;I;
1780037;1008123;Literature;10435578;"Y H Ding; B M Baker; D N Garboczi; W E Biddison; D C Wiley";Immunity;1999;Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical.;;37255;Linear peptide;LLFGYPVAV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LLFGYPVYV;11;19;;tax;transcriptional activator Tax;Protein Tax-1;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;1QSF;HLA-A*02:01;I;
1780057;1004497;Literature;17259989;"Fleur E Tynan; Hugh H Reid; Lars Kjer-Nielsen; John J Miles; Matthew C J Wilce; Lyudmila Kostenko; Natalie A Borg; Nicholas A Williamson; Travis Beddoe; Anthony W Purcell; Scott R Burrows; James McCluskey; Jamie Rossjohn";Nat Immunol;2007;A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule.;;13701;Linear peptide;EPLPQGQLTAY;54;64;;BZLF1;Trans-activator protein BZLF1;P03206;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;;2NX5;HLA-B*35:01;I;The ternary complex of peptide-MHC and TCR was used in the assay.
1780928;1013516;Literature;19139173;"Julia K Archbold; Whitney A Macdonald; Stephanie Gras; Lauren K Ely; John J Miles; Melissa J Bell; Rebekah M Brennan; Travis Beddoe; Matthew C J Wilce; Craig S Clements; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn";J Exp Med;2009;Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition.;;11804;Linear peptide;EENLLDFVRF;281;290;;Epstein-Barr nuclear antigen 6;Epstein-Barr nuclear antigen 6;P03204;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table S1 and PDB 3DXA;x-ray crystallography;3D structure;angstroms;Positive;=;3.5;3DXA;HLA-B*44:05;I;In the structure, TCR molecule is present and binds the peptide-MHC complex. This tertiary structure was also curated.
1780995;1008126;Literature;9586631;"Y H Ding; K J Smith; D N Garboczi; U Utz; W E Biddison; D C Wiley";Immunity;1998;Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids.;;37257;Linear peptide;LLFGYPVYV;11;19;;transcriptional activator Tax;Protein Tax-1;P14079;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;194440;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;1BD2;HLA-A*02:01;I;The structure contains TCR molecule binding the peptide-MHC complex. This tertiary structure was also curated.
1781025;1013978;Literature;14563323;"Jennifer Buslepp; Huanchen Wang; William E Biddison; Ettore Appella; Edward J Collins";Immunity;2003;A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection.;;2999;Linear peptide;ALWGFFPVL;4;12;;chromosome 15 open reading frame 24;ER membrane protein complex subunit 7;Q9NPA0;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 3, Figure 1 and PDB 1LP9;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;1LP9;HLA-A*02:01;I;The structure contains the TCR molecule binding the peptide-MHC complex. The alpha and beta chains of the soluble AHIII 12.2 TCR were produced in E. coli as inclusion bodies and refolded to the native state in vitro. There are two similar molecules in the crystallographic asymmetric unit. The tertiary structure of TCR-pMHC complex as also curated.
1781039;1013976;Literature;9469799;"K C Garcia; M Degano; L R Pease; M Huang; P A Peterson; L Teyton; I A Wilson";Science;1998;Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen.;;100016;Linear peptide;EQYKFYSV;54;61;;mlrq-like protein;Cytochrome c oxidase subunit NDUFA4;Q62425;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Tables 1, 2, Figures 1, 2, 3,4 and PDB 2CKB;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;2CKB;H2-Kb;I;The structure contains the TCR molecule binding the peptide-MHC complex. There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I: MHC alpha-chain: H, beta2-m chain: L, epitope chain: P, TCR alpha-chain: A, TCR beta-chain: B. Complex II: MHC alpha-chain: I, beta2-m chain: M, epitope chain: Q, TCR alpha-chain: C, TCR beta-chain: D. Only Complex I was used for this analysis. The two complexes are oriented in opposite directions and are related by a noncrystallographic symmetry. The tertiary structure of TCR-pMHC was also curated.
1781210;1012909;Literature;16962135;"Susan J Gagnon; Oleg Y Borbulevych; Rebecca L Davis-Harrison; Richard V Turner; Marale Damirjian; Alison Wojnarowicz; William E Biddison; Brian M Baker";J Mol Biol;2006;T cell receptor recognition via cooperative conformational plasticity.;;130542;Linear peptide;LLFGKPVYV + SCM(K5);;;;;;;;;;The epitope is an analog of the Tax 11-19 peptide (LLFGYPVYV) with a Y5K substitution at position 5. This lysine was conjugated to indolyl-butyric acid (Tax-5K-4-(3-Indolyl)-butyric acid).;analog;Fragment of a Natural Sequence Molecule;LLFGYPVYV;11;19;;tax;transcriptional activator Tax;Protein Tax-1;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;2GJ6;HLA-A*02:01;I;The structure contains the TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated.
1781213;1013987;Literature;11017099;"J B Reiser; C Darnault; A Guimezanes; C Gr&eacute;goire; T Mosser; A M Schmitt-Verhulst; J C Fontecilla-Camps; B Malissen; D Housset; G Mazza";Nat Immunol;2000;Crystal structure of a T cell receptor bound to an allogeneic MHC molecule.;;78685;Linear peptide;INFDFNTI;207;214;;potassium channel tetramerisation domain containing 20;BTB/POZ domain-containing protein KCTD20;Q8CDD8;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;1FO0;H2-Kb;I;The structure contains the TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated.
1781214;1013977;Literature;11911820;"Jean Baptiste Reiser; Claude Gr&eacute;goire; Claudine Darnault; Thomas Mosser; Annick Guimezanes; Anne Marie Schmitt-Verhulst; Juan Carlos Fontecilla-Camps; Gilbert Mazza; Bernard Malissen; Dominique Housset";Immunity;2002;A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex.;;34055;Linear peptide;KVITFIDL;246;253;;GTP binding protein 1;GTP-binding protein 1;O08582;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 1, 2, 3, Tables 1, S1, S2, S3 and PDB 1KJ2;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;1KJ2;H2-Kb;I;The crystal structure of epitope/MHC-Kb in complex with the KB-C20 TCR was determined. This tertiary structure was also curated. There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I:  MHC alpha-chain: H, beta2-m chain: L, epitope chain: P, TCR alpha-chain: A, TCR beta-chain: B. Complex II: MHC alpha-chain: I, beta2-m chain: M, epitope chain: Q, TCR alpha-chain: D, TCR beta-chain: E. The two complexes differ only by a 6 degrees rotation in the alpha3/beta2-m membrane-proximal domains.
1781215;1010181;Literature;12563259;"Jean-Baptiste Reiser; Claudine Darnault; Claude Gr&eacute;goire; Thomas Mosser; Gilbert Mazza; Alice Kearney; P Anton van der Merwe; Juan Carlos Fontecilla-Camps; Dominique Housset; Bernard Malissen";Nat Immunol;2003;CDR3 loop flexibility contributes to the degeneracy of TCR recognition.;;54039;Linear peptide;RGYVYQGL;52;59;;nucleocapsid protein;Uncharacterized protein;Q89035;Vesicular stomatitis virus;Vesicular stomatitis virus;11276;;;;;;;;;;;;;mouse (Mus musculus);10090;;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;1NAM;H2-Kb;I;The structure contains the TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated.
1781218;1007938;Literature;18275829;"Jeffrey Ishizuka; Guillaume B E Stewart-Jones; Anton van der Merwe; John I Bell; Andrew J McMichael; E Yvonne Jones";Immunity;2008;The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain.;;20354;Linear peptide;GILGFVFTL;58;66;;Matrix protein 1;Matrix protein 1;P03485;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;2VLJ;HLA-A*02:01;I;The structure contains the TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated. This is the structure of JM22 TCR with HLA-A2-flu in C2 space group.
1781220;1007938;Literature;18275829;"Jeffrey Ishizuka; Guillaume B E Stewart-Jones; Anton van der Merwe; John I Bell; Andrew J McMichael; E Yvonne Jones";Immunity;2008;The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain.;;20354;Linear peptide;GILGFVFTL;58;66;;Matrix protein 1;Matrix protein 1;P03485;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;2VLK;HLA-A*02:01;I;The structure contains the TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated. This is the structure of JM22 TCR with HLA-A2-flu in C2 space group.
1781221;1007938;Literature;18275829;"Jeffrey Ishizuka; Guillaume B E Stewart-Jones; Anton van der Merwe; John I Bell; Andrew J McMichael; E Yvonne Jones";Immunity;2008;The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain.;;20354;Linear peptide;GILGFVFTL;58;66;;Matrix protein 1;Matrix protein 1;P03485;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;2VLR;HLA-A*02:01;I;The structure contains the TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated. The TCR JM22 receptor used is a mutant S99A (TCR beta-chain). It is a naturally conserved residue (E:S99). There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I: MHC alpha-chain: A, beta-2-microglobulin chain: B, epitope chain: C, TCR alpha-chain:D, TCR beta-chain: E. Complex II: MHC alpha-chain: F, beta-2-microglobulin chain: G, epitope chain: H, TCR alpha-chain: I, TCR beta-chain: J.
1781222;1014251;Literature;19167249;"Stephanie Gras; Scott R Burrows; Lars Kjer-Nielsen; Craig S Clements; Yu Chih Liu; Lucy C Sullivan; Melissa J Bell; Andrew G Brooks; Anthony W Purcell; James McCluskey; Jamie Rossjohn";Immunity;2009;The shaping of T cell receptor recognition by self-tolerance.;;16878;Linear peptide;FLRGRAYGL;325;333;;Epstein-Barr nuclear antigen 3;Epstein-Barr nuclear antigen 3;P12977;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2b;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;3FFC;HLA-B*08:01;I;The structure contains the TCR molecule binding to the peptide-MHC complex.
1781233;1013980;Literature;16186824;"Fleur E Tynan; Scott R Burrows; Ashley M Buckle; Craig S Clements; Natalie A Borg; John J Miles; Travis Beddoe; James C Whisstock; Matthew C Wilce; Sharon L Silins; Jacqueline M Burrows; Lars Kjer-Nielsen; Lyudmila Kostenko; Anthony W Purcell; James McCluskey; Jamie Rossjohn";Nat Immunol;2005;T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.;;38458;Linear peptide;LPEPLPQGQLTAY;52;64;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human herpesvirus 4 strain B95-8;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, Figures 1, 2, and PDB 2AK4;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;2AK4;HLA-B*35:08;I;"The structure contains the TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated. There are four molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I: MHC alpha-chain: A, beta2-m chain: B, epitope chain: C, TCR alpha-chain: D, TCR beta-chain: E. Complex II: MHC alpha-chain: F, beta2-m chain: G, epitope chain: H, TCR alpha-chain: I, TCR beta-chain: J. Complex III: MHC alpha-chain: K, beta2-m chain: L, epitope chain: M, TCR alpha-chain: N, TCR beta-chain: P. Complex IV: MHC alpha-chain: Q, beta2-m chain: R, epitope chain: S, TCR alpha-chain: T, TCR beta-chain: U. All TCR-MHC/epitope complexes had well ordered electron density, and the electron density at the TCR-MHC/epitope interface was unambiguous. The individual TCR and MHC/epitope components were almost identical in all complexes. But, there was a TCR-MHC/epitope dimer present in the crystal lattice, made by complexes A (complex I) and B (complex IV). These complexes have distinct conformations, with the TCR adopting two different docking strategies on the MHC/epitope complex that differed by 12 degrees. This rotation axis was parallel to the peptide binding groove, causing atomic shifts in excess of 7 &Aring;, resulting in leaning of the TCR more toward the MHC alpha2-helix. This assay refers to Complex A (complex I)."
1781234;1013980;Literature;16186824;"Fleur E Tynan; Scott R Burrows; Ashley M Buckle; Craig S Clements; Natalie A Borg; John J Miles; Travis Beddoe; James C Whisstock; Matthew C Wilce; Sharon L Silins; Jacqueline M Burrows; Lars Kjer-Nielsen; Lyudmila Kostenko; Anthony W Purcell; James McCluskey; Jamie Rossjohn";Nat Immunol;2005;T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.;;38458;Linear peptide;LPEPLPQGQLTAY;52;64;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human herpesvirus 4 strain B95-8;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, Figures 1, 2, and PDB 2AK4;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;2AK4;HLA-B*35:08;I;"The structure contains the TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated. There are four molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I: MHC alpha-chain: A, beta2-m chain: B, epitope chain: C, TCR alpha-chain: D, TCR beta-chain: E. Complex II: MHC alpha-chain: F, beta2-m chain: G, epitope chain: H, TCR alpha-chain: I, TCR beta-chain: J. Complex III: MHC alpha-chain: K, beta2-m chain: L, epitope chain: M, TCR alpha-chain: N, TCR beta-chain: P. Complex IV: MHC alpha-chain: Q, beta2-m chain: R, epitope chain: S, TCR alpha-chain: T, TCR beta-chain: U. All TCR-MHC/epitope complexes had well ordered electron density, and the electron density at the TCR-MHC/epitope interface was unambiguous. The individual TCR and MHC/epitope components were almost identical in all complexes. But, there was a TCR-MHC/epitope dimer present in the crystal lattice, made by complexes A (complex I) and B (complex IV). These complexes have distinct conformations, with the TCR adopting two different docking strategies on the MHC/epitope complex that differed by 12 degrees. This rotation axis was parallel to the peptide binding groove, causing atomic shifts in excess of 7 &Aring;, resulting in leaning of the TCR more toward the MHC alpha2-helix. This assay refers to Complex B (complex IV)."
1781235;1013981;Literature;16600963;"Steven M Dunn; Pierre J Rizkallah; Emma Baston; Tara Mahon; Brian Cameron; Ruth Moysey; Feng Gao; Malkit Sami; Jonathan Boulter; Yi Li; Bent K Jakobsen";Protein Sci;2006;Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity.;;59278;Linear peptide;SLLMWITQC;157;165;;Cancer/testis antigen 1;Cancer/testis antigen 1;P78358;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 3, 4, Table 3A,B and PDB 2F54;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;2F54;HLA-A*02:01;I;The structure contains the TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated. There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I: MHC alpha-chain: A, beta2-m chain: B, epitope chain: C, TCR alpha-chain: D, TCR beta-chain: E. Complex II: MHC alpha-chain: F, beta2-m chain: G, epitope chain: H, TCR alpha-chain: K, TCR beta-chain: L. One important difference between the two molecules is that MHC residue Q155, located at the interface between the MHC and the CDR2alpha, adopts two different conformations. In the first molecule (AV-wt1, complex I), it contacts S51 of CDR2alpha, while in the other molecule (AV-wt2, complex II), it points toward T94 of TCRalpha. This assay refers to the complex I (AV-wt1).
1781237;1013981;Literature;16600963;"Steven M Dunn; Pierre J Rizkallah; Emma Baston; Tara Mahon; Brian Cameron; Ruth Moysey; Feng Gao; Malkit Sami; Jonathan Boulter; Yi Li; Bent K Jakobsen";Protein Sci;2006;Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity.;;59278;Linear peptide;SLLMWITQC;157;165;;Cancer/testis antigen 1;Cancer/testis antigen 1;P78358;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 3, 4, Table 3A,B and PDB 2F54;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;2F54;HLA-A*02:01;I;The structure contains the TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated. There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I: MHC alpha-chain: A, beta2-m chain: B, epitope chain: C, TCR alpha-chain: D, TCR beta-chain: E. Complex II: MHC alpha-chain: F, beta2-m chain: G, epitope chain: H, TCR alpha-chain: K, TCR beta-chain: L. One important difference between the two molecules is that MHC residue Q155, located at the interface between the MHC and the CDR2alpha, adopts two different conformations. In the first molecule (AV-wt1, complex I), it contacts S51 of CDR2alpha, while in the other molecule (AV-wt2, complex II), it points toward T94 of TCRalpha. This assay refers to the complex Ii (AV-wt2).
1781239;1013981;Literature;16600963;"Steven M Dunn; Pierre J Rizkallah; Emma Baston; Tara Mahon; Brian Cameron; Ruth Moysey; Feng Gao; Malkit Sami; Jonathan Boulter; Yi Li; Bent K Jakobsen";Protein Sci;2006;Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity.;;59278;Linear peptide;SLLMWITQC;157;165;;Cancer/testis antigen 1;Cancer/testis antigen 1;P78358;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 3, 4, Table 3A,B and PDB 2F53;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;2F53;HLA-A*02:01;I;The structure contains the mutant c49c50 TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated.
1781571;1013975;Literature;18941216;"Lindsay L Jones; Leremy A Colf; Jennifer D Stone; K Christopher Garcia; David M Kranz";J Immunol;2008;Distinct CDR3 conformations in TCRs determine the level of cross-reactivity for diverse antigens, but not the docking orientation.;;97581;Linear peptide;QLSPFPFDL;932;940;;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Q60597;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Table II, Figures 4, 5 6, 7 and PDB 3E3Q;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;3E3Q;H2-Ld;I;The structure contains the TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated. A platform Ld module containing only the alpha1 and alpha2 domains and five stability mutations (F9Y, V12Y, I23T, N30D, A49V, I66V, W97R, and K131R), called Ld-m31, was used for binding. The MHC molecule is missing the beta2-m domain. There are eight molecules in the crystallographic asymmetric unit. PDB chains for the first (curated) complex are: Complex I : MHC alpha-chain: A, epitope chain: Q, TCR alpha-chain: D, TCR beta-chain: E.
1781572;1013975;Literature;18941216;"Lindsay L Jones; Leremy A Colf; Jennifer D Stone; K Christopher Garcia; David M Kranz";J Immunol;2008;Distinct CDR3 conformations in TCRs determine the level of cross-reactivity for diverse antigens, but not the docking orientation.;;97581;Linear peptide;QLSPFPFDL;932;940;;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Q60597;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Table II, Figures 4, 5 6, 7 and PDB 3E2H;x-ray crystallography;3D structure;angstroms;Positive;=;3.8;3E2H;H2-Ld;I;The structure contains the TCR molecule binding to the peptide-MHC complex. This tertiary structure was also curated. A platform Ld module containing only the alpha1 and alpha2 domains and five stability mutations (F9Y, V12Y, I23T, N30D, A49V, I66V, W97R, and K131R), called Ld-m31, was used for binding. The MHC molecule is missing the beta2-m domain.
1782792;1013985;Literature;15837811;"Ji-Li Chen; Guillaume Stewart-Jones; Giovanna Bossi; Nikolai M Lissin; Linda Wooldridge; Ed Man Lik Choi; Gerhard Held; P Rod Dunbar; Robert M Esnouf; Malkit Sami; Jonathan M Boulter; Pierre Rizkallah; Christoph Renner; Andrew Sewell; P Anton van der Merwe; Bent K Jakobsen; Gillian Griffiths; E Yvonne Jones; Vincenzo Cerundolo";J Exp Med;2005;Structural and kinetic basis for heightened immunogenicity of T cell vaccines.;;59278;Linear peptide;SLLMWITQC;157;165;;NY-ESO-1 protein;Cancer/testis antigen 1;P78358;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table I, Figure 1 and PDB 2BNR;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;2BNR;HLA-A*02:01;I;The structure contains the 1G4 TCR molecule binding to the epitope-MHC complex. This tertiary structure was also curated.
1782794;1013985;Literature;15837811;"Ji-Li Chen; Guillaume Stewart-Jones; Giovanna Bossi; Nikolai M Lissin; Linda Wooldridge; Ed Man Lik Choi; Gerhard Held; P Rod Dunbar; Robert M Esnouf; Malkit Sami; Jonathan M Boulter; Pierre Rizkallah; Christoph Renner; Andrew Sewell; P Anton van der Merwe; Bent K Jakobsen; Gillian Griffiths; E Yvonne Jones; Vincenzo Cerundolo";J Exp Med;2005;Structural and kinetic basis for heightened immunogenicity of T cell vaccines.;;59283;Linear peptide;SLLMWITQV;;;;;;;;;;The epitope is analog of the NY-ESO-1(157-165) peptide and has the mutation: C9->V9.;analog;Fragment of a Natural Sequence Molecule;SLLMWITQC;157;165;;NY-ESO-1;NY-ESO-1 protein;Cancer/testis antigen 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table I, Figure 1 and PDB 2BNQ;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;2BNQ;HLA-A*02:01;I;The structure contains the 1G4 TCR molecule binding to the epitope-MHC complex. This tertiary structure was also curated.
1783412;1002500;Literature;16375919;"Adnane Achour; Jakob Micha&euml;lsson; Robert A Harris; Hans-Gustaf Ljunggren; Klas K&auml;rre; Gunter Schneider; Tatyana Sandalova";J Mol Biol;2006;Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin.;;30015;Linear peptide;KAVYNFATM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Tables 1, 2, Figures 1, 2, 3, 4, 5, 6, 7 and PDB 2F74;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;2F74;H2-Db;I;"Mouse beta-microglobulin (mbeta2m) has been replaced with human beta-microglobulin (hbeta2m); that enhances the stability of MHC molecule and its peptide exchange capacity (up to 20-fold increase in gp33-MHC affinity). The paper provides a detailed comparison of the two structures of MHC-gp33 complexes with hbeta2m [PDB: 2F74] and mbeta2m [PDB: 1S7Q]. The asymmetric unit contains two complexes overall structures of which are very similar, therefore, only complex (A,B,C) is curated."
1788032;1019712;Literature;17418792;"Leremy A Colf; Alexander J Bankovich; Nicole A Hanick; Natalie A Bowerman; Lindsay L Jones; David M Kranz; K Christopher Garcia";Cell;2007;How a single T cell receptor recognizes both self and foreign MHC.;;97581;Linear peptide;QLSPFPFDL;932;940;;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Q60597;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 1, 3, 4, 6, S3, Tables S1, S2, S3 and PDB 2OI9;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;2OI9;H2-Ld;I;The structure of the 2C scTCR in complex with H-2-Ld/epitope was determined. A platform Ld module containing only the alpha1 and alpha2 domains and stability mutations (F9Y, V12Y, I23T, N30D, A49V, I66V, W97R, and K131R) was used for binding. The MHC molecule is missing the beta2-m domain.
1788033;1019712;Literature;17418792;"Leremy A Colf; Alexander J Bankovich; Nicole A Hanick; Natalie A Bowerman; Lindsay L Jones; David M Kranz; K Christopher Garcia";Cell;2007;How a single T cell receptor recognizes both self and foreign MHC.;;97581;Linear peptide;QLSPFPFDL;932;940;;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Q60597;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 7, Table S1 and PDB 2E7L;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;2E7L;H2-Ld;I;The structure of the high affinity 2C scTCR variant m6 in complex with H-2-Ld/epitope was determined. A platform Ld module containing only the alpha1 and alpha2 domains and stability mutations (F9Y, V12Y, I23T, N30D, A49V, I66V, W97R, and K131R) was used for binding. The MHC molecule is missing the beta2-m domain.
1788221;1012980;Literature;11163232;"J A Speir; J Stevens; E Joly; G W Butcher; I A Wilson";Immunity;2001;Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa.;;95097;Linear peptide;ILFPSSERLISNR;29;41;;ATPase subunit 6;ATP synthase subunit a;P05504;Rattus norvegicus;Rattus norvegicus;10116;;;;;;;;;;;;;rat (Rattus norvegicus);10116;Tables 1, 2, Figures 2, 3, 4 and 1ED3;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;1ED3;RT1-A;I;There are two complexes in the crystallographic asymmetric unit. PDB chains for each complex are: Complex A : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Complex B: MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. There is an approximate 7 degrees rotation between the alpha3 and beta2-m domains of Complex B relative to Complex A, due to crystal packing. The epitope adopts two completely different conformations in the two complexes. The N-terminal residues of the epitope in Complex A rise more swiftly out of the binding groove, compared to the more gradual rise of the same residues of the epitope in Complex B. There was continuous electron density for the epitope, except for the side chains of residues P7-P8 in Complex B. This assay refers to Complex B.
1788478;1019653;Literature;19342659;"Eric Spierings; St&eacute;phanie Gras; Jean-Baptiste Reiser; Bregje Mommaas; Mathilde Almekinders; Michel G D Kester; Anne Chouquet; Madalen Le Gorrec; Jan W Drijfhout; Ferry Ossendorp; Dominique Housset; Els Goulmy";J Immunol;2009;Steric hindrance and fast dissociation explain the lack of immunogenicity of the minor histocompatibility HA-1Arg Null allele.;;150811;Linear peptide;VLRDDLLEA + CITR(R3);;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;VLRDDLLEA;137;145;;;Minor histocompatibility protein HA-1;Minor histocompatibility protein HA-1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 2 and PDB 3FT2;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3FT2;HLA-A*02:01;I;The structure of HLA-A2 in complex with the epitope, a citrullinated HA-1<sup>Arg</sup> peptide, was solved by molecular replacement. The A245V mutant of the HLA-A2 heavy chain was used.
1788479;1019653;Literature;19342659;"Eric Spierings; St&eacute;phanie Gras; Jean-Baptiste Reiser; Bregje Mommaas; Mathilde Almekinders; Michel G D Kester; Anne Chouquet; Madalen Le Gorrec; Jan W Drijfhout; Ferry Ossendorp; Dominique Housset; Els Goulmy";J Immunol;2009;Steric hindrance and fast dissociation explain the lack of immunogenicity of the minor histocompatibility HA-1Arg Null allele.;;136896;Linear peptide;VLHDDLLEA;137;145;;histocompatibility (minor) HA-1;Minor histocompatibility protein HA-1;Q92619;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2 and PDB 3FT3;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3FT3;HLA-A*02:01;I;The structure of HLA-A2 in complex with the epitope was solved by molecular replacement. The A245V mutant of the HLA-A2 heavy chain was used.
1788480;1019653;Literature;19342659;"Eric Spierings; St&eacute;phanie Gras; Jean-Baptiste Reiser; Bregje Mommaas; Mathilde Almekinders; Michel G D Kester; Anne Chouquet; Madalen Le Gorrec; Jan W Drijfhout; Ferry Ossendorp; Dominique Housset; Els Goulmy";J Immunol;2009;Steric hindrance and fast dissociation explain the lack of immunogenicity of the minor histocompatibility HA-1Arg Null allele.;;138924;Linear peptide;VLRDDLLEA;137;145;;Minor histocompatibility protein HA-1;Minor histocompatibility protein HA-1;Q92619;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2 and PDB 3FT4;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3FT4;HLA-A*02:01;I;The structure of HLA-A2 in complex with the epitope was solved by molecular replacement. The A245V mutant of the HLA-A2 heavy chain was used.
1791424;1019644;Literature;10850706;"J C Boyington; S A Motyka; P Schuck; A G Brooks; P D Sun";Nature;2000;Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand.;;141649;Linear peptide;GAVDPLLAL;204;212;;Importin subunit alpha-2;Importin subunit alpha-1;P52292;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, Figures 1, 2, 4 and PDB 1EFX;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;1EFX;HLA-C*03:04;I;The structure of the epitope bound to HLA-Cw3 in complex with the natural killer cell receptor KIR2DL2 was determined by molecular replacement. Interaction of KIR with HLA-peptide complex were not curated.
1792120;1019645;Literature;11323700;"Q R Fan; E O Long; D C Wiley";Nat Immunol;2001;Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex.;;94909;Linear peptide;QYDDAVYKL;;;;;;;;;;The epitope is the consensus peptide motif that was determined by pooled peptide sequencing of peptides binding to HLA-Cw*0401 as described in the reference cited: Fan and Wiley (1999) J Exp Med 190:113-123 [PMID: 10429675].;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3, 5, Tables 2, 3 and PDB 1IM9;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;1IM9;HLA-C*04:01;I;The structure of the epitope bound to HLA-Cw4 in complex with the inhibitory natural killer receptor KIR2DL1 was determined by molecular replacement. Each asymmetric unit contained one KIR2DL1 and two HLA-Cw4 molecules. Two complexes form a crystallographic dimer. Interactions of KIR with the peptide were minimal. Interactions of KIR with the HLA-peptide complex were not curated.
1792326;1019646;Literature;12897781;"Benjamin E Willcox; Leonard M Thomas; Pamela J Bjorkman";Nat Immunol;2003;Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor.;;27125;Linear peptide;ILKEPVHGV;468;476;;pol protein;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Table 1 and PDB 1P7Q;x-ray crystallography;3D structure;angstroms;Positive;=;3.4;1P7Q;HLA-A*02:01;I;The crystal structure of the epitope bound to HLA-A*0201 in complex with LIR-1 D1D2 domains was determined.
1800680;1019702;Literature;18426793;"Lu Deng; Sangwoo Cho; Emilio L Malchiodi; Melissa C Kerzic; Julie Dam; Roy A Mariuzza";J Biol Chem;2008;Molecular architecture of the major histocompatibility complex class I-binding site of Ly49 natural killer cell receptors.;;58560;Linear peptide;SIINFEKL;258;265;;ovalbumin;Gal d 2;P01012;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;mouse (Mus musculus);10090;Tables 1, 2, 3, Figures 2, 3 and PDB 3C8K;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;3C8K;H2-Kb;I;"The crystal structure of the epitope bound to H-2-Kb in complex with the natural killer receptor Ly49C was solved. The epitope/H-2Kb complex  bound to natural killer receptor L49C with KD = 102 &micro;M, as determined by surface plasmon resonance."
1801494;1019655;Literature;19625641;"Rui Wang; Kannan Natarajan; David H Margulies";J Immunol;2009;Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.;;53935;Linear peptide;RGPGRAFVTI;309;318;;Envelope glycoprotein gp160 precursor;Envelope glycoprotein gp160;P04578;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;mouse (Mus musculus);10090;Table I, Figure 4 and PDB 3ECB;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3ECB;H2-Dd;I;
1801497;1019655;Literature;19625641;"Rui Wang; Kannan Natarajan; David H Margulies";J Immunol;2009;Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.;;53935;Linear peptide;RGPGRAFVTI;309;318;;Envelope glycoprotein gp160 precursor;Envelope glycoprotein gp160;P04578;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;mouse (Mus musculus);10090;Tables I, II, III, Figures 1, 2, 3 and PDB 3DMM;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3DMM;H2-Dd;I;"The structure of the epitope/H-2Dd complex bound to murine CD8alpha&szlig; was determined from the crystal structure by molecular replacement. The CD8alphaalpha and CD8alpha&szlig; molecules bound to the epitope/H-2Dd complex with affinities of KD = 6.7 &micro;M and KD = 8.2 &micro;M, respectively, as determined by surface plasmon resonance."
1804353;1021237;Literature;20976198;"Isabel K Macdonald; Maria Harkiolaki; Lawrence Hunt; Timothy Connelley; A Victoria Carroll; Niall D MacHugh; Simon P Graham; E Yvonne Jones; W Ivan Morrison; Darren R Flower; Shirley A Ellis";PLoS Pathog;2010;MHC class I bound to an immunodominant Theileria parva epitope demonstrates unconventional presentation to T cell receptors.;;68823;Linear peptide;VGYPKVKEEML;214;224;;hypothetical protein TP03_0849;;;Theileria parva;Theileria parva;5875;;;;;;;;;;;;;cattle (Bos taurus);9913;Figure 2, 3, S4, S5, Table S1 and PDB 2XFX;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;2XFX;BoLA-6*01301;I;
1811884;1140;Literature;14595439;"Julie Dam; Rongjin Guan; Kannan Natarajan; Nazzareno Dimasi; Lukasz K Chlewicki; David M Kranz; Peter Schuck; David H Margulies; Roy A Mariuzza";Nat Immunol;2003;Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b).;;58560;Linear peptide;SIINFEKL;258;265;;ovalbumin;Gal d 2;P01012;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;mouse (Mus musculus);10090;Table 1,  Figures 2 and PDB 1 P1Z;x-ray crystallography;3D structure;angstroms;Positive;=;3.3;1P1Z;H2-Kb;I;The crystal structure of the epitope/H-2Kb complex bound to the extracellular portion of wild type Ly49C natural killer cell receptor was determined by molecular replacement. The Ly9C molecule does not directly contact the epitope.
1831424;1021225;Literature;20844028;"Jun Liu; Peng Wu; Feng Gao; Jianxun Qi; Ai Kawana-Tachikawa; Jing Xie; Christopher J Vavricka; Aikichi Iwamoto; Taisheng Li; George F Gao";J Virol;2010;Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein.;;50779;Linear peptide;QFKDNVILL;346;354;;N protein;Nucleoprotein;P59595;SARS coronavirus Urbani;Severe acute respiratory syndrome-related coronavirus;694009;;;;;;;;;;;;;human (Homo sapiens);9606;Table 3, Figures 3, 4 and PDB 3I6L;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;3I6L;HLA-A*24:02;I;The structure of the epitope complexed with HLA-A*2402 was determined by molecular replacement.
1831431;1020851;Literature;20616031;"Stephanie Gras; Lukasz Kedzierski; Sophie A Valkenburg; Karen Laurie; Yu Chih Liu; Justin T Denholm; Michael J Richards; Guus F Rimmelzwaan; Anne Kelso; Peter C Doherty; Stephen J Turner; Jamie Rossjohn; Katherine Kedzierska";Proc Natl Acad Sci U S A;2010;Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.;;38472;Linear peptide;LPFERATIM;418;426;;nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Brevig Mission/1/1918(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 4, S1, Table S3 and PDB 3LKN;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3LKN;HLA-B*35:01;I;
1831432;1020851;Literature;20616031;"Stephanie Gras; Lukasz Kedzierski; Sophie A Valkenburg; Karen Laurie; Yu Chih Liu; Justin T Denholm; Michael J Richards; Guus F Rimmelzwaan; Anne Kelso; Peter C Doherty; Stephen J Turner; Jamie Rossjohn; Katherine Kedzierska";Proc Natl Acad Sci U S A;2010;Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.;;38468;Linear peptide;LPFDRTTIM;418;426;;nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 4, S1, Table S3 and PDB 3LKO;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3LKO;HLA-B*35:01;I;
1831433;1020851;Literature;20616031;"Stephanie Gras; Lukasz Kedzierski; Sophie A Valkenburg; Karen Laurie; Yu Chih Liu; Justin T Denholm; Michael J Richards; Guus F Rimmelzwaan; Anne Kelso; Peter C Doherty; Stephen J Turner; Jamie Rossjohn; Katherine Kedzierska";Proc Natl Acad Sci U S A;2010;Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.;;38467;Linear peptide;LPFDKSTIM;418;426;;nucleocapsid protein;Nucleoprotein;P03466;Influenza A virus (A/Udorn/307/1972(H3N2));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 4, S1, Table S3 and PDB 3LKP;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3LKP;HLA-B*35:01;I;
1831434;1020851;Literature;20616031;"Stephanie Gras; Lukasz Kedzierski; Sophie A Valkenburg; Karen Laurie; Yu Chih Liu; Justin T Denholm; Michael J Richards; Guus F Rimmelzwaan; Anne Kelso; Peter C Doherty; Stephen J Turner; Jamie Rossjohn; Katherine Kedzierska";Proc Natl Acad Sci U S A;2010;Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.;;97466;Linear peptide;LPFDKTTIM;418;426;;nucleocapsid protein;Nucleoprotein;P03466;Influenza A virus (A/Memphis/13/1978(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 4, S1, Table S3 and PDB 3LKQ;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3LKQ;HLA-B*35:01;I;
1831435;1020851;Literature;20616031;"Stephanie Gras; Lukasz Kedzierski; Sophie A Valkenburg; Karen Laurie; Yu Chih Liu; Justin T Denholm; Michael J Richards; Guus F Rimmelzwaan; Anne Kelso; Peter C Doherty; Stephen J Turner; Jamie Rossjohn; Katherine Kedzierska";Proc Natl Acad Sci U S A;2010;Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.;;38471;Linear peptide;LPFEKSTVM;418;426;;nucleocapsid protein;Nucleoprotein;P03466;Influenza A virus (A/Memphis/4/1980(H3N2));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 4, S1, Table S3 and PDB 3LKS;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3LKS;HLA-B*35:01;I;
1831436;1020851;Literature;20616031;"Stephanie Gras; Lukasz Kedzierski; Sophie A Valkenburg; Karen Laurie; Yu Chih Liu; Justin T Denholm; Michael J Richards; Guus F Rimmelzwaan; Anne Kelso; Peter C Doherty; Stephen J Turner; Jamie Rossjohn; Katherine Kedzierska";Proc Natl Acad Sci U S A;2010;Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.;;116136;Linear peptide;LPFERATVM;418;426;;nucleocapsid protein;Nucleoprotein;P03466;Influenza A virus (A/Auckland/1/2009(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 4, S1, Table S3 and PDB 3LKR;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3LKR;HLA-B*35:01;I;
1831741;1020893;Literature;20711359;"Sophie A Valkenburg; Stephanie Gras; Carole Guillonneau; Nicole L La Gruta; Paul G Thomas; Anthony W Purcell; Jamie Rossjohn; Peter C Doherty; Stephen J Turner; Katherine Kedzierska";PLoS Pathog;2010;Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold.;;4304;Linear peptide;ASAENMETM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;ASNENMETM;366;374;;;nucleoprotein;Nucleoprotein;Influenza A virus;Influenza A virus;mouse (Mus musculus);10090;Figure 3, Table 1 and PDB 3FTG;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3FTG;H2-Db;I;
1831825;1021998;Literature;21543847;"R&oacute;is&iacute;n M McMahon; Lone Friis; Christian Siebold; Manuel A Friese; Lars Fugger; E Yvonne Jones";Acta Crystallogr D Biol Crystallogr;2011;Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis.;;117959;Linear peptide;KLIETYFSK;45;53;;proteolipid protein;Myelin proteolipid protein;P60201;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3, Tables 1, 2 and PDB 2XPG;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;2XPG;HLA-A*03:01;I;The structure of the epitope bound to HLA-A*0301 was determined from the crystal structure, solved by molecular replacement.
1832109;1022077;Literature;21450819;"Xin Li; Jun Liu; Jianxun Qi; Feng Gao; Qirun Li; Xiaoying Li; Nianzhi Zhang; Chun Xia; George F Gao";J Virol;2011;Two distinct conformations of a rinderpest virus epitope presented by bovine major histocompatibility complex class I N*01801: a host strategy to present featured peptides.;;27800;Linear peptide;IPAYGVLTI;407;415;;H protein;Hemagglutinin glycoprotein;P41355;Rinderpest morbillivirus;Rinderpest morbillivirus;11241;;;;;;;;;;;;;cattle (Bos taurus);9913;Table 2, Figures 4, 5, 6, 8 and PDB 3PWV;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;3PWV;BoLA-2*01801;I;"The crystal structure of the epitope in complex  with bovine MHC I allele N*01801 and bovine &szlig;2m was determined."
1833553;1022067;Literature;21606376;"E Bridie Day; Carole Guillonneau; Stephanie Gras; Nicole L La Gruta; Dario A A Vignali; Peter C Doherty; Anthony W Purcell; Jamie Rossjohn; Stephen J Turner";Proc Natl Acad Sci U S A;2011;Structural basis for enabling T-cell receptor diversity within biased virus-specific CD8+ T-cell responses.;;61151;Linear peptide;SSLENFRAYV;224;233;;Polymerase acidic protein;Polymerase acidic protein;P03433;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 1, Table S1 and PDB 3PQY;x-ray crystallography;3D structure;angstroms;Positive;=;3.2;3PQY;H2-Db;I;The structure of the epitope bound to H-2Db and in complex with the epitope-specific 6218 TCR was determined.
1834428;1021960;Literature;20934997;"Christina Bade-D&ouml;ding; Alex Theodossis; Stephanie Gras; Lars Kjer-Nielsen; Britta Eiz-Vesper; Axel Seltsam; Trevor Huyton; Jamie Rossjohn; James McCluskey; Rainer Blasczyk";Haematologica;2011;The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family.;;146144;Linear peptide;AEMYGSVTEHPSPSPL;52;67;;Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1 / hnRNP C2) variant;Heterogeneous nuclear ribonucleoproteins C1/C2;P07910;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 1, 2, 3, Supplementary Table S4, Figure S1 S2, and PDB 3LN4;x-ray crystallography;3D structure;angstroms;Positive;=;1.3;3LN4;HLA-B*41:03;I;The central region of the 16-mer peptide in the B*41:03 structure (residues -G5-SVTEHP-S12-) was disordered.
1834431;1021960;Literature;20934997;"Christina Bade-D&ouml;ding; Alex Theodossis; Stephanie Gras; Lars Kjer-Nielsen; Britta Eiz-Vesper; Axel Seltsam; Trevor Huyton; Jamie Rossjohn; James McCluskey; Rainer Blasczyk";Haematologica;2011;The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family.;;146305;Linear peptide;HEEAVSVDRVL;227;237;;methylthioadenosine phosphorylase;S-methyl-5'-thioadenosine phosphorylase;Q13126;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 1, 2, 3, Supplementary Table S4, Figure S1 S2, and PDB 3LN5;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3LN5;HLA-B*41:04;I;
1838568;1022226;Literature;21538979;"Jingxian Liu; Kenneth Y Chen; Ee C Ren";Eur J Immunol;2011;Structural insights into the binding of hepatitis B virus core peptide to HLA-A2 alleles: towards designing better vaccines.;;16833;Linear peptide;FLPSDFFPSV;18;27;;core protein;Capsid protein;Q76R61;Hepatitis B virus;Hepatitis B virus;10407;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3, 4, Tables 1, 2 and PDB 3OX8;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;3OX8;HLA-A*02:03;I;
1838569;1022226;Literature;21538979;"Jingxian Liu; Kenneth Y Chen; Ee C Ren";Eur J Immunol;2011;Structural insights into the binding of hepatitis B virus core peptide to HLA-A2 alleles: towards designing better vaccines.;;16833;Linear peptide;FLPSDFFPSV;18;27;;core protein;Capsid protein;Q76R61;Hepatitis B virus;Hepatitis B virus;10407;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3, 4, Tables 1, 2 and PDB 3OXR;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3OXR;HLA-A*02:06;I;
1838570;1022226;Literature;21538979;"Jingxian Liu; Kenneth Y Chen; Ee C Ren";Eur J Immunol;2011;Structural insights into the binding of hepatitis B virus core peptide to HLA-A2 alleles: towards designing better vaccines.;;16833;Linear peptide;FLPSDFFPSV;18;27;;core protein;Capsid protein;Q76R61;Hepatitis B virus;Hepatitis B virus;10407;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3, 4, Tables 1, 2 and PDB 3OXS;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3OXS;HLA-A*02:07;I;
1844796;1140;Literature;14595439;"Julie Dam; Rongjin Guan; Kannan Natarajan; Nazzareno Dimasi; Lukasz K Chlewicki; David M Kranz; Peter Schuck; David H Margulies; Roy A Mariuzza";Nat Immunol;2003;Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b).;;58560;Linear peptide;SIINFEKL;258;265;;ovalbumin;Gal d 2;P01012;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;mouse (Mus musculus);10090;Table 1,  Figures 2 and PDB 1P4L;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;1P4L;H2-Kb;I;The crystal structure of the epitope/H-2Kb complex bound to the extracellular portion of mutant Ly49C natural killer cell receptor was determined by molecular replacement. The Ly9C molecule does not directly contact the epitope.
1848918;1022200;Literature;19655750;"Patrick H N Celie; Mireille Toebes; Boris Rodenko; Huib Ovaa; Anastassis Perrakis; Ton N M Schumacher";J Am Chem Soc;2009;UV-induced ligand exchange in MHC class I protein crystals.;;189237;Linear peptide;KILGGVFAV + MCM(G5, A8);;;;;;;;;;The epitope was synthesized using (2-nitro)phenylglycine at position 5 and 3-amino-3-(2-nitro)phenyl-propionic acid at position 8 to introduce UV-sensitive nitro-phenyl groups.;analog;Fragment of a Natural Sequence Molecule;GILGFVFTL;58;66;;;Matrix protein 1;Matrix protein 1;Influenza A virus;Influenza A virus;human (Homo sapiens);9606;Figure 2, S1, Table S1 and PDB 2X4N;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;2X4N;HLA-A*02:01;I;"HLA-A2.1:KILGJ(1)VFJ(2)V crystals were subjected to UV irradiation prior to vitrification and X-ray data collection. In the resulting structure, the electron density for residues 5&minus;7, between the two cleavage sites has largely disappeared. This implies that cleavage has occurred at both sites and that the central part of the peptide has dissociated from the MHC class I protein. Notably, peptide residues Lys-1 to Gly-4 (KILG) and Val-9 remain bound in almost identical positions as in the non-exposed structure [PDB: 2X70]."
1848920;1022200;Literature;19655750;"Patrick H N Celie; Mireille Toebes; Boris Rodenko; Huib Ovaa; Anastassis Perrakis; Ton N M Schumacher";J Am Chem Soc;2009;UV-induced ligand exchange in MHC class I protein crystals.;;189237;Linear peptide;KILGGVFAV + MCM(G5, A8);;;;;;;;;;The epitope was synthesized using (2-nitro)phenylglycine at position 5 and 3-amino-3-(2-nitro)phenyl-propionic acid at position 8 to introduce UV-sensitive nitro-phenyl groups.;analog;Fragment of a Natural Sequence Molecule;GILGFVFTL;58;66;;;Matrix protein 1;Matrix protein 1;Influenza A virus;Influenza A virus;human (Homo sapiens);9606;Figure 2, S1, Table S1 and PDB 2X70;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;2X70;HLA-A*02:01;I;Crystals of the epitope/HLA-A2.1 complex were not exposed to UV light to induce cleavage of the epitope.
1848921;1022200;Literature;19655750;"Patrick H N Celie; Mireille Toebes; Boris Rodenko; Huib Ovaa; Anastassis Perrakis; Ton N M Schumacher";J Am Chem Soc;2009;UV-induced ligand exchange in MHC class I protein crystals.;;32201;Linear peptide;KLTPLCVTL;120;128;;Envelope glycoprotein gp160 precursor;Envelope glycoprotein gp160;P04578;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, Table S1 and PDB 2X4O;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;2X4O;HLA-A*02:01;I;
1848938;1022200;Literature;19655750;"Patrick H N Celie; Mireille Toebes; Boris Rodenko; Huib Ovaa; Anastassis Perrakis; Ton N M Schumacher";J Am Chem Soc;2009;UV-induced ligand exchange in MHC class I protein crystals.;;27125;Linear peptide;ILKEPVHGV;309;317;;reverse transcriptase;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, S2, Table S1 and PDB 2X4U;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;2X4U;HLA-A*02:01;I;
1848939;1022200;Literature;19655750;"Patrick H N Celie; Mireille Toebes; Boris Rodenko; Huib Ovaa; Anastassis Perrakis; Ton N M Schumacher";J Am Chem Soc;2009;UV-induced ligand exchange in MHC class I protein crystals.;;44920;Linear peptide;NLVPMVATV;495;503;;65 kDa lower matrix phosphoprotein;65 kDa phosphoprotein;Q6SW59;Human betaherpesvirus 5;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 4, Table S1 and PDB 2X4R;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;2X4R;HLA-A*02:01;I;
1848940;1022200;Literature;19655750;"Patrick H N Celie; Mireille Toebes; Boris Rodenko; Huib Ovaa; Anastassis Perrakis; Ton N M Schumacher";J Am Chem Soc;2009;UV-induced ligand exchange in MHC class I protein crystals.;;3078;Linear peptide;AMDSNTLEL;373;381;;nucleocapsid protein;Nucleoprotein;P03466;Influenza A virus (A/Vietnam/1194/2004(H5N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 5, Table S1, S2 and PDB 2X4S;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;2X4S;HLA-A*02:01;I;
1848955;1022200;Literature;19655750;"Patrick H N Celie; Mireille Toebes; Boris Rodenko; Huib Ovaa; Anastassis Perrakis; Ton N M Schumacher";J Am Chem Soc;2009;UV-induced ligand exchange in MHC class I protein crystals.;;189251;Linear peptide;MILGGVFAV + MCM(G5, A8);;;;;;;;;;The epitope was synthesized using (2-nitro)phenylglycine at position 5 and 3-amino-3-(2-nitro)phenyl-propionic acid at position 8 to introduce UV-sensitive nitro-phenyl groups. Residue 1 is a seleno-methionine.;analog;Fragment of a Natural Sequence Molecule;GILGFVFTL;58;66;;;Matrix protein 1;Matrix protein 1;Influenza A virus;Influenza A virus;human (Homo sapiens);9606;Figure 4, Tables S1, S2 and PDB 2X4P;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;2X4P;HLA-A*02:01;I;The epitope was crystallized with HLA-A2.1. There are two complexes in the asymmetric unit. PDB 2X4P is also associated with [PMID: 19655751].
1848965;1021361;Literature;20831383;"Jun Liu; Yeping Sun; Jianxun Qi; Fuliang Chu; Hao Wu; Feng Gao; Taisheng Li; Jinghua Yan; George F Gao";J Infect Dis;2010;The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes.;;21041;Linear peptide;GLMWLSYFV;88;96;;Membrane glycoprotein;Membrane protein;P59596;SARS coronavirus TJF;Severe acute respiratory syndrome-related coronavirus;694009;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 5 and PDB 3I6G;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;3I6G;HLA-A*02:01;I;
1848966;1021361;Literature;20831383;"Jun Liu; Yeping Sun; Jianxun Qi; Fuliang Chu; Hao Wu; Feng Gao; Taisheng Li; Jinghua Yan; George F Gao";J Infect Dis;2010;The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes.;;64710;Linear peptide;TLACFVLAAV;60;69;;Membrane glycoprotein;Membrane protein;P59596;SARS coronavirus TJF;Severe acute respiratory syndrome-related coronavirus;694009;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 5 and PDB 3I6K;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;3I6K;HLA-A*02:01;I;
1850157;1021690;Literature;21282516;"Oleg Y Borbulevych; Kurt H Piepenbrink; Brian M Baker";J Immunol;2011;Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics.;;36357;Linear peptide;LGYGFVNYI;87;95;;ELAV-like protein 4 (Paraneoplastic encephalomyelitis antigen HuD) (Hu-antigen D);ELAV-like protein 4;P26378;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 1, S1 and PDB 3PWL;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3PWL;HLA-A*02:01;I;
1850158;1021690;Literature;21282516;"Oleg Y Borbulevych; Kurt H Piepenbrink; Brian M Baker";J Immunol;2011;Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics.;;158963;Linear peptide;LLYGFVNYI;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LGYGFVNYI;87;95;;ELAVL4;ELAV-like protein 4 (Paraneoplastic encephalomyelitis antigen HuD) (Hu-antigen D);ELAV-like protein 4;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figure 5, Supplemental Figure 1 and PDB 3PWN;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;3PWN;HLA-A*02:01;I;
1850159;1021690;Literature;21282516;"Oleg Y Borbulevych; Kurt H Piepenbrink; Brian M Baker";J Immunol;2011;Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics.;;158964;Linear peptide;LLYGFVNYV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LGYGFVNYI;87;95;;ELAVL4;ELAV-like protein 4 (Paraneoplastic encephalomyelitis antigen HuD) (Hu-antigen D);ELAV-like protein 4;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figure 5, Supplemental Figure 1 and PDB 3PWJ;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3PWJ;HLA-A*02:01;I;
1852493;1022178;Literature;21280120;"Bernhard Loll; Christine R&uuml;ckert; Chee Seng Hee; Wolfram Saenger; Barbara Uchanska-Ziegler; Andreas Ziegler";Protein Sci;2011;Loss of recognition by cross-reactive T cells and its relation to a C-terminus-induced conformational reorientation of an HLA-B*2705-bound peptide.;;152130;Linear peptide;SRRWRRWNR;502;510;;Voltage-dependent L-type calcium channel subunit alpha-1D;Voltage-dependent L-type calcium channel subunit alpha-1D;Q01668;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3, 4, Tables I, II and PDB 3LV3;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3LV3;HLA-B*27:05;I;
1853166;1022337;Literature;21825122;"Dibyendu Samanta; Gayatri Mukherjee; Udupi A Ramagopal; Rodolfo J Chaparro; Stanley G Nathenson; Teresa P DiLorenzo; Steven C Almo";Proc Natl Acad Sci U S A;2011;Structural and functional characterization of a single-chain peptide-MHC molecule that modulates both naive and activated CD8+ T cells.;;102926;Linear peptide;VYLKTNVFL;206;214;;glucose-6-phosphatase, catalytic, related;Glucose-6-phosphatase 2;Q9Z186;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 1, S3, S5, Tables S1, S2 and PDB 3NWM;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;3NWM;H2-Kd;I;"The crystal structure was determined of a single chain construct  (scKd.IGRP) of the epitope covalently linked to &szlig;2m, which is covalently linked to the heavy chain of H-2Kd. Specifically, the C terminus of IGRP206&ndash;214 (VYLKTNVFL) was fused to the N terminus of beta2m with a GGGAS(G4S)2 linker and the C terminus of beta2m was fused to the N terminus of the H-2Kd heavy chain with a (G4S)4 linker."
1859221;1021176;Literature;21124993;"John J Miles; Anna M Bulek; David K Cole; Emma Gostick; Andrea J A Schauenburg; Garry Dolton; Vanessa Venturi; Miles P Davenport; Mai Ping Tan; Scott R Burrows; Linda Wooldridge; David A Price; Pierre J Rizkallah; Andrew K Sewell";PLoS Pathog;2010;Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection.;;20788;Linear peptide;GLCTLVAML;259;267;;BMLF1 protein;mRNA export factor ICP27 homolog;Q04360;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;PDB 3O4L;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;3O4L;HLA-A*02:01;I;
1862713;1022151;Literature;20619457;"Oleg Y Borbulevych; Priscilla Do; Brian M Baker";Mol Immunol;2010;Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A*0201: implications for WT1-based cancer therapeutics.;;54882;Linear peptide;RMFPNAPYL;126;134;;Wilms tumor protein;Wilms tumor protein;P19544;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 1, 2, 3, S1 and PDB 3HPJ;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3HPJ;HLA-A*02:01;I;
1862718;1019715;Literature;19196958;"Jan Petersen; Stephanie J Wurzbacher; Nicholas A Williamson; Sri H Ramarathinam; Hugh H Reid; Ashish K N Nair; Anne Y Zhao; Roza Nastovska; Geordie Rudge; Jamie Rossjohn; Anthony W Purcell";Proc Natl Acad Sci U S A;2009;Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes.;;153883;Linear peptide;RVASPTSGV;1097;1105;;Insulin receptor substrate 2;Insulin receptor substrate 2;Q9Y4H2;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table1, S1, Figures 1, 2 and PDB 3FQW;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3FQW;HLA-A*02:01;I;
1862719;1019715;Literature;19196958;"Jan Petersen; Stephanie J Wurzbacher; Nicholas A Williamson; Sri H Ramarathinam; Hugh H Reid; Ashish K N Nair; Anne Y Zhao; Roza Nastovska; Geordie Rudge; Jamie Rossjohn; Anthony W Purcell";Proc Natl Acad Sci U S A;2009;Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes.;;153882;Linear peptide;RVASPTSGV + PHOS(S4);1097;1105;;Insulin receptor substrate 2;Insulin receptor substrate 2;Q9Y4H2;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table1, S1, Figures 1, 2 and PDB 3FQX;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3FQX;HLA-A*02:01;I;
1862720;1019715;Literature;19196958;"Jan Petersen; Stephanie J Wurzbacher; Nicholas A Williamson; Sri H Ramarathinam; Hugh H Reid; Ashish K N Nair; Anne Y Zhao; Roza Nastovska; Geordie Rudge; Jamie Rossjohn; Anthony W Purcell";Proc Natl Acad Sci U S A;2009;Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes.;;153906;Linear peptide;YLDSGIHSGA;30;39;;Catenin beta-1;Catenin beta-1;P35222;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table1, S1, Figures 1, 2 and PDB 3FQN;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3FQN;HLA-A*02:01;I;
1862721;1019715;Literature;19196958;"Jan Petersen; Stephanie J Wurzbacher; Nicholas A Williamson; Sri H Ramarathinam; Hugh H Reid; Ashish K N Nair; Anne Y Zhao; Roza Nastovska; Geordie Rudge; Jamie Rossjohn; Anthony W Purcell";Proc Natl Acad Sci U S A;2009;Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes.;;153905;Linear peptide;YLDSGIHSGA + PHOS(S4);30;39;;Catenin beta-1;Catenin beta-1;P35222;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table1, S1, Figures 1, 2 and PDB 3FQR;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3FQR;HLA-A*02:01;I;
1862722;1019715;Literature;19196958;"Jan Petersen; Stephanie J Wurzbacher; Nicholas A Williamson; Sri H Ramarathinam; Hugh H Reid; Ashish K N Nair; Anne Y Zhao; Roza Nastovska; Geordie Rudge; Jamie Rossjohn; Anthony W Purcell";Proc Natl Acad Sci U S A;2009;Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes.;;153833;Linear peptide;GLLGSPVRA;38;46;;M-phase inducer phosphatase 2;M-phase inducer phosphatase 2;P30305;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table1, S1, Figures 1, 2 and PDB 3FQT;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3FQT;HLA-A*02:01;I;
1862723;1019715;Literature;19196958;"Jan Petersen; Stephanie J Wurzbacher; Nicholas A Williamson; Sri H Ramarathinam; Hugh H Reid; Ashish K N Nair; Anne Y Zhao; Roza Nastovska; Geordie Rudge; Jamie Rossjohn; Anthony W Purcell";Proc Natl Acad Sci U S A;2009;Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes.;;153832;Linear peptide;GLLGSPVRA + PHOS(S5);38;46;;M-phase inducer phosphatase 2;M-phase inducer phosphatase 2;P30305;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table1, S1, Figures 1, 2 and PDB 3FQU;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3FQU;HLA-A*02:01;I;
1864231;1013643;Literature;18836451;"Fiyaz Mohammed; Mark Cobbold; Angela L Zarling; Mahboob Salim; Gregory A Barrett-Wilt; Jeffrey Shabanowitz; Donald F Hunt; Victor H Engelhard; Benjamin E Willcox";Nat Immunol;2008;Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self.;;99844;Linear peptide;RQASLSISV + PHOS(S4);526;534;;protein kinase D2 isoform A;Serine/threonine-protein kinase D2;Q9BZL6;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 3, 4, 5, 6, supplementary Figure 1, supplementary Tables 3, 4, 5, 6 and PDB 3BGM;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;3BGM;HLA-A*02:01;I;
1864232;1013643;Literature;18836451;"Fiyaz Mohammed; Mark Cobbold; Angela L Zarling; Mahboob Salim; Gregory A Barrett-Wilt; Jeffrey Shabanowitz; Donald F Hunt; Victor H Engelhard; Benjamin E Willcox";Nat Immunol;2008;Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self.;;99843;Linear peptide;RQASIELPSM + PHOS(S4);249;258;;lymphocyte-specific protein 1;Lymphocyte-specific protein 1;P33241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 3, 4, 5, 6, supplementary Figure 1, supplementary Tables 3, 4, 5, 6 and PDB 3BH8;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3BH8;HLA-A*02:01;I;
1864233;1013643;Literature;18836451;"Fiyaz Mohammed; Mark Cobbold; Angela L Zarling; Mahboob Salim; Gregory A Barrett-Wilt; Jeffrey Shabanowitz; Donald F Hunt; Victor H Engelhard; Benjamin E Willcox";Nat Immunol;2008;Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self.;;99845;Linear peptide;RTYSGPMNKV + PHOS(S4);53;62;;premature ovarian failure, 1B;Protein POF1B;Q8WVV4;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 3, 4, supplementary Tables 3, 4, 5, 6 and PDB 3BH9;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3BH9;HLA-A*02:01;I;
1864234;1013643;Literature;18836451;"Fiyaz Mohammed; Mark Cobbold; Angela L Zarling; Mahboob Salim; Gregory A Barrett-Wilt; Jeffrey Shabanowitz; Donald F Hunt; Victor H Engelhard; Benjamin E Willcox";Nat Immunol;2008;Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self.;;99826;Linear peptide;KMDSFLDMQL + PHOS(S4);49;58;;Nedd4 binding protein 2;NEDD4-binding protein 2;Q86UW6;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 3, 4, supplementary Figure 1, supplementary Tables 3, 4, 5, 6 and PDB 3BHB;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;3BHB;HLA-A*02:01;I;
1865141;1016617;Literature;19789338;"Marianne J B van Stipdonk; Daniel Badia-Martinez; Marjolein Sluijter; Rienk Offringa; Thorbald van Hall; Adnane Achour";Cancer Res;2009;Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100.;;157194;Linear peptide;EGPRNQDWL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EGSRNQDWL;25;33;;Silver locus protein;Melanocyte protein Pmel 17;Melanocyte protein PMEL;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Figure 4, Supplementary Figure S6, Supplementary Table 1 and PDB 3CHI;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;3CH1;H2-Db;I;
1865142;1016617;Literature;19789338;"Marianne J B van Stipdonk; Daniel Badia-Martinez; Marjolein Sluijter; Rienk Offringa; Thorbald van Hall; Adnane Achour";Cancer Res;2009;Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100.;;157197;Linear peptide;EGSRNQDWL;25;33;;Melanocyte protein Pmel 17;Melanocyte protein PMEL;Q60696;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 4, Supplementary Figure S6, Supplementary Table 1 and PDB 3CCH;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3CCH;H2-Db;I;
1865143;1016617;Literature;19789338;"Marianne J B van Stipdonk; Daniel Badia-Martinez; Marjolein Sluijter; Rienk Offringa; Thorbald van Hall; Adnane Achour";Cancer Res;2009;Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100.;;96518;Linear peptide;KVPRNQDWL;25;33;;Melanocyte protein Pmel 17 precursor;Melanocyte protein PMEL;P40967;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 4, Supplementary Figure S6, Supplementary Table 1 and PDB 3CC5;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3CC5;H2-Db;I;
1865376;1019350;Literature;20053942;"Ji-Li Chen; Anthony J Morgan; Guillaume Stewart-Jones; Dawn Shepherd; Giovanna Bossi; Linda Wooldridge; Sarah L Hutchinson; Andrew K Sewell; Gillian M Griffiths; P Anton van der Merwe; E Yvonne Jones; Antony Galione; Vincenzo Cerundolo";J Immunol;2010;Ca2+ release from the endoplasmic reticulum of NY-ESO-1-specific T cells is modulated by the affinity of TCR and by the use of the CD8 coreceptor.;;157972;Linear peptide;SLLMWITQL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;SLLMWITQC;157;165;;;Cancer/testis antigen 1;Cancer/testis antigen 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 3, Supplemental Table 1and PDB 3KLA;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3KLA;HLA-A*02:01;I;
1865543;1019714;Literature;19177349;"Pravin Kumar; Ardeschir Vahedi-Faridi; Wolfram Saenger; Andreas Ziegler; Barbara Uchanska-Ziegler";Protein Sci;2009;Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity.;;11010;Linear peptide;EADPTGHSY;161;169;;Melanoma-associated antigen 1;Melanoma-associated antigen 1;P43355;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 3, 4, Table 1 and PDB 3BO8;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3BO8;HLA-A*01:01;I;
1866516;1022533;Literature;21900158;"Nianzhi Zhang; Jianxun Qi; Sijia Feng; Feng Gao; Jun Liu; Xiaocheng Pan; Rong Chen; Qirun Li; Zhaosan Chen; Xiaoying Li; Chun Xia; George F Gao";J Virol;2011;Crystal structure of swine major histocompatibility complex class I SLA-1 0401 and identification of 2009 pandemic swine-origin influenza A H1N1 virus cytotoxic T lymphocyte epitope peptides.;;4862;Linear peptide;ATAAATEAY;154;162;;VP35;Polymerase cofactor VP35;Q05127;Zaire ebolavirus;Zaire ebolavirus;186538;;;;;;;;;;;;;pig (Sus scrofa);9823;Tables 3, 4, Figures 1, 3, 4, 6, 7 and  PDB 3QQ4;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3QQ4;SLA-1*04:01;I;
1866520;1022533;Literature;21900158;"Nianzhi Zhang; Jianxun Qi; Sijia Feng; Feng Gao; Jun Liu; Xiaocheng Pan; Rong Chen; Qirun Li; Zhaosan Chen; Xiaoying Li; Chun Xia; George F Gao";J Virol;2011;Crystal structure of swine major histocompatibility complex class I SLA-1 0401 and identification of 2009 pandemic swine-origin influenza A H1N1 virus cytotoxic T lymphocyte epitope peptides.;;164134;Linear peptide;NSDTVGWSW;449;457;;neuraminidase;Neuraminidase;P03468;Influenza A virus (A/Beijing/01/2009(H1N1));Influenza A virus;11320;;;;;;;;;;;;;pig (Sus scrofa);9823;Tables 3, 4, Figures 1, 3, 4, 6, 7, and PDB 3QQ3;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3QQ3;SLA-1*04:01;I;
1898995;1022615;Literature;22039305;"Alice E Denton; Robb Wesselingh; Stephanie Gras; Carole Guillonneau; Matthew R Olson; Justine D Mintern; Weiguang Zeng; David C Jackson; Jamie Rossjohn; Philip D Hodgkin; Peter C Doherty; Stephen J Turner";J Immunol;2011;Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses.;;58560;Linear peptide;SIINFEKL;258;265;;ovalbumin;Gal d 2;P01012;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;mouse (Mus musculus);10090;Table 1, Figure 8, Supplementary Figure 4, and PDB 3P9L;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3P9L;H2-Kb;I;
1898998;1022615;Literature;22039305;"Alice E Denton; Robb Wesselingh; Stephanie Gras; Carole Guillonneau; Matthew R Olson; Justine D Mintern; Weiguang Zeng; David C Jackson; Jamie Rossjohn; Philip D Hodgkin; Peter C Doherty; Stephen J Turner";J Immunol;2011;Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses.;;158737;Linear peptide;EIINFEKL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;SIINFEKL;258;265;;;Ovalbumin;Gal d 2;Gallus gallus;Gallus gallus;mouse (Mus musculus);10090;Table 1, Figure 8, Supplementary Figure 4, and PDB 3PAB;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;3PAB;H2-Kb;I;
1899001;1022615;Literature;22039305;"Alice E Denton; Robb Wesselingh; Stephanie Gras; Carole Guillonneau; Matthew R Olson; Justine D Mintern; Weiguang Zeng; David C Jackson; Jamie Rossjohn; Philip D Hodgkin; Peter C Doherty; Stephen J Turner";J Immunol;2011;Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses.;;159093;Linear peptide;SIIGFEKL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;SIINFEKL;258;265;;;Ovalbumin;Gal d 2;Gallus gallus;Gallus gallus;mouse (Mus musculus);10090;Table 1, Figure 8, Supplementary Figure 4, and PDB 3P9M;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3P9M;H2-Kb;I;
1903118;1021690;Literature;21282516;"Oleg Y Borbulevych; Kurt H Piepenbrink; Brian M Baker";J Immunol;2011;Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics.;;36357;Linear peptide;LGYGFVNYI;87;95;;ELAV-like protein 4 (Paraneoplastic encephalomyelitis antigen HuD) (Hu-antigen D);ELAV-like protein 4;P26378;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3, 4, S2, S3, S4 and PDB 3PWP;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;3PWP;HLA-A*02:01;I;The crystal structure of the ternary complex of the A6 TCR bound to epitope/HLA-A2 complex was determined.
1903587;1019643;Literature;19605354;"David K Cole; Fang Yuan; Pierre J Rizkallah; John J Miles; Emma Gostick; David A Price; George F Gao; Bent K Jakobsen; Andrew K Sewell";J Biol Chem;2009;Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.;;12941;Linear peptide;ELAGIGILTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Tables 1, 2, Figures 1, 2, 3 and PDB 3HG1;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;3HG1;HLA-A*02:01;I;The peptide-MHC complex was crystallized in the presence of TCR (see TCR assay).
1907579;1013577;Literature;11287414;"A K Sharma; J J Kuhns; S Yan; R H Friedline; B Long; R Tisch; E J Collins";J Biol Chem;2001;Class I major histocompatibility complex anchor substitutions alter the conformation of T cell receptor contacts.;;95098;Linear peptide;ILSALVGIL;;;;;;;;;;The epitope is a GP2 variant with mutations: I2 ->L2 and V5->L5. There are two MHC/Epitope molecules in the crystallographic asymmetric unit. The epitopes in the two molecules are not equivalent and the orientation of the P5 side chain is different. As such, each epitope is curated separately. This is epitope from Molecule 1.;analog;Fragment of a Natural Sequence Molecule;IISAVVGIL;654;662;;;Receptor tyrosine-protein kinase erbB-2 precursor;Receptor tyrosine-protein kinase erbB-2;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table II, Figures 2, 3 and PDB 1EEZ (molecule 2);x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1EEZ;HLA-A*02:01;I;There are two molecules in the crystallographic asymmetric unit. PDB chains for each molecule are: Molecule 1 : MHC alpha-chain: A, beta2-m chain: B, epitope chain: C. Molecule 2 : MHC alpha-chain: D, beta2-m chain: E, epitope chain: F. There is clear electron density for the peptide terminal residues in both molecules. In molecule 1, the density is continuous over the peptide main chain but the side chain for residue P6 is undefined. In molecule 2, the electron density is broken at residues P6 and P7. The epitopes in the two molecules are not equivalent and the orientation of the P5 side chain is different. As such, each epitope is curated separately. This assay refers to Molecule 2.
1927802;1022152;Literature;20806940;"C&eacute;line Douat-Casassus; Oleg Borbulevych; Marion Tarbe; Nadine Gervois; Francine Jotereau; Brian M Baker; St&eacute;phane Quideau";J Med Chem;2010;Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognition.;;164061;Non-peptidic;N-[3-({[N-{2-[(beta-Ala-Leu-Ala)NH]ethyl}-N-(indol-3-ylacetyl)Gly]amino}methyl)benzoyl]-Leu-Thr-Val;;;CHEBI_63865;;;;;;;"In ELA-1, the central GIGI tetrapeptide is replaced with a 3-aminomethylbenzoic acid (AMBA) spacer combined with N-(2-aminoethyl)glycine unit bearing a tryptophan-like side chain that extends away from the backbone by an additional carbonyl unit. The N-terminal glutamate is also replaced with a protease-resistant &szlig;-alanine.";analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figures 2, 3, Supplementary Figure and PDB 3O3A;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3O3A;HLA-A*02:01;I;
1927803;1022152;Literature;20806940;"C&eacute;line Douat-Casassus; Oleg Borbulevych; Marion Tarbe; Nadine Gervois; Francine Jotereau; Brian M Baker; St&eacute;phane Quideau";J Med Chem;2010;Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognition.;;164062;Non-peptidic;N-[3-({[N-{2-[(alpha-Glu-Leu-Ala)NH]ethyl}-N-(indol-3-ylacetyl)Gly]amino}methyl)benzoyl]-Leu-Thr-Val;;;CHEBI_63869;;;;;;;In ELA-1.1, the central GIGI tetrapeptide is replaced with a 3-aminomethylbenzoic acid (AMBA) spacer combined with N-(2-aminoethyl)glycine unit bearing a tryptophan-like side chain that extends away from the backbone by an additional carbonyl unit.;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figure 2, Supplementary Figure and PDB 3O3B;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3O3B;HLA-A*02:01;I;
1927804;1022152;Literature;20806940;"C&eacute;line Douat-Casassus; Oleg Borbulevych; Marion Tarbe; Nadine Gervois; Francine Jotereau; Brian M Baker; St&eacute;phane Quideau";J Med Chem;2010;Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognition.;;164063;Non-peptidic;N-(3-{[(N-{2-[(alpha-Glu-Leu-Ala)NH]ethyl}-Trp)amino]methyl}benzoyl)-Leu-Thr-Val;;;CHEBI_63870;;;;;;;In ELA-2, the central GIGI tetrapeptide is replaced with a 3-aminomethylbenzoic acid (AMBA) spacer combined with combined it with a reduced peptide bond introduced between the glycine at P4 and a standard tryptophan at P5.;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figure 3, Supplementary Figure and PDB 3O3D;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3O3D;HLA-A*02:01;I;
1927805;1022152;Literature;20806940;"C&eacute;line Douat-Casassus; Oleg Borbulevych; Marion Tarbe; Nadine Gervois; Francine Jotereau; Brian M Baker; St&eacute;phane Quideau";J Med Chem;2010;Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognition.;;164064;Non-peptidic;N-(3-{[(N-{2-[(beta-Ala-Leu-Ala)NH]ethyl}-Trp)amino]methyl}benzoyl)-Leu-Thr-Val;;;CHEBI_63871;;;;;;;"In ELA-2.1, the central GIGI tetrapeptide is replaced with a 3-aminomethylbenzoic acid (AMBA) spacer combined with combined it with a reduced peptide bond introduced between the glycine at P4 and a standard tryptophan at P5. The N-terminal glutamate is also replaced with a protease-resistant &szlig;-alanine.";analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figures 3, Supplementary Figure and PDB 3O3E;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3O3E;HLA-A*02:01;I;
1930221;1022891;Literature;22323539;"Rebekah M Brennan; Jan Petersen; Michelle A Neller; John J Miles; Jacqueline M Burrows; Corey Smith; James McCluskey; Rajiv Khanna; Jamie Rossjohn; Scott R Burrows";J Immunol;2012;The impact of a large and frequent deletion in the human TCR beta locus on antiviral immunity.;;55170;Linear peptide;RPHERNGFTVL;265;275;;tegument protein pp65;65 kDa phosphoprotein;Q6SW59;Human betaherpesvirus 5;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Supplemental Tables 2, 3, Figure 4 and PDB  3VCL;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3VCL;HLA-B*07:02;I;The crystal structure of the epitope in complex with HLA-B*0702 was determined by molecular replacement.
1930413;1022868;Literature;22245737;"Anna M Bulek; David K Cole; Ania Skowera; Garry Dolton; Stephanie Gras; Florian Madura; Anna Fuller; John J Miles; Emma Gostick; David A Price; Jan W Drijfhout; Robin R Knight; Guo C Huang; Nikolai Lissin; Peter E Molloy; Linda Wooldridge; Bent K Jakobsen; Jamie Rossjohn; Mark Peakman; Pierre J Rizkallah; Andrew K Sewell";Nat Immunol;2012;Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.;;103041;Linear peptide;ALWGPDPAAA;15;24;;Insulin precursor;Insulin;P01308;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, Supplementary Table 1, Supplementary Figures 3, 4 and PDB 3UTQ (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3UTQ;HLA-A*02:01;I;
1930658;1022962;Literature;22431983;"Chaithanya Madhurantakam; Adil D Duru; Tatyana Sandalova; John R Webb; Adnane Achour";PLoS One;2012;Inflammation-associated nitrotyrosination affects TCR recognition through reduced stability and alteration of the molecular surface of the MHC complex.;;5628;Linear peptide;AVYNFATM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;AVYNFATC;34;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Table I, Figures 1, 2, 3  and PDB 3ROO;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3ROO;H2-Kb;I;There are two identical complexes in the asymmetric unit.
1930659;1022962;Literature;22431983;"Chaithanya Madhurantakam; Adil D Duru; Tatyana Sandalova; John R Webb; Adnane Achour";PLoS One;2012;Inflammation-associated nitrotyrosination affects TCR recognition through reduced stability and alteration of the molecular surface of the MHC complex.;;167727;Linear peptide;AVYNFATM + NIT(Y3);;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;AVYNFATC;34;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Table I, Figures 1, 3  and PDB 3ROL;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3ROL;H2-Kb;I;There are two complexes in the asymmetric unit.
1930706;1022691;Literature;22160697;"Amy A Simpson; Fiyaz Mohammed; Mahboob Salim; Amy Tranter; Alan B Rickinson; Hans J Stauss; Paul A H Moss; Neil M Steven; Benjamin E Willcox";Proc Natl Acad Sci U S A;2011;Structural and energetic evidence for highly peptide-specific tumor antigen targeting via allo-MHC restriction.;;6568;Linear peptide;CLGGLLTMV;426;434;;Latent membrane protein 2;Latent membrane protein 2;P13285;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table S2, Figure 2 and PDB 3REW;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3REW;HLA-A*02:01;I;There are two complexes in the asymmetric unit.
1931585;1022077;Literature;21450819;"Xin Li; Jun Liu; Jianxun Qi; Feng Gao; Qirun Li; Xiaoying Li; Nianzhi Zhang; Chun Xia; George F Gao";J Virol;2011;Two distinct conformations of a rinderpest virus epitope presented by bovine major histocompatibility complex class I N*01801: a host strategy to present featured peptides.;;27800;Linear peptide;IPAYGVLTI;407;415;;H protein;Hemagglutinin glycoprotein;P41355;Rinderpest morbillivirus;Rinderpest morbillivirus;11241;;;;;;;;;;;;;cattle (Bos taurus);9913;Table 2, Figures 4, 5, 6, 8 and PDB 3PWU;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3PWU;BoLA-2*01801;I;"The crystal structure of the epitope in complex  with bovine MHC I allele N*01801 and murine &szlig;2m was determined."
1937883;1022665;Literature;22140258;"Stephanie Gras; Pascal G Wilmann; Zhenjun Chen; Hanim Halim; Yu Chih Liu; Lars Kjer-Nielsen; Anthony W Purcell; Scott R Burrows; James McCluskey; Jamie Rossjohn";J Immunol;2012;A structural basis for varied alphabeta TCR usage against an immunodominant EBV antigen restricted to a HLA-B8 molecule.;;16878;Linear peptide;FLRGRAYGL;325;333;;Epstein-Barr nuclear antigen 3;Epstein-Barr nuclear antigen 3;P12977;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Supplementary Figure 1, Supplementary Table I and PDB 3SJV;x-ray crystallography;3D structure;angstroms;Positive;=;3.1;3SJV;HLA-B*08:01;I;The crystal structure of the epitope/HLA-B8 complex bound to the RL42 TCR was determined using molecular replacement. There are four complexes in the asymmetric unit.
1938895;1022665;Literature;22140258;"Stephanie Gras; Pascal G Wilmann; Zhenjun Chen; Hanim Halim; Yu Chih Liu; Lars Kjer-Nielsen; Anthony W Purcell; Scott R Burrows; James McCluskey; Jamie Rossjohn";J Immunol;2012;A structural basis for varied alphabeta TCR usage against an immunodominant EBV antigen restricted to a HLA-B8 molecule.;;174111;Linear peptide;FLRGRAYVL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;FLRGRAYGL;325;333;;EBV nuclear antigen 3, EBNA-3, Epstein-Barr nuclear antigen 3A, EBV nuclear antigen 3A, EBNA-3A;Epstein-Barr nuclear antigen 3;Epstein-Barr nuclear antigen 3;Human gammaherpesvirus 4;Human gammaherpesvirus 4;human (Homo sapiens);9606;Figure 2, Supplementary Figure 1, Supplementary Table I and PDB 3SKM;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3SKM;HLA-B*08:01;I;
1940981;1018721;Literature;20064447;"Oleg Y Borbulevych; Kurt H Piepenbrink; Brian E Gloor; Daniel R Scott; Ruth F Sommese; David K Cole; Andrew K Sewell; Brian M Baker";Immunity;2009;T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility.;;42094;Linear peptide;MLWGYLQYV;549;557;;telomer length regulation protein TEL1;Serine/threonine-protein kinase TEL1;P38110;Saccharomyces cerevisiae RM11-1a;Saccharomyces cerevisiae;4932;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 3, S2, S3 and PDB 3H9S;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;3H9S;HLA-A*02:01;I;The structure contains A6 TCR bound to the peptide-HLA complex.
1942935;1022200;Literature;19655750;"Patrick H N Celie; Mireille Toebes; Boris Rodenko; Huib Ovaa; Anastassis Perrakis; Ton N M Schumacher";J Am Chem Soc;2009;UV-induced ligand exchange in MHC class I protein crystals.;;189251;Linear peptide;MILGGVFAV + MCM(G5, A8);;;;;;;;;;The epitope was synthesized using (2-nitro)phenylglycine at position 5 and 3-amino-3-(2-nitro)phenyl-propionic acid at position 8 to introduce UV-sensitive nitro-phenyl groups. Residue 1 is a seleno-methionine.;analog;Fragment of a Natural Sequence Molecule;GILGFVFTL;58;66;;;Matrix protein 1;Matrix protein 1;Influenza A virus;Influenza A virus;human (Homo sapiens);9606;Figure 5, Tables S1, S2 and PDB 2X4Q;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;2X4Q;HLA-A*02:01;I;"The epitope was crystallized with HLA-A2.1(Se-M&szlig;2m) in which both the N-terminal and C-terminal methionine residues of &szlig;2m are replaced by seleno-methionine. PDB 2X4Q is also associated with [PMID: 19655751]."
1942984;1024522;Literature;19655751;"Boris Rodenko; Mireille Toebes; Patrick H N Celie; Anastassis Perrakis; Ton N M Schumacher; Huib Ovaa";J Am Chem Soc;2009;Class I major histocompatibility complexes loaded by a periodate trigger.;;179869;Linear peptide;NLVPMVATV + MCM(P4);;;;;;;;;;The modified residue B in the epitope is a vicinal diol-containing amino acid residue, 4-amino-2,3-dihydroxybutyric acid, which allows the peptide to be cleaved by NaIO<sub>4</sub>.;analog;Fragment of a Natural Sequence Molecule;NLVPMVATV;495;503;;;65 kDa lower matrix phosphoprotein;65 kDa phosphoprotein;Human betaherpesvirus 5;Human betaherpesvirus 5;human (Homo sapiens);9606;Figure 1, Supporting Figure 2, Supporting Table 1 and PDB 2X4T;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;2X4T;HLA-A*02:01;I;"The epitope was crystallized with HLA-A2.1(Se-M&szlig;2m) in which both the N-terminal and C-terminal methionine residues of &szlig;2m are replaced by seleno-methionine. There are two complexes in the asymmetric unit."
1953318;1024479;Literature;22722860;"Patricia T Illing; Julian P Vivian; Nadine L Dudek; Lyudmila Kostenko; Zhenjun Chen; Mandvi Bharadwaj; John J Miles; Lars Kjer-Nielsen; Stephanie Gras; Nicholas A Williamson; Scott R Burrows; Anthony W Purcell; Jamie Rossjohn; James McCluskey";Nature;2012;Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.;;137341;Non-peptidic;abacavir;;;CHEBI_421707;;;;;;;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Table 4, Figure 4, Supplementary Figure 3 and PDB 3VRJ;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3VRJ;HLA-B*57:01;I;The crystal structure of HLA-B*57:01 in complex with abacavir and the self peptide LTTKLTNTNI was determined.
1953319;1024479;Literature;22722860;"Patricia T Illing; Julian P Vivian; Nadine L Dudek; Lyudmila Kostenko; Zhenjun Chen; Mandvi Bharadwaj; John J Miles; Lars Kjer-Nielsen; Stephanie Gras; Nicholas A Williamson; Scott R Burrows; Anthony W Purcell; Jamie Rossjohn; James McCluskey";Nature;2012;Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.;;137341;Non-peptidic;abacavir;;;CHEBI_421707;;;;;;;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Table 4, Figure 4, Supplementary Figure 3 and PDB 3VRI;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;3VRI;HLA-B*57:01;I;The crystal structure of HLA-B*57:01 in complex with abacavir and the self peptide RVAQLEQVYI was determined.
1953320;1024479;Literature;22722860;"Patricia T Illing; Julian P Vivian; Nadine L Dudek; Lyudmila Kostenko; Zhenjun Chen; Mandvi Bharadwaj; John J Miles; Lars Kjer-Nielsen; Stephanie Gras; Nicholas A Williamson; Scott R Burrows; Anthony W Purcell; Jamie Rossjohn; James McCluskey";Nature;2012;Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.;;174193;Linear peptide;LTTKLTNTNI;46;55;;Cytochrome c oxidase subunit 2;Cytochrome c oxidase subunit 2;P00403;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Table 4, Figure 4, Supplementary Figure 3 and PDB 3VRJ;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3VRJ;HLA-B*57:01;I;The crystal structure of HLA-B*57:01 in complex with abacavir and the epitope, a self peptide was determined.
1953321;1024479;Literature;22722860;"Patricia T Illing; Julian P Vivian; Nadine L Dudek; Lyudmila Kostenko; Zhenjun Chen; Mandvi Bharadwaj; John J Miles; Lars Kjer-Nielsen; Stephanie Gras; Nicholas A Williamson; Scott R Burrows; Anthony W Purcell; Jamie Rossjohn; James McCluskey";Nature;2012;Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.;;174266;Linear peptide;RVAQLEQVYI;54;63;;small nuclear ribonucleoprotein polypeptide D3;Small nuclear ribonucleoprotein Sm D3;P62318;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Table 4, Figure 4, Supplementary Figure 3 and PDB 3VRI;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;3VRI;HLA-B*57:01;I;The crystal structure of HLA-B*57:01 in complex with abacavir and the epitope, a self peptide was determined.
1956150;1025104;Literature;22952231;"Julia Ekeruche-Makinde; Mathew Clement; David K Cole; Emily S J Edwards; Kristin Ladell; John J Miles; Katherine K Matthews; Anna Fuller; Katy A Lloyd; Florian Madura; Garry M Dolton; Johanne Pentier; Anna Lissina; Emma Gostick; Tiffany K Baxter; Brian M Baker; Pierre J Rizkallah; David A Price; Linda Wooldridge; Andrew K Sewell";J Biol Chem;2012;T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting.;;175797;Linear peptide;FLTGIGIITV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Supplementary Table S1, Figure 6 and PDB 4GKS;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;4GKS;HLA-A*02:01;I;There are two structures in the asymmetric unit.
1956151;1025104;Literature;22952231;"Julia Ekeruche-Makinde; Mathew Clement; David K Cole; Emily S J Edwards; Kristin Ladell; John J Miles; Katherine K Matthews; Anna Fuller; Katy A Lloyd; Florian Madura; Garry M Dolton; Johanne Pentier; Anna Lissina; Emma Gostick; Tiffany K Baxter; Brian M Baker; Pierre J Rizkallah; David A Price; Linda Wooldridge; Andrew K Sewell";J Biol Chem;2012;T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting.;;175795;Linear peptide;FATGIGIITV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Supplementary Table S1, Figure 6 and PDB 4GKN;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;4GKN;HLA-A*02:01;I;There are two complexes in the asymmetric unit.
1958972;1025182;Literature;22645359;"David A Ostrov; Barry J Grant; Yuri A Pompeu; John Sidney; Mikkel Harndahl; Scott Southwood; Carla Oseroff; Shun Lu; Jean Jakoncic; Cesar Augusto F de Oliveira; Lun Yang; Hu Mei; Leming Shi; Jeffrey Shabanowitz; A Michelle English; Amanda Wriston; Andrew Lucas; Elizabeth Phillips; Simon Mallal; Howard M Grey; Alessandro Sette; Donald F Hunt; Soren Buus; Bjoern Peters";Proc Natl Acad Sci U S A;2012;Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.;;175861;Linear peptide;HSITYLLPV;;;;;;;;;;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 3, S3, Table S4, and PDB 3UPR;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3UPR;HLA-B*57:01;I;The crystal structure of the epitope bound to HLA-B*57:01 in the presence of abacavir was determined. The asymmetric unit contained two epitope-abacavir-HLA complexes.
1959540;1025143;Literature;23015716;"Jun Liu; Shihong Zhang; Shuguang Tan; Yong Yi; Bin Wu; Bin Cao; Fengcai Zhu; Chen Wang; Hua Wang; Jianxun Qi; George F Gao";J Virol;2012;Cross-allele cytotoxic T lymphocyte responses against 2009 pandemic H1N1 influenza A virus among HLA-A24 and HLA-A3 supertype-positive individuals.;;176343;Linear peptide;LYASPQLEGF;649;658;;polymerase PA;Polymerase acidic protein;P03433;Influenza A virus (A/California/04/2009(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 6, Table 3 and PDB 4F7M;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;4F7M;HLA-A*24:02;I;The crystal structure of the epitope in complex with HLA-A*24:02 was solved by molecular replacement. There are two complexes in the asymmetric unit.
1959541;1025143;Literature;23015716;"Jun Liu; Shihong Zhang; Shuguang Tan; Yong Yi; Bin Wu; Bin Cao; Fengcai Zhu; Chen Wang; Hua Wang; Jianxun Qi; George F Gao";J Virol;2012;Cross-allele cytotoxic T lymphocyte responses against 2009 pandemic H1N1 influenza A virus among HLA-A24 and HLA-A3 supertype-positive individuals.;;144297;Linear peptide;FYRYGFVANF;496;505;;polymerase PB1;RNA-directed RNA polymerase catalytic subunit;P03431;Influenza A virus (A/California/04/2009(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 6, Table 3 and PDB 4F7P;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;4F7P;HLA-A*24:02;I;The crystal structure of the epitope in complex with HLA-A*24:02 was solved by molecular replacement.
1959542;1025143;Literature;23015716;"Jun Liu; Shihong Zhang; Shuguang Tan; Yong Yi; Bin Wu; Bin Cao; Fengcai Zhu; Chen Wang; Hua Wang; Jianxun Qi; George F Gao";J Virol;2012;Cross-allele cytotoxic T lymphocyte responses against 2009 pandemic H1N1 influenza A virus among HLA-A24 and HLA-A3 supertype-positive individuals.;;124692;Linear peptide;RYGFVANF;498;505;;polymerase PB1;RNA-directed RNA polymerase catalytic subunit;P03431;Influenza A virus (A/California/04/2009(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 6, Table 3 and PDB 4F7T;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;4F7T;HLA-A*24:02;I;The crystal structure of the epitope in complex with HLA-A*24:02 was solved by molecular replacement. There are two complexes in the asymmetric unit.
1959721;1025182;Literature;22645359;"David A Ostrov; Barry J Grant; Yuri A Pompeu; John Sidney; Mikkel Harndahl; Scott Southwood; Carla Oseroff; Shun Lu; Jean Jakoncic; Cesar Augusto F de Oliveira; Lun Yang; Hu Mei; Leming Shi; Jeffrey Shabanowitz; A Michelle English; Amanda Wriston; Andrew Lucas; Elizabeth Phillips; Simon Mallal; Howard M Grey; Alessandro Sette; Donald F Hunt; Soren Buus; Bjoern Peters";Proc Natl Acad Sci U S A;2012;Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.;;137341;Non-peptidic;abacavir;;;CHEBI_421707;;;;;;;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 3, S3, Table S4, and PDB 3UPR;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3UPR;HLA-B*57:01;I;The crystal structure of peptide HSITYLLPV bound to HLA-B*57:01 in the presence of abacavir was determined. The asymmetric unit contained two epitope-abacavir-HLA complexes.
1960472;1023056;Literature;22536152;"Alex T Chen; Markus Cornberg; Stephanie Gras; Carole Guillonneau; Jamie Rossjohn; Andrew Trees; Sebastien Emonet; Juan C de la Torre; Raymond M Welsh; Liisa K Selin";PLoS Pathog;2012;Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope.;;76205;Linear peptide;YTVKYPNL;205;212;;nucleoprotein;Nucleoprotein;P09992;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;11623;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 1, Table S1 and PDB 3P4M;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;3P4M;H2-Kb;I;There are two complexes in the asymmetric unit.
1960473;1023056;Literature;22536152;"Alex T Chen; Markus Cornberg; Stephanie Gras; Carole Guillonneau; Jamie Rossjohn; Andrew Trees; Sebastien Emonet; Juan C de la Torre; Raymond M Welsh; Liisa K Selin";PLoS Pathog;2012;Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope.;;76204;Linear peptide;YTVKFPNM;205;212;;Nucleoprotein;;;Cali mammarenavirus;Cali mammarenavirus;2169993;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 1, Table S1 and PDB 3P4N;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;3P4N;H2-Kb;I;There are two complexes in the asymmetric unit.
1960474;1023056;Literature;22536152;"Alex T Chen; Markus Cornberg; Stephanie Gras; Carole Guillonneau; Jamie Rossjohn; Andrew Trees; Sebastien Emonet; Juan C de la Torre; Raymond M Welsh; Liisa K Selin";PLoS Pathog;2012;Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope.;;75945;Linear peptide;YTAKYPNL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;YTVKYPNL;205;212;;;Nucleoprotein;Nucleoprotein;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Figure 1, Table S1 and PDB 3P4O;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;3P4O;H2-Kb;I;There are two complexes in the asymmetric unit.
1960810;1021688;Literature;21280120;"Bernhard Loll; Christine R&uuml;ckert; Chee Seng Hee; Wolfram Saenger; Barbara Uchanska-Ziegler; Andreas Ziegler";Protein Sci;2011;Loss of recognition by cross-reactive T cells and its relation to a C-terminus-induced conformational reorientation of an HLA-B*2705-bound peptide.;;152130;Linear peptide;SRRWRRWNR;502;510;;Voltage-dependent L-type calcium channel subunit alpha-1D;Voltage-dependent L-type calcium channel subunit alpha-1D;Q01668;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3, Tables I, II and PDB 3LV3;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3LV3;HLA-B*27:05;I;The crystal structure of the epitope in complex with HLA-B*2705 was solved by molecular replacement. There is one epitope/MHC complex per asymmetric unit.
1962201;1025262;Literature;23041567;"Jianhua Zhang; Yong Chen; Jianxun Qi; Feng Gao; Yanjie Liu; Jun Liu; Xuyu Zhou; Jim Kaufman; Chun Xia; George F Gao";J Immunol;2012;Narrow groove and restricted anchors of MHC class I molecule BF2*0401 plus peptide transporter restriction can explain disease susceptibility of B4 chickens.;;177755;Linear peptide;IDWFEGKE;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;IDWFDGKE;319;326;;pigpen, fusion;RNA-binding protein FUS;;Gallus gallus;Gallus gallus;chicken (Gallus gallus);9031;Table I, Figure 7 and PDB 4G43;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;4G43;BF2*0401;I;The crystal structure of the epitope bound to BF2*0401 was determined by molecular replacement. There are two complexes in the asymmetric unit.
1962202;1025262;Literature;23041567;"Jianhua Zhang; Yong Chen; Jianxun Qi; Feng Gao; Yanjie Liu; Jun Liu; Xuyu Zhou; Jim Kaufman; Chun Xia; George F Gao";J Immunol;2012;Narrow groove and restricted anchors of MHC class I molecule BF2*0401 plus peptide transporter restriction can explain disease susceptibility of B4 chickens.;;177751;Linear peptide;IDWFDGKD;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;IDWFDGKE;319;326;;pigpen, fusion;RNA-binding protein FUS;;Gallus gallus;Gallus gallus;chicken (Gallus gallus);9031;Table I, Figure 7 and PDB 4G42;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;4G42;BF2*0401;I;The crystal structure of the epitope bound to BF2*0401 was determined by molecular replacement. There are two BF2*0401-IE8 molecules per asymmetric unit.
1962206;1025262;Literature;23041567;"Jianhua Zhang; Yong Chen; Jianxun Qi; Feng Gao; Yanjie Liu; Jun Liu; Xuyu Zhou; Jim Kaufman; Chun Xia; George F Gao";J Immunol;2012;Narrow groove and restricted anchors of MHC class I molecule BF2*0401 plus peptide transporter restriction can explain disease susceptibility of B4 chickens.;;177752;Linear peptide;IDWFDGKE;319;326;;RNA-binding protein FUS;;;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;chicken (Gallus gallus);9031;Table I, Figures 1, 2 and PDB 4E0R;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;4E0R;BF2*0401;I;The crystal structure of the epitope bound to BF2*0401 was determined by molecular replacement. There are two BF2*0401-IE8 molecules per asymmetric unit.
1962304;1025254;Literature;22837158;"Eva B Allerbring; Adil D Duru; Hannes Uchtenhagen; Chaithanya Madhurantakam; Markus B Tomek; Sebastian Grimm; Pooja A Mazumdar; Rosmarie Friemann; Michael Uhlin; Tatyana Sandalova; Per-&Aring;ke Nygren; Adnane Achour";Eur J Immunol;2012;Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics.;;29967;Linear peptide;KAVANFATM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis virus (strain WE);Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Table 2, Figure 4, Supplementary Figures 3, 4 and PDB 3QUK;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;3QUK;H2-Db;I;The crystal structure of the epitope in complex with H-2Db was determined by molecular replacement.
1962305;1025254;Literature;22837158;"Eva B Allerbring; Adil D Duru; Hannes Uchtenhagen; Chaithanya Madhurantakam; Markus B Tomek; Sebastian Grimm; Pooja A Mazumdar; Rosmarie Friemann; Michael Uhlin; Tatyana Sandalova; Per-&Aring;ke Nygren; Adnane Achour";Eur J Immunol;2012;Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics.;;29988;Linear peptide;KAVSNFATM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis virus (strain WE);Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Table 2, Figure 4, Supplementary Figures 3, 4 and PDB 3QUL;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3QUL;H2-Db;I;The crystal structure of the epitope in complex with H-2Db was determined by molecular replacement.
1962428;1025264;Literature;23042604;"Lenong Li; Yasameen Muzahim; Marlene Bouvier";Nat Struct Mol Biol;2012;Crystal structure of adenovirus E3-19K bound to HLA-A2 reveals mechanism for immunomodulation.;;37257;Linear peptide;LLFGYPVYV;11;19;;Protein Tax-1;Protein Tax-1;P14079;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;194440;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 1, 2, 3, 4 and PDB 4E5X;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;4E5X;HLA-A*02:01;I;The crystal structure of a complex of epitope-HLA-A2-Ad2 E3-19K was determined by molecular replacement. There were two complexes in the asymmetric unit. MHC binds to E3-19K immunomodulator.
1965226;1025033;Literature;9177355;"G F Gao; J Tormo; U C Gerth; J R Wyer; A J McMichael; D I Stuart; J I Bell; E Y Jones; B K Jakobsen";Nature;1997;Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2.;;27125;Linear peptide;ILKEPVHGV;309;317;;reverse transcriptase;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, Figure 1 and PDB 1AKJ;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;1AKJ;HLA-A*02:01;I;The crystal structure of the epitope in complex with HLA-A*0201 bound to homodimeric CD8alphaalpha was determined by molecular replacement. The structure contains one CD8alphaalpha/HLA-A2/epitope complex per asymmetric unit.
1965350;1024916;Literature;8624811;"K J Smith; S W Reid; D I Stuart; A J McMichael; E Y Jones; J I Bell";Immunity;1996;An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501.;;110738;Linear peptide;VPLRPMTY;75;82;;nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 3, 4, 5 and PDB 1A1N;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;1A1N;HLA-B*35:01;I;The crystal structure of the epitope bound to HLA-B*3501 was determined by molecular replacement.
1965478;1025378;Literature;23209377;"William H McCoy 4th; Xiaoli Wang; Wayne M Yokoyama; Ted H Hansen; Daved H Fremont";PLoS Biol;2012;Structural mechanism of ER retrieval of MHC class I by cowpox.;;58560;Linear peptide;SIINFEKL;258;265;;ovalbumin;Gal d 2;P01012;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 3, Table S2 and PDB 4HKJ;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;4HKJ;H2-Kb;I;The crystal structure of the epitope bound to H-2Kb in complex with the orthopoxvirus cowpox SeMet-labeled CPXV203 protein (chain D) was determined. There are four complexes in the asymmetric unit.
1966212;1025343;Literature;23161907;"Guillaume B Stewart-Jones; Peter Simpson; P Anton van der Merwe; Philippa Easterbrook; Andrew J McMichael; Sarah L Rowland-Jones; E Yvonne Jones; Geraldine M Gillespie";Proc Natl Acad Sci U S A;2012;Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms.;;29804;Linear peptide;KAFSPEVIPMF;17;27;;p24 protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, S1 Figure 4 and PDB 2YPK;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;2YPK;HLA-B*57:01;I;The crystal structure of the epitope bound to HLA-B*5701 was determined by molecular replacement.
1966213;1025343;Literature;23161907;"Guillaume B Stewart-Jones; Peter Simpson; P Anton van der Merwe; Philippa Easterbrook; Andrew J McMichael; Sarah L Rowland-Jones; E Yvonne Jones; Geraldine M Gillespie";Proc Natl Acad Sci U S A;2012;Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms.;;29804;Linear peptide;KAFSPEVIPMF;17;27;;p24 protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, S1, Figures 1, 2, 3, 4 and PDB 2YPL;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;2YPL;HLA-B*57:03;I;The crystal structure of the epitope bound to HLA-B*5703 in complex with the AGA1 TCR was determined by molecular replacement.
1967643;1025382;Literature;23255554;"Julia Ekeruche-Makinde; John J Miles; Hugo A van den Berg; Ania Skowera; David K Cole; Garry Dolton; Andrea J A Schauenburg; Mai Ping Tan; Johanne M Pentier; Sian Llewellyn-Lacey; Kim M Miles; Anna M Bulek; Mathew Clement; Tamsin Williams; Andrew Trimby; Mick Bailey; Pierre Rizkallah; Jamie Rossjohn; Mark Peakman; David A Price; Scott R Burrows; Andrew K Sewell; Linda Wooldridge";Blood;2013;Peptide length determines the outcome of TCR/peptide-MHCI engagement.;;179820;Linear peptide;ILAKFLHWL;540;548;;Telomerase reverse transcriptase;Telomerase reverse transcriptase;O14746;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 8, Table S2 and PDB 4I4W;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;4I4W;HLA-A*02:01;I;
1969138;1025028;Literature;10604468;"J Tormo; K Natarajan; D H Margulies; R A Mariuzza";Nature;1999;Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand.;;53935;Linear peptide;RGPGRAFVTI;318;327;;protein env-lor;Envelope glycoprotein gp160;P04578;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure  1, Table 1 and PDB 1QO3;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1QO3;H2-Dd;I;The crystal structure of the epitope/H-2Dd complex bound to the NK cell receptor Ly49A NKD (residues 127-262) was solved by molecular replacement. There is one Ly49A dimer and one epitope/H-2Dd molecule in the asymmetric unit.
1970933;1025030;Literature;22020283;"Julian P Vivian; Renee C Duncan; Richard Berry; Geraldine M O'Connor; Hugh H Reid; Travis Beddoe; Stephanie Gras; Philippa M Saunders; Maya A Olshina; Jacqueline M L Widjaja; Christopher M Harpur; Jie Lin; Sebastien M Maloveste; David A Price; Bernard A P Lafont; Daniel W McVicar; Craig S Clements; Andrew G Brooks; Jamie Rossjohn";Nature;2011;Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B.;;98894;Linear peptide;LSSPVTKSF;93;101;;Ig kappa chain C region;Ig kappa chain C region;;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, Supplementary Figure 2, Supplementary Table 2 and PDB 3VH8;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3VH8;HLA-B*57:01;I;The crystal structure of the epitope bound to HLA-B*5701 in complex with killer cell mmunoglobulin-like receptor KIR3DL1*001 was determined by molecular replacement. There are two complexes in the asymmetric unit.
1970947;1025014;Literature;15583017;"Jean K Lee; Guillaume Stewart-Jones; Tao Dong; Karl Harlos; Kati Di Gleria; Lucy Dorrell; Daniel C Douek; P Anton van der Merwe; E Yvonne Jones; Andrew J McMichael";J Exp Med;2004;T cell cross-reactivity and conformational changes during TCR engagement.;;131070;Linear peptide;SLFNTVATL;38;46;;Gag protein;Gag polyprotein;P04591;HIV-1 M:A;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 4 and PDB 2V2X;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;2V2X;HLA-A*02:01;I;
1970948;1025014;Literature;15583017;"Jean K Lee; Guillaume Stewart-Jones; Tao Dong; Karl Harlos; Kati Di Gleria; Lucy Dorrell; Daniel C Douek; P Anton van der Merwe; E Yvonne Jones; Andrew J McMichael";J Exp Med;2004;T cell cross-reactivity and conformational changes during TCR engagement.;;59613;Linear peptide;SLYNTVATL;38;46;;Gag protein;Gag polyprotein;P04591;HIV-1 M:B;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 4 and PDB 2V2W;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;2V2W;HLA-A*02:01;I;
1971462;1025511;Literature;23236061;"Yuichi Yagita; Nozomi Kuse; Kimiko Kuroki; Hiroyuki Gatanaga; Jonathan M Carlson; Takayuki Chikata; Zabrina L Brumme; Hayato Murakoshi; Tomohiro Akahoshi; Nico Pfeifer; Simon Mallal; Mina John; Toyoyuki Ose; Haruki Matsubara; Ryo Kanda; Yuko Fukunaga; Kazutaka Honda; Yuka Kawashima; Yasuo Ariumi; Shinichi Oka; Katsumi Maenaka; Masafumi Takiguchi";J Virol;2013;Distinct HIV-1 escape patterns selected by cytotoxic T cells with identical epitope specificity.;;102104;Linear peptide;TAFTIPSI;283;290;;pol protein;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 6, Supplemental Table 1 and PDB 3W39;x-ray crystallography;3D structure;angstroms;Positive;=;3.1;3W39;HLA-B*52:01;I;The crystal structure of the epitope bound to HLA-B*52:01 was determined by molecular replacement.
1971837;315367;Literature;10975842;"K Maenaka; T Maenaka; H Tomiyama; M Takiguchi; D I Stuart; E Y Jones";J Immunol;2000;Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes.;;180337;Linear peptide;LPPVVAKEI;747;755;;pol protein;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 1, 3, 4 and PDB 1E27;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1,00E+27;HLA-B*51:01;I;The crystal structure of the epitope bound to HLA-B*5101 was determined by molecular replacement.
1971838;315367;Literature;10975842;"K Maenaka; T Maenaka; H Tomiyama; M Takiguchi; D I Stuart; E Y Jones";J Immunol;2000;Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes.;;102104;Linear peptide;TAFTIPSI;283;290;;pol protein;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Tables I, II, Figures 1, 3, 4, 7 and PDB 1E28;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;1,00E+28;HLA-B*51:01;I;The crystal structure of the epitope bound to HLA-B*5101 was determined by molecular replacement.
1974507;1025633;Literature;23493558;"Sophie A Valkenburg; Stephanie Gras; Carole Guillonneau; Lauren A Hatton; Nicola A Bird; Kelly-Anne Twist; Hanim Halim; David C Jackson; Anthony W Purcell; Stephen J Turner; Peter C Doherty; Jamie Rossjohn; Katherine Kedzierska";Proc Natl Acad Sci U S A;2013;Preemptive priming readily overcomes structure-based mechanisms of virus escape.;;4629;Linear peptide;ASNENTETM;367;375;;NP;Nucleoprotein;P03466;Influenza A virus (A/swine/Korea/S452/2004(H9N2));Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 2, Table S1 and PDB 4HUW;x-ray crystallography;3D structure;angstroms;Positive;=;3.2;4HUW;H2-Db;I;There are four complexes in the asymmetric unit.
1974510;1025633;Literature;23493558;"Sophie A Valkenburg; Stephanie Gras; Carole Guillonneau; Lauren A Hatton; Nicola A Bird; Kelly-Anne Twist; Hanim Halim; David C Jackson; Anthony W Purcell; Stephen J Turner; Peter C Doherty; Jamie Rossjohn; Katherine Kedzierska";Proc Natl Acad Sci U S A;2013;Preemptive priming readily overcomes structure-based mechanisms of virus escape.;;4631;Linear peptide;ASNENWETM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;ASNENMETM;366;374;;Nucleocapsid protein, Protein N;Nucleoprotein;Nucleoprotein;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;mouse (Mus musculus);10090;Figure 2, Table S1 and PDB 4HUV;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;4HUV;H2-Db;I;There are two complexes int he asymmetric unit.
1974517;1025633;Literature;23493558;"Sophie A Valkenburg; Stephanie Gras; Carole Guillonneau; Lauren A Hatton; Nicola A Bird; Kelly-Anne Twist; Hanim Halim; David C Jackson; Anthony W Purcell; Stephen J Turner; Peter C Doherty; Jamie Rossjohn; Katherine Kedzierska";Proc Natl Acad Sci U S A;2013;Preemptive priming readily overcomes structure-based mechanisms of virus escape.;;4573;Linear peptide;ASNENIETM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;ASNENMETM;366;374;;Nucleocapsid protein, Protein N;Nucleoprotein;Nucleoprotein;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;mouse (Mus musculus);10090;Figure 2, Table S1 and PDB 4HUU;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;4HUU;H2-Db;I;The structure contains two complexes in the asymmetric unit.
1975808;1017753;Literature;19698083;"Kurt H Piepenbrink; Oleg Y Borbulevych; Ruth F Sommese; John Clemens; Kathryn M Armstrong; Clare Desmond; Priscilla Do; Brian M Baker";Biochem J;2009;Fluorine substitutions in an antigenic peptide selectively modulate T-cell receptor binding in a minimally perturbing manner.;;186691;Linear peptide;LLFGFPVYV + SCM(F5);;;;;;;;;;Position Y5 of the natural sequence is substituted with a 4-fluoro-phenylalanine residue.;analog;Fragment of a Natural Sequence Molecule;LLFGYPVYV;11;19;;tax;transcriptional activator Tax;Protein Tax-1;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;human (Homo sapiens);9606;Tables 4, Figures 6, S1 and PDB 3D39;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;3D39;HLA-A*02:01;I;The crystal structure of epitope/HLA-A2 in complex with the Tax-specific A6 TCR was determined by molecular replacement. The epitope is an analog of the Tax peptide with residue Y5 substituted with a 4-fluoro-phenylalanine residue.
1975809;1017753;Literature;19698083;"Kurt H Piepenbrink; Oleg Y Borbulevych; Ruth F Sommese; John Clemens; Kathryn M Armstrong; Clare Desmond; Priscilla Do; Brian M Baker";Biochem J;2009;Fluorine substitutions in an antigenic peptide selectively modulate T-cell receptor binding in a minimally perturbing manner.;;186691;Linear peptide;LLFGFPVYV + SCM(F5);;;;;;;;;;Position Y5 of the natural sequence is substituted with a 3,4-difluoro-phenylalanine residue.;analog;Fragment of a Natural Sequence Molecule;LLFGYPVYV;11;19;;tax;transcriptional activator Tax;Protein Tax-1;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;human (Homo sapiens);9606;Tables 4, Figures 6, S1 and PDB 3D3V;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;3D3V;HLA-A*02:01;I;The crystal structure of epitope/HLA-A2 in complex with the Tax-specific A6 TCR was determined by molecular replacement. The epitope is an analog of the Tax peptide with residue Y5 substituted with a 3,4-difluoro-phenylalanine residue.
1975989;1025721;Literature;23521884;"Kristin Ladell; Masao Hashimoto; Maria Candela Iglesias; Pascal G Wilmann; James E McLaren; St&eacute;phanie Gras; Takayuki Chikata; Nozomi Kuse; Sol&egrave;ne Fastenackels; Emma Gostick; John S Bridgeman; Vanessa Venturi; Za&iuml;na A&iuml;t Arkoub; Henri Agut; David J van Bockel; Jorge R Almeida; Daniel C Douek; Laurence Meyer; Alain Venet; Masafumi Takiguchi; Jamie Rossjohn; David A Price; Victor Appay";Immunity;2013;A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.;;33250;Linear peptide;KRWIILGLNK;263;272;;Gag-Pol polyprotein;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 5, S4 and PDB 4G9D;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;4G9D;HLA-B*27:05;I;
1976482;1025029;Literature;22019736;"Daniel R Scott; Oleg Y Borbulevych; Kurt H Piepenbrink; Steven A Corcelli; Brian M Baker";J Mol Biol;2011;Disparate degrees of hypervariable loop flexibility control T-cell receptor cross-reactivity, specificity, and binding mechanism.;;184429;Linear peptide;LLFGFPVYV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LLFGYPVYV;11;19;;tax;transcriptional activator Tax;Protein Tax-1;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;human (Homo sapiens);9606;Table 1, Figures 5, S7 and PDB 3QFJ;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;3QFJ;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex bound to the A6 TCR was determined.
1977147;1025721;Literature;23521884;"Kristin Ladell; Masao Hashimoto; Maria Candela Iglesias; Pascal G Wilmann; James E McLaren; St&eacute;phanie Gras; Takayuki Chikata; Nozomi Kuse; Sol&egrave;ne Fastenackels; Emma Gostick; John S Bridgeman; Vanessa Venturi; Za&iuml;na A&iuml;t Arkoub; Henri Agut; David J van Bockel; Jorge R Almeida; Daniel C Douek; Laurence Meyer; Alain Venet; Masafumi Takiguchi; Jamie Rossjohn; David A Price; Victor Appay";Immunity;2013;A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.;;184136;Linear peptide;KRWIIMGLNK;261;270;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1 and PDB 4G8I;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;4G8I;HLA-B*27:05;I;
1977191;1024918;Literature;9729040;"A Achour; K Persson; R A Harris; J Sundb&auml;ck; C L Sentman; Y Lindqvist; G Schneider; K K&auml;rre";Immunity;1998;The crystal structure of H-2Dd MHC class I complexed with the HIV-1-derived peptide P18-I10 at 2.4 A resolution: implications for T cell and NK cell recognition.;;53935;Linear peptide;RGPGRAFVTI;311;320;;Envelope glycoprotein gp160 precursor;Envelope glycoprotein gp160;P04578;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 1, 2, 3, 4, Tables 1, 2 and PDB 1BII;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;1BII;H2-Dd;I;The crystal structure of the epitope/ H-2Dd complex was determined by molecular replacement.
1977437;1024919;Literature;9761682;"H Li; K Natarajan; E L Malchiodi; D H Margulies; R A Mariuzza";J Mol Biol;1998;Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120.;;53935;Linear peptide;RGPGRAFVTI;311;320;;Envelope glycoprotein gp160;Envelope glycoprotein gp160;P04578;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 1, 3, 4, 5, Tables 2, 3, 4 and PDB 1DDH;x-ray crystallography;3D structure;angstroms;Positive;=;3.1;1DDH;H2-Dd;I;The crystal structure of the epitope/H-2Dd complex was determined by molecular replacement.
1977505;1024920;Literature;10601290;"T J Kirksey; R R Pogue-Caley; J A Frelinger; E J Collins";J Biol Chem;1999;The structural basis for the increased immunogenicity of two HIV-reverse transcriptase peptide variant/class I major histocompatibility complexes.;;186569;Linear peptide;YLKEPVHGV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;ILKEPVHGV;309;317;;;reverse transcriptase;Gag-Pol polyprotein;Human immunodeficiency virus 1;Human immunodeficiency virus 1;human (Homo sapiens);9606;Table I, Figures 1, 4 and PDB 1I1Y;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1I1Y;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. There are two complexes in the asymmetric unit.
1977506;1024920;Literature;10601290;"T J Kirksey; R R Pogue-Caley; J A Frelinger; E J Collins";J Biol Chem;1999;The structural basis for the increased immunogenicity of two HIV-reverse transcriptase peptide variant/class I major histocompatibility complexes.;;183203;Linear peptide;FLKEPVHGV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;ILKEPVHGV;309;317;;;reverse transcriptase;Gag-Pol polyprotein;Human immunodeficiency virus 1;Human immunodeficiency virus 1;human (Homo sapiens);9606;Table I, Figures 1, 4 and PDB 1I1F;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;1I1F;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. There are two complexes in the asymmetric unit.
1977518;1024917;Literature;8976183;"S W Reid; S McAdam; K J Smith; P Klenerman; C A O'Callaghan; K Harlos; B K Jakobsen; A J McMichael; J I Bell; D I Stuart; E Y Jones";J Exp Med;1996;Antagonist HIV-1 Gag peptides induce structural changes in HLA B8.;;183363;Linear peptide;GGKKKYKL;24;31;;gag polyprotein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3 and PDB 1AGD;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;1AGD;HLA-B*08:01;I;The crystal structure of the epitope/HLA-B8 complex was determined by molecular replacement.
1977521;1024917;Literature;8976183;"S W Reid; S McAdam; K J Smith; P Klenerman; C A O'Callaghan; K Harlos; B K Jakobsen; A J McMichael; J I Bell; D I Stuart; E Y Jones";J Exp Med;1996;Antagonist HIV-1 Gag peptides induce structural changes in HLA B8.;;183365;Linear peptide;GGKKKYRL;24;31;;gag polyprotein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3 and PDB 1AGE;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1AGE;HLA-B*08:01;I;The crystal structure of the epitope/HLA-B8 complex was determined by molecular replacement.
1977644;1024917;Literature;8976183;"S W Reid; S McAdam; K J Smith; P Klenerman; C A O'Callaghan; K Harlos; B K Jakobsen; A J McMichael; J I Bell; D I Stuart; E Y Jones";J Exp Med;1996;Antagonist HIV-1 Gag peptides induce structural changes in HLA B8.;;183364;Linear peptide;GGKKKYQL;24;31;;gag polyprotein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3 and PDB 1AGC;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;1AGC;HLA-B*08:01;I;The crystal structure of the epitope/HLA-B8 complex was determined by molecular replacement.
1977646;1024917;Literature;8976183;"S W Reid; S McAdam; K J Smith; P Klenerman; C A O'Callaghan; K Harlos; B K Jakobsen; A J McMichael; J I Bell; D I Stuart; E Y Jones";J Exp Med;1996;Antagonist HIV-1 Gag peptides induce structural changes in HLA B8.;;183366;Linear peptide;GGKKRYKL;24;31;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3 and PDB 1AGF;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1AGF;HLA-B*08:01;I;The crystal structure of the epitope/HLA-B8 complex was determined by molecular replacement.
1977648;1024917;Literature;8976183;"S W Reid; S McAdam; K J Smith; P Klenerman; C A O'Callaghan; K Harlos; B K Jakobsen; A J McMichael; J I Bell; D I Stuart; E Y Jones";J Exp Med;1996;Antagonist HIV-1 Gag peptides induce structural changes in HLA B8.;;183371;Linear peptide;GGRKKYKL;24;31;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3 and PDB 1AGB;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1AGB;HLA-B*08:01;I;The crystal structure of the epitope/HLA-B8 complex was determined by molecular replacement.
1978068;1025812;Literature;23566939;"Ling Niu; Hao Cheng; Shihong Zhang; Shuguang Tan; Yudan Zhang; Jianxun Qi; Jun Liu; George F Gao";Mol Immunol;2013;Structural basis for the differential classification of HLA-A*6802 and HLA-A*6801 into the A2 and A3 supertypes.;;65108;Linear peptide;TLTSCNTSV;199;207;;protein env-lor;Envelope glycoprotein gp160;P04578;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, Figures 1, 3, 4, 5, 6, S1 and PDB 4I48;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;4I48;HLA-A*68:02;I;The crystal structure of the epitope/HLA-A*6802 complex was determined by molecular replacement.
1978069;1025812;Literature;23566939;"Ling Niu; Hao Cheng; Shihong Zhang; Shuguang Tan; Yudan Zhang; Jianxun Qi; Jun Liu; George F Gao";Mol Immunol;2013;Structural basis for the differential classification of HLA-A*6802 and HLA-A*6801 into the A2 and A3 supertypes.;;62404;Linear peptide;SVYDFFVWL;180;188;;Tyrosinase-related protein-2;L-dopachrome tautomerase;P40126;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, Figures 1, 3, 4, 5, 6 and PDB 4HX1;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;4HX1;HLA-A*68:02;I;The crystal structure of the epitope/HLA-A*6802 complex was determined by molecular replacement.
1978070;1025812;Literature;23566939;"Ling Niu; Hao Cheng; Shihong Zhang; Shuguang Tan; Yudan Zhang; Jianxun Qi; Jun Liu; George F Gao";Mol Immunol;2013;Structural basis for the differential classification of HLA-A*6802 and HLA-A*6801 into the A2 and A3 supertypes.;;1913;Linear peptide;AIFQSSMTK;158;166;;reverse transcriptase;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, Figures 1, 3, 4, 5, 6 and PDB 4HWZ;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;4HWZ;HLA-A*68:01;I;The crystal structure of the epitope/HLA-A*6801 complex was determined by molecular replacement.
1981439;1026301;Literature;23569211;"Yu Chih Liu; John J Miles; Michelle A Neller; Emma Gostick; David A Price; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2013;Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule.;;38458;Linear peptide;LPEPLPQGQLTAY;52;64;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 3, 4 and PDB 4JRX;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;4JRX;HLA-B*35:08;I;The crystal structure of the epitope/HLA-B*35:08 complex bound to the CA5 TCR was determined.
1981451;1026301;Literature;23569211;"Yu Chih Liu; John J Miles; Michelle A Neller; Emma Gostick; David A Price; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2013;Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule.;;38458;Linear peptide;LPEPLPQGQLTAY;52;64;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 3, 5 and PDB 4JRY;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;4JRY;HLA-B*35:08;I;The crystal structure of the epitope/HLA-B*35:08 complex bound to the SB47 TCR was determined.
1981559;1026077;Literature;23698002;"Florian Madura; Pierre J Rizkallah; Kim M Miles; Christopher J Holland; Anna M Bulek; Anna Fuller; Andrea J A Schauenburg; John J Miles; Nathaniel Liddy; Malkit Sami; Yi Li; Moushumi Hossain; Brian M Baker; Bent K Jakobsen; Andrew K Sewell; David K Cole";J Biol Chem;2013;T-cell receptor specificity maintained by altered thermodynamics.;;12941;Linear peptide;ELAGIGILTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Supplementary Table S1 and PDB 4JFF;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;4JFF;HLA-A*02:01;I;"The crystal structure of the epitope/HLA-A2 complex bound by the alpha24&szlig;17 TCR was determined by molecular replacement."
1981560;1026077;Literature;23698002;"Florian Madura; Pierre J Rizkallah; Kim M Miles; Christopher J Holland; Anna M Bulek; Anna Fuller; Andrea J A Schauenburg; John J Miles; Nathaniel Liddy; Malkit Sami; Yi Li; Moushumi Hossain; Brian M Baker; Bent K Jakobsen; Andrew K Sewell; David K Cole";J Biol Chem;2013;T-cell receptor specificity maintained by altered thermodynamics.;;189960;Linear peptide;ELAAIGILTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Supplementary Table S6, Supplementary Fig S1, S4 and PDB 4JFP;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;4JFP;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. There are two complexes in the asymmetric unit.
1981580;1026078;Literature;23678186;"Yu Zhang; Yulin Ren; Yan Wu; Bao Zhao; Lipeng Qiu; Xiaodong Li; Dongping Xu; Jun Liu; George F Gao; Songdong Meng";J Virol;2013;The L60V variation in hepatitis B virus core protein elicits new epitope-specific cytotoxic T lymphocytes and enhances viral replication.;;187197;Linear peptide;VCWGELMNL;60;68;;Core protein;Capsid protein;Q76R61;Hepatitis B virus;Hepatitis B virus;10407;;;;;;;;;;;;;human (Homo sapiens);9606;Table 3, Figure 1 and PDB 4K7F;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;4K7F;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex was determined by molecular replacement.
1981676;1026077;Literature;23698002;"Florian Madura; Pierre J Rizkallah; Kim M Miles; Christopher J Holland; Anna M Bulek; Anna Fuller; Andrea J A Schauenburg; John J Miles; Nathaniel Liddy; Malkit Sami; Yi Li; Moushumi Hossain; Brian M Baker; Bent K Jakobsen; Andrew K Sewell; David K Cole";J Biol Chem;2013;T-cell receptor specificity maintained by altered thermodynamics.;;189962;Linear peptide;ELAGIGALTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 4, 5, 7, Supplementary Figures S1, Supplementary Table S1, Table 1 and PDB 4JFE;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;4JFE;HLA-A*02:01;I;"The crystal structure of the epitope/HLA-A2 complex  bound by the alpha24&szlig;17 TCR was determined by molecular replacement."
1981679;1026077;Literature;23698002;"Florian Madura; Pierre J Rizkallah; Kim M Miles; Christopher J Holland; Anna M Bulek; Anna Fuller; Andrea J A Schauenburg; John J Miles; Nathaniel Liddy; Malkit Sami; Yi Li; Moushumi Hossain; Brian M Baker; Bent K Jakobsen; Andrew K Sewell; David K Cole";J Biol Chem;2013;T-cell receptor specificity maintained by altered thermodynamics.;;189944;Linear peptide;ALAGIGILTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Supplementary Table S6, Supplementary Fig S1, S4 and PDB 4JFO;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;4JFO;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. There are two complexes in the asymmetric unit.
1981681;1026077;Literature;23698002;"Florian Madura; Pierre J Rizkallah; Kim M Miles; Christopher J Holland; Anna M Bulek; Anna Fuller; Andrea J A Schauenburg; John J Miles; Nathaniel Liddy; Malkit Sami; Yi Li; Moushumi Hossain; Brian M Baker; Bent K Jakobsen; Andrew K Sewell; David K Cole";J Biol Chem;2013;T-cell receptor specificity maintained by altered thermodynamics.;;189963;Linear peptide;ELAGIGIATV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Supplementary Table S6, Supplementary Fig S1, S4 and PDB 4JFQ;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;4JFQ;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. There are two complexes in the asymmetric unit.
1982854;1024929;Literature;16951352;"Geraldine M A Gillespie; Guillaume Stewart-Jones; Jaya Rengasamy; Tara Beattie; Job J Bwayo; Francis A Plummer; Rupert Kaul; Andrew J McMichael; Philippa Easterbrook; Tao Dong; E Yvonne Jones; Sarah L Rowland-Jones";J Immunol;2006;Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection.;;187163;Linear peptide;KGFNPEVIPMF;162;172;;Gag polyprotein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table III, Figure 6 and PDB 2HJK;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;2HJK;HLA-B*57:03;I;The crystal structure of the epitope/HLA-B*5703 complex was solved by molecular replacement. There is one epitope/HLA-B*5703 complex per asymmetric unit.
1982855;1024929;Literature;16951352;"Geraldine M A Gillespie; Guillaume Stewart-Jones; Jaya Rengasamy; Tara Beattie; Job J Bwayo; Francis A Plummer; Rupert Kaul; Andrew J McMichael; Philippa Easterbrook; Tao Dong; E Yvonne Jones; Sarah L Rowland-Jones";J Immunol;2006;Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection.;;187158;Linear peptide;KAFNPEIIPMF;155;165;;Gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table III, Figure 6 and PDB 2HJL;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;2HJL;HLA-B*57:03;I;The crystal structure of the epitope/HLA-B*5703 complex was solved by molecular replacement. There is one epitope/HLA-B*5703 complex per asymmetric unit.
1983071;1026375;Literature;23749632;"Melissa J Rist; Alex Theodossis; Nathan P Croft; Michelle A Neller; Andrew Welland; Zhenjun Chen; Lucy C Sullivan; Jacqueline M Burrows; John J Miles; Rebekah M Brennan; Stephanie Gras; Rajiv Khanna; Andrew G Brooks; James McCluskey; Anthony W Purcell; Jamie Rossjohn; Scott R Burrows";J Immunol;2013;HLA peptide length preferences control CD8+ T cell responses.;;187225;Linear peptide;SELEIKRY;173;180;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 4, 5, 6, 7, 8, Table I, Supplemental Tables I, II and PDB 4JQV;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;4JQV;HLA-B*18:01;I;
1983072;1026375;Literature;23749632;"Melissa J Rist; Alex Theodossis; Nathan P Croft; Michelle A Neller; Andrew Welland; Zhenjun Chen; Lucy C Sullivan; Jacqueline M Burrows; John J Miles; Rebekah M Brennan; Stephanie Gras; Rajiv Khanna; Andrew G Brooks; James McCluskey; Anthony W Purcell; Jamie Rossjohn; Scott R Burrows";J Immunol;2013;HLA peptide length preferences control CD8+ T cell responses.;;187222;Linear peptide;EECDSELEIKRY;169;180;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 4, 5, 6, 7, 8, Table I, Supplemental Tables I, II and PDB 4JQX;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;4JQX;HLA-B*44:03;I;
1983073;1026448;Literature;23805144;"David K Cole; Malkit Sami; Daniel R Scott; Pierre J Rizkallah; Oleg Y Borbulevych; Penio T Todorov; Ruth K Moysey; Bent K Jakobsen; Jonathan M Boulter; Brian M Baker; Yi Li";Front Immunol;2013;Increased Peptide Contacts Govern High Affinity Binding of a Modified TCR Whilst Maintaining a Native pMHC Docking Mode.;;37257;Linear peptide;LLFGYPVYV;11;19;;Protein Tax-1;Protein Tax-1;P14079;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;194440;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 3, 4, 5, Supplementary Tables 1, 3 and PDB 4FTV;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;4FTV;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex bound by the high affinity A6c134 TCR was determined by molecular replacement. There is one molecule of the ternary TCR-epitope-HLA-A2 complex per asymmetric unit.
1983275;315009;Literature;1448153;"H C Guo; T S Jardetzky; T P Garrett; W S Lane; J L Strominger; D C Wiley";Nature;1992;Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle.;;188063;Linear peptide;AVA;;;;unknown protein eluted from human MHC allele;;;unidentified;unidentified;32644;The epitope is from a collection of bound, endogenous peptides.The epitope sequence comes from models of residues E-V-A and A-R that were built for peptide positions P1, P2, P3 at the N-terminus and PC-1, PC carboxy terminal, respectively.;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2 and PDB 1HSB;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;1HSB;HLA-A*68:01;I;The structure represents the average image from the collection of bound peptides of 9, 10, and 11 amino acids eluted from HLA-Aw68. There is clear electron density for the first three and last two residues of the peptides, but not for any of the in between residues. The middle part of the peptide density is sparse and unconnected, presumable representing an average of diverse conformations and/or length. Models of residues E-V-A and A-R were built for peptide positions P1, P2, P3 and PC-1, PC, respectively.
1984805;1024928;Literature;16702212;"Erik Martinez-Hackert; Nadia Anikeeva; Spyros A Kalams; Bruce D Walker; Wayne A Hendrickson; Yuri Sykulev";J Biol Chem;2006;Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes.;;59613;Linear peptide;SLYNTVATL;77;85;;Gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Supplemental Table 1S, Figures 3, 4 and PDB 1T21;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1T21;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. The complexes were in the monoclinic crystal space group P2<sub>1</sub>.
1984806;1024928;Literature;16702212;"Erik Martinez-Hackert; Nadia Anikeeva; Spyros A Kalams; Bruce D Walker; Wayne A Hendrickson; Yuri Sykulev";J Biol Chem;2006;Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes.;;59613;Linear peptide;SLYNTVATL;77;85;;Gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Supplemental Table 1S, Figures 3, 4 and PDB 1T22;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1T22;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. The complexes were in the orthorhombic crystal space group P2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>.
1984807;1024928;Literature;16702212;"Erik Martinez-Hackert; Nadia Anikeeva; Spyros A Kalams; Bruce D Walker; Wayne A Hendrickson; Yuri Sykulev";J Biol Chem;2006;Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes.;;189288;Linear peptide;SLYNTIATL;77;85;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Supplemental Table 1S, Figure 4 and PDB 1T20;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1T20;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. The complexes were in the monoclinic crystal space group P2<sub>1</sub>.
1984842;1024928;Literature;16702212;"Erik Martinez-Hackert; Nadia Anikeeva; Spyros A Kalams; Bruce D Walker; Wayne A Hendrickson; Yuri Sykulev";J Biol Chem;2006;Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes.;;189277;Linear peptide;SLFNTIAVL;77;85;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Supplemental Table 1S, Figure 4 and PDB 1T1W;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1T1W;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. The complexes were in the monoclinic crystal space group P2<sub>1</sub>.
1984843;1024928;Literature;16702212;"Erik Martinez-Hackert; Nadia Anikeeva; Spyros A Kalams; Bruce D Walker; Wayne A Hendrickson; Yuri Sykulev";J Biol Chem;2006;Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes.;;189280;Linear peptide;SLYLTVATL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;SLYNTVATL;77;85;;;Gag protein;Gag polyprotein;Human immunodeficiency virus 1;Human immunodeficiency virus 1;human (Homo sapiens);9606;Supplemental Table 1S, Figure 4 and PDB 1T1X;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1T1X;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. The complexes were in the monoclinic crystal space group P2<sub>1</sub>.
1984844;1024928;Literature;16702212;"Erik Martinez-Hackert; Nadia Anikeeva; Spyros A Kalams; Bruce D Walker; Wayne A Hendrickson; Yuri Sykulev";J Biol Chem;2006;Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes.;;180153;Linear peptide;SLANTVATL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;SLYNTVATL;77;85;;;Gag protein;Gag polyprotein;Human immunodeficiency virus 1;Human immunodeficiency virus 1;human (Homo sapiens);9606;Supplemental Table 1S, Figures 3, 4 and PDB 1S8D;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1S8D;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. The complexes were in the monoclinic crystal space group P2<sub>1</sub>.
1984845;1024928;Literature;16702212;"Erik Martinez-Hackert; Nadia Anikeeva; Spyros A Kalams; Bruce D Walker; Wayne A Hendrickson; Yuri Sykulev";J Biol Chem;2006;Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes.;;189296;Linear peptide;SLYNVVATL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;SLYNTVATL;77;85;;;Gag protein;Gag polyprotein;Human immunodeficiency virus 1;Human immunodeficiency virus 1;human (Homo sapiens);9606;Supplemental Table 1S, Figure 4 and PDB 1T1Y;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1T1Y;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. The complexes were in the monoclinic crystal space group P2<sub>1</sub>.
1984846;1024928;Literature;16702212;"Erik Martinez-Hackert; Nadia Anikeeva; Spyros A Kalams; Bruce D Walker; Wayne A Hendrickson; Yuri Sykulev";J Biol Chem;2006;Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes.;;189203;Linear peptide;ALYNTAAAL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;SLYNTVATL;77;85;;;Gag protein;Gag polyprotein;Human immunodeficiency virus 1;Human immunodeficiency virus 1;human (Homo sapiens);9606;Supplemental Table 1S, Figure 4 and PDB 1T1Z;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;1T1Z;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined by molecular replacement. The complexes were in the monoclinic crystal space group P2<sub>1</sub>.
1985613;1024930;Literature;17202356;"Fuliang Chu; Zhiyong Lou; Yu Wai Chen; Yiwei Liu; Bin Gao; Lili Zong; Abdul Hamid Khan; John I Bell; Zihe Rao; George F Gao";J Immunol;2007;First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A*01 complexed with two immunogenic SIV epitopes and insights into CTL escape.;;66760;Linear peptide;TTPESANL;28;35;;tat protein;Protein Tat;P05911;Simian immunodeficiency virus;Simian immunodeficiency virus;11723;;;;;;;;;;;;;rhesus macaque (Macaca mulatta);9544;Tables I, II, III, Figures 3, 4, 5, 6 and PDB 1ZVS;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;1ZVS;Mamu-A1*001:01;I;The crystal structure of the epitope/Mamu-A*01 complex was determined by molecular replacement.
1985679;1024927;Literature;16388312;"Astrid K N Iversen; Guillaume Stewart-Jones; Gerald H Learn; Natasha Christie; Christina Sylvester-Hviid; Andrew E Armitage; Rupert Kaul; Tara Beattie; Jean K Lee; Yanping Li; Pojchong Chotiyarnwong; Tao Dong; Xiaoning Xu; Mark A Luscher; Kelly MacDonald; Henrik Ullum; Bente Klarlund-Pedersen; Peter Skinh&oslash;j; Lars Fugger; S&oslash;ren Buus; James I Mullins; E Yvonne Jones; P Anton van der Merwe; Andrew J McMichael";Nat Immunol;2006;Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope.;;189277;Linear peptide;SLFNTIAVL;7;15;;Gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 5, Supplementary Table 2 and PDB 2C7U;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;2C7U;HLA-A*02:01;I;There are two complexes in the asymmetric unit.
1985806;1016406;Literature;19620307;"Mitsuo Honda; Rui Wang; Wing-Pui Kong; Masaru Kanekiyo; Wataru Akahata; Ling Xu; Kazuhiro Matsuo; Kannan Natarajan; Howard Robinson; Tedi E Asher; David A Price; Daniel C Douek; David H Margulies; Gary J Nabel";J Immunol;2009;Different vaccine vectors delivering the same antigen elicit CD8+ T cell responses with distinct clonotype and epitope specificity.;;188249;Linear peptide;IGPGRAFYA;307;315;;Envelope glycoprotein gp160 precursor;Envelope glycoprotein gp160;P04578;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 6, S3, Table SII and PDB 3E6F;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;3E6F;H2-Dd;I;The crystal structure of the epitope/H-2Dd complex was solved by molecular replacement. There is one complex in the asymmetric unit.
1985809;1016406;Literature;19620307;"Mitsuo Honda; Rui Wang; Wing-Pui Kong; Masaru Kanekiyo; Wataru Akahata; Ling Xu; Kazuhiro Matsuo; Kannan Natarajan; Howard Robinson; Tedi E Asher; David A Price; Daniel C Douek; David H Margulies; Gary J Nabel";J Immunol;2009;Different vaccine vectors delivering the same antigen elicit CD8+ T cell responses with distinct clonotype and epitope specificity.;;188253;Linear peptide;IGPGRAFYTI;319;328;;envelope glycoprotein;Envelope glycoprotein gp160;P04578;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 6, S3, Table SII and PDB 3E6H;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3E6H;H2-Dd;I;The crystal structure of the epitope/H-2Dd complex was solved by molecular replacement. There is one complex in the asymmetric unit.
1985867;1024925;Literature;16081817;"Guillaume B E Stewart-Jones; Geraldine Gillespie; Ian M Overton; Rupert Kaul; Philippe Roche; Andrew J McMichael; Sarah Rowland-Jones; E Yvonne Jones";J Immunol;2005;Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression.;;28657;Linear peptide;ISPRTLNAW;147;155;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Tables I, II, III, Figures 1, 2, 3 and PDB 2BVP;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;2BVP;HLA-B*57:03;I;The crystal structure of the epitope/HLA-B*5703 complex was solved by molecular replacement. There is one complex per asymmetric unit.
1985870;1024925;Literature;16081817;"Guillaume B E Stewart-Jones; Geraldine Gillespie; Ian M Overton; Rupert Kaul; Philippe Roche; Andrew J McMichael; Sarah Rowland-Jones; E Yvonne Jones";J Immunol;2005;Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression.;;29804;Linear peptide;KAFSPEVIPMF;30;40;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Tables I, II, III, Figures 1, 2, 3 and PDB 2BVO;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;2BVO;HLA-B*57:03;I;The crystal structure of the epitope/HLA-B*5703 complex was solved by molecular replacement. There is one complex per asymmetric unit.
1985871;1024925;Literature;16081817;"Guillaume B E Stewart-Jones; Geraldine Gillespie; Ian M Overton; Rupert Kaul; Philippe Roche; Andrew J McMichael; Sarah Rowland-Jones; E Yvonne Jones";J Immunol;2005;Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression.;;187159;Linear peptide;KAFSPEVI;30;37;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Tables I, II, III, Figures 1, 2, 3 and PDB 2BVQ;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;2BVQ;HLA-B*57:03;I;The crystal structure of the epitope/HLA-B*5703 complex was solved by molecular replacement. There is one complex per asymmetric unit.
2006464;1015058;Literature;19412183;"Stefan Tenzer; Edmund Wee; Anne Burgevin; Guillaume Stewart-Jones; Lone Friis; Kasper Lamberth; Chih-hao Chang; Mikkel Harndahl; Mirjana Weimershaus; Jan Gerstoft; Nadja Akkad; Paul Klenerman; Lars Fugger; E Yvonne Jones; Andrew J McMichael; S&oslash;ren Buus; Hansj&ouml;rg Schild; Peter van Endert; Astrid K N Iversen";Nat Immunol;2009;Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.;;127083;Linear peptide;SLFNTVATLY;50;59;;Gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 5, Supplementary Table 3 and PDB 3GIV;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3GIV;HLA-A*02:01;I;The crystal structure of the epitope bound to HLA-A*0201 was determined. There are two identical complexes in the asymmetric unit.
2008223;1026077;Literature;23698002;"Florian Madura; Pierre J Rizkallah; Kim M Miles; Christopher J Holland; Anna M Bulek; Anna Fuller; Andrea J A Schauenburg; John J Miles; Nathaniel Liddy; Malkit Sami; Yi Li; Moushumi Hossain; Brian M Baker; Bent K Jakobsen; Andrew K Sewell; David K Cole";J Biol Chem;2013;T-cell receptor specificity maintained by altered thermodynamics.;;189960;Linear peptide;ELAAIGILTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 4, 5, 7, Supplementary Figures S1, Supplementary Table S1, Table 1 and PDB 4JFD;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;4JFD;HLA-A*02:01;I;"The crystal structure of the epitope/HLA-A2 complex  bound by the alpha24&szlig;17 TCR was determined by molecular replacement."
2012327;1450;Literature;15100292;"Lucas Malard Velloso; Jakob Micha&euml;lsson; Hans-Gustaf Ljunggren; Gunter Schneider; Adnane Achour";J Immunol;2004;Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.;;30015;Linear peptide;KAVYNFATM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Table I, Figure 1 and PDB 1S7Q;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;1S7Q;H2-Kb;I;"Coordinates for the first N-terminal residue of the peptide were not determined. The same structure with resolution 2.9 &Aring; has been published earlier [PDB: 1N59]."
2012328;1450;Literature;15100292;"Lucas Malard Velloso; Jakob Micha&euml;lsson; Hans-Gustaf Ljunggren; Gunter Schneider; Adnane Achour";J Immunol;2004;Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.;;30015;Linear peptide;KAVYNFATM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Table I, Figure 1 and PDB 1S7U;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1S7U;H2-Db;I;"The same structure with resolution 2.85 &Aring; has been published earlier [PDB: 1N5A]."
2012331;1450;Literature;15100292;"Lucas Malard Velloso; Jakob Micha&euml;lsson; Hans-Gustaf Ljunggren; Gunter Schneider; Adnane Achour";J Immunol;2004;Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.;;29975;Linear peptide;KAVFNFATM;;;;;;;;;;The epitope differs from gp33 natural epitope by two substitutions at the C-terminal C9M and Y4F. Protein name is taken from Hudrisier et al. (1997) Virology 234: 62 [PMID: 9234947].;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Table I, Figure 1 and PDB 1S7T;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;1S7T;H2-Kb;I;Coordinates for the first N-terminal residue of the peptide were not determined. There are two complexes in the asymmetric unit.
2012332;1450;Literature;15100292;"Lucas Malard Velloso; Jakob Micha&euml;lsson; Hans-Gustaf Ljunggren; Gunter Schneider; Adnane Achour";J Immunol;2004;Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.;;29975;Linear peptide;KAVFNFATM;;;;;;;;;;The epitope differs from gp33 natural epitope by two substitutions at the C-terminal C9M and Y4F. Protein name is taken from Hudrisier et al. (1997) Virology 234: 62 [PMID: 9234947].;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Table I, Figure 1 and PDB 1S7X;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;1S7X;H2-Db;I;There are four complexes in the asymmetric unit.
2012694;1026954;Literature;22101157;"Jarrett J Adams; Samanthi Narayanan; Baoyu Liu; Michael E Birnbaum; Andrew C Kruse; Natalie A Bowerman; Wei Chen; Aron M Levin; Janet M Connolly; Cheng Zhu; David M Kranz; K Christopher Garcia";Immunity;2011;T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex.;;97581;Linear peptide;QLSPFPFDL;932;940;;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Q60597;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 1, 5, 6, Table S1, Figure S4, S5 and PDB 3TF7;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;3TF7;H2-Ld;I;The crystal structure of the epitope/H-2Ld complex bound to the 42F3 TCR scFv was determined by molecular replacement. There are two complexes in the asymmetric unit.
2012695;1026954;Literature;22101157;"Jarrett J Adams; Samanthi Narayanan; Baoyu Liu; Michael E Birnbaum; Andrew C Kruse; Natalie A Bowerman; Wei Chen; Aron M Levin; Janet M Connolly; Cheng Zhu; David M Kranz; K Christopher Garcia";Immunity;2011;T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex.;;227921;Linear peptide;FLSPFWFDI;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;QLSPFPFDL;932;940;;Alpha-ketoglutarate dehydrogenase, 2-oxoglutarate dehydrogenase complex component E1, OGDC-E1;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Figure 5, Table S1, Figure S4, S5 and PDB 3TPU;x-ray crystallography;3D structure;angstroms;Positive;=;3.1;3TPU;H2-Ld;I;The crystal structure of the epitope/H-2Ld complex bound to the 42F3 TCR scFv was determined by molecular replacement. There are four complexes in the asymmetric unit.
2012696;1026954;Literature;22101157;"Jarrett J Adams; Samanthi Narayanan; Baoyu Liu; Michael E Birnbaum; Andrew C Kruse; Natalie A Bowerman; Wei Chen; Aron M Levin; Janet M Connolly; Cheng Zhu; David M Kranz; K Christopher Garcia";Immunity;2011;T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex.;;227929;Linear peptide;QLSDVPMDL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;QLSPFPFDL;932;940;;Alpha-ketoglutarate dehydrogenase, 2-oxoglutarate dehydrogenase complex component E1, OGDC-E1;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Figure 5, Table S1, Figure S4, S5 and PDB 3TFK;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;3TFK;H2-Ld;I;The crystal structure of the epitope/H-2Ld complex bound to the 42F3 TCR scFv was determined by molecular replacement.
2012697;1026954;Literature;22101157;"Jarrett J Adams; Samanthi Narayanan; Baoyu Liu; Michael E Birnbaum; Andrew C Kruse; Natalie A Bowerman; Wei Chen; Aron M Levin; Janet M Connolly; Cheng Zhu; David M Kranz; K Christopher Garcia";Immunity;2011;T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex.;;227931;Linear peptide;SPLDSLWWI;;;;;;;;;;;mimotope;Fragment of a Natural Sequence Molecule;QLSPFPFDL;932;940;;Alpha-ketoglutarate dehydrogenase, 2-oxoglutarate dehydrogenase complex component E1, OGDC-E1;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Figures 5, 6, Table S1, Figure S4, S5 and PDB 3TJH;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3TJH;H2-Ld;I;The crystal structure of the epitope/H-2Ld complex bound to the 42F3 TCR scFv was determined by molecular replacement.
2012729;1026949;Literature;24127554;"Zu T Shen; Tina T Nguyen; Keith A Daniels; Raymond M Welsh; Lawrence J Stern";J Immunol;2013;Disparate epitopes mediating protective heterologous immunity to unrelated viruses share peptide-MHC structural features recognized by cross-reactive T cells.;;2124;Linear peptide;AIVNYANL;198;205;;Hypothetical protein;Protein A11;Q80HV8;Vaccinia virus;Vaccinia virus;10245;;;;;;;;;;;;;mouse (Mus musculus);10090;Table II, Figure 6 and PDB 3TIE;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;3TIE;H2-Kb;I;The crystal structure of the epitope bound to H-2Kb was determined by molecular replacement.
2012730;1026949;Literature;24127554;"Zu T Shen; Tina T Nguyen; Keith A Daniels; Raymond M Welsh; Lawrence J Stern";J Immunol;2013;Disparate epitopes mediating protective heterologous immunity to unrelated viruses share peptide-MHC structural features recognized by cross-reactive T cells.;;5628;Linear peptide;AVYNFATM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;AVYNFATC;34;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;Table II, Figure 6 and PDB 3TID;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3TID;H2-Kb;I;The crystal structure of the epitope bound to H-2Kb was determined by molecular replacement.
2014597;1026965;Literature;24192765;"Akihisa Shimizu; Ai Kawana-Tachikawa; Atsushi Yamagata; Chungyong Han; Dayong Zhu; Yusuke Sato; Hitomi Nakamura; Tomohiko Koibuchi; Jonathan Carlson; Eric Martin; Chanson J Brumme; Yi Shi; George F Gao; Zabrina L Brumme; Shuya Fukai; Aikichi Iwamoto";Sci Rep;2013;Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection.;;56620;Linear peptide;RYPLTFGWCF;134;143;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Supplementary Figure 4, Supplementary Table 2 and PDB 3VXN;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3VXN;HLA-A*24:02;I;The crystal structure of the epitope in complex with HLA-A*2402 was determined by molecular replacement.
2014598;1026965;Literature;24192765;"Akihisa Shimizu; Ai Kawana-Tachikawa; Atsushi Yamagata; Chungyong Han; Dayong Zhu; Yusuke Sato; Hitomi Nakamura; Tomohiko Koibuchi; Jonathan Carlson; Eric Martin; Chanson J Brumme; Yi Shi; George F Gao; Zabrina L Brumme; Shuya Fukai; Aikichi Iwamoto";Sci Rep;2013;Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection.;;193060;Linear peptide;RFPLTFGWCF;143;152;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Supplementary Figure 4, Supplementary Table 2 and PDB 3VXO;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3VXO;HLA-A*24:02;I;The crystal structure of the epitope in complex with HLA-A*2402 was determined by molecular replacement. There are two complexes in the asymmetric unit.
2014599;1026965;Literature;24192765;"Akihisa Shimizu; Ai Kawana-Tachikawa; Atsushi Yamagata; Chungyong Han; Dayong Zhu; Yusuke Sato; Hitomi Nakamura; Tomohiko Koibuchi; Jonathan Carlson; Eric Martin; Chanson J Brumme; Yi Shi; George F Gao; Zabrina L Brumme; Shuya Fukai; Aikichi Iwamoto";Sci Rep;2013;Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection.;;193071;Linear peptide;RYPLTLGWCF;133;142;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Supplementary Figure 4, Supplementary Table 2 and PDB 3VXP;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;3VXP;HLA-A*24:02;I;The crystal structure of the epitope in complex with HLA-A*2402 was determined by molecular replacement. There are two complexes in the asymmetric unit.
2019394;1027013;Literature;24196962;"David K Cole; Kim M Miles; Florian Madura; Christopher J Holland; Andrea J A Schauenburg; Andrew J Godkin; Anna M Bulek; Anna Fuller; Hephzibah J E Akpovwa; Phillip G Pymm; Nathaniel Liddy; Malkit Sami; Yi Li; Pierre J Rizkallah; Bent K Jakobsen; Andrew K Sewell";J Biol Chem;2014;T-cell receptor (TCR)-peptide specificity overrides affinity-enhancing TCR-major histocompatibility complex interactions.;;179820;Linear peptide;ILAKFLHWL;540;548;;Telomerase reverse transcriptase;Telomerase reverse transcriptase;O14746;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 4, Figure 4 and PDB 4MNQ;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;4MNQ;HLA-A*02:01;I;"The crystal structure of the epitope/HLA-A*0201 complex bound by the enhanced affinity ILA1alpha1&szlig;1 TCR was determined."
2021479;1027117;Literature;24338476;"Levon Halabelian; Stefano Ricagno; Sofia Giorgetti; Carlo Santambrogio; Alberto Barbiroli; Sara Pellegrino; Adnane Achour; Rita Grandori; Loredana Marchese; Sara Raimondi; P Patrizia Mangione; Gennaro Esposito; Raya Al-Shawi; J Paul Simons; Ivana Speck; Monica Stoppini; Martino Bolognesi; Vittorio Bellotti";J Biol Chem;2014;Class I major histocompatibility complex, the trojan horse for secretion of amyloidogenic beta2-microglobulin.;;194977;Linear peptide;YLLMWITQV;;;;;;;;;;The epitope is a modified peptide ligand variant from the melanoma-associated antigen NY-ESO-1.;analog;Fragment of a Natural Sequence Molecule;SLLMWITQC;157;165;;NY-ESO-1;NY-ESO-1 protein;Cancer/testis antigen 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 3, Table II and PDB 4L29;x-ray crystallography;3D structure;angstroms;Positive;=;3.1;4L29;HLA-A*02:01;I;"The crystal structure of the epitope in complex with HLA-A*0201 heavy chain and wild type &szlig;2m was solved by molecular replacement. The asymmetric unit contains fourteen MHC moieties, arranged in two juxtaposed heptameric rings, a previously unreported packing for MHC crystal structures, containing 69% solvent content."
2021480;1027117;Literature;24338476;"Levon Halabelian; Stefano Ricagno; Sofia Giorgetti; Carlo Santambrogio; Alberto Barbiroli; Sara Pellegrino; Adnane Achour; Rita Grandori; Loredana Marchese; Sara Raimondi; P Patrizia Mangione; Gennaro Esposito; Raya Al-Shawi; J Paul Simons; Ivana Speck; Monica Stoppini; Martino Bolognesi; Vittorio Bellotti";J Biol Chem;2014;Class I major histocompatibility complex, the trojan horse for secretion of amyloidogenic beta2-microglobulin.;;194977;Linear peptide;YLLMWITQV;;;;;;;;;;The epitope is a modified peptide ligand variant from the melanoma-associated antigen NY-ESO-1.;analog;Fragment of a Natural Sequence Molecule;SLLMWITQC;157;165;;NY-ESO-1;NY-ESO-1 protein;Cancer/testis antigen 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 3, Table II and PDB 4L3C;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;4L3C;HLA-A*02:01;I;"The crystal structure of the epitope in complex with HLA-A*0201 heavy chain and &szlig;2m with mutation D76N was solved by molecular replacement. The asymmetric unit contains fourteen MHC moieties, arranged in two juxtaposed heptameric rings, a previously unreported packing for MHC crystal structures, containing 69% solvent content."
2030850;1027245;Literature;24509977;"Corey Smith; Stephanie Gras; Rebekah M Brennan; Nicola L Bird; Sophie A Valkenburg; Kelly-Anne Twist; Jacqueline M Burrows; John J Miles; Daniel Chambers; Scott Bell; Scott Campbell; Katherine Kedzierska; Scott R Burrows; Jamie Rossjohn; Rajiv Khanna";Sci Rep;2014;Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire.;;13257;Linear peptide;ELRRKMMYM;199;207;;"UL123; IE1";55 kDa immediate-early protein 1;F5HCM1;Human herpesvirus 5 strain Merlin;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 6, 7, Supplemental Table 1 and PDB 4QRU;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;4QRU;HLA-B*08:01;I;The structure of the epitope/HLA-B8 complex was determined by molecular replacement.
2030851;1027245;Literature;24509977;"Corey Smith; Stephanie Gras; Rebekah M Brennan; Nicola L Bird; Sophie A Valkenburg; Kelly-Anne Twist; Jacqueline M Burrows; John J Miles; Daniel Chambers; Scott Bell; Scott Campbell; Katherine Kedzierska; Scott R Burrows; Jamie Rossjohn; Rajiv Khanna";Sci Rep;2014;Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire.;;13133;Linear peptide;ELKRKMIYM;199;207;;"UL123; IE1";55 kDa immediate-early protein 1;F5HCM1;Human herpesvirus 5 TB40;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 6, 7, Supplemental Table 1 and PDB 4QRS;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;4QRS;HLA-B*08:01;I;The structure of the epitope/HLA-B8 complex was determined by molecular replacement.
2030852;1027245;Literature;24509977;"Corey Smith; Stephanie Gras; Rebekah M Brennan; Nicola L Bird; Sophie A Valkenburg; Kelly-Anne Twist; Jacqueline M Burrows; John J Miles; Daniel Chambers; Scott Bell; Scott Campbell; Katherine Kedzierska; Scott R Burrows; Jamie Rossjohn; Rajiv Khanna";Sci Rep;2014;Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire.;;240792;Linear peptide;ELNRKMIYM;51;59;;Major immediate-early protein;55 kDa immediate-early protein 1;F5HCM1;Human betaherpesvirus 5;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 6, 7, Supplemental Table 1 and PDB 4QRT;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;4QRT;HLA-B*08:01;I;The structure of the epitope/HLA-B8 complex was determined by molecular replacement.
2094113;1027305;Literature;24550293;"Jingxian Liu; Ziwei Xiao; Hui Ling Ko; Meixin Shen; Ee Chee Ren";Proc Natl Acad Sci U S A;2014;Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11.;;41975;Linear peptide;MLIYSMWGK;61;69;;Virion envelope protein A14;Virion membrane protein A14;Q76ZQ3;Vaccinia virus;Vaccinia virus;10245;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, S1, S2, Table 1 and PDB 4N8V;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;4N8V;HLA-A*11:01;I;The crystal structure of the epitope/HLA-A*11:01 complex bound by human killer cell Ig-like receptor KIR2DS2-*001 was determined by molecular replacement. There are two ternary complexes in the asymmetric unit.
2096526;1027214;Literature;24395804;"Sergio Qui&ntilde;ones-Parra; Emma Grant; Liyen Loh; Thi H O Nguyen; Kristy-Anne Campbell; Steven Y C Tong; Adrian Miller; Peter C Doherty; Dhanasekaran Vijaykrishna; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Proc Natl Acad Sci U S A;2014;Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities.;;7136;Linear peptide;CTELKLSDY;44;52;;nucleoprotein;Nucleoprotein;P03466;H7N9 subtype;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 4, Table S8 and PDB 4NQV;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;4NQV;HLA-A*01:01;I;The crystal structure of the epitope in complex with HLA-A*0101 was determined by molecular replacement.
2096527;1027214;Literature;24395804;"Sergio Qui&ntilde;ones-Parra; Emma Grant; Liyen Loh; Thi H O Nguyen; Kristy-Anne Campbell; Steven Y C Tong; Adrian Miller; Peter C Doherty; Dhanasekaran Vijaykrishna; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Proc Natl Acad Sci U S A;2014;Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities.;;181983;Linear peptide;CTELKLNDY;44;52;;nucleocapsid protein;Nucleoprotein;P03466;H1N1 subtype;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 4, Table S8 and PDB 4NQX;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;4NQX;HLA-A*01:01;I;The crystal structure of the epitope in complex with HLA-A*0101 was determined by molecular replacement.
2097909;1019190;Literature;20212169;"Alex Theodossis; Carole Guillonneau; Andrew Welland; Lauren K Ely; Craig S Clements; Nicholas A Williamson; Andrew I Webb; Jacqueline A Wilce; Roger J Mulder; Michelle A Dunstone; Peter C Doherty; James McCluskey; Anthony W Purcell; Stephen J Turner; Jamie Rossjohn";Proc Natl Acad Sci U S A;2010;Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.;;134905;Linear peptide;EEAGRAFSF;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EEFGRAFSF;77;85;;;HLA-DPA1 protein;HLA class II histocompatibility antigen, DP alpha 1 chain;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 1, S1, Table S1 and PDB 3L3D;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3L3D;HLA-B*44:02;I;The crystal structure of the epitope bound to HLA-B*4402 was determined by molecular replacement. The X-ray structures of B44 in complex with five alanine-scan mutants of the DPalpha peptide (F3A, R5A, F7A, F3AR5A, and R5AF7A) were solved in the same space group, were isomorphous to each other, and the peptides are free from crystal contacts. Thus any conformational changes observed can be attributed to the specific mutation within the peptide.
2097975;1019190;Literature;20212169;"Alex Theodossis; Carole Guillonneau; Andrew Welland; Lauren K Ely; Craig S Clements; Nicholas A Williamson; Andrew I Webb; Jacqueline A Wilce; Roger J Mulder; Michelle A Dunstone; Peter C Doherty; James McCluskey; Anthony W Purcell; Stephen J Turner; Jamie Rossjohn";Proc Natl Acad Sci U S A;2010;Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.;;134907;Linear peptide;EEFGAAFSF;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EEFGRAFSF;77;85;;;HLA-DPA1 protein;HLA class II histocompatibility antigen, DP alpha 1 chain;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 1, S1, Table S1 and PDB 3L3G;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3L3G;HLA-B*44:02;I;The crystal structure of the epitope bound to HLA-B*4402 was determined by molecular replacement. The X-ray structures of B44 in complex with five alanine-scan mutants of the DPalpha peptide (F3A, R5A, F7A, F3AR5A, and R5AF7A) were solved in the same space group, were isomorphous to each other, and the peptides are free from crystal contacts. Thus any conformational changes observed can be attributed to the specific mutation within the peptide.
2097976;1019190;Literature;20212169;"Alex Theodossis; Carole Guillonneau; Andrew Welland; Lauren K Ely; Craig S Clements; Nicholas A Williamson; Andrew I Webb; Jacqueline A Wilce; Roger J Mulder; Michelle A Dunstone; Peter C Doherty; James McCluskey; Anthony W Purcell; Stephen J Turner; Jamie Rossjohn";Proc Natl Acad Sci U S A;2010;Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.;;134908;Linear peptide;EEFGRAASF;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EEFGRAFSF;77;85;;;HLA-DPA1 protein;HLA class II histocompatibility antigen, DP alpha 1 chain;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 1, S1, Table S1 and PDB 3L3I;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3L3I;HLA-B*44:02;I;The crystal structure of the epitope bound to HLA-B*4402 was determined by molecular replacement. The X-ray structures of B44 in complex with five alanine-scan mutants of the DPalpha peptide (F3A, R5A, F7A, F3AR5A, and R5AF7A) were solved in the same space group, were isomorphous to each other, and the peptides are free from crystal contacts. Thus any conformational changes observed can be attributed to the specific mutation within the peptide.
2097977;1019190;Literature;20212169;"Alex Theodossis; Carole Guillonneau; Andrew Welland; Lauren K Ely; Craig S Clements; Nicholas A Williamson; Andrew I Webb; Jacqueline A Wilce; Roger J Mulder; Michelle A Dunstone; Peter C Doherty; James McCluskey; Anthony W Purcell; Stephen J Turner; Jamie Rossjohn";Proc Natl Acad Sci U S A;2010;Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.;;134904;Linear peptide;EEAGAAFSF;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EEFGRAFSF;77;85;;;HLA-DPA1 protein;HLA class II histocompatibility antigen, DP alpha 1 chain;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 1, S1, Table S1 and PDB 3L3J;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;3L3J;HLA-B*44:02;I;The crystal structure of the epitope bound to HLA-B*4402 was determined by molecular replacement. The X-ray structures of B44 in complex with five alanine-scan mutants of the DPalpha peptide (F3A, R5A, F7A, F3AR5A, and R5AF7A) were solved in the same space group, were isomorphous to each other, and the peptides are free from crystal contacts. Thus any conformational changes observed can be attributed to the specific mutation within the peptide.
2097978;1019190;Literature;20212169;"Alex Theodossis; Carole Guillonneau; Andrew Welland; Lauren K Ely; Craig S Clements; Nicholas A Williamson; Andrew I Webb; Jacqueline A Wilce; Roger J Mulder; Michelle A Dunstone; Peter C Doherty; James McCluskey; Anthony W Purcell; Stephen J Turner; Jamie Rossjohn";Proc Natl Acad Sci U S A;2010;Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.;;134906;Linear peptide;EEFGAAASF;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EEFGRAFSF;77;85;;;HLA-DPA1 protein;HLA class II histocompatibility antigen, DP alpha 1 chain;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 1, S1, Table S1 and PDB 3L3K;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3L3K;HLA-B*44:02;I;The crystal structure of the epitope bound to HLA-B*4402 was determined by molecular replacement. The X-ray structures of B44 in complex with five alanine-scan mutants of the DPalpha peptide (F3A, R5A, F7A, F3AR5A, and R5AF7A) were solved in the same space group, were isomorphous to each other, and the peptides are free from crystal contacts. Thus any conformational changes observed can be attributed to the specific mutation within the peptide.
2098234;1019752;Literature;20566715;"Stephanie Gras; Zhenjun Chen; John J Miles; Yu Chih Liu; Melissa J Bell; Lucy C Sullivan; Lars Kjer-Nielsen; Rebekah M Brennan; Jacqueline M Burrows; Michelle A Neller; Rajiv Khanna; Anthony W Purcell; Andrew G Brooks; James McCluskey; Jamie Rossjohn; Scott R Burrows";J Exp Med;2010;Allelic polymorphism in the T cell receptor and its impact on immune responses.;;24536;Linear peptide;HPVGEADYFEY;407;417;;Epstein-Barr nuclear antigen 1;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 4, S2, Table S1 and PDB 3MV7;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3MV7;HLA-B*35:01;I;The crystal structure of the epitope/HLA-B*3501 complex bound by the TK3 TCR was determined by molecular replacement. There is one complex in the asymmetric unit.
2098235;1019752;Literature;20566715;"Stephanie Gras; Zhenjun Chen; John J Miles; Yu Chih Liu; Melissa J Bell; Lucy C Sullivan; Lars Kjer-Nielsen; Rebekah M Brennan; Jacqueline M Burrows; Michelle A Neller; Rajiv Khanna; Anthony W Purcell; Andrew G Brooks; James McCluskey; Jamie Rossjohn; Scott R Burrows";J Exp Med;2010;Allelic polymorphism in the T cell receptor and its impact on immune responses.;;24536;Linear peptide;HPVGEADYFEY;407;417;;Epstein-Barr nuclear antigen 1;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 4, S2, Table S1 and PDB 3MV8;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3MV8;HLA-B*35:01;I;The crystal structure of the epitope/HLA-B*3501 complex bound by the TK3(Gln55His) TCR was determined by molecular replacement. There is one complex in the asymmetric unit.
2098236;1019752;Literature;20566715;"Stephanie Gras; Zhenjun Chen; John J Miles; Yu Chih Liu; Melissa J Bell; Lucy C Sullivan; Lars Kjer-Nielsen; Rebekah M Brennan; Jacqueline M Burrows; Michelle A Neller; Rajiv Khanna; Anthony W Purcell; Andrew G Brooks; James McCluskey; Jamie Rossjohn; Scott R Burrows";J Exp Med;2010;Allelic polymorphism in the T cell receptor and its impact on immune responses.;;24536;Linear peptide;HPVGEADYFEY;407;417;;Epstein-Barr nuclear antigen 1;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 4, S2, Table S1 and PDB 3MV9;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;3MV9;HLA-B*35:01;I;The crystal structure of the epitope/HLA-B*3501 complex bound by the TK3(Gln55Ala) TCR was determined by molecular replacement. There is one complex in the asymmetric unit.
2104700;1027642;Literature;24795457;"Jonathan A Trujillo; Stephanie Gras; Kelly-Anne Twist; Nathan P Croft; Rudragouda Channappanavar; Jamie Rossjohn; Anthony W Purcell; Stanley Perlman";J Immunol;2014;Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes.;;227830;Linear peptide;RAVIFANI + AIB(A2);;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;RCQIFANI;457;464;;S;Spike glycoprotein precursor (S glycoprotein) (Peplomer protein) (E2);Spike glycoprotein;Murine hepatitis virus strain JHM;Murine coronavirus;mouse (Mus musculus);10090;Figure 7, Table II and PDB 4PV9;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;4PV9;H2-Kb;I;The crystal structure of the epitope in complex with H-2 Kb was determined. The residue at position 2 is L-aminobutyric acid (Aba, an isostereomer of cysteine). There are two complexes in the asymmetric unit.
2104708;1027642;Literature;24795457;"Jonathan A Trujillo; Stephanie Gras; Kelly-Anne Twist; Nathan P Croft; Rudragouda Channappanavar; Jamie Rossjohn; Anthony W Purcell; Stanley Perlman";J Immunol;2014;Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes.;;227828;Linear peptide;RAFIFANI + AIB(A2);;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;RCQIFANI;457;464;;S;Spike glycoprotein precursor (S glycoprotein) (Peplomer protein) (E2);Spike glycoprotein;Murine hepatitis virus strain JHM;Murine coronavirus;mouse (Mus musculus);10090;Figure 7, Table II and PDB 4PV8;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;4PV8;H2-Kb;I;The crystal structure of the epitope in complex with H-2 Kb was determined. The residue at position 2 is L-aminobutyric acid (Aba, an isostereomer of cysteine). There are two complexes in the asymmetric unit.
2105207;1027859;Literature;24600035;"Chihiro Motozono; Nozomi Kuse; Xiaoming Sun; Pierre J Rizkallah; Anna Fuller; Shinichi Oka; David K Cole; Andrew K Sewell; Masafumi Takiguchi";J Immunol;2014;Molecular basis of a dominant T cell response to an HIV reverse transcriptase 8-mer epitope presented by the protective allele HLA-B*51:01.;;102104;Linear peptide;TAFTIPSI;128;135;;reverse transcriptase p51 subunit;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 3, 4, Table I, Supplemental Tables II, III and PDB 4MJI;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;4MJI;HLA-B*51:01;I;The crystal structure of the epitope/HLA-B*51:01 complex bound to the 3B TCR was solved by molecular replacement. There are two complexes in the asymmetric unit.
2105750;1027914;Literature;24886641;"Chungyong Han; Ai Kawana-Tachikawa; Akihisa Shimizu; Dayong Zhu; Hitomi Nakamura; Eisuke Adachi; Tadashi Kikuchi; Michiko Koga; Tomohiko Koibuchi; George F Gao; Yusuke Sato; Atsushi Yamagata; Eric Martin; Shuya Fukai; Zabrina L Brumme; Aikichi Iwamoto";Retrovirology;2014;Switching and emergence of CTL epitopes in HIV-1 infection.;;230028;Linear peptide;NYTPGPGIRF;129;138;;Protein Nef;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 6, S1, Table S1 and PDB 3WL9;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3WL9;HLA-A*24:02;I;The crystal structure of the epitope/HLA-A*24:02 complex was determined.
2105751;1027914;Literature;24886641;"Chungyong Han; Ai Kawana-Tachikawa; Akihisa Shimizu; Dayong Zhu; Hitomi Nakamura; Eisuke Adachi; Tadashi Kikuchi; Michiko Koga; Tomohiko Koibuchi; George F Gao; Yusuke Sato; Atsushi Yamagata; Eric Martin; Shuya Fukai; Zabrina L Brumme; Aikichi Iwamoto";Retrovirology;2014;Switching and emergence of CTL epitopes in HIV-1 infection.;;230030;Linear peptide;NYTPGPGTRF;126;135;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 6, S1, Table S1 and PDB 3WLB;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3WLB;HLA-A*24:02;I;The crystal structure of the epitope/HLA-A*24:02 complex was determined.
2106428;1027926;Literature;24759101;"Yu Chih Liu; Zhenjun Chen; Michelle A Neller; John J Miles; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2014;A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism.;;227777;Linear peptide;HPVAEADYFEY;407;417;;EBNA-1;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 4 and PDB 4PRN;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;4PRN;HLA-B*35:01;I;The crystal structure of the epitope/HLA-B*35:01 complex was determined by molecular replacement.
2106429;1027926;Literature;24759101;"Yu Chih Liu; Zhenjun Chen; Michelle A Neller; John J Miles; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2014;A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism.;;227777;Linear peptide;HPVAEADYFEY;407;417;;EBNA-1;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 4 and PDB 4PRB;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;4PRB;HLA-B*35:08;I;The crystal structure of the epitope/HLA-B*35:08 complex was determined by molecular replacement.
2106430;1027926;Literature;24759101;"Yu Chih Liu; Zhenjun Chen; Michelle A Neller; John J Miles; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2014;A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism.;;24525;Linear peptide;HPVGDADYFEY;407;417;;Epstein-Barr nuclear antigen 1;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 4 and PDB 4PR5;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;4PR5;HLA-B*35:01;I;The crystal structure of the epitope/HLA-B*35:01 complex was determined by molecular replacement.
2106431;1027926;Literature;24759101;"Yu Chih Liu; Zhenjun Chen; Michelle A Neller; John J Miles; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2014;A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism.;;24525;Linear peptide;HPVGDADYFEY;407;417;;Epstein-Barr nuclear antigen 1;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 4 and PDB 4PRD;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;4PRD;HLA-B*35:08;I;The crystal structure of the epitope/HLA-B*35:08 complex was determined by molecular replacement.
2106432;1027926;Literature;24759101;"Yu Chih Liu; Zhenjun Chen; Michelle A Neller; John J Miles; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2014;A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism.;;227778;Linear peptide;HPVGQADYFEY;49;59;;nuclear antigen EBNA1;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 4 and PDB 4PRA;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;4PRA;HLA-B*35:01;I;The crystal structure of the epitope/HLA-B*35:01 complex was determined by molecular replacement.
2106433;1027926;Literature;24759101;"Yu Chih Liu; Zhenjun Chen; Michelle A Neller; John J Miles; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2014;A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism.;;227778;Linear peptide;HPVGQADYFEY;49;59;;nuclear antigen EBNA1;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 4 and PDB 4PRE;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;4PRE;HLA-B*35:08;I;The crystal structure of the epitope/HLA-B*35:08 complex was determined by molecular replacement.
2107034;1027926;Literature;24759101;"Yu Chih Liu; Zhenjun Chen; Michelle A Neller; John J Miles; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2014;A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism.;;24536;Linear peptide;HPVGEADYFEY;407;417;;Epstein-Barr nuclear antigen 1;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 3, Figures 5, 6 and PDB 4PRI;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;4PRI;HLA-B*35:08;I;The crystal structure of the epitope/HLA-B*35:08 complex bound to the TK3 TCR was solved by molecular replacement.
2115547;1028013;Literature;24829406;"Mingwei Sun; Jun Liu; Jianxun Qi; Boris Tefsen; Yi Shi; Jinghua Yan; George F Gao";J Immunol;2014;Nalpha-terminal acetylation for T cell recognition: molecular basis of MHC class I-restricted nalpha-acetylpeptide presentation.;;230049;Linear peptide;SHVAVENAL;2;10;;ATP-dependent RNA helicase DDX3X;ATP-dependent RNA helicase DDX3X;O00571;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables II, III, IV, Figures 1, 2, 3, 4, 5, S1, S2 and PDB 4O2E;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;4O2E;HLA-B*39:01;I;The crystal structure of the epitope bound to HLA-B*3901 was determined, solved by molecular replacement. There are two complexes in the asymmetric unit.
2115591;1028013;Literature;24829406;"Mingwei Sun; Jun Liu; Jianxun Qi; Boris Tefsen; Yi Shi; Jinghua Yan; George F Gao";J Immunol;2014;Nalpha-terminal acetylation for T cell recognition: molecular basis of MHC class I-restricted nalpha-acetylpeptide presentation.;;230048;Linear peptide;SHVAVENAL + ACET(S1);2;10;;ATP-dependent RNA helicase DDX3X;ATP-dependent RNA helicase DDX3X;O00571;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables II, III, IV, Figures 1, 2, 3, 4, 5, S1, S2 and PDB 4O2C;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;4O2C;HLA-B*39:01;I;The crystal structure of the epitope bound to HLA-B*3901 was determined, solved by molecular replacement.
2115593;1028013;Literature;24829406;"Mingwei Sun; Jun Liu; Jianxun Qi; Boris Tefsen; Yi Shi; Jinghua Yan; George F Gao";J Immunol;2014;Nalpha-terminal acetylation for T cell recognition: molecular basis of MHC class I-restricted nalpha-acetylpeptide presentation.;;229998;Linear peptide;HVAVENAL;3;10;;ATP-dependent RNA helicase DDX3X;ATP-dependent RNA helicase DDX3X;O00571;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table II, IV, Figures 2, 3, 4, 5 and PDB 4O2F;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;4O2F;HLA-B*39:01;I;The crystal structure of the epitope bound to HLA-B*3901 was determined, solved by molecular replacement. There are two complexes in the asymmetric unit.
2116136;1028014;Literature;24990997;"Joanna A L Choo; Jingxian Liu; Xinyu Toh; Gijsbert M Grotenbreg; Ee Chee Ren";J Virol;2014;The immunodominant influenza A virus M158-66 cytotoxic T lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans.;;20354;Linear peptide;GILGFVFTL;58;66;;Matrix protein 1;Matrix protein 1;P03485;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 2, 3, Figures 4, 5 and PDB 4NT6;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;4NT6;HLA-C*08:01;I;The crystal structure of the epitope bound to HLA-C*08:01 was determined by molecular replacement.
2117747;1028073;Literature;25063871;"Deanna Lamont; Gayatri Mukherjee; P Rajesh Kumar; Dibyendu Samanta; Caroline G McPhee; Thomas W H Kay; Steven C Almo; Teresa P DiLorenzo; David V Serreze";J Immunol;2014;Compensatory mechanisms allow undersized anchor-deficient class I MHC ligands to mediate pathogenic autoreactive T cell responses.;;233118;Linear peptide;YQLENYCGL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;YQLENYC;103;109;;;Insulin-2;Insulin-2;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Tables I, II, Figures 4, 5, 8 and PDB 3WS3;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;3WS3;H2-Db;I;The crystal structure of the epitope/H-2Db complex was determined. The epitope was also shown to bind H-2Db in a MHC stabilization assay using RMA-S cells and a refolding assay with H-2Db. There are two complexes in the asymmetric unit.
2117749;1028073;Literature;25063871;"Deanna Lamont; Gayatri Mukherjee; P Rajesh Kumar; Dibyendu Samanta; Caroline G McPhee; Thomas W H Kay; Steven C Almo; Teresa P DiLorenzo; David V Serreze";J Immunol;2014;Compensatory mechanisms allow undersized anchor-deficient class I MHC ligands to mediate pathogenic autoreactive T cell responses.;;114027;Linear peptide;YAIENYLEL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;YQLENYC;103;109;;;Insulin-2;Insulin-2;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Tables I, II, Figures 4, 8 and PDB 3WS6;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3WS6;H2-Db;I;The crystal structure of the epitope/H-2Db complex was determined. The epitope was also shown to bind H-2Db in a MHC stabilization assay using RMA-S cells. There are two complexes in the asymmetric unit.
2118925;1028105;Literature;24550723;"Brian G Pierce; Lance M Hellman; Moushumi Hossain; Nishant K Singh; Craig W Vander Kooi; Zhiping Weng; Brian M Baker";PLoS Comput Biol;2014;Computational design of the affinity and specificity of a therapeutic T cell receptor.;;12941;Linear peptide;ELAGIGILTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 4, S3, Tables S2, S3 and PDB 4L3E;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;4L3E;HLA-A*02:01;I;"The crystal structure of the epitope/HLA-A*0201 complex bound by the DMF5 alphaD26Y/&szlig;L98W TCR was determined."
2119217;1028140;Literature;21795600;"Oleg Y Borbulevych; Sujatha M Santhanagopolan; Moushumi Hossain; Brian M Baker";J Immunol;2011;TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms.;;12941;Linear peptide;ELAGIGILTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table II, Figure 3, Supplemental Figure 1 and PDB 3QDM;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;3QDM;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex bound to the DMF4 TCR was determined.
2119218;1028140;Literature;21795600;"Oleg Y Borbulevych; Sujatha M Santhanagopolan; Moushumi Hossain; Brian M Baker";J Immunol;2011;TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms.;;12941;Linear peptide;ELAGIGILTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table II, Supplemental Figure 1 and PDB 3QDG;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;3QDG;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex bound to the DMF5 TCR was determined.
2119221;1028140;Literature;21795600;"Oleg Y Borbulevych; Sujatha M Santhanagopolan; Moushumi Hossain; Brian M Baker";J Immunol;2011;TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms.;;155;Linear peptide;AAGIGILTV;27;35;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Q16655;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table II, Figure 3, Supplemental Figure 1 and PDB 3QEQ;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3QEQ;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex bound to the DMF4 TCR was determined.
2119222;1028140;Literature;21795600;"Oleg Y Borbulevych; Sujatha M Santhanagopolan; Moushumi Hossain; Brian M Baker";J Immunol;2011;TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms.;;155;Linear peptide;AAGIGILTV;27;35;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Q16655;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table II, Supplemental Figure 1 and PDB 3QDJ;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;3QDJ;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex bound to the DMF5 TCR was determined.
2119628;1028144;Literature;25135637;"Jonathan A Trujillo; Nathan P Croft; Nadine L Dudek; Rudragouda Channappanavar; Alex Theodossis; Andrew I Webb; Michelle A Dunstone; Patricia T Illing; Noah S Butler; Craig Fett; David C Tscharke; Jamie Rossjohn; Stanley Perlman; Anthony W Purcell";J Biol Chem;2014;The cellular redox environment alters antigen presentation.;;422251;Linear peptide;CSLWNGPHL + (C1);510;518;;spike glycoprotein (S);Spike glycoprotein;P11224;Murine hepatitis virus strain JHM;Murine coronavirus;694005;;;;;;;;;;;;;mouse (Mus musculus);10090;Tables 2, 4, Figure 5 and PDB 4PG2;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;4PG2;H2-Db;I;The crystal structure of the S-glutathionylated epitope/H-2Db complex was determined.
2369612;1028339;Literature;25311806;"Rieuwert Hoppes; Rimke Oostvogels; Jolien J Luimstra; Kim Wals; Mireille Toebes; Laura Bies; Reggy Ekkebus; Pramila Rijal; Patrick H N Celie; Julie H Huang; Maarten E Emmelot; Robbert M Spaapen; Henk Lokhorst; Ton N M Schumacher; Tuna Mutis; Boris Rodenko; Huib Ovaa";J Immunol;2014;Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.;;237747;Linear peptide;GVAGIGILTG + MCM(G1, V2, G10);;;;;;;;;;The epitope is a chemically enhanced altered peptide ligand (CPL). Residue 1 is D-alpha-methyl-phenylglycine (am-phg), residue 2 is norvaline (NVA) and residue 10 is propargylglycine (PRG).;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figure 2 and PDB 4WJ5;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;4WJ5;HLA-A*02:01;I;The crystal structure of the epitope CPL in complex with HLA-A*0201 was determined. There are two copies of the HLA-A*0201-peptide complex in the asymmetric unit.
2369706;1027926;Literature;24759101;"Yu Chih Liu; Zhenjun Chen; Michelle A Neller; John J Miles; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2014;A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism.;;24525;Linear peptide;HPVGDADYFEY;407;417;;Epstein-Barr nuclear antigen 1;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 3, Figures 5, 6 and PDB 4PRH;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;4PRH;HLA-B*35:08;I;The crystal structure of the epitope/HLA-B*35:08 complex bound by the TK3 TCR was determined by molecular replacement.
2369707;1027926;Literature;24759101;"Yu Chih Liu; Zhenjun Chen; Michelle A Neller; John J Miles; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2014;A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism.;;227778;Linear peptide;HPVGQADYFEY;49;59;;nuclear antigen EBNA1;Epstein-Barr nuclear antigen 1;P03211;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 3, Figures 5, 6 and PDB 4PRP;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;4PRP;HLA-B*35:01;I;The crystal structure of the epitope/HLA-B*35:01 complex bound by the TK3 TCR was determined by molecular replacement.
2371146;1028368;Literature;25355921;"Usha K Nivarthi; Stephanie Gras; Lars Kjer-Nielsen; Richard Berry; Isabelle S Lucet; John J Miles; Samantha L Tracy; Anthony W Purcell; David S Bowden; Margaret Hellard; Jamie Rossjohn; James McCluskey; Mandvi Bharadwaj";J Immunol;2014;An extensive antigenic footprint underpins immunodominant TCR adaptability against a hypervariable viral determinant.;;24762;Linear peptide;HSKKKCDEL;1395;1403;;polyprotein;Genome polyprotein;P27958;Hepacivirus C;Hepacivirus C;11103;;;;;;;;;;;;;human (Homo sapiens);9606;Table III, Figure 3 and PDB 4QRQ;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;4QRQ;HLA-B*08:01;I;"The crystal structure of HLA-B*0801&ndash;epitope complex was solved."
2371151;1028368;Literature;25355921;"Usha K Nivarthi; Stephanie Gras; Lars Kjer-Nielsen; Richard Berry; Isabelle S Lucet; John J Miles; Samantha L Tracy; Anthony W Purcell; David S Bowden; Margaret Hellard; Jamie Rossjohn; James McCluskey; Mandvi Bharadwaj";J Immunol;2014;An extensive antigenic footprint underpins immunodominant TCR adaptability against a hypervariable viral determinant.;;24762;Linear peptide;HSKKKCDEL;1395;1403;;polyprotein;Genome polyprotein;P27958;Hepacivirus C;Hepacivirus C;11103;;;;;;;;;;;;;human (Homo sapiens);9606;Table III and PDB 4QRP;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;4QRP;HLA-B*08:01;I;"The structure of the HLA-B*0801&ndash;epitope complex bound by the DD31 TCR was solved. The asymmetric unit contained two DD31 TCR&ndash;HLA-B*0801&ndash;HSK complexes and one unliganded DD31 TCR."
2375331;1028461;Literature;25471691;"Florian Madura; Pierre J Rizkallah; Christopher J Holland; Anna Fuller; Anna Bulek; Andrew J Godkin; Andrea J Schauenburg; David K Cole; Andrew K Sewell";Eur J Immunol;2015;"Structural basis for ineffective T-cell responses to MHC anchor residue-improved &quot;&quot;heteroclitic&quot;&quot; peptides.";;10987;Linear peptide;EAAGIGILTV;26;35;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Q16655;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3 and PDB 4QOK;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;4QOK;HLA-A*02:01;I;The crystal structure of the HLA-A*0201/epitope complex bound to the MEL5 TCR was determined by molecular replacement.
2375606;1028458;Literature;25452463;"Daniel G Pellicci; Adam P Uldrich; J&eacute;r&ocirc;me Le Nours; Fiona Ross; Eric Chabrol; Sidonia B G Eckle; Renate de Boer; Ricky T Lim; Kirsty McPherson; Gurdyal Besra; Amy R Howell; Lorenzo Moretta; James McCluskey; Mirjam H M Heemskerk; Stephanie Gras; Jamie Rossjohn; Dale I Godfrey";J Exp Med;2014;The molecular bases of delta/alphabeta T cell-mediated antigen recognition.;;28061;Linear peptide;IPSINVHHY;113;121;;pp65;65 kDa phosphoprotein;Q6SW59;Human betaherpesvirus 5;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Tables S1, S3, Figure 9, 10 and PDB 4QRR;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;4QRR;HLA-B*35:01;I;The crystal structure of the HLA-B*35:01/epitope complex bound to the clone 12 delta/alphabetaTCR was determined.
2381525;1028559;Literature;25505266;"Chopie Hassan; Eric Chabrol; Lorenz Jahn; Michel G D Kester; Arnoud H de Ru; Jan W Drijfhout; Jamie Rossjohn; J H Frederik Falkenburg; Mirjam H M Heemskerk; Stephanie Gras; Peter A van Veelen";J Biol Chem;2015;Naturally processed non-canonical HLA-A*02:01 presented peptides.;;239405;Linear peptide;ALQDAGDSSRKEYFI;114;128;;Glycophorin-C;Glycophorin-C;P04921;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 3, Figures 2, 3 and PDB 4U6X;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;4U6X;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex was determined by molecular replacement.
2381531;1028559;Literature;25505266;"Chopie Hassan; Eric Chabrol; Lorenz Jahn; Michel G D Kester; Arnoud H de Ru; Jan W Drijfhout; Jamie Rossjohn; J H Frederik Falkenburg; Mirjam H M Heemskerk; Stephanie Gras; Peter A van Veelen";J Biol Chem;2015;Naturally processed non-canonical HLA-A*02:01 presented peptides.;;239662;Linear peptide;FLNKDLEVDGHFVTM;44;58;;Ras-related protein Rab-9A;Ras-related protein Rab-9A;P51151;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 3, Figures 2, 3 and PDB 4U6Y;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;4U6Y;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex was determined by molecular replacement.
2381683;1028565;Literature;25392532;"Jean-Baptiste Reiser; Fran&ccedil;ois Legoux; St&eacute;phanie Gras; Eric Trudel; Anne Chouquet; Alexandra L&eacute;ger; Madalen Le Gorrec; Paul Machillot; Marc Bonneville; Xavier Saulquin; Dominique Housset";J Immunol;2014;Analysis of relationships between peptide/MHC structural features and naive T cell frequency in humans.;;240105;Linear peptide;NLVPMCATV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;NLVPMVATV;495;503;;suppresses interferon response, inhibits NK cell cytotoxicity, binds NKp30;tegument protein pp65;65 kDa phosphoprotein;Human betaherpesvirus 5;Human betaherpesvirus 5;human (Homo sapiens);9606;Tables 1, s1, Figure 1 and PDB 3MRC;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3MRC;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined by molecular replacement.
2381684;1028565;Literature;25392532;"Jean-Baptiste Reiser; Fran&ccedil;ois Legoux; St&eacute;phanie Gras; Eric Trudel; Anne Chouquet; Alexandra L&eacute;ger; Madalen Le Gorrec; Paul Machillot; Marc Bonneville; Xavier Saulquin; Dominique Housset";J Immunol;2014;Analysis of relationships between peptide/MHC structural features and naive T cell frequency in humans.;;133256;Linear peptide;NLVPMGATV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;NLVPMVATV;495;503;;suppresses interferon response, inhibits NK cell cytotoxicity, binds NKp30;tegument protein pp65;65 kDa phosphoprotein;Human betaherpesvirus 5;Human betaherpesvirus 5;human (Homo sapiens);9606;Tables 1, s1, Figure 1 and PDB 3MRD;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3MRD;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined by molecular replacement.
2381685;1028565;Literature;25392532;"Jean-Baptiste Reiser; Fran&ccedil;ois Legoux; St&eacute;phanie Gras; Eric Trudel; Anne Chouquet; Alexandra L&eacute;ger; Madalen Le Gorrec; Paul Machillot; Marc Bonneville; Xavier Saulquin; Dominique Housset";J Immunol;2014;Analysis of relationships between peptide/MHC structural features and naive T cell frequency in humans.;;20788;Linear peptide;GLCTLVAML;259;267;;BMLF1 protein;mRNA export factor ICP27 homolog;Q04360;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, s1, Figure 1 and PDB 3MRE;x-ray crystallography;3D structure;angstroms;Positive;=;1.1;3MRE;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined by molecular replacement.
2381686;1028565;Literature;25392532;"Jean-Baptiste Reiser; Fran&ccedil;ois Legoux; St&eacute;phanie Gras; Eric Trudel; Anne Chouquet; Alexandra L&eacute;ger; Madalen Le Gorrec; Paul Machillot; Marc Bonneville; Xavier Saulquin; Dominique Housset";J Immunol;2014;Analysis of relationships between peptide/MHC structural features and naive T cell frequency in humans.;;6435;Linear peptide;CINGVCWTV;1073;1081;;polyprotein;Genome polyprotein;P27958;Hepacivirus C;Hepacivirus C;11103;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, s1, Figure 1 and PDB 3MRG;x-ray crystallography;3D structure;angstroms;Positive;=;1.3;3MRG;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined by molecular replacement.
2381687;1028565;Literature;25392532;"Jean-Baptiste Reiser; Fran&ccedil;ois Legoux; St&eacute;phanie Gras; Eric Trudel; Anne Chouquet; Alexandra L&eacute;ger; Madalen Le Gorrec; Paul Machillot; Marc Bonneville; Xavier Saulquin; Dominique Housset";J Immunol;2014;Analysis of relationships between peptide/MHC structural features and naive T cell frequency in humans.;;95281;Linear peptide;CISGVCWTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;CINGVCWTV;1073;1081;;;polyprotein;Genome polyprotein;Hepacivirus C;Hepacivirus C;human (Homo sapiens);9606;Tables 1, s1, Figure 1 and PDB 3MRH;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;3MRH;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined by molecular replacement.
2381688;1028565;Literature;25392532;"Jean-Baptiste Reiser; Fran&ccedil;ois Legoux; St&eacute;phanie Gras; Eric Trudel; Anne Chouquet; Alexandra L&eacute;ger; Madalen Le Gorrec; Paul Machillot; Marc Bonneville; Xavier Saulquin; Dominique Housset";J Immunol;2014;Analysis of relationships between peptide/MHC structural features and naive T cell frequency in humans.;;239509;Linear peptide;CINGVVWTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;CINGVCWTV;1073;1081;;;polyprotein;Genome polyprotein;Hepacivirus C;Hepacivirus C;human (Homo sapiens);9606;Tables 1, s1, Figure 1 and PDB 3MRL;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;3MRL;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined by molecular replacement.
2381689;1028565;Literature;25392532;"Jean-Baptiste Reiser; Fran&ccedil;ois Legoux; St&eacute;phanie Gras; Eric Trudel; Anne Chouquet; Alexandra L&eacute;ger; Madalen Le Gorrec; Paul Machillot; Marc Bonneville; Xavier Saulquin; Dominique Housset";J Immunol;2014;Analysis of relationships between peptide/MHC structural features and naive T cell frequency in humans.;;138368;Linear peptide;ELAGWGILTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Tables 1, s1, Figure 1 and PDB 3MRO;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;3MRO;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined by molecular replacement.
2381690;1028565;Literature;25392532;"Jean-Baptiste Reiser; Fran&ccedil;ois Legoux; St&eacute;phanie Gras; Eric Trudel; Anne Chouquet; Alexandra L&eacute;ger; Madalen Le Gorrec; Paul Machillot; Marc Bonneville; Xavier Saulquin; Dominique Housset";J Immunol;2014;Analysis of relationships between peptide/MHC structural features and naive T cell frequency in humans.;;138486;Linear peptide;LLAGIGTVPI;178;187;;solute carrier organic anion transporter family member 2A1;Solute carrier organic anion transporter family member 2A1;Q92959;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, s1, Figure 1 and PDB 3MRR;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;3MRR;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined by molecular replacement.
2396847;1028781;Literature;25605945;"Malgorzata A Garstka; Alexander Fish; Patrick H N Celie; Robbie P Joosten; George M C Janssen; Ilana Berlin; Rieuwert Hoppes; Magda Stadnik; Lennert Janssen; Huib Ovaa; Peter A van Veelen; Anastassis Perrakis; Jacques Neefjes";Proc Natl Acad Sci U S A;2015;The first step of peptide selection in antigen presentation by MHC class I molecules.;;15248;Linear peptide;FAPGNYPAL;324;332;;Nucleoprotein;Nucleoprotein;O57286;Murine respirovirus;Murine respirovirus;11191;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 3, 4, S3, S4, Table S4, S5 and PDB 4PG9;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;4PG9;H2-Kb;I;The crystal structure of the epitope/H-2Kb complex was determined.
2396848;1028781;Literature;25605945;"Malgorzata A Garstka; Alexander Fish; Patrick H N Celie; Robbie P Joosten; George M C Janssen; Ilana Berlin; Rieuwert Hoppes; Magda Stadnik; Lennert Janssen; Huib Ovaa; Peter A van Veelen; Anastassis Perrakis; Jacques Neefjes";Proc Natl Acad Sci U S A;2015;The first step of peptide selection in antigen presentation by MHC class I molecules.;;242477;Linear peptide;FAPGNWPAL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;FAPGNYPAL;324;332;;;Nucleoprotein;Nucleoprotein;Murine respirovirus;Murine respirovirus;mouse (Mus musculus);10090;Figure 3, 4, S3, S4, Table S4, S5 and PDB 4PGB;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;4PGB;H2-Kb;I;The crystal structure of the epitope/H-2Kb complex was determined.
2396849;1028781;Literature;25605945;"Malgorzata A Garstka; Alexander Fish; Patrick H N Celie; Robbie P Joosten; George M C Janssen; Ilana Berlin; Rieuwert Hoppes; Magda Stadnik; Lennert Janssen; Huib Ovaa; Peter A van Veelen; Anastassis Perrakis; Jacques Neefjes";Proc Natl Acad Sci U S A;2015;The first step of peptide selection in antigen presentation by MHC class I molecules.;;121291;Linear peptide;FAPGNYPAL + SCM(Y6);;;;;;;;;;The residue at position 6 is 3,5-diiodo-L-tyrosine.;analog;Fragment of a Natural Sequence Molecule;FAPGNYPAL;324;332;;;Nucleoprotein;Nucleoprotein;Murine respirovirus;Murine respirovirus;mouse (Mus musculus);10090;Figure 3, 4, S3, S4, Table S4, S5 and PDB 4PGC;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;4PGC;H2-Kb;I;The crystal structure of the epitope/H-2Kb complex was determined.
2396850;1028781;Literature;25605945;"Malgorzata A Garstka; Alexander Fish; Patrick H N Celie; Robbie P Joosten; George M C Janssen; Ilana Berlin; Rieuwert Hoppes; Magda Stadnik; Lennert Janssen; Huib Ovaa; Peter A van Veelen; Anastassis Perrakis; Jacques Neefjes";Proc Natl Acad Sci U S A;2015;The first step of peptide selection in antigen presentation by MHC class I molecules.;;242480;Linear peptide;FAPGNYPAF;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;FAPGNYPAL;324;332;;;Nucleoprotein;Nucleoprotein;Murine respirovirus;Murine respirovirus;mouse (Mus musculus);10090;Figure 3, 4, S3, S4, Table S4, S5 and PDB 4PGD;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;4PGD;H2-Kb;I;The crystal structure of the epitope/H-2Kb complex was determined.
2396851;1028781;Literature;25605945;"Malgorzata A Garstka; Alexander Fish; Patrick H N Celie; Robbie P Joosten; George M C Janssen; Ilana Berlin; Rieuwert Hoppes; Magda Stadnik; Lennert Janssen; Huib Ovaa; Peter A van Veelen; Anastassis Perrakis; Jacques Neefjes";Proc Natl Acad Sci U S A;2015;The first step of peptide selection in antigen presentation by MHC class I molecules.;;242481;Linear peptide;FAPGNYPAW;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;FAPGNYPAL;324;332;;;Nucleoprotein;Nucleoprotein;Murine respirovirus;Murine respirovirus;mouse (Mus musculus);10090;Figure 3, 4, S3, S4, Table S4, S5 and PDB 4PGE;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;4PGE;H2-Kb;I;The crystal structure of the epitope/H-2Kb complex was determined.
2402268;1028794;Literature;25348595;"Joanna A L Choo; Sock Yue Thong; Jiawei Yap; Wim J E van Esch; Manfred Raida; Rob Meijers; Julien Lescar; Steven H L Verhelst; Gijsbert M Grotenbreg";Angew Chem Int Ed Engl;2014;Bioorthogonal cleavage and exchange of major histocompatibility complex ligands by employing azobenzene-containing peptides.;;244166;Linear peptide;AIMXYPK + ABA(X4);;;;;;;;;;The residue at position 4 of the epitope sequence is 4-[(E)-[5-(2-azanylethyl)-2-oxidanyl-phenyl]diazenyl]benzoic acid. The epitope was designed so the azobenzene-containing linker replaces four nonessential amino acids in a peptide sequence known to bind to MHC.;analog;Fragment of a Natural Sequence Molecule;IMPARFYPK;110;118;;;polymerase;Protein P;Hepatitis B virus;Hepatitis B virus;human (Homo sapiens);9606;Figures 1, S4, S5, S6, Table S4 and PDB 4UQ2;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;4UQ2;HLA-A*11:01;I;The crystal structure of the epitope in complex with HLA-A*11:01 was determined. There are two molecules in the asymmetric unit.
2402269;1028794;Literature;25348595;"Joanna A L Choo; Sock Yue Thong; Jiawei Yap; Wim J E van Esch; Manfred Raida; Rob Meijers; Julien Lescar; Steven H L Verhelst; Gijsbert M Grotenbreg";Angew Chem Int Ed Engl;2014;Bioorthogonal cleavage and exchange of major histocompatibility complex ligands by employing azobenzene-containing peptides.;;244206;Linear peptide;GLSXXL + MCM(X4, X5);;;;;;;;;;The residue at position 4 of the epitope sequence is 4-[(E)-[5-(2-azanylethyl)-2-oxidanyl-phenyl]diazenyl]benzoic acid. The epitope was designed so the azobenzene-containing linker replaces four nonessential amino acids in a peptide sequence known to bind to MHC. The residue at position 5 of the epitope sequence is (2S)-2,5,5-tris(azanyl)pentanoic acid.;analog;Fragment of a Natural Sequence Molecule;GLSRYVARL;412;420;;Pol;Polymerase;Protein P;Hepatitis B virus;Hepatitis B virus;human (Homo sapiens);9606;"Tables‚ÄÖS5,&thinsp;S6, Figures‚ÄÖS8,&thinsp;S9 and PDB 4UQ3";x-ray crystallography;3D structure;angstroms;Positive;=;2.1;4UQ3;HLA-A*02:01;I;The crystal structure of the epitope in complex with HLA-A*02:01 was determined. There are two molecules in the asymmetric unit.
2423531;1028840;Literature;25808313;"Henrik N Kl&oslash;verpris; David K Cole; Anna Fuller; Jonathan Carlson; Konrad Beck; Andrea J Schauenburg; Pierre J Rizkallah; S&oslash;ren Buus; Andrew K Sewell; Philip Goulder";Retrovirology;2015;A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape.;;102149;Linear peptide;TPQDLNTML;67;75;;GAG protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 3, Supplementary Table S1 and PDB 4U1H;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;4U1H;HLA-B*07:02;I;The crystal structure of the epitope bound to HLA-B*07:02 was determined.
2423532;1028840;Literature;25808313;"Henrik N Kl&oslash;verpris; David K Cole; Anna Fuller; Jonathan Carlson; Konrad Beck; Andrea J Schauenburg; Pierre J Rizkallah; S&oslash;ren Buus; Andrew K Sewell; Philip Goulder";Retrovirology;2015;A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape.;;102149;Linear peptide;TPQDLNTML;67;75;;GAG protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 3, Supplementary Table S1 and PDB 4U1I;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;4U1I;HLA-B*81:01;I;The crystal structure of the epitope bound to HLA-B*8101 was determined.
2423576;1028840;Literature;25808313;"Henrik N Kl&oslash;verpris; David K Cole; Anna Fuller; Jonathan Carlson; Konrad Beck; Andrea J Schauenburg; Pierre J Rizkallah; S&oslash;ren Buus; Andrew K Sewell; Philip Goulder";Retrovirology;2015;A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape.;;102149;Linear peptide;TPQDLNTML;67;75;;GAG protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 3, Supplementary Table S1 and PDB 4U1J;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;4U1J;HLA-B*42:01;I;The crystal structure of the epitope bound to HLA-B*4201 was determined.
2423577;1028840;Literature;25808313;"Henrik N Kl&oslash;verpris; David K Cole; Anna Fuller; Jonathan Carlson; Konrad Beck; Andrea J Schauenburg; Pierre J Rizkallah; S&oslash;ren Buus; Andrew K Sewell; Philip Goulder";Retrovirology;2015;A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape.;;371292;Linear peptide;RPQVPLRPM;69;77;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 3, Figure 4, Supplementary Table S2 and PDB 4U1K;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;4U1K;HLA-B*07:02;I;The crystal structure of the epitope bound to HLA-B*0702 was determined.
2423578;1028840;Literature;25808313;"Henrik N Kl&oslash;verpris; David K Cole; Anna Fuller; Jonathan Carlson; Konrad Beck; Andrea J Schauenburg; Pierre J Rizkallah; S&oslash;ren Buus; Andrew K Sewell; Philip Goulder";Retrovirology;2015;A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape.;;371292;Linear peptide;RPQVPLRPM;69;77;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 3, Figure 4, Supplementary Table S2 and PDB 4U1L;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;4U1L;HLA-B*81:01;I;The crystal structure of the epitope bound to HLA-B*8101 was determined.
2423579;1028840;Literature;25808313;"Henrik N Kl&oslash;verpris; David K Cole; Anna Fuller; Jonathan Carlson; Konrad Beck; Andrea J Schauenburg; Pierre J Rizkallah; S&oslash;ren Buus; Andrew K Sewell; Philip Goulder";Retrovirology;2015;A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape.;;371292;Linear peptide;RPQVPLRPM;69;77;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 3, Figure 4, Supplementary Table S2 and PDB 4U1M;x-ray crystallography;3D structure;angstroms;Positive;=;1.2;4U1M;HLA-B*42:01;I;The crystal structure of the epitope bound to HLA-B*4201 was determined.
2423580;1028840;Literature;25808313;"Henrik N Kl&oslash;verpris; David K Cole; Anna Fuller; Jonathan Carlson; Konrad Beck; Andrea J Schauenburg; Pierre J Rizkallah; S&oslash;ren Buus; Andrew K Sewell; Philip Goulder";Retrovirology;2015;A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape.;;371292;Linear peptide;RPQVPLRPM;69;77;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 3, Figure 4, Supplementary Table S2 and PDB 4U1N;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;4U1N;HLA-B*42:02;I;The crystal structure of the epitope bound to HLA-B*4202 was determined.
2423581;1028840;Literature;25808313;"Henrik N Kl&oslash;verpris; David K Cole; Anna Fuller; Jonathan Carlson; Konrad Beck; Andrea J Schauenburg; Pierre J Rizkallah; S&oslash;ren Buus; Andrew K Sewell; Philip Goulder";Retrovirology;2015;A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape.;;231896;Linear peptide;FPRPWLHGL;34;42;;vpr protein;Protein Vpr;P69726;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;PDB 4U1S;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;4U1S;HLA-B*81:01;I;The crystal structure of the epitope bound to HLA-B*8101 was determined.
2442959;1028883;Literature;25855358;"Melissa J Rist; Kelly M Hibbert; Nathan P Croft; Corey Smith; Michelle A Neller; Jacqueline M Burrows; John J Miles; Anthony W Purcell; Jamie Rossjohn; Stephanie Gras; Scott R Burrows";J Immunol;2015;T Cell Cross-Reactivity between a Highly Immunogenic EBV Epitope and a Self-Peptide Naturally Presented by HLA-B*18:01+ Cells.;;418064;Linear peptide;DELEIKAY;146;153;;Integrator complex subunit 11;Integrator complex subunit 11;Q5TA45;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table I, Figures 6, 7 and PDB 4XXC;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;4XXC;HLA-B*18:01;I;The crystal structure of the epitope/HLA-B*18:01 complex was determined by molecular replacement.
2444705;1028938;Literature;25860507;"Paul Chappell; El Kahina Meziane; Michael Harrison; ≈Åukasz Magiera; Clemens Hermann; Laura Mears; Antony G Wrobel; Charlotte Durant; Lise Lotte Nielsen; S&oslash;ren Buus; Nicola Ternette; William Mwangi; Colin Butter; Venugopal Nair; Trudy Ahyee; Richard Duggleby; Alejandro Madrigal; Pietro Roversi; Susan M Lea; Jim Kaufman";Elife;2015;Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding.;;419372;Linear peptide;TAGQEDYDRL;60;69;;Rho-related GTP-binding protein RhoC;Rho-related GTP-binding protein RhoC;Q9PSX7;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;chicken (Gallus gallus);9031;Figure 4, Table 1 and PDB 4D0B;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;4D0B;BF2*2101;I;The crystal structure of the epitope in complex with BF2*2101 was determined.
2444706;1028938;Literature;25860507;"Paul Chappell; El Kahina Meziane; Michael Harrison; ≈Åukasz Magiera; Clemens Hermann; Laura Mears; Antony G Wrobel; Charlotte Durant; Lise Lotte Nielsen; S&oslash;ren Buus; Nicola Ternette; William Mwangi; Colin Butter; Venugopal Nair; Trudy Ahyee; Richard Duggleby; Alejandro Madrigal; Pietro Roversi; Susan M Lea; Jim Kaufman";Elife;2015;Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding.;;419373;Linear peptide;TAGQSNYDRL;;;;hypothetical protein;;;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;chicken (Gallus gallus);9031;Figure 4, Table 1 and PDB 4D0C;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;4D0C;BF2*2101;I;The crystal structure of the epitope in complex with BF2*2101 was determined. Record 4D0C supersedes 2YF5.
2444707;1028938;Literature;25860507;"Paul Chappell; El Kahina Meziane; Michael Harrison; ≈Åukasz Magiera; Clemens Hermann; Laura Mears; Antony G Wrobel; Charlotte Durant; Lise Lotte Nielsen; S&oslash;ren Buus; Nicola Ternette; William Mwangi; Colin Butter; Venugopal Nair; Trudy Ahyee; Richard Duggleby; Alejandro Madrigal; Pietro Roversi; Susan M Lea; Jim Kaufman";Elife;2015;Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding.;;419419;Linear peptide;YELDEKFDRL;;;;hypothetical protein;;;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;chicken (Gallus gallus);9031;Figure 4, 7, Table 1 and PDB 4CVZ;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;4CVZ;BF2*2101;I;The crystal structure of the epitope in complex with BF2*2101 was determined.
2444708;1028938;Literature;25860507;"Paul Chappell; El Kahina Meziane; Michael Harrison; ≈Åukasz Magiera; Clemens Hermann; Laura Mears; Antony G Wrobel; Charlotte Durant; Lise Lotte Nielsen; S&oslash;ren Buus; Nicola Ternette; William Mwangi; Colin Butter; Venugopal Nair; Trudy Ahyee; Richard Duggleby; Alejandro Madrigal; Pietro Roversi; Susan M Lea; Jim Kaufman";Elife;2015;Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding.;;419384;Linear peptide;TNPESKVFYL;110;119;;14-3-3 protein theta;14-3-3 protein theta;Q5ZMD1;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;chicken (Gallus gallus);9031;Figure 4, Table 1 and PDB 2YEZ;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;2YEZ;BF2*2101;I;The crystal structure of the epitope in complex with BF2*2101 was determined.
2444709;1028938;Literature;25860507;"Paul Chappell; El Kahina Meziane; Michael Harrison; ≈Åukasz Magiera; Clemens Hermann; Laura Mears; Antony G Wrobel; Charlotte Durant; Lise Lotte Nielsen; S&oslash;ren Buus; Nicola Ternette; William Mwangi; Colin Butter; Venugopal Nair; Trudy Ahyee; Richard Duggleby; Alejandro Madrigal; Pietro Roversi; Susan M Lea; Jim Kaufman";Elife;2015;Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding.;;419425;Linear peptide;YPYLGPNTL;314;322;;Hypothetical protein;;;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;chicken (Gallus gallus);9031;Figure 6, Table 1 and PDB 4CVX;x-ray crystallography;3D structure;angstroms;Positive;=;3.3;4CVX;BF2*0201;I;The crystal structure of the epitope in complex with BF2*0201 was determined.
2444710;1028938;Literature;25860507;"Paul Chappell; El Kahina Meziane; Michael Harrison; ≈Åukasz Magiera; Clemens Hermann; Laura Mears; Antony G Wrobel; Charlotte Durant; Lise Lotte Nielsen; S&oslash;ren Buus; Nicola Ternette; William Mwangi; Colin Butter; Venugopal Nair; Trudy Ahyee; Richard Duggleby; Alejandro Madrigal; Pietro Roversi; Susan M Lea; Jim Kaufman";Elife;2015;Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding.;;419399;Linear peptide;VIFPAKSL;159;166;;SLP-76 adaptor protein;SLP-76 adaptor protein;Q9DG07;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;chicken (Gallus gallus);9031;Figure 6, 7, Table 1 and PDB 4D0D;x-ray crystallography;3D structure;angstroms;Positive;=;3.1;4D0D;BF2*0201;I;The crystal structure of the epitope in complex with BF2*0201 was determined.
2444711;1028938;Literature;25860507;"Paul Chappell; El Kahina Meziane; Michael Harrison; ≈Åukasz Magiera; Clemens Hermann; Laura Mears; Antony G Wrobel; Charlotte Durant; Lise Lotte Nielsen; S&oslash;ren Buus; Nicola Ternette; William Mwangi; Colin Butter; Venugopal Nair; Trudy Ahyee; Richard Duggleby; Alejandro Madrigal; Pietro Roversi; Susan M Lea; Jim Kaufman";Elife;2015;Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding.;;419367;Linear peptide;SWFRKPMTR;701;709;;microtubule-actin cross-linking factor 1, isoforms 1/2/3/5-like isoform X4;;;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;chicken (Gallus gallus);9031;Figure 6, 7, Table 1 and PDB 4CW1;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;4CW1;BF2*1401;I;The crystal structure of the epitope in complex with BF2*1401 was determined.
2444885;1028958;Literature;24173108;"Sophie A Valkenburg; Sergio Qui&ntilde;ones-Parra; Stephanie Gras; Naomi Komadina; Jodie McVernon; Zhongfang Wang; Hanim Halim; Pina Iannello; Catherine Cole; Karen Laurie; Anne Kelso; Jamie Rossjohn; Peter C Doherty; Stephen J Turner; Katherine Kedzierska";Nat Commun;2013;Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides.;;419119;Linear peptide;ASNEDMETM;27;35;;Nucleoprotein N5D;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 4, Supplementary Table S5 and PDB 4L8D;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;4L8D;H2-Db;I;The crystal structure of the epitope bound to H-2Db was determined.
2444886;1028958;Literature;24173108;"Sophie A Valkenburg; Sergio Qui&ntilde;ones-Parra; Stephanie Gras; Naomi Komadina; Jodie McVernon; Zhongfang Wang; Hanim Halim; Pina Iannello; Catherine Cole; Karen Laurie; Anne Kelso; Jamie Rossjohn; Peter C Doherty; Stephen J Turner; Katherine Kedzierska";Nat Commun;2013;Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides.;;4360;Linear peptide;ASDENMETM;27;35;;Nucleoprotein N3D;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 4, Supplementary Table S5 and PDB 4L8C;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;4L8C;H2-Db;I;The crystal structure of the epitope bound to H-2Db was determined.
2444887;1028958;Literature;24173108;"Sophie A Valkenburg; Sergio Qui&ntilde;ones-Parra; Stephanie Gras; Naomi Komadina; Jodie McVernon; Zhongfang Wang; Hanim Halim; Pina Iannello; Catherine Cole; Karen Laurie; Anne Kelso; Jamie Rossjohn; Peter C Doherty; Stephen J Turner; Katherine Kedzierska";Nat Commun;2013;Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides.;;419121;Linear peptide;ASNEHMETM;27;35;;Nucleoprotein N5H;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;Supplementary Table S5 and PDB 4L8B;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;4L8B;H2-Db;I;The crystal structure of the epitope bound to H-2Db was determined.
2461178;1028961;Literature;22343629;"Yu Chih Liu; Zhenjun Chen; Scott R Burrows; Anthony W Purcell; James McCluskey; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2012;The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule.;;421324;Linear peptide;LPEALPQGQLTAY;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LPEPLPQGQLTAY;52;64;;EB1, Zebra;Trans-activator protein BZLF1;Trans-activator protein BZLF1;Human gammaherpesvirus 4;Human gammaherpesvirus 4;human (Homo sapiens);9606;Supplementary Figure 1, Supplementary Table 2 and PDB 3VFR;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3VFR;HLA-B*35:08;I;The crystal structure of the epitope/HLA-B*3508 complex was determined.
2461179;1028961;Literature;22343629;"Yu Chih Liu; Zhenjun Chen; Scott R Burrows; Anthony W Purcell; James McCluskey; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2012;The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule.;;421325;Linear peptide;LPEPAPQGQLTAY;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LPEPLPQGQLTAY;52;64;;EB1, Zebra;Trans-activator protein BZLF1;Trans-activator protein BZLF1;Human gammaherpesvirus 4;Human gammaherpesvirus 4;human (Homo sapiens);9606;Supplementary Figure 1, Supplementary Table 2 and PDB 3VFS;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3VFS;HLA-B*35:08;I;The crystal structure of the epitope/HLA-B*3508 complex was determined.
2461180;1028961;Literature;22343629;"Yu Chih Liu; Zhenjun Chen; Scott R Burrows; Anthony W Purcell; James McCluskey; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2012;The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule.;;421326;Linear peptide;LPEPLAQGQLTAY;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LPEPLPQGQLTAY;52;64;;EB1, Zebra;Trans-activator protein BZLF1;Trans-activator protein BZLF1;Human gammaherpesvirus 4;Human gammaherpesvirus 4;human (Homo sapiens);9606;Supplementary Figure 1, Supplementary Table 2 and PDB 3VFT;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3VFT;HLA-B*35:08;I;The crystal structure of the epitope/HLA-B*3508 complex was determined.
2461181;1028961;Literature;22343629;"Yu Chih Liu; Zhenjun Chen; Scott R Burrows; Anthony W Purcell; James McCluskey; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2012;The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule.;;421327;Linear peptide;LPEPLPAGQLTAY;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LPEPLPQGQLTAY;52;64;;EB1, Zebra;Trans-activator protein BZLF1;Trans-activator protein BZLF1;Human gammaherpesvirus 4;Human gammaherpesvirus 4;human (Homo sapiens);9606;Supplementary Figure 1, Supplementary Table 2 and PDB 3VFU;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3VFU;HLA-B*35:08;I;The crystal structure of the epitope/HLA-B*3508 complex was determined.
2461182;1028961;Literature;22343629;"Yu Chih Liu; Zhenjun Chen; Scott R Burrows; Anthony W Purcell; James McCluskey; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2012;The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule.;;421328;Linear peptide;LPEPLPQGALTAY;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LPEPLPQGQLTAY;52;64;;EB1, Zebra;Trans-activator protein BZLF1;Trans-activator protein BZLF1;Human gammaherpesvirus 4;Human gammaherpesvirus 4;human (Homo sapiens);9606;Supplementary Figure 1, Supplementary Table 2 and PDB 3VFV;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;3VFV;HLA-B*35:08;I;The crystal structure of the epitope/HLA-B*3508 complex was determined.
2461183;1028961;Literature;22343629;"Yu Chih Liu; Zhenjun Chen; Scott R Burrows; Anthony W Purcell; James McCluskey; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2012;The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule.;;421329;Linear peptide;LPEPLPQGQATAY;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LPEPLPQGQLTAY;52;64;;EB1, Zebra;Trans-activator protein BZLF1;Trans-activator protein BZLF1;Human gammaherpesvirus 4;Human gammaherpesvirus 4;human (Homo sapiens);9606;Supplementary Figure 1, Supplementary Table 2 and PDB 3VFW;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;3VFW;HLA-B*35:08;I;The crystal structure of the epitope/HLA-B*3508 complex was determined.
2461184;1028961;Literature;22343629;"Yu Chih Liu; Zhenjun Chen; Scott R Burrows; Anthony W Purcell; James McCluskey; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2012;The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule.;;38458;Linear peptide;LPEPLPQGQLTAY;52;64;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Figure 1, Supplementary Table 2 and PDB 3VFN;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;3VFN;HLA-B*35:08;I;The crystal structure of the epitope in complex with HLA-B*3508 with mutation 151A in the HLA alpha chain was determined.
2461185;1028961;Literature;22343629;"Yu Chih Liu; Zhenjun Chen; Scott R Burrows; Anthony W Purcell; James McCluskey; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2012;The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule.;;38458;Linear peptide;LPEPLPQGQLTAY;52;64;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Figure 1, Supplementary Table 2 and PDB 3VFM;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3VFM;HLA-B*35:08;I;The crystal structure of the epitope in complex with HLA-B*3508 with mutation 155A in the HLA alpha chain was determined.
2461186;1028961;Literature;22343629;"Yu Chih Liu; Zhenjun Chen; Scott R Burrows; Anthony W Purcell; James McCluskey; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2012;The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule.;;38458;Linear peptide;LPEPLPQGQLTAY;52;64;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Figure 1, Supplementary Table 2 and PDB 3VFO;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3VFO;HLA-B*35:08;I;The crystal structure of the epitope in complex with HLA-B*3508 with mutation 157A in the HLA alpha chain was determined.
2461187;1028961;Literature;22343629;"Yu Chih Liu; Zhenjun Chen; Scott R Burrows; Anthony W Purcell; James McCluskey; Jamie Rossjohn; Stephanie Gras";J Biol Chem;2012;The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule.;;38458;Linear peptide;LPEPLPQGQLTAY;52;64;;Trans-activator protein BZLF1;Trans-activator protein BZLF1;P03206;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Figure 1, Supplementary Table 2 and PDB 3VFP;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3VFP;HLA-B*35:08;I;The crystal structure of the epitope in complex with HLA-B*3508 with mutation 158G in the HLA alpha chain was determined.
2467637;1029101;Literature;26085090;"Chihiro Motozono; James A Pearson; Evy De Leenheer; Pierre J Rizkallah; Konrad Beck; Andrew Trimby; Andrew K Sewell; F Susan Wong; David K Cole";J Biol Chem;2015;Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide.;;106637;Linear peptide;LYLVCGERGF;39;48;;Insulin precursor;Insulin;P01308;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;mouse (Mus musculus);10090;Tables 1, 2, Figures 4, 5, 6 and PDB 4Z78;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;4Z78;H2-Kd;I;The crystal structure of the epitope/H-2-Kd complex was solved by molecular replacement. There are three copies of the complex in the asymmetric unit.
2467638;1029101;Literature;26085090;"Chihiro Motozono; James A Pearson; Evy De Leenheer; Pierre J Rizkallah; Konrad Beck; Andrew Trimby; Andrew K Sewell; F Susan Wong; David K Cole";J Biol Chem;2015;Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide.;;102639;Linear peptide;LYLVCGERG;39;47;;Insulin precursor;Insulin;P01308;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;mouse (Mus musculus);10090;Tables 1, 2, Figures 4, 5, 6 and PDB 4WDI;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;4WDI;H2-Kd;I;The crystal structure of the epitope/H-2-Kd complex was solved by molecular replacement. There are two copies of the complex in the asymmetric unit.
2467639;1029101;Literature;26085090;"Chihiro Motozono; James A Pearson; Evy De Leenheer; Pierre J Rizkallah; Konrad Beck; Andrew Trimby; Andrew K Sewell; F Susan Wong; David K Cole";J Biol Chem;2015;Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide.;;109543;Linear peptide;LYLVCGERV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LYLVCGERG;39;47;;;Insulin precursor;Insulin;Homo sapiens;Homo sapiens;mouse (Mus musculus);10090;Tables 1, 2, Figures 4, 5, 6 and PDB 4Z76;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;4Z76;H2-Kd;I;The crystal structure of the epitope/H-2-Kd complex was solved by molecular replacement. There are two copies of the complex in the asymmetric unit.
2579977;1029636;Literature;26429912;"Xinbo Yang; Mingming Gao; Guobing Chen; Brian G Pierce; Jinghua Lu; Nan-Ping Weng; Roy A Mariuzza";J Biol Chem;2015;Structural Basis for Clonal Diversity of the Public T Cell Response to a Dominant Human Cytomegalovirus Epitope.;;44920;Linear peptide;NLVPMVATV;485;493;;64 kDa lower matrix phosphoprotein;65 kDa phosphoprotein;Q6SW59;Human betaherpesvirus 5;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3 and PDB 5D2L;x-ray crystallography;3D structure;angstroms;Positive;=;3.5;5D2L;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound by the C7 TCR was determined by molecular replacement.
2579978;1029636;Literature;26429912;"Xinbo Yang; Mingming Gao; Guobing Chen; Brian G Pierce; Jinghua Lu; Nan-Ping Weng; Roy A Mariuzza";J Biol Chem;2015;Structural Basis for Clonal Diversity of the Public T Cell Response to a Dominant Human Cytomegalovirus Epitope.;;44920;Linear peptide;NLVPMVATV;485;493;;64 kDa lower matrix phosphoprotein;65 kDa phosphoprotein;Q6SW59;Human betaherpesvirus 5;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3 and PDB 5D2N;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5D2N;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound by the C25 TCR was determined by molecular replacement.
2605771;1029748;Literature;26688548;"Niloufar Ataie; Jingyi Xiang; Neal Cheng; Elliott J Brea; Wenjie Lu; David A Scheinberg; Cheng Liu; Ho Leung Ng";J Mol Biol;2016;Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.;;54882;Linear peptide;RMFPNAPYL;126;134;;Wilms tumor protein;Wilms tumor protein;P19544;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, S1, Tables 1, 2 and PDB 4WUU;x-ray crystallography;3D structure;angstroms;Positive;=;3.1;4WUU;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound by the ESK1 Fab was determined.
2621254;1029828;Literature;26758274;"Daisuke Morita; Yukie Yamamoto; Tatsuaki Mizutani; Takeshi Ishikawa; Juri Suzuki; Tatsuhiko Igarashi; Naoki Mori; Takashi Shiina; Hidetoshi Inoko; Hiroaki Fujita; Kazuhiro Iwai; Yoshimasa Tanaka; Bunzo Mikami; Masahiko Sugita";Nat Commun;2016;Crystal structure of the N-myristoylated lipopeptide-bound MHC class I complex.;;547461;Linear peptide;GGAIS + MYRI(G1);2;6;;Protein Nef;Protein Nef;P05862;Simian immunodeficiency virus;Simian immunodeficiency virus;11723;;;;;;;;;;;;;rhesus macaque (Macaca mulatta);9544;Table 1, Figures 2, 3, Supplementary Figure 2, Supplementary Table 1 and PSB 4ZFZ;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;4ZFZ;Mamu class I;I;The crystal structure of the N-myristoylated epitope in complex with Mamu-B*098 was determined. A cysteine to serine mutation at position 167 in the heavy chain was introduced to improve refolding efficiency. Authors refer to the MHC molecule as Mamu-B*098. This may mean  Mamu-B*098:01:01, Mamu-B*098:01:02, Mamu-B*098:02, Mamu-B*098:03, or Mamu-B*098:04.
2642707;1029876;Literature;26748477;"Bernhard Loll; Heinz Fabian; Hans Huser; Chee-Seng Hee; Alexander Ziegler; Barbara Uchanska-Ziegler; Andreas Ziegler";Arthritis Rheumatol;2016;Increased Conformational Flexibility of HLA-B*27 Subtypes Associated With Ankylosing Spondylitis.;;55635;Linear peptide;RRKWRRWHL;400;408;;Vasoactive intestinal polypeptide receptor 1 precursor;Vasoactive intestinal polypeptide receptor 1;P32241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, Figures 1, 2 and PDB 5DEF;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;5DEF;HLA-B*27:04;I;The crystal structure of HLA-B*27:04 in complex with the epitope was solved by molecular replacement.
2642708;1029876;Literature;26748477;"Bernhard Loll; Heinz Fabian; Hans Huser; Chee-Seng Hee; Alexander Ziegler; Barbara Uchanska-Ziegler; Andreas Ziegler";Arthritis Rheumatol;2016;Increased Conformational Flexibility of HLA-B*27 Subtypes Associated With Ankylosing Spondylitis.;;55635;Linear peptide;RRKWRRWHL;400;408;;Vasoactive intestinal polypeptide receptor 1 precursor;Vasoactive intestinal polypeptide receptor 1;P32241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, Figures 1, 2 and PDB 5DEG;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;5DEG;HLA-B*27:06;I;The crystal structure of HLA-B*27:06 in complex with the epitope was solved by molecular replacement.
2683391;1029894;Literature;26800871;"Ida Hafstrand; Elien M Doorduijn; Adil Doganay Duru; Jeremie Buratto; Claudia Cunha Oliveira; Tatyana Sandalova; Thorbald van Hall; Adnane Achour";J Immunol;2016;The MHC Class I Cancer-Associated Neoepitope Trh4 Linked with Impaired Peptide Processing Induces a Unique Noncanonical TCR Conformer.;;504109;Linear peptide;MCLRMTAVM;379;387;;longevity assurance homolog 5 (S. cerevisiae), isoform CRA_a;Ceramide synthase 5;Q9D6K9;Mus musculus;Mus musculus;10090;The epitope is a T cell epitope associated with impaired peptide processing (TEIPP), derived from the C-terminal portion of a minor splice variant of the commonly expressed cellular protein Trh4 (CerS5). Although derived from nonmutated endogenous proteins, the TEIPP neoantigens are not presented on normal cells and act as immunogenic epitopes.;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 1, Supplementary Figures 1, 2, Supplementary Table 1 and PDB 5E8N;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;5E8N;H2-Db;I;The crystal structure of the epitope/H-2-Db complex was determined, solved by molecular replacement. There are four molecules in the asymmetric unit.
2683396;1029894;Literature;26800871;"Ida Hafstrand; Elien M Doorduijn; Adil Doganay Duru; Jeremie Buratto; Claudia Cunha Oliveira; Tatyana Sandalova; Thorbald van Hall; Adnane Achour";J Immunol;2016;The MHC Class I Cancer-Associated Neoepitope Trh4 Linked with Impaired Peptide Processing Induces a Unique Noncanonical TCR Conformer.;;504108;Linear peptide;MCLRMTAVM + NLeu(M5);379;387;;longevity assurance homolog 5 (S. cerevisiae), isoform CRA_a;Ceramide synthase 5;Q9D6K9;Mus musculus;Mus musculus;10090;The Met residue at position 5 is substituted with norleucine (NLE). The unsubstituted peptide is a T cell epitope associated with impaired peptide processing (TEIPP), derived from the C-terminal portion of a minor splice variant of the commonly expressed cellular protein Trh4 (CerS5). Although derived from nonmutated endogenous proteins, the TEIPP neoantigens are not presented on normal cells and act as immunogenic epitopes.;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 4, Supplementary Figure 2, Supplementary Table 1 and PDB 5E8P;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5E8P;H2-Db;I;The crystal structure of the epitope/H-2-Db complex was determined, solved by molecular replacement. There are two molecules in the asymmetric unit.
2683397;1029894;Literature;26800871;"Ida Hafstrand; Elien M Doorduijn; Adil Doganay Duru; Jeremie Buratto; Claudia Cunha Oliveira; Tatyana Sandalova; Thorbald van Hall; Adnane Achour";J Immunol;2016;The MHC Class I Cancer-Associated Neoepitope Trh4 Linked with Impaired Peptide Processing Induces a Unique Noncanonical TCR Conformer.;;504106;Linear peptide;MCLRMTAVM + AIB(C2);379;387;;longevity assurance homolog 5 (S. cerevisiae), isoform CRA_a;Ceramide synthase 5;Q9D6K9;Mus musculus;Mus musculus;10090;The Cys residue at position 2 is substituted with alpha-aminobutyric acid (ABU). The unsubstituted peptide is a T cell epitope associated with impaired peptide processing (TEIPP), derived from the C-terminal portion of a minor splice variant of the commonly expressed cellular protein Trh4 (CerS5). Although derived from nonmutated endogenous proteins, the TEIPP neoantigens are not presented on normal cells and act as immunogenic epitopes.;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 4, Supplementary Figure 2, Supplementary Table 1 and PDB 5E8O;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5E8O;H2-Db;I;The crystal structure of the epitope/H-2-Db complex was determined, solved by molecular replacement. There are four molecules in the asymmetric unit.
2723237;1029802;Literature;26758806;"Marine C C Raman; Pierre J Rizkallah; Ruth Simmons; Zoe Donnellan; Joseph Dukes; Giovanna Bossi; Gabrielle S Le Provost; Penio Todorov; Emma Baston; Emma Hickman; Tara Mahon; Namir Hassan; Annelise Vuidepot; Malkit Sami; David K Cole; Bent K Jakobsen";Sci Rep;2016;Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy.;;14672;Linear peptide;EVDPIGHLY;168;176;;Melanoma-associated antigen 3;Melanoma-associated antigen 3;P43357;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Table 1 and PDB 5BRZ;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;5BRZ;HLA-A*01:01;I;The crystal structure of the HLA-A*01:01/epitope complex bound by the MAG-IC3 TCR was determined.
2723238;1029802;Literature;26758806;"Marine C C Raman; Pierre J Rizkallah; Ruth Simmons; Zoe Donnellan; Joseph Dukes; Giovanna Bossi; Gabrielle S Le Provost; Penio Todorov; Emma Baston; Emma Hickman; Tara Mahon; Namir Hassan; Annelise Vuidepot; Malkit Sami; David K Cole; Bent K Jakobsen";Sci Rep;2016;Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy.;;509235;Linear peptide;ESDPIVAQY;24337;24345;;Titin;Titin;Q8WZ42;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Table 1 and PDB 5BS0;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;5BS0;HLA-A*01:01;I;The crystal structure of the HLA-A*01:01/epitope complex bound by the MAG-IC3 TCR was determined.
2723540;1029982;Literature;26917722;"Valentina Bianchi; Anna Bulek; Anna Fuller; Angharad Lloyd; Meriem Attaf; Pierre J Rizkallah; Garry Dolton; Andrew K Sewell; David K Cole";J Biol Chem;2016;A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen.;;74641;Linear peptide;YLEPGPVTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;YLEPGPVTA;280;288;;;Melanocyte protein Pmel 17 precursor;Melanocyte protein PMEL;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 1, Table 3 and PDB 5EU6;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5EU6;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound by the PMEL17 TCR was determined, solved by molecular replacement.
2723541;1029982;Literature;26917722;"Valentina Bianchi; Anna Bulek; Anna Fuller; Angharad Lloyd; Meriem Attaf; Pierre J Rizkallah; Garry Dolton; Andrew K Sewell; David K Cole";J Biol Chem;2016;A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen.;;74638;Linear peptide;YLEPGPVTA;280;288;;Melanocyte protein Pmel 17 precursor;Melanocyte protein PMEL;P40967;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 5, Table 3 and PDB 5EU3;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5EU3;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined, solved by molecular replacement.
2723543;1029982;Literature;26917722;"Valentina Bianchi; Anna Bulek; Anna Fuller; Angharad Lloyd; Meriem Attaf; Pierre J Rizkallah; Garry Dolton; Andrew K Sewell; David K Cole";J Biol Chem;2016;A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen.;;74567;Linear peptide;YLAPGPVTA;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;YLEPGPVTA;280;288;;;Melanocyte protein Pmel 17 precursor;Melanocyte protein PMEL;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 1, 5, Table 3 and PDB 5EU4;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5EU4;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined, solved by molecular replacement.
2723545;1029982;Literature;26917722;"Valentina Bianchi; Anna Bulek; Anna Fuller; Angharad Lloyd; Meriem Attaf; Pierre J Rizkallah; Garry Dolton; Andrew K Sewell; David K Cole";J Biol Chem;2016;A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen.;;534529;Linear peptide;YLEPAPVTA;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;YLEPGPVTA;280;288;;;Melanocyte protein Pmel 17 precursor;Melanocyte protein PMEL;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 1, 5, Table 3 and PDB 5EU5;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;5EU5;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined, solved by molecular replacement.
2724217;1030030;Literature;26824387;"Curtis McMurtrey; Thomas Trolle; Tiffany Sansom; Soumya G Remesh; Thomas Kaever; Wilfried Bardet; Kenneth Jackson; Rima McLeod; Alessandro Sette; Morten Nielsen; Dirk M Zajonc; Ira J Blader; Bjoern Peters; William Hildebrand";Elife;2016;Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove.;;546880;Linear peptide;FVLELEPEWTVK;16;27;;ubiquitin family protein;Ubiquitin family protein;B6KDY1;Toxoplasma gondii GT1;Toxoplasma gondii;5811;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 9, Supplementary file 4 and PDB 5DDH;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;5DDH;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
2724218;1030030;Literature;26824387;"Curtis McMurtrey; Thomas Trolle; Tiffany Sansom; Soumya G Remesh; Thomas Kaever; Wilfried Bardet; Kenneth Jackson; Rima McLeod; Alessandro Sette; Morten Nielsen; Dirk M Zajonc; Ira J Blader; Bjoern Peters; William Hildebrand";Elife;2016;Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove.;;546879;Linear peptide;FVLELEPEWTV;16;26;;ubiquitin family protein;Ubiquitin family protein;B6KDY1;Toxoplasma gondii GT1;Toxoplasma gondii;5811;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 9, Supplementary file 4 and PDB 5D9S;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;5D9S;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
2751474;1030086;Literature;26983786;"Victor Y Du; Anju Bansal; Jonathan Carlson; Jesus F Salazar-Gonzalez; Maria G Salazar; Kristin Ladell; Stephanie Gras; Tracy M Josephs; Sonya L Heath; David A Price; Jamie Rossjohn; Eric Hunter; Paul A Goepfert";J Immunol;2016;HIV-1-Specific CD8 T Cells Exhibit Limited Cross-Reactivity during Acute Infection.;;538952;Linear peptide;RPMTFKGAL;77;85;;nef protein, partial;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 7, Table II and PDB 5EO0;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;5EO0;HLA-B*07:02;I;The crystal structure of the epitope/HLA-B*07:02 complex was determined.
2751475;1030086;Literature;26983786;"Victor Y Du; Anju Bansal; Jonathan Carlson; Jesus F Salazar-Gonzalez; Maria G Salazar; Kristin Ladell; Stephanie Gras; Tracy M Josephs; Sonya L Heath; David A Price; Jamie Rossjohn; Eric Hunter; Paul A Goepfert";J Immunol;2016;HIV-1-Specific CD8 T Cells Exhibit Limited Cross-Reactivity during Acute Infection.;;538954;Linear peptide;RPMTYKGAL;86;94;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 7, Table II and PDB 5EO1;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;5EO1;HLA-B*07:02;I;The crystal structure of the epitope/HLA-B*07:02 complex was determined.
2765209;1030122;Literature;27045007;"Philippa M Saunders; Phillip Pymm; Gabriella Pietra; Victoria A Hughes; Corinne Hitchen; Geraldine M O'Connor; Fabrizio Loiacono; Jacqueline Widjaja; David A Price; Michela Falco; Maria Cristina Mingari; Lorenzo Moretta; Daniel W McVicar; Jamie Rossjohn; Andrew G Brooks; Julian P Vivian";J Exp Med;2016;Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition.;;98894;Linear peptide;LSSPVTKSF;93;101;;Ig kappa chain C region;Ig kappa chain C region;;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 4, 5 and PDB 5B38;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;5B38;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex bound by the Killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1*005) was determined by molecular replacement.
2765210;1030122;Literature;27045007;"Philippa M Saunders; Phillip Pymm; Gabriella Pietra; Victoria A Hughes; Corinne Hitchen; Geraldine M O'Connor; Fabrizio Loiacono; Jacqueline Widjaja; David A Price; Michela Falco; Maria Cristina Mingari; Lorenzo Moretta; Daniel W McVicar; Jamie Rossjohn; Andrew G Brooks; Julian P Vivian";J Exp Med;2016;Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition.;;98894;Linear peptide;LSSPVTKSF;93;101;;Ig kappa chain C region;Ig kappa chain C region;;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 4, 5 and PDB 5B39;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;5B39;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex bound by the Killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1*015) was determined by molecular replacement.
2827283;1030117;Literature;27036003;"Sophie A Valkenburg; Tracy M Josephs; E Bridie Clemens; Emma J Grant; Thi H O Nguyen; George C Wang; David A Price; Adrian Miller; Steven Y C Tong; Paul G Thomas; Peter C Doherty; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Proc Natl Acad Sci U S A;2016;Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses.;;538549;Linear peptide;GILEFVFTL;58;66;;matrix protein 1;Matrix protein 1;P03485;Influenza A virus (A/chicken/Anhui/1/1998(H9N2));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 4, Table S6 and PDB 5HHP;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;5HHP;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined by molecular replacement.
2827284;1030117;Literature;27036003;"Sophie A Valkenburg; Tracy M Josephs; E Bridie Clemens; Emma J Grant; Thi H O Nguyen; George C Wang; David A Price; Adrian Miller; Steven Y C Tong; Paul G Thomas; Peter C Doherty; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Proc Natl Acad Sci U S A;2016;Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses.;;538554;Linear peptide;GIWGFVFTL;58;66;;matrix protein 1;Matrix protein 1;P03485;Influenza A virus (A/bar-headed goose/Qinghai/3/2005(H5N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 4, Table S6 and PDB 5HHQ;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5HHQ;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined by molecular replacement.
2827285;1030117;Literature;27036003;"Sophie A Valkenburg; Tracy M Josephs; E Bridie Clemens; Emma J Grant; Thi H O Nguyen; George C Wang; David A Price; Adrian Miller; Steven Y C Tong; Paul G Thomas; Peter C Doherty; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Proc Natl Acad Sci U S A;2016;Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses.;;538552;Linear peptide;GILGLVFTL;58;66;;matrix protein 1;Matrix protein 1;P03485;Influenza A virus (A/Canterbury/236/2005(H3N2));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 4, Table S6 and PDB 5HHN;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5HHN;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined by molecular replacement.
2827286;1030117;Literature;27036003;"Sophie A Valkenburg; Tracy M Josephs; E Bridie Clemens; Emma J Grant; Thi H O Nguyen; George C Wang; David A Price; Adrian Miller; Steven Y C Tong; Paul G Thomas; Peter C Doherty; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Proc Natl Acad Sci U S A;2016;Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses.;;538549;Linear peptide;GILEFVFTL;58;66;;matrix protein 1;Matrix protein 1;P03485;Influenza A virus (A/chicken/Anhui/1/1998(H9N2));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 4, Table S7 and PDB 5HHO;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;5HHO;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound by the JM22 TCR was determined by molecular replacement.
2827287;1030117;Literature;27036003;"Sophie A Valkenburg; Tracy M Josephs; E Bridie Clemens; Emma J Grant; Thi H O Nguyen; George C Wang; David A Price; Adrian Miller; Steven Y C Tong; Paul G Thomas; Peter C Doherty; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Proc Natl Acad Sci U S A;2016;Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses.;;538552;Linear peptide;GILGLVFTL;58;66;;matrix protein 1;Matrix protein 1;P03485;Influenza A virus (A/Canterbury/236/2005(H3N2));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 4, Table S7 and PDB 5HHM;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;5HHM;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound by the JM22 TCR was determined by molecular replacement.
2830541;1030344;Literature;27170754;"Shuhua Fan; Yanan Wu; Song Wang; Zhenbao Wang; Bo Jiang; Yanjie Liu; Ruiying Liang; Wenzhong Zhou; Nianzhi Zhang; Chun Xia";J Virol;2016;Structural and Biochemical Analyses of Swine Major Histocompatibility Complex Class I Complexes and Prediction of the Epitope Map of Important Influenza A Virus Strains.;;538901;Linear peptide;KMNTQFTAV;402;410;;hemagglutinin;Hemagglutinin;P03452;Influenza A virus (A/Beijing/01/2009(H1N1));Influenza A virus;11320;;;;;;;;;;;;;pig (Sus scrofa);9823;Figures 1, 2, 4, 5, 6, Tables 1, 2, 3 and PDB 5H94;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;5H94;SLA-3*02:02;I;The crystal structure of the epitope bound to SLA-3*0202, cloned from Chinese Heishan pigs, was determined by molecular replacement.
2833311;1030418;Literature;27238970;"Daniel T Harris; Nishant K Singh; Qi Cai; Sheena N Smith; Craig Vander Kooi; Erik Procko; David M Kranz; Brian M Baker";Structure;2016;An Engineered Switch in T Cell Receptor Specificity Leads to an Unusual but Functional Binding Geometry.;;12941;Linear peptide;ELAGIGILTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figures 1, 2, S2 and PDB 5E9D;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;5E9D;HLA-A*02:01;I;The crystal structure of the HLA-A*02:01/epitope complex bound by the RD1-MART1(HIGH) TCR was determined. There are two TCR-pMHC complexes in the asymmetric unit.
2851450;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;558212;Linear peptide;YLGGPDFPTI;;;;;;;;;;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;analog;Fragment of a Natural Sequence Molecule;ALWGPDPAAA;15;24;;;Insulin precursor;Insulin;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 6, Supplementary Table S2 and PDB 5C0G;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;5C0G;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
2851451;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;558006;Linear peptide;AQWGPDPAAA;;;;;;;;;;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;analog;Fragment of a Natural Sequence Molecule;ALWGPDPAAA;15;24;;;Insulin precursor;Insulin;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 6, Supplementary Table S2 and PDB 5C0D;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;5C0D;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
2851452;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;558174;Linear peptide;RQFGPDWIVA;79;88;;butanol dehydrogenase;;;[Clostridium] asparagiforme;[Clostridium] asparagiforme;333367;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;;;;;;;;;;;;human (Homo sapiens);9606;Figure 6, Supplementary Table S2 and PDB 5C0J;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;5C0J;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
2851453;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;177958;Linear peptide;RQWGPDPAAV;;;;;;;;;;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;analog;Fragment of a Natural Sequence Molecule;ALWGPDPAAA;15;24;;;Insulin precursor;Insulin;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 6, Supplementary Table S2 and PDB 5C0F;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;5C0F;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
2851454;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;558213;Linear peptide;YQFGPDFPIA;;;;;;;;;;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;analog;Fragment of a Natural Sequence Molecule;ALWGPDPAAA;15;24;;;Insulin precursor;Insulin;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 6, Supplementary Table S2 and PDB 5C0E;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;5C0E;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
2851456;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;558173;Linear peptide;RQFGPDFPTI;;;;;;;;;;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;analog;Fragment of a Natural Sequence Molecule;ALWGPDPAAA;15;24;;;Insulin precursor;Insulin;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 6, Supplementary Table S2 and PDB 5C0I;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;5C0I;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
2851699;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;558116;Linear peptide;MVWGPDPLYV;124;133;;DUF5119 domain-containing protein;;;Bacteroides fragilis;Bacteroides fragilis;817;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;;;;;;;;;;;;human (Homo sapiens);9606;Figures 3, 6, Table 2, Supplementary Table S1 and PDB 5C0A;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;5C0A;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound to the 1E6 TCR was determined.
2851700;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;558212;Linear peptide;YLGGPDFPTI;;;;;;;;;;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;analog;Fragment of a Natural Sequence Molecule;ALWGPDPAAA;15;24;;;Insulin precursor;Insulin;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 3, 6, Table 2, Supplementary Table S1 and PDB 5C09;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;5C09;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound to the 1E6 TCR was determined.
2851701;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;558006;Linear peptide;AQWGPDPAAA;;;;;;;;;;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;analog;Fragment of a Natural Sequence Molecule;ALWGPDPAAA;15;24;;;Insulin precursor;Insulin;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 3, 6, Table 2, Supplementary Table S1 and PDB 5HYJ;x-ray crystallography;3D structure;angstroms;Positive;=;3.1;5HYJ;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound to the 1E6 TCR was determined.
2851702;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;558174;Linear peptide;RQFGPDWIVA;79;88;;butanol dehydrogenase;;;[Clostridium] asparagiforme;[Clostridium] asparagiforme;333367;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;;;;;;;;;;;;human (Homo sapiens);9606;Figures 3, 6, Table 2, Supplementary Table S1 and PDB 5C0C;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5C0C;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound to the 1E6 TCR was determined.
2851703;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;177958;Linear peptide;RQWGPDPAAV;;;;;;;;;;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;analog;Fragment of a Natural Sequence Molecule;ALWGPDPAAA;15;24;;;Insulin precursor;Insulin;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 3, 6, Table 2, Supplementary Table S1 and PDB 5C08;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;5C08;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound to the 1E6 TCR was determined.
2851704;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;558213;Linear peptide;YQFGPDFPIA;;;;;;;;;;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;analog;Fragment of a Natural Sequence Molecule;ALWGPDPAAA;15;24;;;Insulin precursor;Insulin;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 3, 6, Table 2, Supplementary Table S1 and PDB 5C07;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5C07;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound to the 1E6 TCR was determined.
2851705;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;558173;Linear peptide;RQFGPDFPTI;;;;;;;;;;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;analog;Fragment of a Natural Sequence Molecule;ALWGPDPAAA;15;24;;;Insulin precursor;Insulin;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figures 3, 6, Table 2, Supplementary Table S1 and PDB 5C0B;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5C0B;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound to the 1E6 TCR was determined.
2857540;1030634;Literature;27385781;"Lenong Li; Bernard D Santarsiero; Marlene Bouvier";J Immunol;2016;Structure of the Adenovirus Type 4 (Species E) E3-19K/HLA-A2 Complex Reveals Species-Specific Features in MHC Class I Recognition.;;37257;Linear peptide;LLFGYPVYV;11;19;;transcriptional activator Tax;Protein Tax-1;P14079;Human T-cell leukemia virus type I;Primate T-lymphotropic virus 1;194440;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, Table 1 and PDB 5IRO;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;5IRO;HLA-A*02:01;I;The crystal structure of a complex of epitope-HLA-A*0201-Ad4 E3-19K was determined by molecular replacement from twinned crystals. There are six copies of the complex in the asymmetric unit.
2882683;1030804;Literature;27638468;"Xiaolong Li; Pedro A Lamothe; Robert Ng; Shutong Xu; Maikun Teng; Bruce D Walker; Jia-Huai Wang";Protein Cell;2016;Crystal structure of HLA-B*5801, a protective HLA allele for HIV-1 infection.;;101990;Linear peptide;QASQEVKNW;308;316;;Gag-Pol polyprotein;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Table S1 and PDB 5IM7;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;5IM7;HLA-B*58:01;I;The crystal structure of the epitope/HLA-B*58:01 was determined. There are two independent molecules in one asymmetric unit.
2882684;1030804;Literature;27638468;"Xiaolong Li; Pedro A Lamothe; Robert Ng; Shutong Xu; Maikun Teng; Bruce D Walker; Jia-Huai Wang";Protein Cell;2016;Crystal structure of HLA-B*5801, a protective HLA allele for HIV-1 infection.;;558159;Linear peptide;QASQDVKNW;309;317;;gag-pol polyprotein;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Table S1 and PDB 5IND;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5IND;HLA-B*58:01;I;The crystal structure of the epitope/HLA-B*58:01 was determined. There are two independent molecules in one asymmetric unit.
2882686;1030804;Literature;27638468;"Xiaolong Li; Pedro A Lamothe; Robert Ng; Shutong Xu; Maikun Teng; Bruce D Walker; Jia-Huai Wang";Protein Cell;2016;Crystal structure of HLA-B*5801, a protective HLA allele for HIV-1 infection.;;558160;Linear peptide;QATQEVANW;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;QASQEVKNW;308;316;;;Gag-Pol polyprotein;Gag-Pol polyprotein;Human immunodeficiency virus 1;Human immunodeficiency virus 1;human (Homo sapiens);9606;Figure 1, Table S1 and PDB 5INC;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;5INC;HLA-B*58:01;I;The crystal structure of the epitope/HLA-B*58:01 was determined. There are two independent molecules in one asymmetric unit.
2883683;1029923;Literature;26764037;"Shugang Yao; Jun Liu; Jianxun Qi; Rong Chen; Nianzhi Zhang; Yanjie Liu; Junya Wang; Yanan Wu; George Fu Gao; Chun Xia";J Immunol;2016;Structural Illumination of Equine MHC Class I Molecules Highlights Unconventional Epitope Presentation Manner That Is Evolved in Equine Leukocyte Antigen Alleles.;;56268;Linear peptide;RVEDVTNTAEYW;195;206;;envelope glycoprotein;envelope polyprotein;9626533;Equine infectious anemia virus (STRAIN WSU5);Equine infectious anemia virus;11665;;;;;;;;;;;;;horse (Equus caballus);9796;Table II, Figures 2, 3 and PDB 4ZUV;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;4ZUV;Eqca-N*00602;I;The crystal structure of the epitope/Eqca-N*00602 complex was determined by molecular replacement. There are two molecules in the asymmetric unit.
2883684;1029923;Literature;26764037;"Shugang Yao; Jun Liu; Jianxun Qi; Rong Chen; Nianzhi Zhang; Yanjie Liu; Junya Wang; Yanan Wu; George Fu Gao; Chun Xia";J Immunol;2016;Structural Illumination of Equine MHC Class I Molecules Highlights Unconventional Epitope Presentation Manner That Is Evolved in Equine Leukocyte Antigen Alleles.;;22467;Linear peptide;GSQKLTTGNCNW;21;32;;gag protein;gag protein;9626531;Equine infectious anemia virus (STRAIN WSU5);Equine infectious anemia virus;11665;;;;;;;;;;;;;horse (Equus caballus);9796;Table II, Figures 2, 3, S2, S3 and PDB 4ZUT;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;4ZUT;Eqca-N*00602;I;The crystal structure of the epitope/Eqca-N*00602 complex was determined by molecular replacement. There is one molecule in the asymmetric unit.
2883685;1029923;Literature;26764037;"Shugang Yao; Jun Liu; Jianxun Qi; Rong Chen; Nianzhi Zhang; Yanjie Liu; Junya Wang; Yanan Wu; George Fu Gao; Chun Xia";J Immunol;2016;Structural Illumination of Equine MHC Class I Molecules Highlights Unconventional Epitope Presentation Manner That Is Evolved in Equine Leukocyte Antigen Alleles.;;50248;Linear peptide;QAEVLQERLEW;87;97;;rev protein;envelope polyprotein;9626533;Equine infectious anemia virus (STRAIN WSU5);Equine infectious anemia virus;11665;;;;;;;;;;;;;horse (Equus caballus);9796;Table II, Figures 2, 3 and PDB 4ZUS;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;4ZUS;Eqca-N*00602;I;The crystal structure of the epitope/Eqca-N*00602 complex was determined by molecular replacement. There is one molecule in the asymmetric unit.
2883686;1029923;Literature;26764037;"Shugang Yao; Jun Liu; Jianxun Qi; Rong Chen; Nianzhi Zhang; Yanjie Liu; Junya Wang; Yanan Wu; George Fu Gao; Chun Xia";J Immunol;2016;Structural Illumination of Equine MHC Class I Molecules Highlights Unconventional Epitope Presentation Manner That Is Evolved in Equine Leukocyte Antigen Alleles.;;22467;Linear peptide;GSQKLTTGNCNW;21;32;;gag protein;gag protein;9626531;Equine infectious anemia virus (STRAIN WSU5);Equine infectious anemia virus;11665;;;;;;;;;;;;;horse (Equus caballus);9796;Table II, Figures 4, 5, S2, S3 and PDB 4ZUW;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;4ZUW;Eqca-N*00601;I;The crystal structure of the epitope/Eqca-N*00601 complex was determined by molecular replacement. There is one molecule in the asymmetric unit.
2883689;1029923;Literature;26764037;"Shugang Yao; Jun Liu; Jianxun Qi; Rong Chen; Nianzhi Zhang; Yanjie Liu; Junya Wang; Yanan Wu; George Fu Gao; Chun Xia";J Immunol;2016;Structural Illumination of Equine MHC Class I Molecules Highlights Unconventional Epitope Presentation Manner That Is Evolved in Equine Leukocyte Antigen Alleles.;;558584;Linear peptide;CTSEEMNAF;172;180;;gag protein;gag protein;9626531;Equine infectious anemia virus (STRAIN WSU5);Equine infectious anemia virus;11665;;;;;;;;;;;;;horse (Equus caballus);9796;Table II, Figures 2, 3, 7 and PDB 4ZUU;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;4ZUU;Eqca-N*00602;I;The crystal structure of the epitope/Eqca-N*00602 complex was determined by molecular replacement. There is one molecule in the asymmetric unit.
2883950;1030787;Literature;27645996;"Emma J Grant; Tracy M Josephs; Sophie A Valkenburg; Linda Wooldridge; Margaret Hellard; Jamie Rossjohn; Mandvi Bharadwaj; Katherine Kedzierska; Stephanie Gras";J Biol Chem;2016;Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct alphabetaT Cell Receptor Signatures.;;7291;Linear peptide;CVNGSCFTV;233;241;;neuraminidase;Neuraminidase;P03468;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 1 and PDB 5SWQ;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5SWQ;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
2885468;1030829;Literature;27717799;"Stephanie Gras; Jesseka Chadderton; Claudia M Del Campo; Carine Farenc; Florian Wiede; Tracy M Josephs; Xavier Y X Sng; Michiko Mirams; Katherine A Watson; Tony Tiganis; Kylie M Quinn; Jamie Rossjohn; Nicole L La Gruta";Immunity;2016;Reversed T Cell Receptor Docking on a Major Histocompatibility Class I Complex Limits Involvement in the Immune Response.;;4602;Linear peptide;ASNENMETM;366;374;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 3, Tables 2, S2 and PDB 5SWZ;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;5SWZ;H2-Db;I;The crystal structure of the epitope/H-2Db complex bound by the NP1-B17 TRBV17+ TCR was determined.
2885469;1030829;Literature;27717799;"Stephanie Gras; Jesseka Chadderton; Claudia M Del Campo; Carine Farenc; Florian Wiede; Tracy M Josephs; Xavier Y X Sng; Michiko Mirams; Katherine A Watson; Tony Tiganis; Kylie M Quinn; Jamie Rossjohn; Nicole L La Gruta";Immunity;2016;Reversed T Cell Receptor Docking on a Major Histocompatibility Class I Complex Limits Involvement in the Immune Response.;;4602;Linear peptide;ASNENMETM;366;374;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 3, Tables 2, S2 and PDB 5SWS;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;5SWS;H2-Db;I;The crystal structure of the epitope/H-2Db complex bound by the NP2-B17 TRBV17+ TCR was determined.
3000566;1031070;Literature;27903649;"David K Cole; Hugo A van den Berg; Angharad Lloyd; Michael D Crowther; Konrad Beck; Julia Ekeruche-Makinde; John J Miles; Anna M Bulek; Garry Dolton; Andrea J Schauenburg; Aaron Wall; Anna Fuller; Mathew Clement; Bruno Laugel; Pierre J Rizkallah; Linda Wooldridge; Andrew K Sewell";J Biol Chem;2017;Structural Mechanism Underpinning Cross-reactivity of a CD8+ T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse Transcriptase.;;179820;Linear peptide;ILAKFLHWL;540;548;;Telomerase reverse transcriptase;Telomerase reverse transcriptase;O14746;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 3 and PDB 5MEN;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;5MEN;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound by the ILA1 TCR was determined.
3000568;1031070;Literature;27903649;"David K Cole; Hugo A van den Berg; Angharad Lloyd; Michael D Crowther; Konrad Beck; Julia Ekeruche-Makinde; John J Miles; Anna M Bulek; Garry Dolton; Andrea J Schauenburg; Aaron Wall; Anna Fuller; Mathew Clement; Bruno Laugel; Pierre J Rizkallah; Linda Wooldridge; Andrew K Sewell";J Biol Chem;2017;Structural Mechanism Underpinning Cross-reactivity of a CD8+ T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse Transcriptase.;;569165;Linear peptide;ILGKFLHRL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;ILAKFLHWL;540;548;;;Telomerase reverse transcriptase;Telomerase reverse transcriptase;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figure 3 and PDB 5MEO;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;5MEO;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
3000569;1031070;Literature;27903649;"David K Cole; Hugo A van den Berg; Angharad Lloyd; Michael D Crowther; Konrad Beck; Julia Ekeruche-Makinde; John J Miles; Anna M Bulek; Garry Dolton; Andrea J Schauenburg; Aaron Wall; Anna Fuller; Mathew Clement; Bruno Laugel; Pierre J Rizkallah; Linda Wooldridge; Andrew K Sewell";J Biol Chem;2017;Structural Mechanism Underpinning Cross-reactivity of a CD8+ T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse Transcriptase.;;569167;Linear peptide;ILGKFLHWL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;ILAKFLHWL;540;548;;;Telomerase reverse transcriptase;Telomerase reverse transcriptase;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figure 3 and PDB 5MEP;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;5MEP;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
3000570;1031070;Literature;27903649;"David K Cole; Hugo A van den Berg; Angharad Lloyd; Michael D Crowther; Konrad Beck; Julia Ekeruche-Makinde; John J Miles; Anna M Bulek; Garry Dolton; Andrea J Schauenburg; Aaron Wall; Anna Fuller; Mathew Clement; Bruno Laugel; Pierre J Rizkallah; Linda Wooldridge; Andrew K Sewell";J Biol Chem;2017;Structural Mechanism Underpinning Cross-reactivity of a CD8+ T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse Transcriptase.;;569164;Linear peptide;ILAKFLHTL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;ILAKFLHWL;540;548;;;Telomerase reverse transcriptase;Telomerase reverse transcriptase;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figure 3 and PDB 5MEQ;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;5MEQ;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
3000571;1031070;Literature;27903649;"David K Cole; Hugo A van den Berg; Angharad Lloyd; Michael D Crowther; Konrad Beck; Julia Ekeruche-Makinde; John J Miles; Anna M Bulek; Garry Dolton; Andrea J Schauenburg; Aaron Wall; Anna Fuller; Mathew Clement; Bruno Laugel; Pierre J Rizkallah; Linda Wooldridge; Andrew K Sewell";J Biol Chem;2017;Structural Mechanism Underpinning Cross-reactivity of a CD8+ T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse Transcriptase.;;569162;Linear peptide;ILAKFLHEL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;ILAKFLHWL;540;548;;;Telomerase reverse transcriptase;Telomerase reverse transcriptase;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figure 3 and PDB 5MER;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;5MER;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
3000619;1031073;Literature;27738054;"William J Liu; Shuguang Tan; Min Zhao; Chuansong Quan; Yuhai Bi; Ying Wu; Shuijun Zhang; Haifeng Zhang; Haixia Xiao; Jianxun Qi; Jinghua Yan; Wenjun Liu; Hongjie Yu; Yuelong Shu; Guizhen Wu; George F Gao";J Infect Dis;2016;Cross-immunity Against Avian Influenza A(H7N9) Virus in the Healthy Population Is Affected by Antigenicity-Dependent Substitutions.;;566921;Linear peptide;TIAMELIRMIK;188;198;;nucleocapsid protein;Nucleoprotein;P03466;Influenza A virus (A/California/07/2009(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 5, Table S3 and PDB 4MJ5;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;4MJ5;HLA-A*11:01;I;The crystal structure of the epitope/HLA-A*11:01 complex was determined by molecular replacement.
3000620;1031073;Literature;27738054;"William J Liu; Shuguang Tan; Min Zhao; Chuansong Quan; Yuhai Bi; Ying Wu; Shuijun Zhang; Haifeng Zhang; Haixia Xiao; Jianxun Qi; Jinghua Yan; Wenjun Liu; Hongjie Yu; Yuelong Shu; Guizhen Wu; George F Gao";J Infect Dis;2016;Cross-immunity Against Avian Influenza A(H7N9) Virus in the Healthy Population Is Affected by Antigenicity-Dependent Substitutions.;;566925;Linear peptide;TMVMELIRMIK;188;198;;nucleocapsid protein;Nucleoprotein;P03466;Influenza A virus (A/Anhui/1-YK_RG64/2013(H7N9));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 5, Table S3 and PDB 4MJ6;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;4MJ6;HLA-A*11:01;I;The crystal structure of the epitope/HLA-A*11:01 complex was determined by molecular replacement.
3001127;1030703;Literature;27511732;"Jin Xiao; Wangzhen Xiang; Yan Chai; Joel Haywood; Jianxun Qi; Limin Ba; Peng Qi; Ming Wang; Jun Liu; George F Gao";J Immunol;2016;Diversified Anchoring Features the Peptide Presentation of DLA-88*50801: First Structural Insight into Domestic Dog MHC Class I.;;176033;Linear peptide;KLFSGELTK;289;297;;lathosterol oxidase;;;Canis lupus familiaris;Canis lupus;9612;;;;;;;;;;;;;dog (Canis lupus familiaris);9615;Figures 1, 2, 3, Table II and PDB 5F11;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;5F1I;DLA-88*50801;I;
3001128;1030703;Literature;27511732;"Jin Xiao; Wangzhen Xiang; Yan Chai; Joel Haywood; Jianxun Qi; Limin Ba; Peng Qi; Ming Wang; Jun Liu; George F Gao";J Immunol;2016;Diversified Anchoring Features the Peptide Presentation of DLA-88*50801: First Structural Insight into Domestic Dog MHC Class I.;;176432;Linear peptide;RFLDKDGFIDK;444;454;;cytochrome P450 1B1;;;Canis lupus familiaris;Canis lupus;9612;;;;;;;;;;;;;dog (Canis lupus familiaris);9615;Figures 1, 2, 3, Table II and PDB 5F1N;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5F1N;DLA-88*50801;I;
3134127;1031337;Literature;28250417;"InYoung Song; Anna Gil; Rabinarayan Mishra; Dario Ghersi; Liisa K Selin; Lawrence J Stern";Nat Struct Mol Biol;2017;"Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8&lt;sup&gt;+&lt;/sup&gt; T cell epitope.";;20354;Linear peptide;GILGFVFTL;58;66;;Matrix protein 1;Matrix protein 1;P03485;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 3, 5, 6, Table 1, Supplementary Figure 5 and PDB 5ISZ;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5ISZ;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02 complex bound by the LS01 TCR was determined.
3134128;1031337;Literature;28250417;"InYoung Song; Anna Gil; Rabinarayan Mishra; Dario Ghersi; Liisa K Selin; Lawrence J Stern";Nat Struct Mol Biol;2017;"Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8&lt;sup&gt;+&lt;/sup&gt; T cell epitope.";;20354;Linear peptide;GILGFVFTL;58;66;;Matrix protein 1;Matrix protein 1;P03485;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 3, 4, 6, Table 1, Supplementary Figure 5 and PDB 5JHD;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;5JHD;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02 complex bound by the LS10 TCR was determined.
3137928;1031463;Literature;28179428;"Soumya G Remesh; Massimo Andreatta; Ge Ying; Thomas Kaever; Morten Nielsen; Curtis McMurtrey; William Hildebrand; Bjoern Peters; Dirk M Zajonc";J Biol Chem;2017;Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.;;437661;Linear peptide;GLKEGIPAL;;;;hypothetical protein;;;Toxoplasma gondii;Toxoplasma gondii;5811;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 4, Table 1 and PDB 5ENW;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;5ENW;HLA-A*02:01;I;The crystal structure of the refolded epitope/HLA-A*02:01 complex was determined.
3137929;1031463;Literature;28179428;"Soumya G Remesh; Massimo Andreatta; Ge Ying; Thomas Kaever; Morten Nielsen; Curtis McMurtrey; William Hildebrand; Bjoern Peters; Dirk M Zajonc";J Biol Chem;2017;Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.;;606261;Linear peptide;GLKEGIPALDN;;;;hypothetical protein;;;Toxoplasma gondii;Toxoplasma gondii;5811;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 4, Table 1 and PDB 5F7D;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;5F7D;HLA-A*02:01;I;The crystal structure of the refolded epitope/HLA-A*02:01 complex was determined.
3137930;1031463;Literature;28179428;"Soumya G Remesh; Massimo Andreatta; Ge Ying; Thomas Kaever; Morten Nielsen; Curtis McMurtrey; William Hildebrand; Bjoern Peters; Dirk M Zajonc";J Biol Chem;2017;Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.;;606262;Linear peptide;GLLPELPAV;;;;hypothetical protein;;;Toxoplasma gondii;Toxoplasma gondii;5811;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 4, Table 1 and PDB 5FA3;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;5FA3;HLA-A*02:01;I;The crystal structure of the refolded epitope/HLA-A*02:01 complex was determined.
3137931;1031463;Literature;28179428;"Soumya G Remesh; Massimo Andreatta; Ge Ying; Thomas Kaever; Morten Nielsen; Curtis McMurtrey; William Hildebrand; Bjoern Peters; Dirk M Zajonc";J Biol Chem;2017;Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.;;606263;Linear peptide;GLLPELPAVGGNE;;;;hypothetical protein;;;Toxoplasma gondii;Toxoplasma gondii;5811;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 4, Table 1 and PDB 5EOT;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5EOT;HLA-A*02:01;I;The crystal structure of the refolded epitope/HLA-A*02:01 complex was determined.
3137932;1031463;Literature;28179428;"Soumya G Remesh; Massimo Andreatta; Ge Ying; Thomas Kaever; Morten Nielsen; Curtis McMurtrey; William Hildebrand; Bjoern Peters; Dirk M Zajonc";J Biol Chem;2017;Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.;;606330;Linear peptide;YLSPIASPL;15;23;;putative 60S ribosomal protein L7a;60S ribosomal protein L7a, putative;B9PIM3;Toxoplasma gondii GT1;Toxoplasma gondii;5811;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 4, Table 1 and PDB 5F9J;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;5F9J;HLA-A*02:01;I;The crystal structure of the refolded epitope/HLA-A*02:01 complex was determined.
3137933;1031463;Literature;28179428;"Soumya G Remesh; Massimo Andreatta; Ge Ying; Thomas Kaever; Morten Nielsen; Curtis McMurtrey; William Hildebrand; Bjoern Peters; Dirk M Zajonc";J Biol Chem;2017;Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.;;547104;Linear peptide;YLSPIASPLL;15;24;;putative 60S ribosomal protein L7a;60S ribosomal protein L7a, putative;B9PIM3;Toxoplasma gondii GT1;Toxoplasma gondii;5811;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 4, Table 1 and PDB 5FDW;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;5FDW;HLA-A*02:01;I;The crystal structure of the refolded epitope/HLA-A*02:01 complex was determined.
3137934;1031463;Literature;28179428;"Soumya G Remesh; Massimo Andreatta; Ge Ying; Thomas Kaever; Morten Nielsen; Curtis McMurtrey; William Hildebrand; Bjoern Peters; Dirk M Zajonc";J Biol Chem;2017;Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.;;547106;Linear peptide;YLSPIASPLLDGKSLR;15;30;;putative 60S ribosomal protein L7a;60S ribosomal protein L7a, putative;B9PIM3;Toxoplasma gondii GT1;Toxoplasma gondii;5811;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 4, Table 1 and PDB 5FA4;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;5FA4;HLA-A*02:01;I;The crystal structure of the refolded epitope/HLA-A*02:01 complex was determined.
3197610;1031302;Literature;28218747;"Phillip Pymm; Patricia T Illing; Sri H Ramarathinam; Geraldine M O'Connor; Victoria A Hughes; Corinne Hitchen; David A Price; Bosco K Ho; Daniel W McVicar; Andrew G Brooks; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian";Nat Struct Mol Biol;2017;MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape.;;602746;Linear peptide;TSNLQEQIGW;231;240;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 5 and PDB 5T70;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5T70;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex bound by the NK cell receptor KIR3DL1 was determined.
3197611;1031302;Literature;28218747;"Phillip Pymm; Patricia T Illing; Sri H Ramarathinam; Geraldine M O'Connor; Victoria A Hughes; Corinne Hitchen; David A Price; Bosco K Ho; Daniel W McVicar; Andrew G Brooks; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian";Nat Struct Mol Biol;2017;MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape.;;602775;Linear peptide;TSTTSVASSW;295;304;;KIAA0173;Tubulin polyglutamylase TTLL4;Q14679;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1 and PDB 5T6X;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;5T6X;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex was determined.
3197612;1031302;Literature;28218747;"Phillip Pymm; Patricia T Illing; Sri H Ramarathinam; Geraldine M O'Connor; Victoria A Hughes; Corinne Hitchen; David A Price; Bosco K Ho; Daniel W McVicar; Andrew G Brooks; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian";Nat Struct Mol Biol;2017;MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape.;;602123;Linear peptide;SSTRGISQLW;153;162;;KIAA0618 protein;Nuclear envelope pore membrane protein POM 121;Q96HA1;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1 and PDB 5T6W;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;5T6W;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex was determined.
3197613;1031302;Literature;28218747;"Phillip Pymm; Patricia T Illing; Sri H Ramarathinam; Geraldine M O'Connor; Victoria A Hughes; Corinne Hitchen; David A Price; Bosco K Ho; Daniel W McVicar; Andrew G Brooks; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian";Nat Struct Mol Biol;2017;MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape.;;127246;Linear peptide;TSTLQEQIGW;240;249;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 1, 5 and PDB 5T6Z;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5T6Z;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex bound by the NK cell receptor KIR3DL1 was determined.
3197614;1031302;Literature;28218747;"Phillip Pymm; Patricia T Illing; Sri H Ramarathinam; Geraldine M O'Connor; Victoria A Hughes; Corinne Hitchen; David A Price; Bosco K Ho; Daniel W McVicar; Andrew G Brooks; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian";Nat Struct Mol Biol;2017;MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape.;;602771;Linear peptide;TSTFEDVKILAF;756;767;;thyroid adenoma-associated protein isoform e;Thyroid adenoma-associated protein;Q6YHU6;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 4 and PDB 5T6Y;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;5T6Y;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex was determined.
3198257;1031507;Literature;28423320;"Guobing Chen; Xinbo Yang; Annette Ko; Xiaoping Sun; Mingming Gao; Yongqing Zhang; Alvin Shi; Roy A Mariuzza; Nan-Ping Weng";Cell Rep;2017;"Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8&lt;sup&gt;+&lt;/sup&gt; TCR Repertoires to Immunodominant Viral Antigens.";;20354;Linear peptide;GILGFVFTL;58;66;;Matrix protein 1;Matrix protein 1;P03485;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 5, 6, Tables S6, S7, S8, S9, S10 and PDB 5EUO;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5EUO;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound by the PF6 TCR was determined.
3198286;1031507;Literature;28423320;"Guobing Chen; Xinbo Yang; Annette Ko; Xiaoping Sun; Mingming Gao; Yongqing Zhang; Alvin Shi; Roy A Mariuzza; Nan-Ping Weng";Cell Rep;2017;"Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8&lt;sup&gt;+&lt;/sup&gt; TCR Repertoires to Immunodominant Viral Antigens.";;20354;Linear peptide;GILGFVFTL;58;66;;Matrix protein 1;Matrix protein 1;P03485;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 5, 6, Table S6 and PDB 5E6I;x-ray crystallography;3D structure;angstroms;Positive;=;4.0;5E6I;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound by the PF8 TCR was determined.
3202000;1030383;Literature;27183389;"David K Cole; Anna M Bulek; Garry Dolton; Andrea J Schauenberg; Barbara Szomolay; William Rittase; Andrew Trimby; Prithiviraj Jothikumar; Anna Fuller; Ania Skowera; Jamie Rossjohn; Cheng Zhu; John J Miles; Mark Peakman; Linda Wooldridge; Pierre J Rizkallah; Andrew K Sewell";J Clin Invest;2016;Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.;;558116;Linear peptide;MVWGPDPLYV;124;133;;DUF5119 domain-containing protein;;;Bacteroides fragilis;Bacteroides fragilis;817;The epitope is an altered peptide ligand selected for binding to the 1E6 TCR, which recognizes the natural ligand ALWGPDPAAA bound to HLA-A*0201.;;;;;;;;;;;;human (Homo sapiens);9606;Figure 6, Supplementary Table S2 and PDB 5N1Y;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;5N1Y;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined. Entry 5N1Y supersedes 5C0H.
3202209;1031127;Literature;27903740;"William J Liu; Jiaming Lan; Kefang Liu; Yao Deng; Yanfeng Yao; Shaolian Wu; Hong Chen; Lingling Bao; Haifeng Zhang; Min Zhao; Qihui Wang; Lingxia Han; Yan Chai; Jianxun Qi; Jincun Zhao; Songdong Meng; Chuan Qin; George F Gao; Wenjie Tan";J Immunol;2017;Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC.;;625112;Linear peptide;SFYAPEPITSL;1190;1200;;spike glycoprotein;spike glycoprotein [Human betacoronavirus 2c EMC/2012];667489389;Middle East respiratory syndrome-related coronavirus;Middle East respiratory syndrome-related coronavirus;1335626;;;;;;;;;;;;;mouse (Mus musculus);10090;Table II, Figure 2 and PDB 5GSV;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5GSV;H2-Kd;I;The crystal structure of the epitope/H-2Kd complex was determined. No electron density was observed for the N-terminal Ser residue of the epitope.
3202213;1031127;Literature;27903740;"William J Liu; Jiaming Lan; Kefang Liu; Yao Deng; Yanfeng Yao; Shaolian Wu; Hong Chen; Lingling Bao; Haifeng Zhang; Min Zhao; Qihui Wang; Lingxia Han; Yan Chai; Jianxun Qi; Jincun Zhao; Songdong Meng; Chuan Qin; George F Gao; Wenjie Tan";J Immunol;2017;Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC.;;628705;Linear peptide;YYSIAPHSI;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;YYSIIPHSI;292;300;;;spike glycoprotein;spike glycoprotein [Human betacoronavirus 2c EMC/2012];Middle East respiratory syndrome-related coronavirus;Middle East respiratory syndrome-related coronavirus;mouse (Mus musculus);10090;Table II, Figure 5 and PDB 5GSR;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;5GSR;H2-Kd;I;The crystal structure of the epitope/H-2Kd complex was determined.
3202222;1031127;Literature;27903740;"William J Liu; Jiaming Lan; Kefang Liu; Yao Deng; Yanfeng Yao; Shaolian Wu; Hong Chen; Lingling Bao; Haifeng Zhang; Min Zhao; Qihui Wang; Lingxia Han; Yan Chai; Jianxun Qi; Jincun Zhao; Songdong Meng; Chuan Qin; George F Gao; Wenjie Tan";J Immunol;2017;Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC.;;616629;Linear peptide;FYAPEPITSL;1191;1200;;spike glycoprotein;spike glycoprotein [Human betacoronavirus 2c EMC/2012];667489389;Middle East respiratory syndrome-related coronavirus;Middle East respiratory syndrome-related coronavirus;1335626;;;;;;;;;;;;;mouse (Mus musculus);10090;Table II, Figures 2, 3 and PDB 5GSX;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;5GSX;H2-Kd;I;The crystal structure of the epitope/H-2Kd complex was determined.
3202228;1031127;Literature;27903740;"William J Liu; Jiaming Lan; Kefang Liu; Yao Deng; Yanfeng Yao; Shaolian Wu; Hong Chen; Lingling Bao; Haifeng Zhang; Min Zhao; Qihui Wang; Lingxia Han; Yan Chai; Jianxun Qi; Jincun Zhao; Songdong Meng; Chuan Qin; George F Gao; Wenjie Tan";J Immunol;2017;Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC.;;628707;Linear peptide;YYSIIPHSI;292;300;;spike glycoprotein;spike glycoprotein [Human betacoronavirus 2c EMC/2012];667489389;Middle East respiratory syndrome-related coronavirus;Middle East respiratory syndrome-related coronavirus;1335626;;;;;;;;;;;;;mouse (Mus musculus);10090;Table II, Figures 2, 3, 5 and PDB 5GR7;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;5GR7;H2-Kd;I;The crystal structure of the epitope/H-2Kd complex was determined.
3202231;1031127;Literature;27903740;"William J Liu; Jiaming Lan; Kefang Liu; Yao Deng; Yanfeng Yao; Shaolian Wu; Hong Chen; Lingling Bao; Haifeng Zhang; Min Zhao; Qihui Wang; Lingxia Han; Yan Chai; Jianxun Qi; Jincun Zhao; Songdong Meng; Chuan Qin; George F Gao; Wenjie Tan";J Immunol;2017;Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC.;;620933;Linear peptide;KYYSIIPHSI;291;300;;spike glycoprotein;spike glycoprotein [Human betacoronavirus 2c EMC/2012];667489389;Middle East respiratory syndrome-related coronavirus;Middle East respiratory syndrome-related coronavirus;1335626;;;;;;;;;;;;;mouse (Mus musculus);10090;Table II, Figure 2 and PDB 5GSB;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;5GSB;H2-Kd;I;The crystal structure of the epitope/H-2Kd complex was determined. No electron density was observed for the N-terminal Lys residue.
3243406;1031690;Literature;28903331;"Fiyaz Mohammed; Daniel H Stones; Angela L Zarling; Carrie R Willcox; Jeffrey Shabanowitz; Kara L Cummings; Donald F Hunt; Mark Cobbold; Victor H Engelhard; Benjamin E Willcox";Oncotarget;2017;The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.;;99844;Linear peptide;RQASLSISV + PHOS(S4);526;534;;Serine/threonine-protein kinase D2;Serine/threonine-protein kinase D2;Q9BZL6;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3, Supplementary Table 1 and PDB 4NNX;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;4NNX;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
3243407;1031690;Literature;28903331;"Fiyaz Mohammed; Daniel H Stones; Angela L Zarling; Carrie R Willcox; Jeffrey Shabanowitz; Kara L Cummings; Donald F Hunt; Mark Cobbold; Victor H Engelhard; Benjamin E Willcox";Oncotarget;2017;The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.;;153878;Linear peptide;RQASLSISV;526;534;;Serine/threonine-protein kinase D2;Serine/threonine-protein kinase D2;Q9BZL6;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3, Supplementary Table 1 and PDB 4NNY;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;4NNY;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
3243408;1031690;Literature;28903331;"Fiyaz Mohammed; Daniel H Stones; Angela L Zarling; Carrie R Willcox; Jeffrey Shabanowitz; Kara L Cummings; Donald F Hunt; Mark Cobbold; Victor H Engelhard; Benjamin E Willcox";Oncotarget;2017;The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.;;624113;Linear peptide;RQASIELPSMAV + PHOS(S4);249;260;;Lymphocyte-specific protein 1;Lymphocyte-specific protein 1;P33241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 4, Supplementary Table 1 and PDB 4NO2;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;4NO2;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
3243410;1031690;Literature;28903331;"Fiyaz Mohammed; Daniel H Stones; Angela L Zarling; Carrie R Willcox; Jeffrey Shabanowitz; Kara L Cummings; Donald F Hunt; Mark Cobbold; Victor H Engelhard; Benjamin E Willcox";Oncotarget;2017;The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.;;624114;Linear peptide;RQASIELPSMAV;249;260;;Lymphocyte-specific protein 1;Lymphocyte-specific protein 1;P33241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 4, Supplementary Table 1 and PDB 4NO0;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;4NO0;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.  The complex was crystallized in the presence of LILRB1 (LIR-1, ILT2), a broadly expressed inhibitory receptor that recognises class I MHC with low affinity. The LILRB1 binding site on HLA-A2 involves the alpha3 and beta2m domains but does not involve the alpha1-alpha2 peptide-binding platform, and peptides crystallised in HLA-A2 are identical in conformation in the presence or absence of LILRB1.
3243411;1031690;Literature;28903331;"Fiyaz Mohammed; Daniel H Stones; Angela L Zarling; Carrie R Willcox; Jeffrey Shabanowitz; Kara L Cummings; Donald F Hunt; Mark Cobbold; Victor H Engelhard; Benjamin E Willcox";Oncotarget;2017;The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.;;624135;Linear peptide;RQISQDVKL + PHOS(S4);165;173;;AMP deaminase 2;AMP deaminase 2;Q01433;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 5, Supplementary Table 1 and PDB 4NO3;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;4NO3;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
3243412;1031690;Literature;28903331;"Fiyaz Mohammed; Daniel H Stones; Angela L Zarling; Carrie R Willcox; Jeffrey Shabanowitz; Kara L Cummings; Donald F Hunt; Mark Cobbold; Victor H Engelhard; Benjamin E Willcox";Oncotarget;2017;The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.;;577006;Linear peptide;RQISQDVKL;165;173;;AMP deaminase 2;AMP deaminase 2;Q01433;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 5, Supplementary Table 1 and PDB 4NO5;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;4NO5;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
3264733;1031696;Literature;27920218;"Ad&aacute;n Alp&iacute;zar; Fabio Marino; Antonio Ramos-Fern&aacute;ndez; Manuel Lombard&iacute;a; Anita Jeko; Florencio Pazos; Alberto Paradela; C&eacute;sar Santiago; Albert J R Heck; Miguel Marcilla";Mol Cell Proteomics;2017;A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens.;;223677;Linear peptide;REFSKEPEL;47;55;;Inner centromere protein;Inner centromere protein;Q9NQS7;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table II, Figures 4, 5 and PDB 5EIK;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;5IEK;HLA-B*40:02;I;The crystal structure of the epitope in complex with HLA-B*40:02 was determined.
3270288;1031696;Literature;27920218;"Ad&aacute;n Alp&iacute;zar; Fabio Marino; Antonio Ramos-Fern&aacute;ndez; Manuel Lombard&iacute;a; Anita Jeko; Florencio Pazos; Alberto Paradela; C&eacute;sar Santiago; Albert J R Heck; Miguel Marcilla";Mol Cell Proteomics;2017;A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens.;;610784;Linear peptide;REFSKEPEL + PHOS(S4);47;55;;inner centromere protein INCENP;Inner centromere protein;Q9NQS7;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table II, Figures 4, 5 and PDB 5EIH;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;5IEH;HLA-B*40:02;I;The crystal structure of the epitope in complex with HLA-B*40:02 was determined.
3338675;1031716;Literature;28552904;"Xiaolong Li; Pedro A Lamothe; Bruce D Walker; Jia-Huai Wang";Cell Mol Immunol;2017;Crystal structure of HLA-B*5801 with a TW10 HIV Gag epitope reveals a novel mode of peptide presentation.;;127246;Linear peptide;TSTLQEQIGW;240;249;;Gag-Pol polyprotein;Gag-Pol polyprotein;P04585;HIV-1 M:B_HXB2R;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Table S1 and PDB 5V5L;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5V5L;HLA-B*58:01;I;The crystal structure of the epitope/HLA-B*58:01 complex was determined.
3338676;1031716;Literature;28552904;"Xiaolong Li; Pedro A Lamothe; Bruce D Walker; Jia-Huai Wang";Cell Mol Immunol;2017;Crystal structure of HLA-B*5801 with a TW10 HIV Gag epitope reveals a novel mode of peptide presentation.;;127246;Linear peptide;TSTLQEQIGW;240;249;;Gag-Pol polyprotein;Gag-Pol polyprotein;P04585;HIV-1 M:B_HXB2R;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Table S1 and PDB 5V5M;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;5V5M;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex was determined.
3339205;1031770;Literature;28572406;"Yuan Wang; Nishant K Singh; Timothy T Spear; Lance M Hellman; Kurt H Piepenbrink; Rachel H McMahan; Hugo R Rosen; Craig W Vander Kooi; Michael I Nishimura; Brian M Baker";Proc Natl Acad Sci U S A;2017;How an alloreactive T-cell receptor achieves peptide and MHC specificity.;;32208;Linear peptide;KLVALGINAV;198;207;;NS3 gene product;Genome polyprotein;P27958;Hepacivirus C;Hepacivirus C;11103;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 2 and PDB 5JZI;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;5JZI;HLA-A*02:01;I;The crystal structure of the epitope/A2 complex bound by the 1406 TCR was determined.
3341545;1031830;Literature;28686208;"Daniel Yerly; Yuri Andreiw Pompeu; Ryan J Schutte; Klara K Eriksson; Anette Strhyn; Austin W Bracey; Soren Buus; David A Ostrov";Int J Mol Sci;2017;Structural Elements Recognized by Abacavir-Induced T Cells.;;176751;Linear peptide;VTTDIQVKV;980;988;;Transcription elongation factor SPT5;Transcription elongation factor SPT5;O00267;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1 and PDB 5U98;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5U98;HLA-B*57:01;I;"The crystal structure of self peptide VTTDIQVKV (SPT5a 976&ndash;984) complexed to abacavir and HLA-B*57:01 was determined by molecular replacement."
3341546;1031830;Literature;28686208;"Daniel Yerly; Yuri Andreiw Pompeu; Ryan J Schutte; Klara K Eriksson; Anette Strhyn; Austin W Bracey; Soren Buus; David A Ostrov";Int J Mol Sci;2017;Structural Elements Recognized by Abacavir-Induced T Cells.;;137341;Non-peptidic;abacavir;;;CHEBI_421707;;;;;;;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1 and PDB 5U98;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5U98;HLA-B*57:01;I;"The crystal structure of self peptide VTTDIQVKV (SPT5a 976&ndash;984) complexed to abacavir and HLA-B*57:01 was determined by molecular replacement."
3350944;1031827;Literature;28508865;"Kannan Natarajan; Andrew C McShan; Jiansheng Jiang; Vlad K Kumirov; Rui Wang; Huaying Zhao; Peter Schuck; Mulualem E Tilahun; Lisa F Boyd; Jinfa Ying; Ad Bax; David H Margulies; Nikolaos G Sgourakis";Nat Commun;2017;An allosteric site in the T-cell receptor Cbeta domain plays a critical signalling role.;;53935;Linear peptide;RGPGRAFVTI;311;320;;Envelope glycoprotein gp160 precursor;Envelope glycoprotein gp160;P04578;HIV-1 M:B_HXB2R;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;mouse (Mus musculus);10090;Table 1, Figure 2 and PDB 5IVX;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5IVX;H2-Db;I;The crystal structure of the epitope/H-2Db complex bound by the B4.2.3 TCR was determined.
3466587;1031919;Literature;28698575;"Ziwei Xiao; Zhiyong Ye; Vikeramjeet Singh Tadwal; Meixin Shen; Ee Chee Ren";Sci Rep;2017;Dual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens.;;60930;Linear peptide;SSCSSCPLSK;208;217;;Latent membrane protein 2;Latent membrane protein 2;P13285;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Supplementary Table 2, Figures 6, 7, Supplementary Figure 7 and PDB 5GRD;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;5GRD;HLA-A*11:01;I;The crystal structure of the epitope in complex with HLA-A*11:01 was determined.
3466589;1031919;Literature;28698575;"Ziwei Xiao; Zhiyong Ye; Vikeramjeet Singh Tadwal; Meixin Shen; Ee Chee Ren";Sci Rep;2017;Dual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens.;;682137;Linear peptide;SSCPLSK;211;217;;Latent membrane protein 2;Latent membrane protein 2;P13285;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Supplementary Table 3, Figures 6, 7, Supplementary Figure 7 and PDB 5GSD;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;5GSD;HLA-A*11:01;I;The crystal structure of the epitope in complex with HLA-A*11:01 was determined.
3466597;1031919;Literature;28698575;"Ziwei Xiao; Zhiyong Ye; Vikeramjeet Singh Tadwal; Meixin Shen; Ee Chee Ren";Sci Rep;2017;Dual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens.;;688636;Discontinuous peptide on multi chain;"C: S208, S209, C210, S211, S212, C213; D: S211, S212, C213, P214, L215, S216, K217";;;Q69135;;Latent membrane protein 2;P13285;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Supplementary Table 4, Figure 6, Supplementary Figure 7 and PDB 5GRG;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;5GRG;HLA-A*11:01;I;The crystal structure of HLA-A*11:01 in complex with two overlapping peptides, SSCSSC + SSCPLSK, was determined.
3473792;1032115;Literature;28649982;"Gurman Kaur; Stephanie Gras; Jesse I Mobbs; Julian P Vivian; Adrian Cortes; Thomas Barber; Subita Balaram Kuttikkatte; Lise Torp Jensen; Kathrine E Attfield; Calliope A Dendrou; Mary Carrington; Gil McVean; Anthony W Purcell; Jamie Rossjohn; Lars Fugger";Nat Commun;2017;Structural and regulatory diversity shape HLA-C protein expression levels.;;692175;Linear peptide;SAEPVPLQL;67;75;;Protein Rev;Protein Rev;P04618;Human immunodeficiency virus type 1 BH10;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Table 1, Figures 5, 6 and PDB 5VGD;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;5VGD;HLA-C*05:01;I;The crystal structure of the epitope in complex with HLA-C*05:01:01:01 was determined.
3473798;1032115;Literature;28649982;"Gurman Kaur; Stephanie Gras; Jesse I Mobbs; Julian P Vivian; Adrian Cortes; Thomas Barber; Subita Balaram Kuttikkatte; Lise Torp Jensen; Kathrine E Attfield; Calliope A Dendrou; Mary Carrington; Gil McVean; Anthony W Purcell; Jamie Rossjohn; Lars Fugger";Nat Commun;2017;Structural and regulatory diversity shape HLA-C protein expression levels.;;448090;Linear peptide;RYRPGTVAL;41;49;;Histone H3.1;Histone H3.1;P68431;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Table 1, Figures 5, 6 and PDB 5VGE;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;5VGE;HLA-C*07:02;I;The crystal structure of the epitope in complex with HLA-C*07:02:01:03 was determined.
3476980;1032119;Literature;28855257;"Jesse I Mobbs; Patricia T Illing; Nadine L Dudek; Andrew G Brooks; Daniel G Baker; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian";J Biol Chem;2017;The molecular basis for peptide repertoire selection in the human leucocyte antigen (HLA) C*06:02 molecule.;;490583;Linear peptide;ARTELYRSL;539;547;;Protein AATF;Protein AATF;Q9NY61;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3 and PDB 5W6A;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;5W6A;HLA-C*06:02;I;The crystal structure of the epitope in complex with HLA-C*06:02 was determined. There are two complexes in the asymmetric unit.
3476981;1032119;Literature;28855257;"Jesse I Mobbs; Patricia T Illing; Nadine L Dudek; Andrew G Brooks; Daniel G Baker; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian";J Biol Chem;2017;The molecular basis for peptide repertoire selection in the human leucocyte antigen (HLA) C*06:02 molecule.;;614198;Linear peptide;ARFNDLRFV;133;141;;Runt-related transcription factor 3;Runt-related transcription factor 3;Q13761;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 4 and PDB 5W69;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;5W69;HLA-C*06:02;I;The crystal structure of the epitope in complex with HLA-C*06:02 was determined. There are four complexes in the asymmetric unit.
3477181;1032129;Literature;28655516;"Pengcheng Wei; Yi Yang; Zhaoxin Liu; Zuoqin Luo; Wenya Tu; Junyan Han; Yunhua Deng; Lei Yin";J Invest Dermatol;2017;Characterization of Autoantigen Presentation by HLA-C*06:02 in Psoriasis.;;489841;Linear peptide;VRSRRCLRL;57;65;;ADAMTSL5 protein, partial;ADAMTS-like protein 5;Q6ZMM2;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Supplemental Tables S2, S3 and PDB 5XS3;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;5XS3;HLA-C*06:02;I;The crystal structure of the epitope in complex with HLA-C*06:02 was determined.
3477288;1032127;Literature;21937447;"Francis K Insaidoo; Oleg Y Borbulevych; Moushumi Hossain; Sujatha M Santhanagopolan; Tiffany K Baxter; Brian M Baker";J Biol Chem;2011;Loss of T cell antigen recognition arising from changes in peptide and major histocompatibility complex protein flexibility: implications for vaccine design.;;155;Linear peptide;AAGIGILTV;27;35;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Q16655;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3 and PDB 3QFD;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;3QFD;HLA-A*02:01;I;The crystal structure of the epitope in complex with HLA-A*0201 was determined. There are two complexes in the asymmetric unit. The conformation of the epitope in complex with HLA-A*02 was analyzed by NMR and compared to the binding of peptide ALGIGILTV with HLA-A*02. The ALG nonamer showed two distinct peaks compared to one peak for the epitope, indicating greater conformational heterogeneity for the center of ALG when bound to HLA-A*02.
3477370;1032160;Literature;28903331;"Fiyaz Mohammed; Daniel H Stones; Angela L Zarling; Carrie R Willcox; Jeffrey Shabanowitz; Kara L Cummings; Donald F Hunt; Mark Cobbold; Victor H Engelhard; Benjamin E Willcox";Oncotarget;2017;The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.;;99844;Linear peptide;RQASLSISV + PHOS(S4);526;534;;Serine/threonine-protein kinase D2;Serine/threonine-protein kinase D2;Q9BZL6;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3, 6, Supplementary Table 1 and PDB 4NNX;x-ray crystallography;3D structure;angstroms;Positive;;2.1;4NNX;HLA-A*02:01;I;The crystal structure of the epitope in complex with HLA-A*02:01 was determined.
3477373;1032160;Literature;28903331;"Fiyaz Mohammed; Daniel H Stones; Angela L Zarling; Carrie R Willcox; Jeffrey Shabanowitz; Kara L Cummings; Donald F Hunt; Mark Cobbold; Victor H Engelhard; Benjamin E Willcox";Oncotarget;2017;The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.;;153878;Linear peptide;RQASLSISV;526;534;;Serine/threonine-protein kinase D2;Serine/threonine-protein kinase D2;Q9BZL6;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 3, 6, Supplementary Table 1 and PDB 4NNY;x-ray crystallography;3D structure;angstroms;Positive;;1.9;4NNY;HLA-A*02:01;I;The crystal structure of the epitope in complex with HLA-A*02:01 was determined.
3477374;1032160;Literature;28903331;"Fiyaz Mohammed; Daniel H Stones; Angela L Zarling; Carrie R Willcox; Jeffrey Shabanowitz; Kara L Cummings; Donald F Hunt; Mark Cobbold; Victor H Engelhard; Benjamin E Willcox";Oncotarget;2017;The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.;;624113;Linear peptide;RQASIELPSMAV + PHOS(S4);249;260;;Lymphocyte-specific protein 1;Lymphocyte-specific protein 1;P33241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 4, Supplementary Tables 1, 2  and PDB 4NO2;x-ray crystallography;3D structure;angstroms;Positive;;2.0;4NO2;HLA-A*02:01;I;The crystal structure of the epitope in complex with HLA-A*02:01 was determined.
3477375;1032160;Literature;28903331;"Fiyaz Mohammed; Daniel H Stones; Angela L Zarling; Carrie R Willcox; Jeffrey Shabanowitz; Kara L Cummings; Donald F Hunt; Mark Cobbold; Victor H Engelhard; Benjamin E Willcox";Oncotarget;2017;The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.;;624114;Linear peptide;RQASIELPSMAV;249;260;;Lymphocyte-specific protein 1;Lymphocyte-specific protein 1;P33241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 4, 6, Supplementary Tables 1, 2 and PDB 4NO0;x-ray crystallography;3D structure;angstroms;Positive;;2.7;4NO0;HLA-A*02:01;I;The crystal structure of the epitope in complex with HLA-A*02:01 was determined. To obtain crystals, the complex was co-crystallized in the presence of LILRB1 (LIR-1, ILT2), a broadly expressed inhibitory receptor that recognizes class I MHC with low affinity and does not involve the alpha1-alpha2 peptide-binding platform.
3477376;1032160;Literature;28903331;"Fiyaz Mohammed; Daniel H Stones; Angela L Zarling; Carrie R Willcox; Jeffrey Shabanowitz; Kara L Cummings; Donald F Hunt; Mark Cobbold; Victor H Engelhard; Benjamin E Willcox";Oncotarget;2017;The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.;;624135;Linear peptide;RQISQDVKL + PHOS(S4);165;173;;AMP deaminase 2;AMP deaminase 2;Q01433;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 5, Supplementary Table 1 and PDB 4NO3;x-ray crystallography;3D structure;angstroms;Positive;;1.7;4NO3;HLA-A*02:01;I;The crystal structure of the epitope in complex with HLA-A*02:01 was determined.
3478292;1032160;Literature;28903331;"Fiyaz Mohammed; Daniel H Stones; Angela L Zarling; Carrie R Willcox; Jeffrey Shabanowitz; Kara L Cummings; Donald F Hunt; Mark Cobbold; Victor H Engelhard; Benjamin E Willcox";Oncotarget;2017;The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.;;577006;Linear peptide;RQISQDVKL;165;173;;AMP deaminase 2;AMP deaminase 2;Q01433;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, 5, 6, Supplementary Table 1 and PDB 4NO5;x-ray crystallography;3D structure;angstroms;Positive;;2.1;4NO5;HLA-A*02:01;I;The crystal structure of the epitope in complex with HLA-A*02:01 was determined.
3480514;1032119;Literature;28855257;"Jesse I Mobbs; Patricia T Illing; Nadine L Dudek; Andrew G Brooks; Daniel G Baker; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian";J Biol Chem;2017;The molecular basis for peptide repertoire selection in the human leucocyte antigen (HLA) C*06:02 molecule.;;693021;Linear peptide;VRSRRALRL + AIB(C6) + AIB(A6);;;;;;;;;;The epitope is an analogue of a melanocyte auto-antigen (VRSRR-abu-LRL of ADAMTSL5) where an alpha-aminobutyric acid residue (abu) is substituted in place of cysteine in the P6 position.;analog;Fragment of a Natural Sequence Molecule;VRSRRCLRL;57;65;;;ADAMTSL5 protein, partial;ADAMTS-like protein 5;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figures 2, 5 and PDB 5W67;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;5W67;HLA-C*06:02;I;The crystal structure of the epitope in complex with HLA-C*06:02 was determined. There is one complex in the asymmetric unit.
3480551;1032126;Literature;21683626;"Lei Yin; Eric Huseby; James Scott-Browne; Kira Rubtsova; Clamencia Pinilla; Frances Crawford; Philippa Marrack; Shaodong Dai; John W Kappler";Immunity;2011;A single T cell receptor bound to major histocompatibility complex class I and class II glycoproteins reveals switchable TCR conformers.;;696969;Linear peptide;WIYVYRPM;;;;;;;;;;;mimotope;Fragment of a Natural Sequence Molecule;FEAQGALANIAVD;53;65;;;H-2 class II histocompatibility antigen, E-U alpha chain;H-2 class II histocompatibility antigen, E-U alpha chain;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Figure 2, Table S1 and PDB 3RGV;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;3RGV;H2-Kb;I;"The crystal structure of the epitope bound to H-2Kb was determined. The pWM epitope was expressed covalently linked to the N-terminus of &szlig;2m via a flexible linker (GCGGS)."
3563386;1032278;Literature;28931605;"Xinbo Yang; Guobing Chen; Nan-Ping Weng; Roy A Mariuzza";J Biol Chem;2017;Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.;;20354;Linear peptide;GILGFVFTL;58;66;;Matrix protein 1;Matrix protein 1;P03485;Influenza A virus;Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3, 4 and PDB 5TEZ;x-ray crystallography;3D structure;angstroms;Positive;;1.7;5TEZ;HLA-A*02:01;I;The crystal structure of the epitope in complex with HLA-A*02:01 and bound by the F50 TCR was determined.
3563415;1032274;Literature;28945243;"Abigail Culshaw; Kristin Ladell; Stephanie Gras; James E McLaren; Kelly L Miners; Carine Farenc; Heleen van den Heuvel; Emma Gostick; Wanwisa Dejnirattisai; Apirath Wangteeraprasert; Thaneeya Duangchinda; Pojchong Chotiyarnwong; Wannee Limpitikul; Sirijitt Vasanawathana; Prida Malasit; Tao Dong; Jamie Rossjohn; Juthathip Mongkolsapaya; David A Price; Gavin R Screaton";Nat Immunol;2017;"Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8&lt;sup&gt;+&lt;/sup&gt; T cell response.";;22825;Linear peptide;GTSGSPIVNR;133;142;;nonstructural protein 3;Genome polyprotein;P17763;Dengue virus 1;Dengue virus;12637;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Table 2 and PDB 5WJL;x-ray crystallography;3D structure;angstroms;Positive;=;3.2;5WJL;HLA-A*11:01;I;The crystal structure of the epitope in complex with HLA-A*11:01 was determined.
3563416;1032274;Literature;28945243;"Abigail Culshaw; Kristin Ladell; Stephanie Gras; James E McLaren; Kelly L Miners; Carine Farenc; Heleen van den Heuvel; Emma Gostick; Wanwisa Dejnirattisai; Apirath Wangteeraprasert; Thaneeya Duangchinda; Pojchong Chotiyarnwong; Wannee Limpitikul; Sirijitt Vasanawathana; Prida Malasit; Tao Dong; Jamie Rossjohn; Juthathip Mongkolsapaya; David A Price; Gavin R Screaton";Nat Immunol;2017;"Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8&lt;sup&gt;+&lt;/sup&gt; T cell response.";;22825;Linear peptide;GTSGSPIVNR;133;142;;nonstructural protein 3;Genome polyprotein;P17763;Dengue virus 1;Dengue virus;12637;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 3, 4, Table 2 and PDB 5WKF;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;5WKF;HLA-A*11:01;I;The crystal structure of the epitope in complex with HLA-A*11:01 and bound by the D30 TCR was determined.
3563417;1032274;Literature;28945243;"Abigail Culshaw; Kristin Ladell; Stephanie Gras; James E McLaren; Kelly L Miners; Carine Farenc; Heleen van den Heuvel; Emma Gostick; Wanwisa Dejnirattisai; Apirath Wangteeraprasert; Thaneeya Duangchinda; Pojchong Chotiyarnwong; Wannee Limpitikul; Sirijitt Vasanawathana; Prida Malasit; Tao Dong; Jamie Rossjohn; Juthathip Mongkolsapaya; David A Price; Gavin R Screaton";Nat Immunol;2017;"Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8&lt;sup&gt;+&lt;/sup&gt; T cell response.";;22820;Linear peptide;GTSGSPIINR;133;142;;Nonstructural protein NS3;Genome polyprotein;P17763;Dengue virus 3;Dengue virus;12637;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Table 2 and PDB 5WJN;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;5WJN;HLA-A*11:01;I;The crystal structure of the epitope in complex with HLA-A*11:01 was determined.
3563419;1032274;Literature;28945243;"Abigail Culshaw; Kristin Ladell; Stephanie Gras; James E McLaren; Kelly L Miners; Carine Farenc; Heleen van den Heuvel; Emma Gostick; Wanwisa Dejnirattisai; Apirath Wangteeraprasert; Thaneeya Duangchinda; Pojchong Chotiyarnwong; Wannee Limpitikul; Sirijitt Vasanawathana; Prida Malasit; Tao Dong; Jamie Rossjohn; Juthathip Mongkolsapaya; David A Price; Gavin R Screaton";Nat Immunol;2017;"Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8&lt;sup&gt;+&lt;/sup&gt; T cell response.";;22820;Linear peptide;GTSGSPIINR;133;142;;Nonstructural protein NS3;Genome polyprotein;P17763;Dengue virus 3;Dengue virus;12637;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 3, 4, Table 2 and PDB 5WKH;x-ray crystallography;3D structure;angstroms;Positive;=;3.2;5WKH;HLA-A*11:01;I;The crystal structure of the epitope in complex with HLA-A*11:01 and bound by the D30 TCR was determined.
3786311;1032350;Literature;29025991;"Jiansheng Jiang; Kannan Natarajan; Lisa F Boyd; Giora I Morozov; Michael G Mage; David H Margulies";Science;2017;Crystal structure of a TAPBPR-MHC I complex reveals the mechanism of peptide editing in antigen presentation.;;735128;Linear peptide;RGPGC;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;RGPGR;316;320;;;Envelope glycoprotein gp160 precursor;Envelope glycoprotein gp160;Human immunodeficiency virus 1;Human immunodeficiency virus 1;mouse (Mus musculus);10090;Figure 2, S3, Table S2 and PDB 5WES;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;5WES;H2-Dd;I;The crystal structure of the epitope in complex with H-2-Dd was determined. The epitope was disulfide linked to the H-2-Dd heavy chain through mutated residue S73C.
3786911;1032350;Literature;29025991;"Jiansheng Jiang; Kannan Natarajan; Lisa F Boyd; Giora I Morozov; Michael G Mage; David H Margulies";Science;2017;Crystal structure of a TAPBPR-MHC I complex reveals the mechanism of peptide editing in antigen presentation.;;735129;Linear peptide;RGPGCA;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;RGPGRA;316;321;;;Envelope glycoprotein gp160 precursor;Envelope glycoprotein gp160;Human immunodeficiency virus 1;Human immunodeficiency virus 1;mouse (Mus musculus);10090;Figure S3, Table S2 and PDB 5WET;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;5WET;H2-Dd;I;The crystal structure of the epitope in complex with H-2-Dd was determined. The epitope was disulfide linked to the H-2-Dd heavy chain through mutated residue S73C.
3786912;1032350;Literature;29025991;"Jiansheng Jiang; Kannan Natarajan; Lisa F Boyd; Giora I Morozov; Michael G Mage; David H Margulies";Science;2017;Crystal structure of a TAPBPR-MHC I complex reveals the mechanism of peptide editing in antigen presentation.;;735130;Linear peptide;RGPGCAFVTI;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;RGPGRAFVTI;316;325;;;Envelope glycoprotein gp160 precursor;Envelope glycoprotein gp160;Human immunodeficiency virus 1;Human immunodeficiency virus 1;mouse (Mus musculus);10090;Figure S3, Table S2 and PDB 5WEU;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;5WEU;H2-Dd;I;The crystal structure of the epitope in complex with H-2-Dd was determined. The epitope was disulfide linked to the H-2-Dd heavy chain through mutated residue S73C.
3788008;1032454;Literature;28975614;"Amandine Bovay; Vincent Zoete; Garry Dolton; Anna M Bulek; David K Cole; Pierre J Rizkallah; Anna Fuller; Konrad Beck; Olivier Michielin; Daniel E Speiser; Andrew K Sewell; Silvia A Fuertes Marraco";Eur J Immunol;2018;T cell receptor alpha variable 12-2 bias in the immunodominant response to Yellow fever virus.;;121572;Linear peptide;LLWNGPMAV;214;222;;non-structural protein NS4b;Genome polyprotein;P03314;Yellow fever virus;Yellow fever virus;11089;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 4 and PDB 5N6B;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;5N6B;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex was determined.
3794639;1032576;Literature;29209312;"David K Cole; Anna Fuller; Garry Dolton; Efthalia Zervoudi; Mateusz Legut; Kim Miles; Lori Blanchfield; Florian Madura; Christopher J Holland; Anna M Bulek; John S Bridgeman; John J Miles; Andrea J A Schauenburg; Konrad Beck; Brian D Evavold; Pierre J Rizkallah; Andrew K Sewell";Front Immunol;2017;Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope.;;59613;Linear peptide;SLYNTVATL;77;85;;Gag polyprotein;Gag polyprotein;P04591;HIV-1 M:B_HXB2R;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 4 and PDB 5NME;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;5NME;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex bound by the 868 TCR was determined, solved by molecular replacement.
3794640;1032576;Literature;29209312;"David K Cole; Anna Fuller; Garry Dolton; Efthalia Zervoudi; Mateusz Legut; Kim Miles; Lori Blanchfield; Florian Madura; Christopher J Holland; Anna M Bulek; John S Bridgeman; John J Miles; Andrea J A Schauenburg; Konrad Beck; Brian D Evavold; Pierre J Rizkallah; Andrew K Sewell";Front Immunol;2017;Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope.;;189288;Linear peptide;SLYNTIATL;77;85;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 4 and PDB 5NMF;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;5NMF;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex bound by the 868 TCR was determined, solved by molecular replacement.
3794641;1032576;Literature;29209312;"David K Cole; Anna Fuller; Garry Dolton; Efthalia Zervoudi; Mateusz Legut; Kim Miles; Lori Blanchfield; Florian Madura; Christopher J Holland; Anna M Bulek; John S Bridgeman; John J Miles; Andrea J A Schauenburg; Konrad Beck; Brian D Evavold; Pierre J Rizkallah; Andrew K Sewell";Front Immunol;2017;Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope.;;189277;Linear peptide;SLFNTIAVL;77;85;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 4 and PDB 5NMG;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;5NMG;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex bound by the 868 TCR was determined, solved by molecular replacement.
3794642;1032576;Literature;29209312;"David K Cole; Anna Fuller; Garry Dolton; Efthalia Zervoudi; Mateusz Legut; Kim Miles; Lori Blanchfield; Florian Madura; Christopher J Holland; Anna M Bulek; John S Bridgeman; John J Miles; Andrea J A Schauenburg; Konrad Beck; Brian D Evavold; Pierre J Rizkallah; Andrew K Sewell";Front Immunol;2017;Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope.;;189288;Linear peptide;SLYNTIATL;77;85;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 4 and PDB 5NMH;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;5NMH;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined, solved by molecular replacement.
3794643;1032576;Literature;29209312;"David K Cole; Anna Fuller; Garry Dolton; Efthalia Zervoudi; Mateusz Legut; Kim Miles; Lori Blanchfield; Florian Madura; Christopher J Holland; Anna M Bulek; John S Bridgeman; John J Miles; Andrea J A Schauenburg; Konrad Beck; Brian D Evavold; Pierre J Rizkallah; Andrew K Sewell";Front Immunol;2017;Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope.;;189277;Linear peptide;SLFNTIAVL;77;85;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 4 and PDB 5NMK;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;5NMK;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A2 complex was determined, solved by molecular replacement.
3795943;1032664;Literature;29253009;"Ida Hafstrand; Daniel Badia-Martinez; Benjamin John Josey; Melissa Norstr&ouml;m; J&eacute;r&eacute;mie Buratto; Sara Pellegrino; Adil Doganay Duru; Tatyana Sandalova; Adnane Achour";PLoS One;2017;Crystal structures of H-2Db in complex with the LCMV-derived peptides GP92 and GP392 explain pleiotropic effects of glycosylation on antigen presentation and immunogenicity.;;6972;Linear peptide;CSANNSHHYI;92;101;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;P09991;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;11623;;;;;;;;;;;;;mouse (Mus musculus);10090;Figires 1, 2, 3, S2, Table 1 and PDB 5JWE;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;5JWE;H2-Db;I;The crystal structure of the epitope/H-2Db complex was solved by molecular replacement. There are four complexes in the asymmetric unit.
3795944;1032664;Literature;29253009;"Ida Hafstrand; Daniel Badia-Martinez; Benjamin John Josey; Melissa Norstr&ouml;m; J&eacute;r&eacute;mie Buratto; Sara Pellegrino; Adil Doganay Duru; Tatyana Sandalova; Adnane Achour";PLoS One;2017;Crystal structures of H-2Db in complex with the LCMV-derived peptides GP92 and GP392 explain pleiotropic effects of glycosylation on antigen presentation and immunogenicity.;;72826;Linear peptide;WLVTNGSYL;392;400;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;P09991;Lymphocytic choriomeningitis mammarenavirus;Lymphocytic choriomeningitis mammarenavirus;11623;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 1, 2, 3, S2, Table 1 and PDB 5JWD;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;5JWD;H2-Db;I;The crystal structure of the epitope/H-2Db complex was solved by molecular replacement. There is one complex in the asymmetric unit.
3799133;1032804;Literature;28615212;"Yi Shi; Ai Kawana-Tachikawa; Feng Gao; Jianxun Qi; Chuansheng Liu; Jia Gao; Hao Cheng; Takamasa Ueno; Aikichi Iwamoto; George F Gao";J Virol;2017;Conserved Vdelta1 Binding Geometry in a Setting of Locus-Disparate pHLA Recognition by delta/alphabeta T Cell Receptors (TCRs): Insight into Recognition of HIV Peptides by TCRs.;;56620;Linear peptide;RYPLTFGWCF;134;143;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1 and PDB 5XOV;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;5XOV;HLA-A*24:02;I;The crystal structure of the epitope/HLA-A*24:02 complex bound by the S19-2 TCR was determined.
3799136;1032804;Literature;28615212;"Yi Shi; Ai Kawana-Tachikawa; Feng Gao; Jianxun Qi; Chuansheng Liu; Jia Gao; Hao Cheng; Takamasa Ueno; Aikichi Iwamoto; George F Gao";J Virol;2017;Conserved Vdelta1 Binding Geometry in a Setting of Locus-Disparate pHLA Recognition by delta/alphabeta T Cell Receptors (TCRs): Insight into Recognition of HIV Peptides by TCRs.;;27943;Linear peptide;IPLTEEAEL;392;400;;pol protein;Gag-Pol polyprotein;P18096;Human immunodeficiency virus 2;Human immunodeficiency virus 2;11709;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1 and PDB 5XOT;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;5XOT;HLA-B*35:01;I;The crystal structure of the epitope/HLA-A*35:01 complex bound by the TU55-2 TCR was determined.
3799143;1032804;Literature;28615212;"Yi Shi; Ai Kawana-Tachikawa; Feng Gao; Jianxun Qi; Chuansheng Liu; Jia Gao; Hao Cheng; Takamasa Ueno; Aikichi Iwamoto; George F Gao";J Virol;2017;Conserved Vdelta1 Binding Geometry in a Setting of Locus-Disparate pHLA Recognition by delta/alphabeta T Cell Receptors (TCRs): Insight into Recognition of HIV Peptides by TCRs.;;27943;Linear peptide;IPLTEEAEL;392;400;;pol protein;Gag-Pol polyprotein;P18096;Human immunodeficiency virus 2;Human immunodeficiency virus 2;11709;;;;;;;;;;;;;human (Homo sapiens);9606;PDB 5XOS;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;5XOS;HLA-B*35:01;I;The crystal structure of the epitope/HLA-A*35:01 complex was determined.
3803817;1032488;Literature;29150238;"Natalija Van Braeckel-Budimir; Stephanie Gras; Kristin Ladell; Tracy M Josephs; Lecia Pewe; Stina L Urban; Kelly L Miners; Carine Farenc; David A Price; Jamie Rossjohn; John T Harty";Immunity;2017;A T Cell Receptor Locus Harbors a Malaria-Specific Immune Response Gene.;;187087;Linear peptide;SQLLNAKYL;40;48;;acid phosphatase;Acid phosphatase, putative;Q4YI47;Plasmodium berghei ANKA;Plasmodium berghei;5821;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 2, Table S2 and PDB 5WLI;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;5WLI;H2-Db;I;The crystal structure of the epitope/H-2Db complex was determined. There are four complexes in the asymmetric unit.
3803818;1032488;Literature;29150238;"Natalija Van Braeckel-Budimir; Stephanie Gras; Kristin Ladell; Tracy M Josephs; Lecia Pewe; Stina L Urban; Kelly L Miners; Carine Farenc; David A Price; Jamie Rossjohn; John T Harty";Immunity;2017;A T Cell Receptor Locus Harbors a Malaria-Specific Immune Response Gene.;;187087;Linear peptide;SQLLNAKYL;40;48;;acid phosphatase;Acid phosphatase, putative;Q4YI47;Plasmodium berghei ANKA;Plasmodium berghei;5821;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 3, Table S2 and PDB 5WLG;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5WLG;H2-Db;I;The crystal structure of the epitope/H-2Db complex bound by the NB1 TCR was determined.
3803861;1032868;Literature;29374075;"Blake F Frey; Jiansheng Jiang; Yongjun Sui; Lisa F Boyd; Bin Yu; Gwen Tatsuno; Rolf Billeskov; Shahram Solaymani-Mohammadi; Phillip W Berman; David H Margulies; Jay A Berzofsky";J Immunol;2018;Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity.;;745239;Linear peptide;IGPGRAFYTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;IGPGRAFYT;314;322;;;Envelope glycoprotein gp160 precursor;Envelope glycoprotein gp160;HIV-1 M:B_MN;Human immunodeficiency virus 1;mouse (Mus musculus);10090;Table I, Figure 6, Supplemental Figure 1 and PDB 5KD7;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;5KD7;H2-Dd;I;The crystal structure of the epitope/H-2Dd complex was determined. There are four complexes in the asymmetric unit.
3803862;1032868;Literature;29374075;"Blake F Frey; Jiansheng Jiang; Yongjun Sui; Lisa F Boyd; Bin Yu; Gwen Tatsuno; Rolf Billeskov; Shahram Solaymani-Mohammadi; Phillip W Berman; David H Margulies; Jay A Berzofsky";J Immunol;2018;Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity.;;745240;Linear peptide;IGPGRAFYTVI;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;IGPGRAFYTT;314;323;;;Envelope glycoprotein gp160 precursor;Envelope glycoprotein gp160;HIV-1 M:B_MN;Human immunodeficiency virus 1;mouse (Mus musculus);10090;Table I, Figure 6, Supplemental Figure 1 and PDB 5KD4;x-ray crystallography;3D structure;angstroms;Positive;=;3.1;5KD4;H2-Dd;I;The crystal structure of the epitope/H-2Dd complex was determined.
3803863;1032868;Literature;29374075;"Blake F Frey; Jiansheng Jiang; Yongjun Sui; Lisa F Boyd; Bin Yu; Gwen Tatsuno; Rolf Billeskov; Shahram Solaymani-Mohammadi; Phillip W Berman; David H Margulies; Jay A Berzofsky";J Immunol;2018;Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity.;;188252;Linear peptide;IGPGRAFYT;314;322;;Envelope glycoprotein gp160 precursor;Envelope glycoprotein gp160;P04578;HIV-1 M:B_MN;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;mouse (Mus musculus);10090;Table I, Figure 6, Supplemental Figure 1 and PDB 5T7G;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5T7G;H2-Dd;I;The crystal structure of the epitope/H-2Dd complex was determined. There are two complexes in the asymmetric unit.
3804382;1032927;Literature;29441070;"Jugmohit S Toor; Arjun A Rao; Andrew C McShan; Mark Yarmarkovich; Santrupti Nerli; Karissa Yamaguchi; Ada A Madejska; Son Nguyen; Sarvind Tripathi; John M Maris; Sofie R Salama; David Haussler; Nikolaos G Sgourakis";Front Immunol;2018;A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.;;758235;Linear peptide;AQDIYRASY;;;;;;;;;;;neo-epitope;Fragment of a Natural Sequence Molecule;ARDIYRASY;1274;1282;;Anaplastic lymphoma kinase;ALK tyrosine kinase receptor;ALK tyrosine kinase receptor;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 3, Supplementary Figures 1, 2, 5, Supplementary Tables 2, 3 and PDB 5TXS;x-ray crystallography;3D structure;angstroms;Positive;=;1.7;5TXS;HLA-B*15:01;I;The crystal structure of the epitope in complex with HLA-B*15:01 was determined.
3804383;1032927;Literature;29441070;"Jugmohit S Toor; Arjun A Rao; Andrew C McShan; Mark Yarmarkovich; Santrupti Nerli; Karissa Yamaguchi; Ada A Madejska; Son Nguyen; Sarvind Tripathi; John M Maris; Sofie R Salama; David Haussler; Nikolaos G Sgourakis";Front Immunol;2018;A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.;;758236;Linear peptide;AQDIYRASYY;;;;;;;;;;;neo-epitope;Fragment of a Natural Sequence Molecule;ARDIYRASYY;1274;1283;;Anaplastic lymphoma kinase;ALK tyrosine kinase receptor;ALK tyrosine kinase receptor;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 3, Supplementary Figures 1, 2, 5,  Supplementary Tables 2, 3 and PDB 5VZ5;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;5VZ5;HLA-B*15:01;I;The crystal structure of the epitope in complex with HLA-B*15:01 was determined.
3804384;1032927;Literature;29441070;"Jugmohit S Toor; Arjun A Rao; Andrew C McShan; Mark Yarmarkovich; Santrupti Nerli; Karissa Yamaguchi; Ada A Madejska; Son Nguyen; Sarvind Tripathi; John M Maris; Sofie R Salama; David Haussler; Nikolaos G Sgourakis";Front Immunol;2018;A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.;;758236;Linear peptide;AQDIYRASYY;;;;;;;;;;;neo-epitope;Fragment of a Natural Sequence Molecule;ARDIYRASYY;1274;1283;;Anaplastic lymphoma kinase;ALK tyrosine kinase receptor;ALK tyrosine kinase receptor;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Supplementary Tables 2, 4, Figure 5, Supplementary Figures 7, 12 and PDB 6AT9;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;6AT9;HLA-A*01:01;I;The crystal structure of the epitope in complex with HLA-A*01:01 was determined.
3806758;1032975;Literature;29263258;"Ruiying Liang; Yaping Sun; Yanjie Liu; Junya Wang; Yanan Wu; Zibin Li; Lizhen Ma; Nan Zhang; Lijie Zhang; Xiaohui Wei; Zehui Qu; Nianzhi Zhang; Chun Xia";J Virol;2018;Major Histocompatibility Complex Class I (FLA-E*01801) Molecular Structure in Domestic Cats Demonstrates Species-Specific Characteristics in Presenting Viral Antigen Peptides.;;750847;Linear peptide;RMANVSTGR;40;48;;gag protein [Feline immunodeficiency virus];gag protein;9626702;Feline immunodeficiency virus;Feline immunodeficiency virus;11673;;;;;;;;;;;;;cat (Felis catus);9685;Tables 1, 2, Figures 1, 3, 4 and PDB 5XMF;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5XMF;FLA-E*01801;I;The crystal structure of the epitope in complex with feline MHC class I molecule FLA-E*01801 was determined. Only one FLA-E*01801 complex was contained within one asymmetric unit.
3817467;1032986;Literature;29437277;"Sri H Ramarathinam; Stephanie Gras; Sheilajen Alcantara; Amanda W S Yeung; Nicole A Mifsud; Secondo Sonza; Patricia T Illing; Elias N Glaros; Robert J Center; Shane R Thomas; Stephen J Kent; Nicola Ternette; Damian F J Purcell; Jamie Rossjohn; Anthony W Purcell";Proteomics;2018;Identification of Native and Posttranslationally Modified HLA-B*57:01-Restricted HIV Envelope Derived Epitopes Using Immunoproteomics.;;764523;Linear peptide;RVKEKYQHLW + SCM(W10);2;11;;Envelope surface glycoprotein gp160, precursor;Envelope glycoprotein gp160;P04578;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;The epitope modification is Trp->Kynurenin(W)@10.;;;;;;;;;;;;human (Homo sapiens);9606;Figure 4, Tables S-6, S-7 and PDB 6BXP;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;6BXP;HLA-B*57:01;I;The crystal structure of the epitope in complex with HLA-B*57:01 was determined.
3817468;1032986;Literature;29437277;"Sri H Ramarathinam; Stephanie Gras; Sheilajen Alcantara; Amanda W S Yeung; Nicole A Mifsud; Secondo Sonza; Patricia T Illing; Elias N Glaros; Robert J Center; Shane R Thomas; Stephen J Kent; Nicola Ternette; Damian F J Purcell; Jamie Rossjohn; Anthony W Purcell";Proteomics;2018;Identification of Native and Posttranslationally Modified HLA-B*57:01-Restricted HIV Envelope Derived Epitopes Using Immunoproteomics.;;764524;Linear peptide;RVKEKYQHLW;2;11;;Envelope surface glycoprotein gp160, precursor;Envelope glycoprotein gp160;P04578;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 4, Tables S-6, S-7 and PDB 6BXQ;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;6BXQ;HLA-B*57:01;I;The crystal structure of the epitope in complex with HLA-B*57:01 was determined.
3825378;1033026;Literature;29531227;"Kok Fei Chan; Benjamin S Gully; Stephanie Gras; Dennis X Beringer; Lars Kjer-Nielsen; Jonathan Cebon; James McCluskey; Weisan Chen; Jamie Rossjohn";Nat Commun;2018;Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide.;;753317;Linear peptide;APRGPHGGAASGL;60;72;;Cancer/testis antigen 1;Cancer/testis antigen 1;P78358;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Table 2 and PDB 6AT5;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;6AT5;HLA-B*07:02;I;The crystal structure of the epitope/HLA-B*07:02 complex was determined.
3825379;1033026;Literature;29531227;"Kok Fei Chan; Benjamin S Gully; Stephanie Gras; Dennis X Beringer; Lars Kjer-Nielsen; Jonathan Cebon; James McCluskey; Weisan Chen; Jamie Rossjohn";Nat Commun;2018;Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide.;;753317;Linear peptide;APRGPHGGAASGL;60;72;;Cancer/testis antigen 1;Cancer/testis antigen 1;P78358;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Figure 5, Table 2 and PDB 6AVF;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;6AVF;HLA-B*07:02;I;The crystal structure of the epitope/HLA-B*07:02 complex bound by the KFJ5 TCR was determined.
3825380;1033026;Literature;29531227;"Kok Fei Chan; Benjamin S Gully; Stephanie Gras; Dennis X Beringer; Lars Kjer-Nielsen; Jonathan Cebon; James McCluskey; Weisan Chen; Jamie Rossjohn";Nat Commun;2018;Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide.;;753317;Linear peptide;APRGPHGGAASGL;60;72;;Cancer/testis antigen 1;Cancer/testis antigen 1;P78358;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Figure 5, Table 2 and PDB 6AVG;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;6AVG;HLA-B*07:02;I;The crystal structure of the epitope/HLA-B*07:02 complex bound by the KFJ37 TCR was determined.
3830306;1033060;Literature;29507106;"Ida Hafstrand; Elien M Doorduijn; Renhua Sun; Anna Talyzina; Marjolein Sluijter; Sara Pellegrino; Tatyana Sandalova; Adil Doganay Duru; Thorbald van Hall; Adnane Achour";J Immunol;2018;The Immunogenicity of a Proline-Substituted Altered Peptide Ligand toward the Cancer-Associated TEIPP Neoepitope Trh4 Is Unrelated to Complex Stability.;;753509;Linear peptide;MCPRMTAVM;;;;;;;;;;The unsubstituted peptide is a T cell epitope associated with impaired peptide processing (TEIPP), derived from the C-terminal portion of a minor splice variant of the commonly expressed cellular protein Trh4 (CerS5). Although derived from nonmutated endogenous proteins, the TEIPP neoantigens are not presented on normal cells and act as immunogenic epitopes.;neo-epitope;Fragment of a Natural Sequence Molecule;MCLRMTAVM;379;387;;;longevity assurance homolog 5 (S. cerevisiae), isoform CRA_a;Ceramide synthase 5;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Figures 3, 4, 5, Supplementary Figures 1, 2, Supplementary Table 1 and PDB 5MZM;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;5MZM;H2-Db;I;The crystal structure of epitope in complex with H-2Db was determined. There are two complexes in  the asymmetric unit.
3838478;1033084;Literature;29599287;"Athanasios Papakyriakou; Emma Reeves; Mary Beton; Halina Mikolajek; Leon Douglas; Grace Cooper; Tim Elliott; J&ouml;rn M Werner; Edward James";J Biol Chem;2018;The partial dissociation of MHC class I-bound peptides exposes their N terminus to trimming by endoplasmic reticulum aminopeptidase 1.;;58560;Linear peptide;SIINFEKL;258;265;;Ovalbumin;Gal d 2;P01012;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 3, Supplemental Figure S1, Table 1 and PDB 5OQF;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;5OQF;H2-Kb;I;"The crystal structure of the epitope tethered to H2-Kb was determined using a single chain trimer composed of the ovalbumin-derived peptide linked to the N-terminus of beta-2microglobulin followed by the WT MHC I heavy chain H-2Kb (SL8-&szlig;2m-Kb). The C-terminus of SL8 is tethered to the Kb binding groove through a disulfide bond between Y84C of Kb and a second cysteine within the peptide-&szlig;2m linker."
3929541;1033352;Literature;29735483;"Louise C Rowntree; Thi H O Nguyen; Hanim Halim; Anthony W Purcell; Jamie Rossjohn; Stephanie Gras; Tom C Kotsimbos; Nicole A Mifsud";J Immunol;2018;Inability To Detect Cross-Reactive Memory T Cells Challenges the Frequency of Heterologous Immunity among Common Viruses.;;55252;Linear peptide;RPPIFIRRL;379;387;;Epstein-Barr nuclear antigen 3;Epstein-Barr nuclear antigen 3;P12977;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table IV, Figure 4 and PDB 5WMO;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;5WMO;HLA-B*07:02;I;The crystal structure of the epitope/HLA-B*07:02 complex was determined.
3929543;1033352;Literature;29735483;"Louise C Rowntree; Thi H O Nguyen; Hanim Halim; Anthony W Purcell; Jamie Rossjohn; Stephanie Gras; Tom C Kotsimbos; Nicole A Mifsud";J Immunol;2018;Inability To Detect Cross-Reactive Memory T Cells Challenges the Frequency of Heterologous Immunity among Common Viruses.;;60089;Linear peptide;SPIVPSFDM;473;481;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Table IV, Figure 4 and PDB 5WMN;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;5WMN;HLA-B*07:02;I;The crystal structure of the epitope/HLA-B*07:02 complex was determined.
3929545;1033352;Literature;29735483;"Louise C Rowntree; Thi H O Nguyen; Hanim Halim; Anthony W Purcell; Jamie Rossjohn; Stephanie Gras; Tom C Kotsimbos; Nicole A Mifsud";J Immunol;2018;Inability To Detect Cross-Reactive Memory T Cells Challenges the Frequency of Heterologous Immunity among Common Viruses.;;65748;Linear peptide;TPRVTGGGAM;417;426;;tegument protein pp65;65 kDa phosphoprotein;Q6SW59;Human betaherpesvirus 5;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Table IV, Figure 4 and PDB 5WMP;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;5WMP;HLA-B*07:02;I;The crystal structure of the epitope/HLA-B*07:02 complex was determined.
3929547;1033352;Literature;29735483;"Louise C Rowntree; Thi H O Nguyen; Hanim Halim; Anthony W Purcell; Jamie Rossjohn; Stephanie Gras; Tom C Kotsimbos; Nicole A Mifsud";J Immunol;2018;Inability To Detect Cross-Reactive Memory T Cells Challenges the Frequency of Heterologous Immunity among Common Viruses.;;53128;Linear peptide;RAKFKQLL;190;197;;BZLF1;Trans-activator protein BZLF1;P03206;Human gammaherpesvirus 4;Human gammaherpesvirus 4;10376;;;;;;;;;;;;;human (Homo sapiens);9606;Table V, Figure 4 and PDB 3SPV;x-ray crystallography;3D structure;angstroms;Positive;=;1.3;3SPV;HLA-B*08:01;I;The crystal structure of the epitope/HLA-B*08:01 complex was determined.
3929550;1033352;Literature;29735483;"Louise C Rowntree; Thi H O Nguyen; Hanim Halim; Anthony W Purcell; Jamie Rossjohn; Stephanie Gras; Tom C Kotsimbos; Nicole A Mifsud";J Immunol;2018;Inability To Detect Cross-Reactive Memory T Cells Challenges the Frequency of Heterologous Immunity among Common Viruses.;;13263;Linear peptide;ELRSRYWAI;380;388;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Wilson-Smith/1933(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Table V, Figure 4 and PDB 5WMQ;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;5WMQ;HLA-B*08:01;I;The crystal structure of the epitope/HLA-B*08:01 complex was determined.
3929552;1033352;Literature;29735483;"Louise C Rowntree; Thi H O Nguyen; Hanim Halim; Anthony W Purcell; Jamie Rossjohn; Stephanie Gras; Tom C Kotsimbos; Nicole A Mifsud";J Immunol;2018;Inability To Detect Cross-Reactive Memory T Cells Challenges the Frequency of Heterologous Immunity among Common Viruses.;;51089;Linear peptide;QIKVRVDMV;88;96;;immediate early transcriptional regulator;55 kDa immediate-early protein 1;F5HCM1;Human betaherpesvirus 5;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Table V, Figure 4 and PDB 5WMR;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;5WMR;HLA-B*08:01;I;The crystal structure of the epitope/HLA-B*08:01 complex was determined.
3931467;1033218;Literature;29772011;"Katie Tungatt; Garry Dolton; Sophie B Morgan; Meriem Attaf; Anna Fuller; Thomas Whalley; Johanneke D Hemmink; Emily Porter; Barbara Szomolay; Maria Montoya; John A Hammond; John J Miles; David K Cole; Alain Townsend; Mick Bailey; Pierre J Rizkallah; Bryan Charleston; Elma Tchilian; Andrew K Sewell";PLoS Pathog;2018;Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pig.;;768385;Linear peptide;DFEREGYSL;290;298;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;pig (Sus scrofa);9823;Figure 7, S5 Table and PDB 5NQ0;x-ray crystallography;3D structure;angstroms;Positive;=;1.1;5NQ0;SLA-1*14:02;I;The crystal structure of the epitope/SLA-1*14:02 complex was determined.
3931468;1033218;Literature;29772011;"Katie Tungatt; Garry Dolton; Sophie B Morgan; Meriem Attaf; Anna Fuller; Thomas Whalley; Johanneke D Hemmink; Emily Porter; Barbara Szomolay; Maria Montoya; John A Hammond; John J Miles; David K Cole; Alain Townsend; Mick Bailey; Pierre J Rizkallah; Bryan Charleston; Elma Tchilian; Andrew K Sewell";PLoS Pathog;2018;Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pig.;;768407;Linear peptide;EFEDLTFLA;252;260;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;pig (Sus scrofa);9823;Figure 7, S5 Table and PDB 5NPZ;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;5NPZ;SLA-1*14:02;I;The crystal structure of the epitope/SLA-1*14:02 complex was determined.
3931469;1033218;Literature;29772011;"Katie Tungatt; Garry Dolton; Sophie B Morgan; Meriem Attaf; Anna Fuller; Thomas Whalley; Johanneke D Hemmink; Emily Porter; Barbara Szomolay; Maria Montoya; John A Hammond; John J Miles; David K Cole; Alain Townsend; Mick Bailey; Pierre J Rizkallah; Bryan Charleston; Elma Tchilian; Andrew K Sewell";PLoS Pathog;2018;Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pig.;;25478;Linear peptide;IAYERMCNI;217;225;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;pig (Sus scrofa);9823;Figure 7, S5 Table and PDB 5NQ2;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;5NQ2;SLA-2*11:04;I;The crystal structure of the epitope/SLA-2*11:04 complex was determined.
3931470;1033218;Literature;29772011;"Katie Tungatt; Garry Dolton; Sophie B Morgan; Meriem Attaf; Anna Fuller; Thomas Whalley; Johanneke D Hemmink; Emily Porter; Barbara Szomolay; Maria Montoya; John A Hammond; John J Miles; David K Cole; Alain Townsend; Mick Bailey; Pierre J Rizkallah; Bryan Charleston; Elma Tchilian; Andrew K Sewell";PLoS Pathog;2018;Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pig.;;768385;Linear peptide;DFEREGYSL;290;298;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;pig (Sus scrofa);9823;S6 Figure, S5 Table and PDB 5NQ1;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5NQ1;SLA-1*14:02;I;The crystal structure of the epitope/SLA-1*14:02 complex using human beta2M was determined.
3931471;1033218;Literature;29772011;"Katie Tungatt; Garry Dolton; Sophie B Morgan; Meriem Attaf; Anna Fuller; Thomas Whalley; Johanneke D Hemmink; Emily Porter; Barbara Szomolay; Maria Montoya; John A Hammond; John J Miles; David K Cole; Alain Townsend; Mick Bailey; Pierre J Rizkallah; Bryan Charleston; Elma Tchilian; Andrew K Sewell";PLoS Pathog;2018;Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pig.;;768407;Linear peptide;EFEDLTFLA;252;260;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;pig (Sus scrofa);9823;S6 Figure, S5 Table and PDB 5NQ3;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;5NQ3;SLA-1*14:02;I;The crystal structure of the epitope/SLA-1*14:02 complex using human beta2M was determined.
4047596;1033236;Literature;29712860;"Philippe Guillaume; Sarah Picaud; Petra Baumgaertner; Nicole Montandon; Julien Schmidt; Daniel E Speiser; George Coukos; Michal Bassani-Sternberg; Panagis Filippakopoulos; David Gfeller";Proc Natl Acad Sci U S A;2018;The C-terminal extension landscape of naturally presented HLA-I ligands.;;505123;Linear peptide;ETSPLTAEKL;114;123;;G1/S-specific cyclin-D2;G1/S-specific cyclin-D2;P30279;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 4, S7, Table S4 and PDB 6EI2;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;6EI2;HLA-A*68:01;I;The crystal structure of the epitope/HLA-A*68:01 complex was determined.
4140699;1033499;Literature;30053426;"Leah V Sibener; Ricardo A Fernandes; Elizabeth M Kolawole; Catherine B Carbone; Fan Liu; Darren McAffee; Michael E Birnbaum; Xinbo Yang; Laura F Su; Wong Yu; Shen Dong; Marvin H Gee; Kevin M Jude; Mark M Davis; Jay T Groves; William A Goddard 3rd; James R Heath; Brian D Evavold; Ronald D Vale; K Christopher Garcia";Cell;2018;Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding.;;27943;Linear peptide;IPLTEEAEL;392;400;;pol protein, partial;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Table S1 and PDB 6BJ2;x-ray crystallography;3D structure;angstroms;Positive;=;3.4;6BJ2;HLA-B*35:01;I;The crystal structure of the epitope/HLA-B*35 complex bound by TCR 589 was determined.
4140700;1033499;Literature;30053426;"Leah V Sibener; Ricardo A Fernandes; Elizabeth M Kolawole; Catherine B Carbone; Fan Liu; Darren McAffee; Michael E Birnbaum; Xinbo Yang; Laura F Su; Wong Yu; Shen Dong; Marvin H Gee; Kevin M Jude; Mark M Davis; Jay T Groves; William A Goddard 3rd; James R Heath; Brian D Evavold; Ronald D Vale; K Christopher Garcia";Cell;2018;Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding.;;27943;Linear peptide;IPLTEEAEL;392;400;;pol protein, partial;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Table S1 and PDB 6BJ3;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;6BJ3;HLA-B*35:01;I;The crystal structure of the epitope/HLA-B*35 complex bound by TCR 55 was determined.
4140702;1033499;Literature;30053426;"Leah V Sibener; Ricardo A Fernandes; Elizabeth M Kolawole; Catherine B Carbone; Fan Liu; Darren McAffee; Michael E Birnbaum; Xinbo Yang; Laura F Su; Wong Yu; Shen Dong; Marvin H Gee; Kevin M Jude; Mark M Davis; Jay T Groves; William A Goddard 3rd; James R Heath; Brian D Evavold; Ronald D Vale; K Christopher Garcia";Cell;2018;Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding.;;780369;Linear peptide;VPLTEDAEL;448;456;;pol protein, partial [Human immunodeficiency virus 1];Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 6, Table S1 and PDB 6BJ8;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;6BJ8;HLA-B*35:01;I;The crystal structure of the epitope/HLA-B*35 complex bound by TCR 55 was determined.
4478379;1033536;Literature;30087171;"Min Zhao; Kefang Liu; Jiejian Luo; Shuguang Tan; Chuansong Quan; Shuijun Zhang; Yan Chai; Jianxun Qi; Yan Li; Yuhai Bi; Haixia Xiao; Gary Wong; Jianfang Zhou; Taijiao Jiang; Wenjun Liu; Hongjie Yu; Jinghua Yan; Yingxia Liu; Yuelong Shu; Guizhen Wu; Aiping Wu; George F Gao; William J Liu";MBio;2018;Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses.;;124495;Linear peptide;LYKKLKREITF;99;109;;matrix protein 1;Matrix protein 1;P03485;Influenza A virus (A/California/04/2009(H1N1));Influenza A virus;11320;The identical sequence is found in matrix 1 protein from Influenza A virus subtype H5N1.;;;;;;;;;;;;human (Homo sapiens);9606;Figure 5, Table S4 and PDB 5WWU;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;5WWU;HLA-A*24:02;I;The crystal structure of the epitope/HLA-A*2402 complex was determined.
4478380;1033536;Literature;30087171;"Min Zhao; Kefang Liu; Jiejian Luo; Shuguang Tan; Chuansong Quan; Shuijun Zhang; Yan Chai; Jianxun Qi; Yan Li; Yuhai Bi; Haixia Xiao; Gary Wong; Jianfang Zhou; Taijiao Jiang; Wenjun Liu; Hongjie Yu; Jinghua Yan; Yingxia Liu; Yuelong Shu; Guizhen Wu; Aiping Wu; George F Gao; William J Liu";MBio;2018;Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses.;;841139;Linear peptide;LYKKLKREMTF;99;109;;matrix protein 1;Matrix protein 1;P03485;Influenza A virus (A/Shanghai/5190T/2013(H7N9));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 5, Table S4 and PDB 5WXD;x-ray crystallography;3D structure;angstroms;Positive;=;3.3;5WXD;HLA-A*24:02;I;"The crystal structure of the epitope/HLA-A*2402 complex was determined. Two data sets were collected. The first data set (this structure) had a lower resolution (3.3 &Aring;) than data set 2 (2.3 &Aring;) [PDB: 5WXC]."
4478381;1033536;Literature;30087171;"Min Zhao; Kefang Liu; Jiejian Luo; Shuguang Tan; Chuansong Quan; Shuijun Zhang; Yan Chai; Jianxun Qi; Yan Li; Yuhai Bi; Haixia Xiao; Gary Wong; Jianfang Zhou; Taijiao Jiang; Wenjun Liu; Hongjie Yu; Jinghua Yan; Yingxia Liu; Yuelong Shu; Guizhen Wu; Aiping Wu; George F Gao; William J Liu";MBio;2018;Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses.;;841139;Linear peptide;LYKKLKREMTF;99;109;;matrix protein 1;Matrix protein 1;P03485;Influenza A virus (A/Shanghai/5190T/2013(H7N9));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure S1, Table S4 and PDB 5WXC;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;5WXC;HLA-A*24:02;I;"The crystal structure of the epitope/HLA-A*2402 complex was determined. Two data sets were collected. Data set 2 (this structure) had a higher resolution (2.3 &Aring;) than data set 1 (3.3 &Aring;)  [PDB: 5WXD]."
4550834;1033576;Literature;29950410;"Yu Zhang; Yan Wu; Mengmeng Deng; Dongping Xu; Xiaodong Li; Zhihui Xu; Jun Hu; Han Zhang; Kefang Liu; Yingze Zhao; Feng Gao; Shengli Bi; George F Gao; Jingmin Zhao; William J Liu; Songdong Meng";J Virol;2018;"CD8&lt;sup&gt;+&lt;/sup&gt; T-Cell Response-Associated Evolution of Hepatitis B Virus Core Protein and Disease Progress.";;858972;Linear peptide;GVWIRTPTA;152;160;;precore/core protein [Hepatitis B virus];External core antigen;P0C767;Hepatitis B virus;Hepatitis B virus;10407;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, Table 2 and PDB 5WSH (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5WSH;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex was determined.
4550835;1033576;Literature;29950410;"Yu Zhang; Yan Wu; Mengmeng Deng; Dongping Xu; Xiaodong Li; Zhihui Xu; Jun Hu; Han Zhang; Kefang Liu; Yingze Zhao; Feng Gao; Shengli Bi; George F Gao; Jingmin Zhao; William J Liu; Songdong Meng";J Virol;2018;"CD8&lt;sup&gt;+&lt;/sup&gt; T-Cell Response-Associated Evolution of Hepatitis B Virus Core Protein and Disease Progress.";;165604;Linear peptide;GVWIRTPPA;152;160;;Precore/core;External core antigen;P0C767;Hepatitis B virus;Hepatitis B virus;10407;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, Table 2 and PDB 5E00 (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;1.7;5,00E+00;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex was determined.
4551190;1022868;Literature;22245737;"Anna M Bulek; David K Cole; Ania Skowera; Garry Dolton; Stephanie Gras; Florian Madura; Anna Fuller; John J Miles; Emma Gostick; David A Price; Jan W Drijfhout; Robin R Knight; Guo C Huang; Nikolai Lissin; Peter E Molloy; Linda Wooldridge; Bent K Jakobsen; Jamie Rossjohn; Mark Peakman; Pierre J Rizkallah; Andrew K Sewell";Nat Immunol;2012;Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.;;103041;Linear peptide;ALWGPDPAAA;15;24;;Insulin precursor;Insulin;P01308;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, Supplementary Table 1, Supplementary Figures 3, 4 and PDB 3UTT (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3UTT;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex bound by the Ie6 TCR was determined. The ternary complex was crystallized in two forms: the triclinic form curated in this assay [PDB: 3UTT] and the monoclinic form [PDB: 3UTS]. The ternary complexes were virtually identical in the two different crystal forms and the analysis in the paper was restricted to this complex solved at higher resolution.
4551191;1022868;Literature;22245737;"Anna M Bulek; David K Cole; Ania Skowera; Garry Dolton; Stephanie Gras; Florian Madura; Anna Fuller; John J Miles; Emma Gostick; David A Price; Jan W Drijfhout; Robin R Knight; Guo C Huang; Nikolai Lissin; Peter E Molloy; Linda Wooldridge; Bent K Jakobsen; Jamie Rossjohn; Mark Peakman; Pierre J Rizkallah; Andrew K Sewell";Nat Immunol;2012;Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.;;103041;Linear peptide;ALWGPDPAAA;15;24;;Insulin precursor;Insulin;P01308;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, Supplementary Table 1, Supplementary Figures 3, 4 and PDB 3UTS (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.7;3UTS;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex bound by the Ie6 TCR was determined. The ternary complex was crystallized in two forms: the triclinic form [PDB: 3UTT] and the monoclinic form [PDB: 3UTS] curated in this assay. The ternary complexes were virtually identical in the two different crystal forms and the analysis in the paper was restricted to the triclinic complex solved at higher resolution.
4551435;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;834064;Linear peptide;NLVPMVHTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;NLVPMVATV;485;493;;;pp65;65 kDa phosphoprotein;Human betaherpesvirus 5;Human betaherpesvirus 5;human (Homo sapiens);9606;PDB 3MRB (V1.1);x-ray crystallography;3D structure;angstroms;Positive;=;1.4;3MRB;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
4551436;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;834063;Linear peptide;NLVPAVATV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;NLVPMVATV;485;493;;;pp65;65 kDa phosphoprotein;Human betaherpesvirus 5;Human betaherpesvirus 5;human (Homo sapiens);9606;PDB 3MR9 (V1.1);x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3MR9;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
4551437;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;832583;Linear peptide;CINGMCWTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;CINGVCWTV;1073;1081;;C protein, E protein, NS1/E2 protein, NS2 protein, NS3 protein, NS4 protein, NS5 protein;polyprotein precursor;Genome polyprotein;Hepacivirus C;Hepacivirus C;human (Homo sapiens);9606;PDB 3MRJ (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3MRJ;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
4551442;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;834121;Linear peptide;PLFQVPEPV;137;145;;Alpha-fetoprotein precursor;Alpha-fetoprotein;P02771;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;PDB 3MRK (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;1.4;3MRK;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
4551445;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;32208;Linear peptide;KLVALGINAV;1406;1415;;Genome polyprotein;Genome polyprotein;P27958;Hepatitis C virus (isolate 1);Hepacivirus C;11103;;;;;;;;;;;;;human (Homo sapiens);9606;PDB 3MRM (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;1.9;3MRM;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
4551450;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;37286;Linear peptide;LLFNILGGWV;1807;1816;;polyprotein precursor;Genome polyprotein;P27958;Hepacivirus C;Hepacivirus C;11103;;;;;;;;;;;;;human (Homo sapiens);9606;PDB 3MRN (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.3;3MRN;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
4551452;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;832625;Linear peptide;ELAGLGINTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;PDB 3MRP (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3MRP;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
4551453;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;44920;Linear peptide;NLVPMVATV;485;493;;pp65;65 kDa phosphoprotein;Q6SW59;Human betaherpesvirus 5;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Table S1 and PDB 3GSN (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.8;3GSN;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound by the RA14 TCR was determined.
4551454;1033623;Literature;22084443;"Yan Wu; Feng Gao; Jun Liu; Jianxun Qi; Emma Gostick; David A Price; George F Gao";J Immunol;2011;Structural basis of diverse peptide accommodation by the rhesus macaque MHC class I molecule Mamu-B*17: insights into immune protection from simian immunodeficiency virus.;;17552;Linear peptide;FQWMGYELW;435;443;;pol protein;Gag-Pol polyprotein;P05896;Simian immunodeficiency virus;Simian immunodeficiency virus;11723;;;;;;;;;;;;;rhesus macaque (Macaca mulatta);9544;Table II, Figures 5, 7 and PDB 3RWE (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.4;3RWE;Mamu-B*017:04;I;The crystal structure of the epitope/Mamu-B*17 complex was solved by molecular replacement.
4551455;1033623;Literature;22084443;"Yan Wu; Feng Gao; Jun Liu; Jianxun Qi; Emma Gostick; David A Price; George F Gao";J Immunol;2011;Structural basis of diverse peptide accommodation by the rhesus macaque MHC class I molecule Mamu-B*17: insights into immune protection from simian immunodeficiency virus.;;28419;Linear peptide;IRYPKTFGW;165;173;;nef protein [Simian immunodeficiency virus];Protein Nef;P05862;Simian immunodeficiency virus;Simian immunodeficiency virus;11723;;;;;;;;;;;;;rhesus macaque (Macaca mulatta);9544;Table II, Figures 3, 5, 6, 7 and PDB 3RWC (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.5;3RWC;Mamu-B*017:04;I;The crystal structure of the epitope/Mamu-B*17 complex was solved by molecular replacement.
4551456;1033623;Literature;22084443;"Yan Wu; Feng Gao; Jun Liu; Jianxun Qi; Emma Gostick; David A Price; George F Gao";J Immunol;2011;Structural basis of diverse peptide accommodation by the rhesus macaque MHC class I molecule Mamu-B*17: insights into immune protection from simian immunodeficiency virus.;;28420;Linear peptide;IRYPKTFGWLW;165;175;;nef protein [Simian immunodeficiency virus];Protein Nef;P05862;Simian immunodeficiency virus;Simian immunodeficiency virus;11723;;;;;;;;;;;;;rhesus macaque (Macaca mulatta);9544;Table II, Figures 3, 6 and PDB 3RWD (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3RWD;Mamu-B*017:04;I;The crystal structure of the epitope/Mamu-B*17 complex was solved by molecular replacement.
4551457;1033623;Literature;22084443;"Yan Wu; Feng Gao; Jun Liu; Jianxun Qi; Emma Gostick; David A Price; George F Gao";J Immunol;2011;Structural basis of diverse peptide accommodation by the rhesus macaque MHC class I molecule Mamu-B*17: insights into immune protection from simian immunodeficiency virus.;;52627;Linear peptide;QTSQWDDPW;199;207;;nef protein [Simian immunodeficiency virus];Protein Nef;P05862;Simian immunodeficiency virus;Simian immunodeficiency virus;11723;;;;;;;;;;;;;rhesus macaque (Macaca mulatta);9544;Table II, Figures 5, 6, 7 and PDB 3RWF (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3RWF;Mamu-B*017:04;I;The crystal structure of the epitope/Mamu-B*17 complex was solved by molecular replacement.
4551458;1033623;Literature;22084443;"Yan Wu; Feng Gao; Jun Liu; Jianxun Qi; Emma Gostick; David A Price; George F Gao";J Immunol;2011;Structural basis of diverse peptide accommodation by the rhesus macaque MHC class I molecule Mamu-B*17: insights into immune protection from simian immunodeficiency virus.;;41672;Linear peptide;MHPAQTSQW;195;203;;nef protein [Simian immunodeficiency virus];Protein Nef;P05862;Simian immunodeficiency virus;Simian immunodeficiency virus;11723;;;;;;;;;;;;;rhesus macaque (Macaca mulatta);9544;Table II, Figures 5, 6 and PDB 3RWG (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3RWG;Mamu-B*017:04;I;The crystal structure of the epitope/Mamu-B*17 complex was solved by molecular replacement.
4551459;1033623;Literature;22084443;"Yan Wu; Feng Gao; Jun Liu; Jianxun Qi; Emma Gostick; David A Price; George F Gao";J Immunol;2011;Structural basis of diverse peptide accommodation by the rhesus macaque MHC class I molecule Mamu-B*17: insights into immune protection from simian immunodeficiency virus.;;42466;Linear peptide;MRHVLEPF;372;379;;pol protein;Gag-Pol polyprotein;P05896;Simian immunodeficiency virus;Simian immunodeficiency virus;11723;;;;;;;;;;;;;rhesus macaque (Macaca mulatta);9544;Table II, Figure 6 and PDB 3RWH (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3RWH;Mamu-B*017:04;I;The crystal structure of the epitope/Mamu-B*17 complex was solved by molecular replacement.
4551461;1033623;Literature;22084443;"Yan Wu; Feng Gao; Jun Liu; Jianxun Qi; Emma Gostick; David A Price; George F Gao";J Immunol;2011;Structural basis of diverse peptide accommodation by the rhesus macaque MHC class I molecule Mamu-B*17: insights into immune protection from simian immunodeficiency virus.;;24198;Linear peptide;HLEVQGYW;66;73;;vif protein;Virion infectivity factor;P05903;Simian immunodeficiency virus;Simian immunodeficiency virus;11723;;;;;;;;;;;;;rhesus macaque (Macaca mulatta);9544;Table II, Figures 1, 3 and PDB 3RWI (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3RWI;Mamu-B*017:04;I;The crystal structure of the epitope/Mamu-B*17 complex was solved by molecular replacement.
4551462;1033623;Literature;22084443;"Yan Wu; Feng Gao; Jun Liu; Jianxun Qi; Emma Gostick; David A Price; George F Gao";J Immunol;2011;Structural basis of diverse peptide accommodation by the rhesus macaque MHC class I molecule Mamu-B*17: insights into immune protection from simian immunodeficiency virus.;;22366;Linear peptide;GSHLEVQGYW;64;73;;vif protein;Virion infectivity factor;P05903;Simian immunodeficiency virus;Simian immunodeficiency virus;11723;;;;;;;;;;;;;rhesus macaque (Macaca mulatta);9544;Table II, Figures 3, 4, 5, 6, 7 and PDB 3RWJ (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.7;3RWJ;Mamu-B*017:04;I;The crystal structure of the epitope/Mamu-B*17 complex was solved by molecular replacement.
4551537;1016521;Literature;19542454;"St&eacute;phanie Gras; Xavier Saulquin; Jean-Baptiste Reiser; Emilie Debeaupuis; Klara Echasserieau; Adrien Kissenpfennig; Fran&ccedil;ois Legoux; Anne Chouquet; Madalen Le Gorrec; Paul Machillot; B&eacute;rang&egrave;re Neveu; Nicole Thielens; Bernard Malissen; Marc Bonneville; Dominique Housset";J Immunol;2009;Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.;;832584;Linear peptide;CINMWCWTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;CINGVCWTV;1073;1081;;C protein, E protein, NS1/E2 protein, NS2 protein, NS3 protein, NS4 protein, NS5 protein;polyprotein precursor;Genome polyprotein;Hepacivirus C;Hepacivirus C;human (Homo sapiens);9606;PDB 3MRI (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3MRI;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined.
4551550;1033674;Literature;21645925;"Yi Shi; Jianxun Qi; Aikichi Iwamoto; George F Gao";Mol Immunol;2011;Plasticity of human CD8alphaalpha binding to peptide-HLA-A*2402.;;56620;Linear peptide;RYPLTFGWCF;134;143;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3 and PDB 3NFN (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.4;3NFN;HLA-A*24:02;I;The crystal structure of the epitope/HLA-A*24:02 complex was determined. Entry 3NFN supersedes 3NFJ.
4551551;1033674;Literature;21645925;"Yi Shi; Jianxun Qi; Aikichi Iwamoto; George F Gao";Mol Immunol;2011;Plasticity of human CD8alphaalpha binding to peptide-HLA-A*2402.;;56620;Linear peptide;RYPLTFGWCF;134;143;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, 2, Figures 1, 2, 3 and PDB 3QZW (v1.2);x-ray crystallography;3D structure;angstroms;Positive;=;2.8;3QZW;HLA-A*24:02;I;The crystal structure of the epitope/HLA-A*24:02 complex bound by human CD8alphaalpha was determined. There are two hCD8alphaalpha/HLA-A*2402 complexes (complex 1 and complex 2) molecules per crystallographic asymmetric unit.
4551552;1033673;Literature;21943705;"Shihong Zhang; Jun Liu; Hao Cheng; Shuguang Tan; Jianxun Qi; Jinghua Yan; George F Gao";Mol Immunol;2011;Structural basis of cross-allele presentation by HLA-A*0301 and HLA-A*1101 revealed by two HIV-derived peptide complexes.;;1913;Linear peptide;AIFQSSMTK;263;271;;Pol polyprotein;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 1, 2, 3 and PDB 3RL1;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3RL1;HLA-A*03:01;I;The crystal structure of the epitope/HLA-A*0301 complex was determined.
4551554;1033673;Literature;21943705;"Shihong Zhang; Jun Liu; Hao Cheng; Shuguang Tan; Jianxun Qi; Jinghua Yan; George F Gao";Mol Immunol;2011;Structural basis of cross-allele presentation by HLA-A*0301 and HLA-A*1101 revealed by two HIV-derived peptide complexes.;;52760;Linear peptide;QVPLRPMTYK;73;82;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figues 1, 2, 3 and PDB 3RL2;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;3RL2;HLA-A*03:01;I;The crystal structure of the epitope/HLA-A*0301 complex was determined.
4551855;1025721;Literature;23521884;"Kristin Ladell; Masao Hashimoto; Maria Candela Iglesias; Pascal G Wilmann; James E McLaren; St&eacute;phanie Gras; Takayuki Chikata; Nozomi Kuse; Sol&egrave;ne Fastenackels; Emma Gostick; John S Bridgeman; Vanessa Venturi; Za&iuml;na A&iuml;t Arkoub; Henri Agut; David J van Bockel; Jorge R Almeida; Daniel C Douek; Laurence Meyer; Alain Venet; Masafumi Takiguchi; Jamie Rossjohn; David A Price; Victor Appay";Immunity;2013;A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.;;33250;Linear peptide;KRWIILGLNK;263;272;;Gag-Pol polyprotein;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Tables 1, S2, Figures 5, S4, S5 and PDB 4G8G (v1.4);x-ray crystallography;3D structure;angstroms;Positive;=;2.4;4G8G;HLA-B*27:05;I;The crystal structure of the epitope/HLA-B*2705 complex bound by the C12C TCR was determined.
4551856;1025721;Literature;23521884;"Kristin Ladell; Masao Hashimoto; Maria Candela Iglesias; Pascal G Wilmann; James E McLaren; St&eacute;phanie Gras; Takayuki Chikata; Nozomi Kuse; Sol&egrave;ne Fastenackels; Emma Gostick; John S Bridgeman; Vanessa Venturi; Za&iuml;na A&iuml;t Arkoub; Henri Agut; David J van Bockel; Jorge R Almeida; Daniel C Douek; Laurence Meyer; Alain Venet; Masafumi Takiguchi; Jamie Rossjohn; David A Price; Victor Appay";Immunity;2013;A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.;;184136;Linear peptide;KRWIIMGLNK;261;270;;gag protein;Gag polyprotein;P04591;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1 and PDB 4G9F (v1.2);x-ray crystallography;3D structure;angstroms;Positive;=;1.9;4G9F;HLA-B*27:05;I;The crystal structure of the epitope/HLA-B*2705 complex bound by the C12C TCR was determined.
4551857;1026965;Literature;24192765;"Akihisa Shimizu; Ai Kawana-Tachikawa; Atsushi Yamagata; Chungyong Han; Dayong Zhu; Yusuke Sato; Hitomi Nakamura; Tomohiko Koibuchi; Jonathan Carlson; Eric Martin; Chanson J Brumme; Yi Shi; George F Gao; Zabrina L Brumme; Shuya Fukai; Aikichi Iwamoto";Sci Rep;2013;Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection.;;56620;Linear peptide;RYPLTFGWCF;134;143;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Supplementary Figure 3, Supplementary Table 2 and PDB 3VXR (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.4;3VXR;HLA-A*24:02;I;The crystal structure of the epitope/ HLA-A*2402 complex bound by the H27-14 TCR was determined by molecular replacement. The complex crystallized in space group C21.
4551858;1026965;Literature;24192765;"Akihisa Shimizu; Ai Kawana-Tachikawa; Atsushi Yamagata; Chungyong Han; Dayong Zhu; Yusuke Sato; Hitomi Nakamura; Tomohiko Koibuchi; Jonathan Carlson; Eric Martin; Chanson J Brumme; Yi Shi; George F Gao; Zabrina L Brumme; Shuya Fukai; Aikichi Iwamoto";Sci Rep;2013;Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection.;;193060;Linear peptide;RFPLTFGWCF;143;152;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Supplementary Figure 3, Supplementary Table 2 and PDB 3VXM (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.5;3VXM;HLA-A*24:02;I;The crystal structure of the epitope/ HLA-A*2402 complex bound by the C1-28 TCR was determined by molecular replacement. The complex crystallized in space group P2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>.
4551859;1026965;Literature;24192765;"Akihisa Shimizu; Ai Kawana-Tachikawa; Atsushi Yamagata; Chungyong Han; Dayong Zhu; Yusuke Sato; Hitomi Nakamura; Tomohiko Koibuchi; Jonathan Carlson; Eric Martin; Chanson J Brumme; Yi Shi; George F Gao; Zabrina L Brumme; Shuya Fukai; Aikichi Iwamoto";Sci Rep;2013;Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection.;;193060;Linear peptide;RFPLTFGWCF;143;152;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Supplementary Figure 3, Supplementary Table 2 and PDB 3VXU (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.7;3VXU;HLA-A*24:02;I;The crystal structure of the epitope/ HLA-A*2402 complex bound by the T36-5 TCR was determined by molecular replacement. The complex crystallized in space group P3<sub>2</sub>.
4551860;1026965;Literature;24192765;"Akihisa Shimizu; Ai Kawana-Tachikawa; Atsushi Yamagata; Chungyong Han; Dayong Zhu; Yusuke Sato; Hitomi Nakamura; Tomohiko Koibuchi; Jonathan Carlson; Eric Martin; Chanson J Brumme; Yi Shi; George F Gao; Zabrina L Brumme; Shuya Fukai; Aikichi Iwamoto";Sci Rep;2013;Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection.;;193060;Linear peptide;RFPLTFGWCF;143;152;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Supplementary Figure 3, Supplementary Table 2 and PDB 3W0W (v1.2);x-ray crystallography;3D structure;angstroms;Positive;=;2.6;3W0W;HLA-A*24:02;I;The crystal structure of the epitope/ HLA-A*2402 complex bound by the T36-5 TCR was determined by molecular replacement. The complex crystallized in space group P2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>.
4551861;1026965;Literature;24192765;"Akihisa Shimizu; Ai Kawana-Tachikawa; Atsushi Yamagata; Chungyong Han; Dayong Zhu; Yusuke Sato; Hitomi Nakamura; Tomohiko Koibuchi; Jonathan Carlson; Eric Martin; Chanson J Brumme; Yi Shi; George F Gao; Zabrina L Brumme; Shuya Fukai; Aikichi Iwamoto";Sci Rep;2013;Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection.;;193071;Linear peptide;RYPLTLGWCF;133;142;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Supplementary Figure 3, Supplementary Table 2 and PDB 3VXS (V1.1);x-ray crystallography;3D structure;angstroms;Positive;=;1.8;3VXS;HLA-A*24:02;I;The crystal structure of the epitope/ HLA-A*2402 complex bound by the H27-14 TCR was determined by molecular replacement. The complex crystallized in space group P2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>.
4552002;1018805;Literature;15537658;"Martin H&uuml;lsmeyer; Patrick Chames; Roman C Hillig; Robyn L Stanfield; Gerhard Held; Pierre G Coulie; Claudia Alings; Gabriele Wille; Wolfram Saenger; Barbara Uchanska-Ziegler; Hennie R Hoogenboom; Andreas Ziegler";J Biol Chem;2005;A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.;;11010;Linear peptide;EADPTGHSY;161;169;;Melanoma-associated antigen 1;Melanoma-associated antigen 1;P43355;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 1 and PDB 1W72 (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.2;1W72;HLA-A*01:01;I;The crystal structure of the epitope/HLA-A1 complex bound by Fab Hyb3 was determined.
4552010;1025254;Literature;22837158;"Eva B Allerbring; Adil D Duru; Hannes Uchtenhagen; Chaithanya Madhurantakam; Markus B Tomek; Sebastian Grimm; Pooja A Mazumdar; Rosmarie Friemann; Michael Uhlin; Tatyana Sandalova; Per-&Aring;ke Nygren; Adnane Achour";Eur J Immunol;2012;Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics.;;837642;Linear peptide;KAPYNFATM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis virus (strain WE);Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;PDB 4NSK (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.6;4NSK;H2-Db;I;The crystal structure of the epitope in complex with H-2Db was determined. Entry 4NSK supersedes 3TBX.
4552054;1013101;Literature;18650441;"Alessandra Beltrami; Maxim Rossmann; Maria Teresa Fiorillo; Fabiana Paladini; Rosa Sorrentino; Wolfram Saenger; Pravin Kumar; Andreas Ziegler; Barbara Uchanska-Ziegler";J Biol Chem;2008;Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes.;;838384;Linear peptide;RRKWRRWHL + CITR(R5, R6);400;408;;Vasoactive intestinal polypeptide receptor 1 precursor;Vasoactive intestinal polypeptide receptor 1;P32241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;PDB 3HCV (v1.3);x-ray crystallography;3D structure;angstroms;Positive;=;2.0;3HCV;HLA-B*27:09;I;The crystal structure of HLA-B*2709 complexed with the double citrullinated vasoactive intestinal peptide type 1 receptor (VIPR) peptide was determined.
4552057;1013101;Literature;18650441;"Alessandra Beltrami; Maxim Rossmann; Maria Teresa Fiorillo; Fabiana Paladini; Rosa Sorrentino; Wolfram Saenger; Pravin Kumar; Andreas Ziegler; Barbara Uchanska-Ziegler";J Biol Chem;2008;Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes.;;838384;Linear peptide;RRKWRRWHL + CITR(R5, R6);400;408;;Vasoactive intestinal polypeptide receptor 1 precursor;Vasoactive intestinal polypeptide receptor 1;P32241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;PDB 3DTX (v1.2);x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3DTX;HLA-B*27:05;I;The crystal structure of HLA-B*2705 complexed with the double citrullinated vasoactive intestinal peptide type 1 receptor (VIPR) peptide was determined.
4552098;1033675;Literature;21561910;"Jun Liu; Lianpan Dai; Jianxun Qi; Feng Gao; Youjun Feng; Wenjun Liu; Jinghua Yan; George F Gao";J Virol;2011;Diverse peptide presentation of rhesus macaque major histocompatibility complex class I Mamu-A 02 revealed by two peptide complex structures and insights into immune escape of simian immunodeficiency virus.;;76175;Linear peptide;YTSGPGIRY;159;167;;nef protein [Simian immunodeficiency virus];Protein Nef;P05862;Simian immunodeficiency virus;Simian immunodeficiency virus;11723;;;;;;;;;;;;;rhesus macaque (Macaca mulatta);9544;Table 1, Figures 1, 3, 4, 5 and PDB 3JTT (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.8;3JTT;Mamu-A1*002:01;I;"The crystal structure of the epitope/Mamu-A*02 complex was determined by molecular replacement. The complex contained rhesus &szlig;2m. There are three molecules in one asymmetric unit."
4552099;1033675;Literature;21561910;"Jun Liu; Lianpan Dai; Jianxun Qi; Feng Gao; Youjun Feng; Wenjun Liu; Jinghua Yan; George F Gao";J Virol;2011;Diverse peptide presentation of rhesus macaque major histocompatibility complex class I Mamu-A 02 revealed by two peptide complex structures and insights into immune escape of simian immunodeficiency virus.;;22314;Linear peptide;GSENLKSLY;71;79;;gag protein;Gag polyprotein;P05894;Simian immunodeficiency virus;Simian immunodeficiency virus;11723;;;;;;;;;;;;;rhesus macaque (Macaca mulatta);9544;Table 1, Figures 1, 3, 4, 5 and PDB 3JTS (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.8;3JTS;Mamu-A1*002:01;I;"The crystal structure of the epitope/Mamu-A*02 complex was determined by molecular replacement. The complex contained human &szlig;2m. There are three molecules in one asymmetric unit."
4552199;1033676;Literature;25028510;"Saeko Yanaka; Takamasa Ueno; Yi Shi; Jianxun Qi; George F Gao; Kouhei Tsumoto; Kenji Sugase";J Biol Chem;2014;Peptide-dependent conformational fluctuation determines the stability of the human leukocyte antigen class I complex.;;841202;Linear peptide;RPQVPLRPMTY;70;80;;Nef protein;Protein Nef;P04601;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Table 1 and PDB 4LNR (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.0;4LNR;HLA-B*35:01;I;The crystal structure of the epitope/HLA-B*35:01 complex was determined.
4557313;1033677;Literature;26523866;"Jarrett J Adams; Samanthi Narayanan; Michael E Birnbaum; Sachdev S Sidhu; Sydney J Blevins; Marvin H Gee; Leah V Sibener; Brian M Baker; David M Kranz; K Christopher Garcia";Nat Immunol;2016;Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity.;;857138;Linear peptide;VPYMAEFGM;;;;;;;;;;;mimotope;Fragment of a Natural Sequence Molecule;QLSPFPFDL;932;940;;Alpha-ketoglutarate dehydrogenase, 2-oxoglutarate dehydrogenase complex component E1, OGDC-E1;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Supplementary Table 1 and PDB 4N5E (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;3.1;4N5E;H2-Ld;I;The crystal structure of the epitope/H-2Ld complex bound by the 42F3 TCR was determined. A mini-H-2Ld scaffold (m31r) was used to present the epitope.
4562386;1033677;Literature;26523866;"Jarrett J Adams; Samanthi Narayanan; Michael E Birnbaum; Sachdev S Sidhu; Sydney J Blevins; Marvin H Gee; Leah V Sibener; Brian M Baker; David M Kranz; K Christopher Garcia";Nat Immunol;2016;Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity.;;855540;Linear peptide;QPAEGGFQL;;;;;;;;;;;mimotope;Fragment of a Natural Sequence Molecule;QLSPFPFDL;932;940;;Alpha-ketoglutarate dehydrogenase, 2-oxoglutarate dehydrogenase complex component E1, OGDC-E1;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Supplementary Table 1 and PDB 4MVB (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;3.1;4MVB;H2-Ld;I;The crystal structure of the epitope/H-2Ld complex bound by the 42F3 TCR was determined. A mini-H-2Ld scaffold (m31r) was used to present the epitope.
4562388;1033677;Literature;26523866;"Jarrett J Adams; Samanthi Narayanan; Michael E Birnbaum; Sachdev S Sidhu; Sydney J Blevins; Marvin H Gee; Leah V Sibener; Brian M Baker; David M Kranz; K Christopher Garcia";Nat Immunol;2016;Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity.;;856305;Linear peptide;SPAEAGFFL;;;;;;;;;;;mimotope;Fragment of a Natural Sequence Molecule;QLSPFPFDL;932;940;;Alpha-ketoglutarate dehydrogenase, 2-oxoglutarate dehydrogenase complex component E1, OGDC-E1;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Supplementary Table 1 and PDB 4MS8 (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;1.9;4MS8;H2-Ld;I;The crystal structure of the epitope/H-2Ld complex bound by the 42F3 TCR was determined. A mini-H-2Ld scaffold (m31r) was used to present the epitope.
4562390;1033677;Literature;26523866;"Jarrett J Adams; Samanthi Narayanan; Michael E Birnbaum; Sachdev S Sidhu; Sydney J Blevins; Marvin H Gee; Leah V Sibener; Brian M Baker; David M Kranz; K Christopher Garcia";Nat Immunol;2016;Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity.;;856307;Linear peptide;SPAPRPLDL;;;;;;;;;;;mimotope;Fragment of a Natural Sequence Molecule;QLSPFPFDL;932;940;;Alpha-ketoglutarate dehydrogenase, 2-oxoglutarate dehydrogenase complex component E1, OGDC-E1;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Supplementary Table 1 and PDB 4MXQ (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.6;4MXQ;H2-Ld;I;The crystal structure of the epitope/H-2Ld complex bound by the 42F3 TCR was determined. A mini-H-2Ld scaffold (m31r) was used to present the epitope.
4562392;1033677;Literature;26523866;"Jarrett J Adams; Samanthi Narayanan; Michael E Birnbaum; Sachdev S Sidhu; Sydney J Blevins; Marvin H Gee; Leah V Sibener; Brian M Baker; David M Kranz; K Christopher Garcia";Nat Immunol;2016;Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity.;;854605;Linear peptide;MPAGRPWDL;;;;;;;;;;;mimotope;Fragment of a Natural Sequence Molecule;QLSPFPFDL;932;940;;Alpha-ketoglutarate dehydrogenase, 2-oxoglutarate dehydrogenase complex component E1, OGDC-E1;2-oxoglutarate dehydrogenase, mitochondrial;2-oxoglutarate dehydrogenase, mitochondrial;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Supplementary Table 1 and PDB 4N0C (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.9;4N0C;H2-Ld;I;The crystal structure of the epitope/H-2Ld complex bound by the 42F3 TCR was determined. A mini-H-2Ld scaffold (m31r) was used to present the epitope.
4562605;1002510;Literature;16221670;"Christine R&uuml;ckert; Maria Teresa Fiorillo; Bernhard Loll; Roberto Moretti; Jacek Biesiadka; Wolfram Saenger; Andreas Ziegler; Rosa Sorrentino; Barbara Uchanska-Ziegler";J Biol Chem;2006;Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLA-B27 subtype.;;126988;Linear peptide;RRRWHRWRL;412;420;;glucagon receptor;Glucagon receptor;P47871;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;PDB 3CZF (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;1.2;3CZF;HLA-B*27:09;I;The crystal structure of the epitope/HLA-B*27:09 complex was determined.
4562606;1007776;Literature;18083574;"Michael Koch; Simon Camp; Trevor Collen; David Avila; Jan Salomonsen; Hans-Joachim Wallny; Andrew van Hateren; Lawrence Hunt; Jansen P Jacob; Fiona Johnston; Denise A Marston; Iain Shaw; P Rod Dunbar; Vincenzo Cerundolo; E Yvonne Jones; Jim Kaufman";Immunity;2007;Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding.;;20110;Linear peptide;GHAEEYGADTL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;GHAEEYGAETL;20;30;;HBAA;Hemoglobin subunit alpha-A (Hemoglobin alpha-A chain) (Alpha-A-globin);Hemoglobin subunit alpha-A;Gallus gallus;Gallus gallus;chicken (Gallus gallus);9031;PDB 5AD0 (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.8;5AD0;BF2*2101;I;The crystal structure of the epitope/BF2*2101 complex was determined. Entry 5AD0 supersedes 2YF1.
4562607;1007776;Literature;18083574;"Michael Koch; Simon Camp; Trevor Collen; David Avila; Jan Salomonsen; Hans-Joachim Wallny; Andrew van Hateren; Lawrence Hunt; Jansen P Jacob; Fiona Johnston; Denise A Marston; Iain Shaw; P Rod Dunbar; Vincenzo Cerundolo; E Yvonne Jones; Jim Kaufman";Immunity;2007;Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding.;;419373;Linear peptide;TAGQSNYDRL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;TAGQEDYDRL;60;69;;;Rho-related GTP-binding protein RhoC;Rho-related GTP-binding protein RhoC;Gallus gallus;Gallus gallus;chicken (Gallus gallus);9031;PDB 4D0C (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.8;4D0C;BF2*2101;I;The crystal structure of the epitope/BF2*2101 complex was determined. Entry 5AD0 supersedes 2YF1. Entry 4D0C supersedes 2YF5.
4562609;1007776;Literature;18083574;"Michael Koch; Simon Camp; Trevor Collen; David Avila; Jan Salomonsen; Hans-Joachim Wallny; Andrew van Hateren; Lawrence Hunt; Jansen P Jacob; Fiona Johnston; Denise A Marston; Iain Shaw; P Rod Dunbar; Vincenzo Cerundolo; E Yvonne Jones; Jim Kaufman";Immunity;2007;Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding.;;419372;Linear peptide;TAGQEDYDRL;60;69;;Rho-related GTP-binding protein RhoC;Rho-related GTP-binding protein RhoC;Q9PSX7;Gallus gallus;Gallus gallus;9031;;;;;;;;;;;;;chicken (Gallus gallus);9031;PDB 4D0B (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.8;4D0B;BF2*2101;I;The crystal structure of the epitope/BF2*2101 complex was determined. Entry 5AD0 supersedes 2YF1. Entry 4D0B supersedes 2YF6.
4562610;1007776;Literature;18083574;"Michael Koch; Simon Camp; Trevor Collen; David Avila; Jan Salomonsen; Hans-Joachim Wallny; Andrew van Hateren; Lawrence Hunt; Jansen P Jacob; Fiona Johnston; Denise A Marston; Iain Shaw; P Rod Dunbar; Vincenzo Cerundolo; E Yvonne Jones; Jim Kaufman";Immunity;2007;Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding.;;21984;Linear peptide;GRAEEYGADTL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;GHAEEYGAETL;20;30;;HBAA;Hemoglobin subunit alpha-A (Hemoglobin alpha-A chain) (Alpha-A-globin);Hemoglobin subunit alpha-A;Gallus gallus;Gallus gallus;chicken (Gallus gallus);9031;PDB 5ACZ (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.7;5ACZ;BF2*2101;I;The crystal structure of the epitope/BF2*2101 complex was determined.
4562690;1025254;Literature;22837158;"Eva B Allerbring; Adil D Duru; Hannes Uchtenhagen; Chaithanya Madhurantakam; Markus B Tomek; Sebastian Grimm; Pooja A Mazumdar; Rosmarie Friemann; Michael Uhlin; Tatyana Sandalova; Per-&Aring;ke Nygren; Adnane Achour";Eur J Immunol;2012;Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics.;;839017;Linear peptide;KAPANFATM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis virus (strain WE);Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;PDB 3TBS (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.5;3TBS;H2-Db;I;The crystal structure of the epitope in complex with H-2Db was determined.
4562691;1025254;Literature;22837158;"Eva B Allerbring; Adil D Duru; Hannes Uchtenhagen; Chaithanya Madhurantakam; Markus B Tomek; Sebastian Grimm; Pooja A Mazumdar; Rosmarie Friemann; Michael Uhlin; Tatyana Sandalova; Per-&Aring;ke Nygren; Adnane Achour";Eur J Immunol;2012;Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics.;;839019;Linear peptide;KAPSNFATM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis virus (strain WE);Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;PDB 3TBT (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.3;3TBT;H2-Db;I;The crystal structure of the epitope in complex with H-2Db was determined.
4562692;1025254;Literature;22837158;"Eva B Allerbring; Adil D Duru; Hannes Uchtenhagen; Chaithanya Madhurantakam; Markus B Tomek; Sebastian Grimm; Pooja A Mazumdar; Rosmarie Friemann; Michael Uhlin; Tatyana Sandalova; Per-&Aring;ke Nygren; Adnane Achour";Eur J Immunol;2012;Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics.;;839021;Linear peptide;KGPANFATM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis virus (strain WE);Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;PDB 3TBV (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.1;3TBV;H2-Db;I;The crystal structure of the epitope in complex with H-2Db was determined.
4562693;1025254;Literature;22837158;"Eva B Allerbring; Adil D Duru; Hannes Uchtenhagen; Chaithanya Madhurantakam; Markus B Tomek; Sebastian Grimm; Pooja A Mazumdar; Rosmarie Friemann; Michael Uhlin; Tatyana Sandalova; Per-&Aring;ke Nygren; Adnane Achour";Eur J Immunol;2012;Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics.;;839022;Linear peptide;KGPSNFATM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis virus (strain WE);Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;PDB 3TBW (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.2;3TBW;H2-Db;I;The crystal structure of the epitope in complex with H-2Db was determined.
4562701;1025254;Literature;22837158;"Eva B Allerbring; Adil D Duru; Hannes Uchtenhagen; Chaithanya Madhurantakam; Markus B Tomek; Sebastian Grimm; Pooja A Mazumdar; Rosmarie Friemann; Michael Uhlin; Tatyana Sandalova; Per-&Aring;ke Nygren; Adnane Achour";Eur J Immunol;2012;Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics.;;839018;Linear peptide;KAPFNFATM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;KAVYNFATC;33;41;;;Glycoprotein polyprotein;Pre-glycoprotein polyprotein GP complex;Lymphocytic choriomeningitis virus (strain WE);Lymphocytic choriomeningitis mammarenavirus;mouse (Mus musculus);10090;PDB 3TBY (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.5;3TBY;H2-Db;I;The crystal structure of the epitope in complex with H-2Db was determined.
4583645;1033760;Literature;30224695;"Timothy P Riley; Lance M Hellman; Marvin H Gee; Juan L Mendoza; Jesus A Alonso; Kendra C Foley; Michael I Nishimura; Craig W Vander Kooi; K Christopher Garcia; Brian M Baker";Nat Chem Biol;2018;T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptability.;;850848;Linear peptide;MMWDRGLGMM;;;;;;;;;;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 2, Supplementary Table 4, Supplementary Figure 1 and PDB 6AMT (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.5;6AMT;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex was determined. There are two molecules in the asymmetric unit.
4583647;1033760;Literature;30224695;"Timothy P Riley; Lance M Hellman; Marvin H Gee; Juan L Mendoza; Jesus A Alonso; Kendra C Foley; Michael I Nishimura; Craig W Vander Kooi; K Christopher Garcia; Brian M Baker";Nat Chem Biol;2018;T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptability.;;850848;Linear peptide;MMWDRGLGMM;;;;;;;;;;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Table 4 and PDB 6AMU (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.2;6AMU;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound by the DMF5 TCR was determined.
4583651;1033760;Literature;30224695;"Timothy P Riley; Lance M Hellman; Marvin H Gee; Juan L Mendoza; Jesus A Alonso; Kendra C Foley; Michael I Nishimura; Craig W Vander Kooi; K Christopher Garcia; Brian M Baker";Nat Chem Biol;2018;T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptability.;;850880;Linear peptide;SMLGIGIVPV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Supplementary Table 4 and PDB 6AM5 (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.4;6AM5;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02:01 complex bound by the DMF5 TCR was determined.
4988502;1034118;Literature;30365927;"Fiyaz Mohammed; Daniel H Stones; Benjamin E Willcox";J Immunol Methods;2019;Application of the immunoregulatory receptor LILRB1 as a crystallisation chaperone for human class I MHC complexes.;;27125;Linear peptide;ILKEPVHGV;902;910;;Gag-Pol polyprotein;Gag-Pol polyprotein;P04585;HIV-1 M:B_MN;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Table 2 and PDB 6EWA;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;6EWA;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 bound by LILRB1 D1D2 region was determined by molecular replacement. There are two complexes in the asymmetric unit.
4988504;1034118;Literature;30365927;"Fiyaz Mohammed; Daniel H Stones; Benjamin E Willcox";J Immunol Methods;2019;Application of the immunoregulatory receptor LILRB1 as a crystallisation chaperone for human class I MHC complexes.;;153880;Linear peptide;RTFSPTYGL;426;434;;Synemin;Synemin;O15061;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 3, Table 2 and PDB 6EWO;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;6EWO;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 bound by LILRB1 D1D2 region was determined by molecular replacement. There are two complexes in the asymmetric unit.
4988505;1034118;Literature;30365927;"Fiyaz Mohammed; Daniel H Stones; Benjamin E Willcox";J Immunol Methods;2019;Application of the immunoregulatory receptor LILRB1 as a crystallisation chaperone for human class I MHC complexes.;;859338;Linear peptide;RLSSPLHFV;400;408;;Protein FAM134A;Protein FAM134A;Q8NC44;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 3, Table 2 and PDB 6EWC;x-ray crystallography;3D structure;angstroms;Positive;=;3.2;6EWC;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 bound by LILRB1 D1D2 region was determined by molecular replacement. There are two complexes in the asymmetric unit.
4988518;1034107;Literature;30341185;"Jin Xiao; Wangzhen Xiang; Yongli Zhang; Weiyu Peng; Min Zhao; Ling Niu; Yan Chai; Jianxun Qi; Fei Wang; Peng Qi; Chungang Pan; Lingxia Han; Ming Wang; Jim Kaufman; George F Gao; William J Liu";J Immunol;2018;An Invariant Arginine in Common with MHC Class II Allows Extension at the C-Terminal End of Peptides Bound to Chicken MHC Class I.;;38389;Linear peptide;LPACVLEV;517;524;;scr;;;Rous sarcoma virus;Rous sarcoma virus;11886;;;;;;;;;;;;;chicken (Gallus gallus);9031;Figures 2, 5, S2, Table II and PDB 5YMW (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5YMW;BF2*1201;I;The crystal structure of the epitope/BF2*1201 complex was determined by molecular replacement.
4988519;1034107;Literature;30341185;"Jin Xiao; Wangzhen Xiang; Yongli Zhang; Weiyu Peng; Min Zhao; Ling Niu; Yan Chai; Jianxun Qi; Fei Wang; Peng Qi; Chungang Pan; Lingxia Han; Ming Wang; Jim Kaufman; George F Gao; William J Liu";J Immunol;2018;An Invariant Arginine in Common with MHC Class II Allows Extension at the C-Terminal End of Peptides Bound to Chicken MHC Class I.;;175571;Linear peptide;AVKGVGTMV;181;189;;nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/chicken/Italy/1067/1999(H7N1));Influenza A virus;11320;;;;;;;;;;;;;chicken (Gallus gallus);9031;Figures 2, 5, S2, Table II and PDB 5YMV (v1.0);x-ray crystallography;3D structure;angstroms;Positive;=;2.1;5YMV;BF2*1201;I;The crystal structure of the epitope/BF2*1201 complex was determined by molecular replacement.
4988678;1034120;Literature;30352798;"Eleanor Clancy-Thompson; Christine A Devlin; Paul M Tyler; Mariah M Servos; Lestat R Ali; Katherine S Ventre; M Aladdin Bhuiyan; Patrick T Bruck; Michael E Birnbaum; Stephanie K Dougan";Cancer Immunol Res;2018;"Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8&lt;sup&gt;+&lt;/sup&gt; T Cell-Effector Responses.";;181475;Linear peptide;TAPDNLGYM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;TAPDNLGYA;455;463;;DHICA oxidase, Tyrosinase-related protein 1, Catalase B, Brown locus protein, TRP-1, TRP1;5,6-dihydroxyindole-2-carboxylic acid oxidase;5,6-dihydroxyindole-2-carboxylic acid oxidase;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Figure 2, Supplementary Figure S1, Supplementary Table S1 and PDB 6MP0 (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.0;6MP0;H2-Db;I;The crystal structures of the epitope/ H-2Db complex was determined. The epitope is expressed as a peptide-beta2M-H-2Db single-chain trimer. The single-chain trimer was constructed with the C-terminus of the TRP1-M9 peptide linked to the N-terminus of mouse beta2M via a 15-amino acid (GGGGS)3 linker, the C-terminus of beta2M linked to the N-terminus of H-2Db with a 20 amino acid (GGGS)4 linker.
4988679;1034120;Literature;30352798;"Eleanor Clancy-Thompson; Christine A Devlin; Paul M Tyler; Mariah M Servos; Lestat R Ali; Katherine S Ventre; M Aladdin Bhuiyan; Patrick T Bruck; Michael E Birnbaum; Stephanie K Dougan";Cancer Immunol Res;2018;"Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8&lt;sup&gt;+&lt;/sup&gt; T Cell-Effector Responses.";;858325;Linear peptide;TAPDNLGKM;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;TAPDNLGYA;455;463;;DHICA oxidase, Tyrosinase-related protein 1, Catalase B, Brown locus protein, TRP-1, TRP1;5,6-dihydroxyindole-2-carboxylic acid oxidase;5,6-dihydroxyindole-2-carboxylic acid oxidase;Mus musculus;Mus musculus;mouse (Mus musculus);10090;Figure 2, Supplementary Figure S1, Supplementary Table S1 and PDB 6MP1 (v1.1);x-ray crystallography;3D structure;angstroms;Positive;=;2.2;6MP1;H2-Db;I;The crystal structures of the epitope/ H-2Db complex was determined. The epitope is expressed as a peptide-beta2M-H-2Db single-chain trimer. The single-chain trimer was constructed with the C-terminus of the TRP1-K8 peptide linked to the N-terminus of mouse beta2M via a 15-amino acid (GGGGS)3 linker, the C-terminus of beta2M linked to the N-terminus of H-2Db with a 20 amino acid (GGGS)4 linker.
5018729;1034317;Literature;30410026;"Patricia T Illing; Phillip Pymm; Nathan P Croft; Hugo G Hilton; Vladimir Jojic; Alex S Han; Juan L Mendoza; Nicole A Mifsud; Nadine L Dudek; James McCluskey; Peter Parham; Jamie Rossjohn; Julian P Vivian; Anthony W Purcell";Nat Commun;2018;HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome.;;176338;Linear peptide;LTVQVARVY;27;35;;Uncharacterized protein C21orf59;UPF0769 protein C21orf59;P57076;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 4, Supplementary Figure 8 and PDB 5VUF;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;5VUF;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex was determined.
5018730;1034317;Literature;30410026;"Patricia T Illing; Phillip Pymm; Nathan P Croft; Hugo G Hilton; Vladimir Jojic; Alex S Han; Juan L Mendoza; Nicole A Mifsud; Nadine L Dudek; James McCluskey; Peter Parham; Jamie Rossjohn; Julian P Vivian; Anthony W Purcell";Nat Commun;2018;HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome.;;176338;Linear peptide;LTVQVARVY;27;35;;Uncharacterized protein C21orf59;UPF0769 protein C21orf59;P57076;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 2, Figure 4, Supplementary Figure 8 and PDB 5VWF;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;5VWF;HLA-B*57:03;I;The crystal structure of the epitope/HLA-B*57:03 complex was determined.
5018735;1034317;Literature;30410026;"Patricia T Illing; Phillip Pymm; Nathan P Croft; Hugo G Hilton; Vladimir Jojic; Alex S Han; Juan L Mendoza; Nicole A Mifsud; Nadine L Dudek; James McCluskey; Peter Parham; Jamie Rossjohn; Julian P Vivian; Anthony W Purcell";Nat Commun;2018;HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome.;;860887;Linear peptide;LSSPVTKSW;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LSSPVTKSF;93;101;;;Ig kappa chain C region;Ig kappa chain C region;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 2, Figure 4, Supplementary Figures 8, 9 and PDB 5VUD;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5VUD;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex was determined.
5018736;1034317;Literature;30410026;"Patricia T Illing; Phillip Pymm; Nathan P Croft; Hugo G Hilton; Vladimir Jojic; Alex S Han; Juan L Mendoza; Nicole A Mifsud; Nadine L Dudek; James McCluskey; Peter Parham; Jamie Rossjohn; Julian P Vivian; Anthony W Purcell";Nat Commun;2018;HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome.;;860887;Linear peptide;LSSPVTKSW;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LSSPVTKSF;93;101;;;Ig kappa chain C region;Ig kappa chain C region;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 2, Figure 4, Supplementary Figures 8, 9 and PDB 5VVP;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5VVP;HLA-B*57:03;I;The crystal structure of the epitope/HLA-B*57:03 complex was determined.
5018737;1034317;Literature;30410026;"Patricia T Illing; Phillip Pymm; Nathan P Croft; Hugo G Hilton; Vladimir Jojic; Alex S Han; Juan L Mendoza; Nicole A Mifsud; Nadine L Dudek; James McCluskey; Peter Parham; Jamie Rossjohn; Julian P Vivian; Anthony W Purcell";Nat Commun;2018;HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome.;;860964;Linear peptide;LTVQVARVW;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LTVQVARVY;27;35;;;Uncharacterized protein C21orf59;UPF0769 protein C21orf59;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 2, Figure 4, Supplementary Figure 8 and PDB 5VUE;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;5VUE;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex was determined.
5018738;1034317;Literature;30410026;"Patricia T Illing; Phillip Pymm; Nathan P Croft; Hugo G Hilton; Vladimir Jojic; Alex S Han; Juan L Mendoza; Nicole A Mifsud; Nadine L Dudek; James McCluskey; Peter Parham; Jamie Rossjohn; Julian P Vivian; Anthony W Purcell";Nat Commun;2018;HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome.;;860964;Linear peptide;LTVQVARVW;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LTVQVARVY;27;35;;;Uncharacterized protein C21orf59;UPF0769 protein C21orf59;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 2, Figure 4, Supplementary Figure 8 and PDB 5VWD;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;5VWD;HLA-B*57:03;I;The crystal structure of the epitope/HLA-B*57:03 complex was determined.
5018743;1034317;Literature;30410026;"Patricia T Illing; Phillip Pymm; Nathan P Croft; Hugo G Hilton; Vladimir Jojic; Alex S Han; Juan L Mendoza; Nicole A Mifsud; Nadine L Dudek; James McCluskey; Peter Parham; Jamie Rossjohn; Julian P Vivian; Anthony W Purcell";Nat Commun;2018;HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome.;;860887;Linear peptide;LSSPVTKSW;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LSSPVTKSF;93;101;;;Ig kappa chain C region;Ig kappa chain C region;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 2, Figure 4, Supplementary Figures 8, 9 and PDB 5VWH;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;5VWH;HLA-B*58:01;I;The crystal structure of the epitope/HLA-B*58:01 complex was determined.
5018744;1034317;Literature;30410026;"Patricia T Illing; Phillip Pymm; Nathan P Croft; Hugo G Hilton; Vladimir Jojic; Alex S Han; Juan L Mendoza; Nicole A Mifsud; Nadine L Dudek; James McCluskey; Peter Parham; Jamie Rossjohn; Julian P Vivian; Anthony W Purcell";Nat Commun;2018;HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome.;;860964;Linear peptide;LTVQVARVW;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;LTVQVARVY;27;35;;;Uncharacterized protein C21orf59;UPF0769 protein C21orf59;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 2, Figure 4, Supplementary Figure 8 and PDB 5VWJ;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5VWJ;HLA-B*58:01;I;The crystal structure of the epitope/HLA-B*58:01 complex was determined.
5019935;1034222;Literature;30552102;"Patricia M Benveniste; Sobhan Roy; Munehide Nakatsugawa; Edward L Y Chen; Linh Nguyen; Douglas G Millar; Pamela S Ohashi; Naoto Hirano; Erin J Adams; Juan Carlos Z&uacute;&ntilde;iga-Pfl&uuml;cker";Sci Immunol;2018;Generation and molecular recognition of melanoma-associated antigen-specific human gammadelta T cells.;;12941;Linear peptide;ELAGIGILTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 3, Table S4 and PDB 6D7G;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;6D7G;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*02 complex bound by the 5F3 TCR was determined. The pMHC was expressed as a single-chain trimeric HLA-A2/beta2M/MART-1 construct.
5039003;1034276;Literature;30575715;"Emma J Grant; Tracy M Josephs; Liyen Loh; E Bridie Clemens; Sneha Sant; Mandvi Bharadwaj; Weisan Chen; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Nat Commun;2018;"Broad CD8&lt;sup&gt;+&lt;/sup&gt; T cell cross-recognition of distinct influenza A strains in humans.";;15501;Linear peptide;FEDLRVLSF;338;346;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Supplementary Table 2 and PDB 6MT6;x-ray crystallography;3D structure;angstroms;Positive;=;1.3;6MT6;HLA-B*37:01;I;The crystal structure of the epitope/HLA-B*37:01 complex was determined.
5039004;1034276;Literature;30575715;"Emma J Grant; Tracy M Josephs; Liyen Loh; E Bridie Clemens; Sneha Sant; Mandvi Bharadwaj; Weisan Chen; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Nat Commun;2018;"Broad CD8&lt;sup&gt;+&lt;/sup&gt; T cell cross-recognition of distinct influenza A strains in humans.";;15501;Linear peptide;FEDLRVLSF;338;346;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Supplementary Table 2 and PDB 6MT3;x-ray crystallography;3D structure;angstroms;Positive;=;1.2;6MT3;HLA-B*18:01;I;The crystal structure of the epitope/HLA-B*18:01 complex was determined.
5039007;1034276;Literature;30575715;"Emma J Grant; Tracy M Josephs; Liyen Loh; E Bridie Clemens; Sneha Sant; Mandvi Bharadwaj; Weisan Chen; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Nat Commun;2018;"Broad CD8&lt;sup&gt;+&lt;/sup&gt; T cell cross-recognition of distinct influenza A strains in humans.";;15501;Linear peptide;FEDLRVLSF;338;346;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Supplementary Table 2 and PDB 6MTL;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;6MTL;HLA-B*44:05;I;The crystal structure of the epitope/HLA-B*44:05 complex was determined.
5039008;1034276;Literature;30575715;"Emma J Grant; Tracy M Josephs; Liyen Loh; E Bridie Clemens; Sneha Sant; Mandvi Bharadwaj; Weisan Chen; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Nat Commun;2018;"Broad CD8&lt;sup&gt;+&lt;/sup&gt; T cell cross-recognition of distinct influenza A strains in humans.";;15501;Linear peptide;FEDLRVLSF;338;346;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 6, Supplementary Table 2 and PDB 6MTM;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;6MTM;HLA-B*37:01;I;The crystal structure of the epitope/HLA-B*37:01 complex bound by the EM2 TCR was determined.
5040471;1034276;Literature;30575715;"Emma J Grant; Tracy M Josephs; Liyen Loh; E Bridie Clemens; Sneha Sant; Mandvi Bharadwaj; Weisan Chen; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Nat Commun;2018;"Broad CD8&lt;sup&gt;+&lt;/sup&gt; T cell cross-recognition of distinct influenza A strains in humans.";;15501;Linear peptide;FEDLRVLSF;338;346;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Supplementary Table 1;purified MHC/direct/fluorescence;50% dissociation temperature;"&deg;C";Positive;;47.5;6MTL;HLA-B*44:05;I;The thermal stability of the complex of the epitope refolded with HLA-B*44:05 was determined.
5040780;1034276;Literature;30575715;"Emma J Grant; Tracy M Josephs; Liyen Loh; E Bridie Clemens; Sneha Sant; Mandvi Bharadwaj; Weisan Chen; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Nat Commun;2018;"Broad CD8&lt;sup&gt;+&lt;/sup&gt; T cell cross-recognition of distinct influenza A strains in humans.";;97298;Linear peptide;FEDLRVSSF;338;346;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Wilson-Smith/1933(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, Supplementary Table 2 and PDB 6MT4;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;6MT4;HLA-B*37:01;I;The crystal structure of the epitope/HLA-B*37:01 complex was determined.
5040793;1034276;Literature;30575715;"Emma J Grant; Tracy M Josephs; Liyen Loh; E Bridie Clemens; Sneha Sant; Mandvi Bharadwaj; Weisan Chen; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska";Nat Commun;2018;"Broad CD8&lt;sup&gt;+&lt;/sup&gt; T cell cross-recognition of distinct influenza A strains in humans.";;872108;Linear peptide;FEDLRLLSF;338;346;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Memphis/4/1973(H3N2));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, Supplementary Table 2 and PDB 6MT5;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;6MT5;HLA-B*37:01;I;The crystal structure of the epitope/HLA-B*37:01 complex was determined.
5050120;1034647;Literature;30808808;"Ida Hafstrand; Ece Canan Sayitoglu; Anca Apavaloaei; Benjamin John Josey; Renhua Sun; Xiao Han; Sara Pellegrino; Didem Ozkazanc; Ren&eacute;e Potens; Linda Janssen; Johan Nilvebrant; Per-&Aring;ke Nygren; Tatyana Sandalova; Sebastian Springer; Anna-Maria Georgoudaki; Adil Doganay Duru; Adnane Achour";Proc Natl Acad Sci U S A;2019;Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin.;;892158;Linear peptide;GL;40;41;;Tapasin;Tapasin;Q9R233;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 1, Supplementary Table S1 and PDB 6GB6 (v1.2);x-ray crystallography;3D structure;angstroms;Positive;=;1.8;6GB6;H2-Kb;I;The crystal structure of the murine MHC-I allele H-2Kb in complex with the dipeptide GL was determined.
5050121;1034647;Literature;30808808;"Ida Hafstrand; Ece Canan Sayitoglu; Anca Apavaloaei; Benjamin John Josey; Renhua Sun; Xiao Han; Sara Pellegrino; Didem Ozkazanc; Ren&eacute;e Potens; Linda Janssen; Johan Nilvebrant; Per-&Aring;ke Nygren; Tatyana Sandalova; Sebastian Springer; Anna-Maria Georgoudaki; Adil Doganay Duru; Adnane Achour";Proc Natl Acad Sci U S A;2019;Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin.;;892158;Linear peptide;GL;40;41;;Tapasin;Tapasin;Q9R233;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 2, Supplementary Table S1 and PDB 6GB5 (v1.2);x-ray crystallography;3D structure;angstroms;Positive;=;2.3;6GB5;H2-Db;I;The crystal structure of the murine MHC-I allele H-2Db refolded with both dipeptide GL and a C-terminally truncated version of SEV corresponding to the stretch of residues FAPGNYP (FP7) was determined.
5050122;1034647;Literature;30808808;"Ida Hafstrand; Ece Canan Sayitoglu; Anca Apavaloaei; Benjamin John Josey; Renhua Sun; Xiao Han; Sara Pellegrino; Didem Ozkazanc; Ren&eacute;e Potens; Linda Janssen; Johan Nilvebrant; Per-&Aring;ke Nygren; Tatyana Sandalova; Sebastian Springer; Anna-Maria Georgoudaki; Adil Doganay Duru; Adnane Achour";Proc Natl Acad Sci U S A;2019;Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin.;;227161;Linear peptide;FAPGNYP;324;330;;Nucleoprotein;Nucleoprotein;O57286;Sendai virus (Z);Murine respirovirus;11191;;;;;;;;;;;;;mouse (Mus musculus);10090;Figure 2, Supplementary Table S1 and PDB 6GB5 (v1.2);x-ray crystallography;3D structure;angstroms;Positive;=;2.3;6GB5;H2-Db;I;The crystal structure of the murine MHC-I allele H-2Db  refolded with both dipeptide GL and a C-terminally truncated version of SEV corresponding to the stretch of residues FAPGNYP (FP7) was determined.
5050123;1034647;Literature;30808808;"Ida Hafstrand; Ece Canan Sayitoglu; Anca Apavaloaei; Benjamin John Josey; Renhua Sun; Xiao Han; Sara Pellegrino; Didem Ozkazanc; Ren&eacute;e Potens; Linda Janssen; Johan Nilvebrant; Per-&Aring;ke Nygren; Tatyana Sandalova; Sebastian Springer; Anna-Maria Georgoudaki; Adil Doganay Duru; Adnane Achour";Proc Natl Acad Sci U S A;2019;Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin.;;227161;Linear peptide;FAPGNYP;324;330;;Nucleoprotein;Nucleoprotein;O57286;Sendai virus (Z);Murine respirovirus;11191;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 3, S2, Supplementary Table S1 and PDB 6GB7 (v1.2);x-ray crystallography;3D structure;angstroms;Positive;=;2.2;6GB7;H2-Db;I;The crystal structure of H-2Db in complex with both the mouse tapasin-associated loop-derived TL10 (EDAGGGGLSK) and the peptide FP7 (FAPGNYP) was determined.
5050124;1034647;Literature;30808808;"Ida Hafstrand; Ece Canan Sayitoglu; Anca Apavaloaei; Benjamin John Josey; Renhua Sun; Xiao Han; Sara Pellegrino; Didem Ozkazanc; Ren&eacute;e Potens; Linda Janssen; Johan Nilvebrant; Per-&Aring;ke Nygren; Tatyana Sandalova; Sebastian Springer; Anna-Maria Georgoudaki; Adil Doganay Duru; Adnane Achour";Proc Natl Acad Sci U S A;2019;Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin.;;889731;Linear peptide;EDAGGGGLSK;34;43;;Tapasin;Tapasin;Q9R233;Mus musculus;Mus musculus;10090;;;;;;;;;;;;;mouse (Mus musculus);10090;Figures 3, S2, Supplementary Table S1 and PDB 6GB7 (v1.2);x-ray crystallography;3D structure;angstroms;Positive;=;2.2;6GB7;H2-Db;I;The crystal structure of H-2Db in complex with both the mouse tapasin-associated loop-derived TL10 (EDAGGGGLSK) and the peptide FP7 (FAPGNYP) was determined.
5346112;1034798;Literature;30315122;"Pouya Faridi; Chen Li; Sri H Ramarathinam; Julian P Vivian; Patricia T Illing; Nicole A Mifsud; Rochelle Ayala; Jiangning Song; Linden J Gearing; Paul J Hertzog; Nicola Ternette; Jamie Rossjohn; Nathan P Croft; Anthony W Purcell";Sci Immunol;2018;A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands.;;895308;Linear peptide;LALLTGVRW;;;;unknown protein eluted from human MHC allele;;;Homo sapiens;Homo sapiens;9606;The epitope is a cis-spliced peptide.;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, Table S3 and PDB 6D2T;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;6D2T;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex was determined. The epitope is a cis-spliced peptide comprised of LALLTG + VRW.
5346114;1034798;Literature;30315122;"Pouya Faridi; Chen Li; Sri H Ramarathinam; Julian P Vivian; Patricia T Illing; Nicole A Mifsud; Rochelle Ayala; Jiangning Song; Linden J Gearing; Paul J Hertzog; Nicola Ternette; Jamie Rossjohn; Nathan P Croft; Anthony W Purcell";Sci Immunol;2018;A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands.;;892355;Linear peptide;GSFDYSGVHLW;;;;unknown protein eluted from human MHC allele;;;Homo sapiens;Homo sapiens;9606;The epitope is a trans-spliced peptide.;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, Table S3 and PDB 6D2R;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;6D2R;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex was determined. The epitope is a trans-spliced peptide that could be spliced as either GSFDY + SGVHLW or GSFDYS + GVHLW.
5346115;1034798;Literature;30315122;"Pouya Faridi; Chen Li; Sri H Ramarathinam; Julian P Vivian; Patricia T Illing; Nicole A Mifsud; Rochelle Ayala; Jiangning Song; Linden J Gearing; Paul J Hertzog; Nicola Ternette; Jamie Rossjohn; Nathan P Croft; Anthony W Purcell";Sci Immunol;2018;A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands.;;906660;Linear peptide;TSMSFVPRPW;;;;unknown protein eluted from human MHC allele;;;Homo sapiens;Homo sapiens;9606;The epitope is a trans-spliced peptide.;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, Table S3 and PDB 6D29;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;6D29;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex was determined. The epitope is a trans-spliced peptide comprised of TSMSF + VPRPW.
5346120;1034798;Literature;30315122;"Pouya Faridi; Chen Li; Sri H Ramarathinam; Julian P Vivian; Patricia T Illing; Nicole A Mifsud; Rochelle Ayala; Jiangning Song; Linden J Gearing; Paul J Hertzog; Nicola Ternette; Jamie Rossjohn; Nathan P Croft; Anthony W Purcell";Sci Immunol;2018;A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands.;;897977;Linear peptide;LSDSTARDVTW;;;;unknown protein eluted from human MHC allele;;;Homo sapiens;Homo sapiens;9606;The epitope is a trans-spliced peptide.;;;;;;;;;;;;human (Homo sapiens);9606;Figure 3, Table S3 and PDB 6D2B;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;6D2B;HLA-B*57:01;I;The crystal structure of the epitope/HLA-B*57:01 complex was determined. The epitope is a trans-spliced peptide comprised of LSDSTA + RDVTW.
5346178;1034476;Literature;30617019;"Lance M Hellman; Kendra C Foley; Nishant K Singh; Jesus A Alonso; Timothy P Riley; Jason R Devlin; Cory M Ayres; Grant L J Keller; Yuting Zhang; Craig W Vander Kooi; Michael I Nishimura; Brian M Baker";Mol Ther;2019;Improving T Cell Receptor On-Target Specificity via Structure-Guided Design.;;12941;Linear peptide;ELAGIGILTV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 3, Table S2 and PDB 6D78;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;6D78;HLA-A*02:01;I;"The crystal structure of the epitope/HLA-A2 complex bound by the DMF5 (alphaD26Y, &szlig;L98W) TCR was determined."
5346181;1034476;Literature;30617019;"Lance M Hellman; Kendra C Foley; Nishant K Singh; Jesus A Alonso; Timothy P Riley; Jason R Devlin; Cory M Ayres; Grant L J Keller; Yuting Zhang; Craig W Vander Kooi; Michael I Nishimura; Brian M Baker";Mol Ther;2019;Improving T Cell Receptor On-Target Specificity via Structure-Guided Design.;;155;Linear peptide;AAGIGILTV;27;35;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Q16655;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figure S2, Table S2 and PDB 6DKP;x-ray crystallography;3D structure;angstroms;Positive;=;3.0;6DKP;HLA-A*02:01;I;"The crystal structure of the epitope/HLA-A2 complex bound by the DMF5(alphaD26Y, alphaY50A, &szlig;L98W) TCR was determined."
5376144;1034865;Literature;30930889;"Sarah A E Galloway; Garry Dolton; Meriem Attaf; Aaron Wall; Anna Fuller; Cristina Rius; Valentina Bianchi; Sarah Theaker; Angharad Lloyd; Marine E Caillaud; Inge Marie Svane; Marco Donia; David K Cole; Barbara Szomolay; Pierre Rizkallah; Andrew K Sewell";Front Immunol;2019;Peptide Super-Agonist Enhances T-Cell Responses to Melanoma.;;910618;Linear peptide;MTSAIGILPV;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;EAAGIGILTV;26;35;;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Figure 6, Table 2 and PDB 6G3J;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;6G3J;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex was determined.
5637586;1035262;Literature;31091334;"Florian Madura; Pierre J Rizkallah; Mateusz Legut; Christopher J Holland; Anna Fuller; Anna Bulek; Andrea J Schauenburg; Andrew Trimby; Jade R Hopkins; Stephen A Wells; Andrew Godkin; John J Miles; Malkit Sami; Yi Li; Nathaniel Liddy; Bent K Jakobsen; E Joel Loveridge; David K Cole; Andrew K Sewell";Eur J Immunol;2019;TCR-induced alteration of primary MHC peptide anchor residue.;;155;Linear peptide;AAGIGILTV;27;35;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Q16655;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 3, Supplementary Table S1 and PDB 6EQA;x-ray crystallography;3D structure;angstroms;Positive;=;3.2;6EQA;HLA-A*02:01;I;The crystal structure of the HLA-A*0201/epitope complex bound by the MEL5 TCR was determined by molecular replacement.
5637587;1035262;Literature;31091334;"Florian Madura; Pierre J Rizkallah; Mateusz Legut; Christopher J Holland; Anna Fuller; Anna Bulek; Andrea J Schauenburg; Andrew Trimby; Jade R Hopkins; Stephen A Wells; Andrew Godkin; John J Miles; Malkit Sami; Yi Li; Nathaniel Liddy; Bent K Jakobsen; E Joel Loveridge; David K Cole; Andrew K Sewell";Eur J Immunol;2019;TCR-induced alteration of primary MHC peptide anchor residue.;;155;Linear peptide;AAGIGILTV;27;35;;Melanoma antigen recognized by T-cells 1;Melanoma antigen recognized by T-cells 1;Q16655;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 2, 3, Supplementary Table S1 and PDB 6EQB;x-ray crystallography;3D structure;angstroms;Positive;=;2.8;6EQB;HLA-A*02:01;I;"The crystal structure of the HLA-A*0201/epitope complex bound by the alpha24&szlig;17 TCR was determined by molecular replacement."
5645262;1035140;Literature;31076531;"Zehui Qu; Zibin Li; Lizhen Ma; Xiaohui Wei; Lijie Zhang; Ruiying Liang; Geng Meng; Nianzhi Zhang; Chun Xia";J Immunol;2019;Structure and Peptidome of the Bat MHC Class I Molecule Reveal a Novel Mechanism Leading to High-Affinity Peptide Binding.;;540360;Linear peptide;DFANTFLP;481;488;;phosphoprotein P;Phosphoprotein;O55778;Hendra henipavirus;Hendra henipavirus;63330;;;;;;;;;;;;;black flying fox (Pteropus alecto);9402;Figures 1, 2, Table I and PDB 6ILC;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;6ILC;Ptal-N*01:01;I;The crystal structure of Ptal-N*01:01 presenting the HEV-derived epitope octapeptide HEV-1 was determined by molecular replacement.
5645263;1035140;Literature;31076531;"Zehui Qu; Zibin Li; Lizhen Ma; Xiaohui Wei; Lijie Zhang; Ruiying Liang; Geng Meng; Nianzhi Zhang; Chun Xia";J Immunol;2019;Structure and Peptidome of the Bat MHC Class I Molecule Reveal a Novel Mechanism Leading to High-Affinity Peptide Binding.;;540360;Linear peptide;DFANTFLP;481;488;;phosphoprotein P;Phosphoprotein;O55778;Hendra henipavirus;Hendra henipavirus;63330;;;;;;;;;;;;;black flying fox (Pteropus alecto);9402;Figure 6, Table I and PDB 6ILE;x-ray crystallography;3D structure;angstroms;Positive;=;2.9;6ILE;Ptal-N*01:01;I;"The crystal structure of  mutant Ptal-N*01:01 &Delta;MDL (residues M52, D53, L54 deleted in alpha1 domain), presenting the HEV-derived epitope octapeptide HEV-1 was determined by molecular replacement."
5645264;1035140;Literature;31076531;"Zehui Qu; Zibin Li; Lizhen Ma; Xiaohui Wei; Lijie Zhang; Ruiying Liang; Geng Meng; Nianzhi Zhang; Chun Xia";J Immunol;2019;Structure and Peptidome of the Bat MHC Class I Molecule Reveal a Novel Mechanism Leading to High-Affinity Peptide Binding.;;540380;Linear peptide;DYINTNLVP;177;185;;fusion protein;Fusion glycoprotein F0;O89342;Hendra henipavirus;Hendra henipavirus;63330;;;;;;;;;;;;;black flying fox (Pteropus alecto);9402;Figure 1, Table I and PDB 6ILF;x-ray crystallography;3D structure;angstroms;Positive;=;2.7;6ILF;Ptal-N*01:01;I;The crystal structure of Ptal-N*01:01 presenting the HEV-derived epitope nonapeptide HEV-2 was determined by molecular replacement.
5645265;1035140;Literature;31076531;"Zehui Qu; Zibin Li; Lizhen Ma; Xiaohui Wei; Lijie Zhang; Ruiying Liang; Geng Meng; Nianzhi Zhang; Chun Xia";J Immunol;2019;Structure and Peptidome of the Bat MHC Class I Molecule Reveal a Novel Mechanism Leading to High-Affinity Peptide Binding.;;923220;Linear peptide;DFANTFLL;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;DFANTFLP;481;488;;;phosphoprotein P;Phosphoprotein;Hendra henipavirus;Hendra henipavirus;black flying fox (Pteropus alecto);9402;Figure 5, Table I and PDB 6ILG;x-ray crystallography;3D structure;angstroms;Positive;=;2.6;6ILG;Ptal-N*01:01;I;The crystal structure of Ptal-N*01:01 presenting the HEV-1 variant epitope with subsititution P8L was determined by molecular replacement.
5649858;1035321;Literature;31324690;"Sunil Kumar Saini; Tripti Tamhane; Raghavendra Anjanappa; Ankur Saikia; Sofie Ramskov; Marco Donia; Inge Marie Svane; S&oslash;ren Nyboe Jakobsen; Maria Garcia-Alai; Martin Zacharias; Rob Meijers; Sebastian Springer; Sine Reker Hadrup";Sci Immunol;2019;Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells.;;44920;Linear peptide;NLVPMVATV;495;503;;tegument protein pp65;65 kDa phosphoprotein;Q6SW59;Human betaherpesvirus 5;Human betaherpesvirus 5;10359;;;;;;;;;;;;;human (Homo sapiens);9606;Figure 1, Table S1 and PDB 6Q3K;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;6Q3K;HLA-A*02:01;I;The crystal structure of the epitope bound to HLA-A*02:01 was determined. HLA-A*02:01 was a disulfide-stabilized variant (called DS-A2) with two cysteines introduced at positions 84 (Y84C) and 139 (A139C) of the heavy chain to increase the stability of the peptide-free state.
5710330;1035443;Literature;31296658;"Ronja Driller; Martin Ballaschk; Peter Schmieder; Barbara Uchanska-Ziegler; Andreas Ziegler; Bernhard Loll";J Biol Chem;2019;Metal-triggered conformational reorientation of a self-peptide bound to a disease-associated HLA-B*27 subtype.;;55635;Linear peptide;RRKWRRWHL;400;408;;Vasoactive intestinal polypeptide receptor 1 precursor;Vasoactive intestinal polypeptide receptor 1;P32241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 2 and PDB 5IB1;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;5IB1;HLA-B*27:05;I;The crystal structure of the epitope in complex with HLA-B*27:05, measured at room temperature, was determined.
5710331;1035443;Literature;31296658;"Ronja Driller; Martin Ballaschk; Peter Schmieder; Barbara Uchanska-Ziegler; Andreas Ziegler; Bernhard Loll";J Biol Chem;2019;Metal-triggered conformational reorientation of a self-peptide bound to a disease-associated HLA-B*27 subtype.;;55635;Linear peptide;RRKWRRWHL;400;408;;Vasoactive intestinal polypeptide receptor 1 precursor;Vasoactive intestinal polypeptide receptor 1;P32241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 4 and PDB 5IB2;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;5IB2;HLA-B*27:05;I;The crystal structure of the epitope in complex with HLA-B*27:05, measured at cryogenic temperature, was determined.
5710332;1035443;Literature;31296658;"Ronja Driller; Martin Ballaschk; Peter Schmieder; Barbara Uchanska-Ziegler; Andreas Ziegler; Bernhard Loll";J Biol Chem;2019;Metal-triggered conformational reorientation of a self-peptide bound to a disease-associated HLA-B*27 subtype.;;55635;Linear peptide;RRKWRRWHL;400;408;;Vasoactive intestinal polypeptide receptor 1 precursor;Vasoactive intestinal polypeptide receptor 1;P32241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3, 5 and PDB 5IB3;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;5IB3;HLA-B*27:05;I;The crystal structure of the epitope in complex with HLA-B*27:05, soaked with Cu2+, was determined at cryogenic temperature.
5710333;1035443;Literature;31296658;"Ronja Driller; Martin Ballaschk; Peter Schmieder; Barbara Uchanska-Ziegler; Andreas Ziegler; Bernhard Loll";J Biol Chem;2019;Metal-triggered conformational reorientation of a self-peptide bound to a disease-associated HLA-B*27 subtype.;;55635;Linear peptide;RRKWRRWHL;400;408;;Vasoactive intestinal polypeptide receptor 1 precursor;Vasoactive intestinal polypeptide receptor 1;P32241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figures 2, 3 and PDB 5IB4;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;5IB4;HLA-B*27:05;I;The crystal structure of the epitope in complex with HLA-B*27:05, soaked with Ni2+, was determined at cryogenic temperature.
5710334;1035443;Literature;31296658;"Ronja Driller; Martin Ballaschk; Peter Schmieder; Barbara Uchanska-Ziegler; Andreas Ziegler; Bernhard Loll";J Biol Chem;2019;Metal-triggered conformational reorientation of a self-peptide bound to a disease-associated HLA-B*27 subtype.;;55635;Linear peptide;RRKWRRWHL;400;408;;Vasoactive intestinal polypeptide receptor 1 precursor;Vasoactive intestinal polypeptide receptor 1;P32241;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 2 and PDB 5IB5;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;5IB5;HLA-B*27:09;I;The crystal structure of the epitope in complex with HLA-B*27:09, soaked with Cu2+, was determined at cryogenic temperature.
5710549;1035114;Literature;31043477;"Yukie Yamamoto; Daisuke Morita; Yoko Shima; Akihiro Midorikawa; Tatsuaki Mizutani; Juri Suzuki; Naoki Mori; Takashi Shiina; Hidetoshi Inoko; Yoshimasa Tanaka; Bunzo Mikami; Masahiko Sugita";J Immunol;2019;Identification and Structure of an MHC Class I-Encoded Protein with the Potential to Present -Myristoylated 4-mer Peptides to T Cells.;;923338;Linear peptide;GGAI + MYRI(G1);2;5;;nef protein [Simian immunodeficiency virus];Protein Nef;P05862;Simian immunodeficiency virus;Simian immunodeficiency virus;11723;;;;;;;;;;;;;rhesus macaque (Macaca mulatta);9544;Table 1, Figures 3, 4, 6, Supplementary Table 1 and PDB 6IWG;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;6IWG;Mamu-B*051:04;I;The crystal structure of the epitope in complex with Mamu-B*05104 was determined.
5710551;1035114;Literature;31043477;"Yukie Yamamoto; Daisuke Morita; Yoko Shima; Akihiro Midorikawa; Tatsuaki Mizutani; Juri Suzuki; Naoki Mori; Takashi Shiina; Hidetoshi Inoko; Yoshimasa Tanaka; Bunzo Mikami; Masahiko Sugita";J Immunol;2019;Identification and Structure of an MHC Class I-Encoded Protein with the Potential to Present -Myristoylated 4-mer Peptides to T Cells.;;923340;Linear peptide;GGGI + MYRI(G1);;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;GGAI + MYRI(G1);2;5;;;nef protein [Simian immunodeficiency virus];Protein Nef;Simian immunodeficiency virus;Simian immunodeficiency virus;rhesus macaque (Macaca mulatta);9544;Table 1, Figure 6, Supplementary Figure 1 and PDB 6IWH;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;6IWH;Mamu-B*051:04;I;The crystal structure of the epitope in complex with Mamu-B*05104 was determined.
5720281;1035477;Literature;31396224;"Shiyan Zhu; Kefang Liu; Yan Chai; Yanan Wu; Dan Lu; Wenling Xiao; Hao Cheng; Yingze Zhao; Chunming Ding; Jianxin Lyu; Yongliang Lou; George F Gao; William J Liu";Front Immunol;2019;"Divergent Peptide Presentations of HLA-A&lt;sup&gt;*&lt;/sup&gt;30 Alleles Revealed by Structures With Pathogen Peptides.";;1913;Linear peptide;AIFQSSMTK;313;321;;pol protein, partial;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, Table 4 and PDB 6J1W;x-ray crystallography;3D structure;angstroms;Positive;=;1.5;6J1W;HLA-A*30:01;I;The crystal structure of the epitope/HLA-A*30:01 complex was determined.
5720282;1035477;Literature;31396224;"Shiyan Zhu; Kefang Liu; Yan Chai; Yanan Wu; Dan Lu; Wenling Xiao; Hao Cheng; Yingze Zhao; Chunming Ding; Jianxin Lyu; Yongliang Lou; George F Gao; William J Liu";Front Immunol;2019;"Divergent Peptide Presentations of HLA-A&lt;sup&gt;*&lt;/sup&gt;30 Alleles Revealed by Structures With Pathogen Peptides.";;7136;Linear peptide;CTELKLSDY;44;52;;Nucleoprotein;Nucleoprotein;P03466;Influenza A virus (A/Puerto Rico/8/1934(H1N1));Influenza A virus;11320;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 3, Table 4 and PDB 6J2A;x-ray crystallography;3D structure;angstroms;Positive;=;1.4;6J2A;HLA-A*30:03;I;The crystal structure of the epitope/HLA-A*30:03 complex was determined.
5720283;1035477;Literature;31396224;"Shiyan Zhu; Kefang Liu; Yan Chai; Yanan Wu; Dan Lu; Wenling Xiao; Hao Cheng; Yingze Zhao; Chunming Ding; Jianxin Lyu; Yongliang Lou; George F Gao; William J Liu";Front Immunol;2019;"Divergent Peptide Presentations of HLA-A&lt;sup&gt;*&lt;/sup&gt;30 Alleles Revealed by Structures With Pathogen Peptides.";;51104;Linear peptide;QIMYNYPAM;3;11;;LOW MOLECULAR WEIGHT PROTEIN ANTIGEN 7 ESXH (10 kDa ANTIGEN) (CFP-7) (PROTEIN TB10.4);ESAT-6-like protein EsxH;P9WNK3;Mycobacterium tuberculosis H37Rv;Mycobacterium tuberculosis;1773;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 3, Table 4 and PDB 6J29;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;6J29;HLA-A*30:03;I;The crystal structure of the epitope/HLA-A*30:03 complex was determined.
5720284;1035477;Literature;31396224;"Shiyan Zhu; Kefang Liu; Yan Chai; Yanan Wu; Dan Lu; Wenling Xiao; Hao Cheng; Yingze Zhao; Chunming Ding; Jianxin Lyu; Yongliang Lou; George F Gao; William J Liu";Front Immunol;2019;"Divergent Peptide Presentations of HLA-A&lt;sup&gt;*&lt;/sup&gt;30 Alleles Revealed by Structures With Pathogen Peptides.";;1913;Linear peptide;AIFQSSMTK;313;321;;pol protein, partial;Gag-Pol polyprotein;P04585;Human immunodeficiency virus 1;Human immunodeficiency virus 1;11676;;;;;;;;;;;;;human (Homo sapiens);9606;Figures 1, 2, Table 4 and PDB 6J1V;x-ray crystallography;3D structure;angstroms;Positive;=;2.0;6J1V;HLA-A*30:03;I;The crystal structure of the epitope/HLA-A*30:03 complex was determined.
6251696;1035662;Literature;31498797;"Dan Lu; Kefang Liu; Di Zhang; Can Yue; Qiong Lu; Hao Cheng; Liang Wang; Yan Chai; Jianxun Qi; Lin-Fa Wang; George F Gao; William J Liu";PLoS Biol;2019;Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats.;;540360;Linear peptide;DFANTFLP;481;488;;phosphoprotein P;Phosphoprotein;O55778;Hendra henipavirus;Hendra henipavirus;63330;;;;;;;;;;;;;black flying fox (Pteropus alecto);9402;Table 1, S2, Figures 2, 3, 4, S3, S5 and PDB 6J2D;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;6J2D;Ptal-N*01:01;I;The crystal structure of the epitope/Ptal-N*01:01 complex was determined. The binding of the epitope to Ptal-N*01:01 was demonstrated by a refolding assay.
6251697;1035662;Literature;31498797;"Dan Lu; Kefang Liu; Di Zhang; Can Yue; Qiong Lu; Hao Cheng; Liang Wang; Yan Chai; Jianxun Qi; Lin-Fa Wang; George F Gao; William J Liu";PLoS Biol;2019;Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats.;;540360;Linear peptide;DFANTFLP;481;488;;phosphoprotein P;Phosphoprotein;O55778;Hendra henipavirus;Hendra henipavirus;63330;;;;;;;;;;;;;black flying fox (Pteropus alecto);9402;Table 1, Figure 5 and PDB 6J2H;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;6J2H;Ptal-N*01:01;I;The crystal structure of the epitope/Ptal-N*01:01 mutant (Met52 Asp53 Leu54 deleted) complex was determined.
6251698;1035662;Literature;31498797;"Dan Lu; Kefang Liu; Di Zhang; Can Yue; Qiong Lu; Hao Cheng; Liang Wang; Yan Chai; Jianxun Qi; Lin-Fa Wang; George F Gao; William J Liu";PLoS Biol;2019;Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats.;;923224;Linear peptide;DFEKEGYSL;289;297;;nucleocapsid protein [Influenza A virus (A/little yellow-shouldered bat/Guatemala/153/2009(H17N10))];Nucleoprotein;P03466;Influenza A virus (A/little yellow-shouldered bat/Guatemala/153/2009(H17N10));Influenza A virus;11320;;;;;;;;;;;;;black flying fox (Pteropus alecto);9402;Table 1, S2, Figures 2, 3, 4, S3, S5 and PDB 6J2I;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;6J2I;Ptal-N*01:01;I;The crystal structure of the epitope/Ptal-N*01:01 complex was determined. The binding of the epitope to Ptal-N*01:01 was demonstrated by a refolding assay.
6251815;1035662;Literature;31498797;"Dan Lu; Kefang Liu; Di Zhang; Can Yue; Qiong Lu; Hao Cheng; Liang Wang; Yan Chai; Jianxun Qi; Lin-Fa Wang; George F Gao; William J Liu";PLoS Biol;2019;Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats.;;947232;Linear peptide;DYINTNVLP;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;DYINTNLVP;177;185;;;fusion protein;Fusion glycoprotein F0;Hendra henipavirus;Hendra henipavirus;black flying fox (Pteropus alecto);9402;Table 1, S2, Figures 2, 3, 4, S3, S5 and PDB 6J2F;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;6J2F;Ptal-N*01:01;I;The crystal structure of the epitope/Ptal-N*01:01 complex was determined. The binding of the epitope to Ptal-N*01:01 was demonstrated by a refolding assay.
6251816;1035662;Literature;31498797;"Dan Lu; Kefang Liu; Di Zhang; Can Yue; Qiong Lu; Hao Cheng; Liang Wang; Yan Chai; Jianxun Qi; Lin-Fa Wang; George F Gao; William J Liu";PLoS Biol;2019;Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats.;;540360;Linear peptide;DFANTFLP;481;488;;phosphoprotein P;Phosphoprotein;O55778;Hendra henipavirus;Hendra henipavirus;63330;;;;;;;;;;;;;black flying fox (Pteropus alecto);9402;Table 1, Figure 3 and PDB 6K7T;x-ray crystallography;3D structure;angstroms;Positive;=;1.6;6K7T;Ptal-N*01:01;I;The crystal structure of the epitope/Ptal-N*01:01 complex, renatured with human beta2m instead of bat beta2m, was determined.
6251824;1035662;Literature;31498797;"Dan Lu; Kefang Liu; Di Zhang; Can Yue; Qiong Lu; Hao Cheng; Liang Wang; Yan Chai; Jianxun Qi; Lin-Fa Wang; George F Gao; William J Liu";PLoS Biol;2019;Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats.;;947203;Linear peptide;DFQESADSFL;65;74;;nucleoprotein NP;Nucleoprotein;P18272;Zaire ebolavirus;Zaire ebolavirus;186538;;;;;;;;;;;;;black flying fox (Pteropus alecto);9402;Table 1, S2, Figures 2, 3, 4, S3, S5  and PDB 6J2E;x-ray crystallography;3D structure;angstroms;Positive;=;2.1;6J2E;Ptal-N*01:01;I;The crystal structure of the epitope/Ptal-N*01:01 complex was determined. The binding of the epitope to Ptal-N*01:01 was demonstrated by a refolding assay.
6251825;1035662;Literature;31498797;"Dan Lu; Kefang Liu; Di Zhang; Can Yue; Qiong Lu; Hao Cheng; Liang Wang; Yan Chai; Jianxun Qi; Lin-Fa Wang; George F Gao; William J Liu";PLoS Biol;2019;Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats.;;947204;Linear peptide;DFQESADSFLL;65;75;;nucleoprotein NP;Nucleoprotein;P18272;Zaire ebolavirus;Zaire ebolavirus;186538;;;;;;;;;;;;;black flying fox (Pteropus alecto);9402;Table 1, S2, Figures 2, 3, 4, S3, S5 and PDB 6J2G;x-ray crystallography;3D structure;angstroms;Positive;=;2.4;6J2G;Ptal-N*01:01;I;The crystal structure of the epitope/Ptal-N*01:01 complex was determined. The binding of the epitope to Ptal-N*01:01 was demonstrated by a refolding assay.
6251826;1035662;Literature;31498797;"Dan Lu; Kefang Liu; Di Zhang; Can Yue; Qiong Lu; Hao Cheng; Liang Wang; Yan Chai; Jianxun Qi; Lin-Fa Wang; George F Gao; William J Liu";PLoS Biol;2019;Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats.;;947210;Linear peptide;DFTCSQISP;422;430;;spike protein [Middle East respiratory syndrome-related coronavirus];spike glycoprotein [Human betacoronavirus 2c EMC/2012];667489389;Middle East respiratory syndrome-related coronavirus;Middle East respiratory syndrome-related coronavirus;1335626;;;;;;;;;;;;;black flying fox (Pteropus alecto);9402;Table 1, S2, Figures 2, 3, S3, S5 and PDB 6J2J;x-ray crystallography;3D structure;angstroms;Positive;=;2.5;6J2J;Ptal-N*01:01;I;The crystal structure of the epitope/Ptal-N*01:01 complex was determined. The binding of the epitope to Ptal-N*01:01 was demonstrated by a refolding assay.
6251970;1035491;Literature;31135967;"Shihoko Komine-Aizawa; Jiansheng Jiang; Satoru Mizuno; Satoshi Hayakawa; Kazuhiro Matsuo; Lisa F Boyd; David H Margulies; Mitsuo Honda";Eur J Immunol;2019;"MHC-restricted Ag85B-specific CD8&lt;sup&gt;+&lt;/sup&gt; T&nbsp;cells are enhanced by recombinant BCG prime and DNA boost immunization in mice.";;76581;Linear peptide;YYQSGLSIV;101;109;;Antigen 85-B;Diacylglycerol acyltransferase/mycolyltransferase Ag85B;P9WQP1;Mycobacterium tuberculosis;Mycobacterium tuberculosis;1773;;;;;;;;;;;;;mouse (Mus musculus);10090;Table 1, Figure 7 and PDB 5TS1;x-ray crystallography;3D structure;angstroms;Positive;=;2.3;5TS1;H2-Kd;I;The crystal structure of the epitope/H2-Kd complex was determined.
6251972;1035491;Literature;31135967;"Shihoko Komine-Aizawa; Jiansheng Jiang; Satoru Mizuno; Satoshi Hayakawa; Kazuhiro Matsuo; Lisa F Boyd; David H Margulies; Mitsuo Honda";Eur J Immunol;2019;"MHC-restricted Ag85B-specific CD8&lt;sup&gt;+&lt;/sup&gt; T&nbsp;cells are enhanced by recombinant BCG prime and DNA boost immunization in mice.";;180078;Linear peptide;YQSGLSIVM;102;110;;Antigen 85-B;Diacylglycerol acyltransferase/mycolyltransferase Ag85B;P9WQP1;Mycobacterium tuberculosis;Mycobacterium tuberculosis;1773;;;;;;;;;;;;;mouse (Mus musculus);10090;Table 1, Figure 7 and PDB 5TRZ;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;5TRZ;H2-Kd;I;The crystal structure of the epitope/H2-Kd complex was determined.
6279274;1035741;Literature;31555277;"Timothy P Riley; Grant L J Keller; Angela R Smith; Lauren M Davancaze; Alyssa G Arbuiso; Jason R Devlin; Brian M Baker";Front Immunol;2019;Structure Based Prediction of Neoantigen Immunogenicity.;;859015;Linear peptide;ILNAMIAKI;;;;;;;;;;;neo-epitope;Fragment of a Natural Sequence Molecule;ILNAMITKI;154;162;;;HAUS augmin-like complex subunit 3;HAUS augmin-like complex subunit 3;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figure 2 and PDB 6PTB;x-ray crystallography;3D structure;angstroms;Positive;=;2.2;6PTB;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex was determined.
6279275;1035741;Literature;31555277;"Timothy P Riley; Grant L J Keller; Angela R Smith; Lauren M Davancaze; Alyssa G Arbuiso; Jason R Devlin; Brian M Baker";Front Immunol;2019;Structure Based Prediction of Neoantigen Immunogenicity.;;952638;Linear peptide;ILNAMIVKI;;;;;;;;;;;analog;Fragment of a Natural Sequence Molecule;ILNAMITKI;154;162;;;HAUS augmin-like complex subunit 3;HAUS augmin-like complex subunit 3;Homo sapiens;Homo sapiens;human (Homo sapiens);9606;Table 1, Figure 2 and PDB 6OPD;x-ray crystallography;3D structure;angstroms;Positive;=;1.8;6OPD;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex was determined.
6279276;1035741;Literature;31555277;"Timothy P Riley; Grant L J Keller; Angela R Smith; Lauren M Davancaze; Alyssa G Arbuiso; Jason R Devlin; Brian M Baker";Front Immunol;2019;Structure Based Prediction of Neoantigen Immunogenicity.;;710995;Linear peptide;ILNAMITKI;154;162;;HAUS augmin-like complex subunit 3;HAUS augmin-like complex subunit 3;Q68CZ6;Homo sapiens;Homo sapiens;9606;;;;;;;;;;;;;human (Homo sapiens);9606;Table 1, Figure 2 and PDB 6PTE;x-ray crystallography;3D structure;angstroms;Positive;=;1.9;6PTE;HLA-A*02:01;I;The crystal structure of the epitope/HLA-A*0201 complex was determined.
6279277;;;;;;;;;;;VMAPRALL;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;3BZF;HLA-E*01:01;;
6279278;;;;;;;;;;;VMAPRTLIL;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;2ESV;HLA-E*01:01;;